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DMPU: N,N′-dimethylpropylene urea 
DMSO: dimethyl sulfoxide 
HMDS: Bis(trimethylsilyl)amine 
HRMS: high resolution mass spectrometry 
LAH: lithium aluminium hydride 
LDA: lithium diisopropylamide 
MTBE: methyl-tert-butyl ether 
NBS: N-bromosuccinimide 
NIS: N-iodosuccinimide 
PMB: para-methoxy benzyl 
PTB: para-tolyl benzyl 
Py: pyridine 
Pyr: pyrrolidine 
rt: room temperature 
TBAF: tetrabutylammonium fluoride 
TBAI: tetrabutylammonium iodide 
TBD: 2-tert-butyl-4-[2-(3-tert-butyl-4-hydroxyphenyl)propan-2-yl]phenol 
Tf: trifluoromethanesulfonyl 
TFA: trifluoroacetic acid 
THF: tetrahydrofuran 
TMS: trimethylsilyl  
4 
 
































1 Introduction ............................................................................................................................................... 6 
1.1 Azetidine .......................................................................................................................................... 6 
1.2 Pyrrolidine ...................................................................................................................................... 37 
1.3 Aim of the project .......................................................................................................................... 47 
2 Results and Discussion ........................................................................................................................... 49 
2.1 Synthesis of Azetidines .................................................................................................................. 49 
2.2 Synthesis of Pyrrolidines................................................................................................................ 76 
2.3 Oxidation of Secondary and Tertiary amines ................................................................................. 80 
2.4 Azetidine as Organocatalyst for a Michael Addition Reaction ...................................................... 88 
2.5 Biological Activity ......................................................................................................................... 89 
3 Conclusion and Future Work .................................................................................................................. 92 
4 Experimental Section .............................................................................................................................. 94 
4.1 General procedures......................................................................................................................... 94 
4.2 Syngenta screening: materials and methods................................................................................. 151 
4.3 X-Ray Crystallographic Information (All the following X-ray structures have been solved by Dr 
Louise Male). ............................................................................................................................................ 158 













Azetidine is a thermodynamically stable four membered nitrogen containing heterocycle. Azetidines are a 
very important class of molecules. They have been used as ligands,
1-2
 synthetic building blocks
3
 and can be 















Figure 1. Azetidine containing compounds. 1, azetidine. 2, azetidine ligand. 3, azetidine palladium complex. 4, 2I-deoxymugineic 




 binding to acetylcholine receptors
7
 and psychotropic potency
8
 of azetidine 
derivatives have been studied and contrasted with their five-membered pyrrolidine congeners, revealing them 
as an intriguing class of compounds. For example it has been shown that ring size variation between 




1.1.1 Synthesis of azetidines  
Azetidines can be prepared by cyclisation of 1,3-diols with amines; compound 6, a tosyl protected pyridyl 
amino alcohol, is tosylated to form compound 7 in 86% yield, which gives azetidine derivative 8 in 92% 




Scheme 1. Cyclisation of 1-3-amino alcohol. 
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Hillier and co-workers reported a formation of azetidine derivatives in yields between 32% and 95%.  
Several bis triflated diols were reacted with different primary amines in the presence of 




 It was found that the nucleophicility of the amine carries an 
important role towards the outcome of the reaction. In fact, lower yields were observed when the HCl salt of 
aminodiphenylmethane or aniline were employed. 
 
Scheme 2. Transformation of bis triflated diols into azetidine derivatives 
 
In 1996, Barluenga and co-workers attempted the synthesis of enantiomerically pure polysubstituted 
azetidines via cyclisation of 1-3 amino alcohols with three stereogenic centres. Such alcohols were 
previously synthesised by the same group.
11
 Compound 11 (syn, syn), first reacted at the hydroxyl and amino 
groups with an excess of methansulfonyl chloride, was then intramolecularly displaced by the sulfonated 
nitrogen in a 4-exo-tet fashion to afford the trans, cis multisubstituted azetidine 12 in 59% yield (Scheme 
3).
12
 Although this methodology does not furnish azetidines in high yield, enantiomerically pure azetidines 
with three stereogenic centres can be obtained. 
 
Scheme 3. Synthesis of enantiopure azetidines with three stereogenic centres 
 
An electrophilic selenium-induced cyclisation of homoallylic benzylamines to form azetidines was observed 
for the first time in the 1997 by Berthe and co-workers. Homoallylic amines 13 were reacted with 1.5 
equivalents of PhSeCl or PhSeBr in the presence of sodium carbonate. A mixture of azetidines 14 and 
pyrrolidines 15 was obtained in most of the cases (entry 1,2,4, Table 1), however, the azetidine was the only 




= Me (entry 3, Table 1). It was speculated that steric hindrance around the 
α-carbon favours the formation of the azetidine. It was also observed that formation of halopyrrolidines does 











 conversion of 13 (%) ratio 14/15 yield (%) 14/15 
1 Ph H 95 70/30 62/16 
2 Me Me 70 86/14 50/6 
3 Et Me 77 100/0 55/0 
4 Me  H 95 28/72 15/37 
 
Different substituted aromatic di-chloro imines 16 were directly converted to cis-azetidines 17 in 54-91% 
yield and high diastereoselectivity (trans-azetidines were not observed) as reported by Aelterman and De 
Kimpe in 1998. The asymmetric nucleophilic attack by the metoxide or cyanide group to the imine, produces 









The high diastereoselectivity of the products might be explained by the formation of the more kinetically 
favoured intermediate 18 where, according to the model proposed by Evans and others,
16-21
 less steric 
congestion is present between the imidoyl carbon substituent (R) and the - aryl substituents (Scheme 4). 
In 1999, Concellòn and co-workers reported the synthesis of azetidines by ring closing of 
aminoiodohydrins.
22
 Enantiopure -aminoaldehydes 19 were iodomethylated using samarium diiodide to 
afford aminoiodohydrins 20, which proved to be not very stable. However, the aminoiodohydrins 20 
obtained were reacted with AgBF4 to afford the azetidinium tetrafluoroborate salts 21 which were converted 
to the azetidines 22 in quantitative yields  and good diastereoisomeric excess (R = Me; de = 81%, R = 
i
Bu; de 
= 79%) by monodebenzylation via hydrogenolysis (Scheme 5).
23
 The use of 
-
BF4 as counterion prevented 
ring opening of the azetidinium salts 21. In fact, ring opening of the azetidinium salts 21 was observed when 
the more nucleophilic iodide was used as counterion. 
 
Scheme 5. Synthesis of azetidines by ring closing of aminoiodohydrins 
 
In 2000, Robin and Rousseau reported the cyclisation of tosylamides to produce azetidines.
24
 
Bis(collidine)bromonium(I)hexafluorophosphate was used as the cyclisation promoter. Different tosylamides 
23a-f were converted to azetidines 24aa-ea in 52.5-95% yields and good diastereoselectivities. One must 
note that only the isomer (2R,3S,4S) 24ba was formed when phenyl group was used as substituent (entry 2, 
Table 2), whereas two isomers were obtained when smaller substituents such as i-Pr and Me were used 
(entry 3 & 4, Table 2). It is also noteworthy that the yield was improved to 95% by the presence of a gem-







Table 2. Synthesis of azetidines via cyclisation of tosylamides 




















A hydrozirconation protocol for the synthesis of chiral azetidines was established starting from Boc 
protected chiral allylic amines 24a-f. The formation of an organozirconium species followed by treatment 
with iodine, diastereoselectively forms the iodocarbamate, which converts to azetidines 25a-f after addition 
of sodium hexamethyldisilazane in THF (Table 3). The attack to the re-face is considered to be favoured, in 
fact, the presence of bulky groups in R
1
 would make the si-face less accessible to the nucleophile (Figure 2). 















dr (cis:trans) yield of 25 (%) 
a Me  Me 94:6 65 
b Bn Bu 96:4 75 
c Bn Me 95:5 65 
d i-Pr Me 50:50 68 
e Ph Me 73:27 80 
f CH2OTBS Me 92:8 65 
 
 
Figure 2. Favoured re-face and unfavoured si-face attack 
 
Couty and co-workers reported the synthesis of enantiopure azetidine-2-carboxylic acids using methyl 
benzylamine as chiral auxiliary.
26
 An enolate, formed by deprotonation of 26 with LiHMDS, displaced the 
halogen intramolecularly to furnish a 1.1:0.9 mixture of diastereoisomers 27a and 27b, which were 
converted to the final products by hydrogenolysis with Pd/C. Although relatively poor diastereoselectivity 
was observed, the two diastereoisomers were easily separated by flash chromatography and the azetidine 2-




Scheme 6. Synthesis of enantiopure azetidine 2-carboxylic acids 
 
In 2006, a synthesis of 3-fluoroazetidines was reported by Van Brandt et al.
27
 Regiospecific 
bromofluorination of imino olefins 29 furnished imines 30. Reduction of the imino group with 
sodiumborohydride produced the amino group which could then displace the halogen intramolecularly to 
afford the azetidines products 31 (Table 4). All the azetidines 31 were obtained in good yields (59-70%) and 
no significant effects of the different substituents were observed (Table 4). 
 





yield of 30 (%) yield of 31 (%) 
1 C6H5 Me 76 70 
2 4-MeC6H4 Me 78 61 
3 4-MeOC6H4 Me 71 65 
4 CHEt2 Me 68 61 
5 t-Bu Me 73 59 
6 C6H5 C6H5 77 60 
 
An electrophile-induced intramolecular cyclisation of homoallylic amino vinylsilanes 32 to obtain azetidines 
was published in 2007 by Banide and co-workers.
28
 Compounds 32 were reacted with N-bromosuccinimide 
to produce the bromonium species (Figure 3), which can be attacked by the amino group to produce 
azetidines 33 and 34 (Table 5). Compounds 33 and 34, with cis configuration, were the only products 
observed and there was no evidence of trans-azetidine formation. It might be speculated that bromine attack 
would occur in a concerted mechanism producing two diastereoisomers bromonium intermediates a and b 
13 
 
which are in equilibrium with the starting material. Bromonium intermediate b would lead to the disfavoured 
transition state B (TS B) where the bromine, the TMS and the R groups would in fact, experience a pseudo 
1,3-diaxial interaction, making the cyclisation difficult to occur. On the other hand, bromonium intermediate 
a would produce the favoured transition state A (TS A), where the bromine, the TMS and the R groups are in 
the pseudo-equatorial positions (Figure 3).  
 
Table 5. Electrophile induced intramolecular cyclisation of amino vinylsilanes 
entry R yield of 33 (%)  yield of 34 (%) 
1 Ph 75 52 
2 Pr 70 39 
3 iPr 55 43 
4 
t





Figure 3. Bromonium intermediates a and b: favoured and unfavoured transition states. 
 
In 2009, Medjahdi and co-workers published a base induced cyclisation, which afforded enantiopure 2-
(hydroxymethyl)azetidines.
29
 Enantiomerically pure oxiranes 35a-d were reacted with potassium carbonate 
at 80 
o
C for 48 hours to provide enantiomerically pure hydroxymethyl azetidines 36a-d in good yields (61-
89%) (Table 6). The configuration of the azetidines 36a-d depends on the configuration of the starting 
oxiranes 35, considering that the intramolecular reaction between the nitrogen and the epoxide follows a SN2 





Table 6. Base induced cyclisation of enantiopure oxiranes 




























Bus = t-BuSO2. 
aisolated yield after column chromatography. b pyrrolidines was also isolated as minor component  
 
Multisubstituted azetidines 38 can be prepared in moderate to good yields (46-76%) by oxidative cyclisation 
of Michael adduct 37 with PhIO and Bu4NI (Scheme 7).
30
 Michael addition of functionalised diethyl 2-
aminomalonates with chalcone in the presence of a phase transfer catalyst (PhEt3NCl) furnished Michael 
adduct 37. 
 
Scheme 7. Synthesis of multisubstituted azetidines via PhIO/Bu4NI mediated oxidative cyclisation 
 
Two possible mechanisms (path a or b) for the formation of the azetidines were speculated as shown in 
(Scheme 8). Compound 37 could react with the iodine(III) species to form the intermediate 39 (path a), 
which might evolve to azetidine via intramolecular reductive elimination. Alternatively, the enol tautomer 40 
could access the intermediate 41 (path b) via an  hyperiodination of the methylene of the phenyl ketone of 




Scheme 8. Cyclisation proposed mechanism (path a or b) 
 
Enantiopure azetidines 43, 44 and 45 were synthesised from nitrile containing azetidine derivatives 42 by 
Leng et al. via a biocatalytic kinetic resolution protocol using enzyme Rhodococcus erythropolis AJ270. 
Nitriles 42 were converted to enantioenriched amides (matched) 43, which were hydrolysed to the carboxylic 
acid (mismatched) 44.
31
 Excellent yields (42-46%) and ee (89.0 up to >99.5 %) were observed in all cases 
and the nature of the electronic substituents seemed not to be relevant for this transformation (Table 7). It is 
worth comparing the reaction times when Ar = 4-Br-C6H4 (entry 4, Table 7), Ar = 3-Br-C6H4 (entry 5, Table 
7) and Ar = 3-Br-C6H4 (entry 6, Table 7). The reaction took five days to completion when Ar = 2-Br-C6H4 
was used (entry 6, Table 7). This might be explained by steric interactions between the Br group and the 
active site of the enzyme where the reaction occurs. 
 
Table 7. Biocatalytic kinetic resolution of nitrile containing azetidine derivatives 
entry Ar time (h) yield of 43 (%) ee of 43 (%) yield of 45 (%) ee of 45 (%) 
1 C6H5 9.5 46 >99.5 49 >99.5 
2 4-Me-C6H4 4.7 45 >99.5 39 >99.5 
3 4-MeO-C6H4 3 45 >99.5 37 90.8 
4 4-Br-C6H4 4.25 43 >99.5 43 89.0 
5 3-Br-C6H4 4.75 42 >99.5 42 >99.5 




Synthesis of 2,3-substituted azetidines via CH activation of picolinamide substrates 46a-f by palladium 
acetate was published by Gang He et al. in 2011.
32
 Several picolinamide substrates were first reacted with 
5% mol of Pd(OAc)2 and then with 2.5% mol of PhI(OAc)2 to afford azetidines 47a-f in 68-91% yields 
(Table 8). The presence of  and  substituents on the picolinamides seemed to favour the formation of 
azetidines (entry 1,2,4,5,6, Table 8), whereas the picolinamide substrate, with no substituent appended, 
converted mainly to the acetoxylated product 48c (entry 3, Table 8). It was speculated that a possible reason 
for the favoured azetidine formation might be the torsional strain imposed by the R
2
 substituent, which 




















Table 8. Synthesis of 2,3-substituted azetidines via CH activation of different picolinamide substrates 




























It was hypothesised that oxidation by PhI(OAc)2 of the kinetically favoured five membered palladacycle 
intermediate 49
33
 (Figure 4) followed by a C-N reductive elimination might be the possible mechanism of the 
reaction.  
 
Figure 4. Five membered palladacycle intermediate 
 
The synthesis of enantioenriched 2,3-substituted azetidines was reported by Harada et al. in 2012.
34
 A one 
pot [N+2+1] cyclisation using lithium amides 50, -  unsaturated esters 51 and dihaloalkane, furnished 2,3-
cis-azetidines 53 in good yields (57% and 82%) and excellent ee (98% and 97%) (Scheme 9). The 




 groups were used. 
This occurred  due to the formation of the most kinetically favoured species 52a, where the bulky groups are 
pointing away from one another (Scheme 9). Intramolecular halogen displacement by the nitrogen leads to 





= Ph (Scheme 9). 
 




Azetidines containing imino sugars analogues were synthesised in 2012 by Lenagh-Snow and co-workers.
35
 
Ditriflate allose 54 were exposed to a bis-triflate displacement by different amines to furnish the protected 
azetidines 55, which were then hydrolysed and reduced to afford the final products 56 in 47-93% yields 
(Scheme 10). 
 
Scheme 10. Synthesis of azetidine containing imino sugar analogues 
 
Azetidines can also be prepared by a selective transformation of 2-bromomethyl-2-methylaziridines as 
reported by Stankovic’ et al. in 2012.
36
 Several aziridines 57 were reacted with several nucleophiles such as 
cyanide, thiocyanide and acetate to obtain 3-substituted azetidines 59 in 92-96% yields (Table 9). A mixture 
of products 59a and 59b was observed when phenate or thiocyanide was used as nucleophile (entry 5 and 6, 
Table 9). It was speculated that the formation of the azetidinium salt 58 followed by attack of the external 
nucleophile is the possible mechanism (Table 9). 
 
Table 9. Selective transformation of 2-bromomethyl-2-methylaziridines into 3 substituted azetidines 
entry R Nu time (h) ratio 59a: 59b yield of 59a or 59b (%) 
1 Me 2 eq KCN 26 100:0 59a (96) 
2 OMe 2 eq KCN 26 100:0 59a (95) 
3 Me 1.1eq NaOAc 24 100:0 59a (95) 
4 OMe 1.1eq NaOAc 22 100:0 59a (92) 
5 Me 1 eq KSCN 4 57:43 59a (55) 
6 Me 2.2 eq PhOH, 5 eq K2CO3 20 57:43 59a (47) 
21 
 
2-substituted iodo-azetidine 63 can be prepared by cyclisation of the homoallylic tosylamine 60 with tert-
butylhypoiodite (Scheme 11). Compound 61 can be produced via iodination by t-BuOI of the sulfonamide 
nitrogen of compound 60. Iodonium ion can be intramolecularly transferred to the olefin to obtain the  





Scheme 11. Synthesis of 2-substituted iodoazetidine 
 
1.1.2 Reactivity of azetidinium ions 
In 2006, Couty and co-workers investigated the regioselectivity in nucleophilic ring opening of azetidinium 
ions.
38
 Differently substituted azetidinium salts 64 and 67 were reacted with oxygenated and nitrogenated 
nucleophiles. Azetidinium salt 64 with substituents in position two and three were mostly attacked on the C4 
carbon (entry 1,2,3, Table 10). On the other hand azetidinium salt 65 with an added methyl group in position 
four was mainly attacked on C2 (entry 4,5, Table 10). An optimised transition state, obtained with 
computational studies, showed the shielding effect of the methyl group in position four distorts the angle of 











Table 10. Regioselectivity in nucleophilic ring opening of azetidinium ions 
entry substrate nucleophile Products 






















































In 2011, De Rycke and co-workers investigated the rates of aziridinium 76 and azetidinium 77 opening.
39
 
DMAP was chosen as a suitable nucleophile to probe reactions with aziridinium and azetidinium 
trifuolomethane sulfonates (Scheme 12). The kinetics of nucleophilic opening of the aziridinium salts were 
followed by UV spectrophotometry, whereas the kinetics of nucleophilic opening of the azetidinium salts, 
being a much slower process, were followed by NMR spectroscopy. The difference in rates corresponded to 
a G
# 
of 5.6 Kcal x mol
-1




Scheme 12. Aziridinium and azetidinium ring opening by DMAP 
 
A regiospecific ring opening of azetidinium salts was studied by Kenis et al. in 2012.
40
 2-trifluoromethyl 
azetidines 80a-d were reacted with Me3OBF4 to afford the corresponding azetidinium salts 81a-d in 
quantitative yields. Compounds 81a-d were then ring opened by oxygen, nitrogen, carbon and sulphur 
nucleophiles and in all cases these non activated 2-CF3 azetidines were opened at C4 affording compounds 
82a-d in 52-88% yields (Table 11). 
 
Table 11. 2-trifluoromethyl azetidinium ring opening 
entry R nucleophile conditions yield of 82 (%) 
1 4-MeC6H4CH2 2 eq NaCN CH3CN, , 3 h 74 
2 4-ClC6H4CH2 2 eq NaCN CH3CN, , 3 h 78 
3 4-MeC6H4CH2 - H2O/CH3CN (1/1), 
, 24 h 
72 
4 2-ClC6H4CH2 - H2O/CH3CN (1/1), 
, 24 h 
88 
5 4-MeC6H4CH2 2 eq PhSH CH3CN, , 3 h 64 
6 2-ClC6H4CH2 2 eq PhSH CH3CN, , 3 h 63 
7 Bn 2 eq BnNH2 CH3CN, rt, 2 h 56 
8 2-ClC6H4CH2 2 eq BnNH2 CH3CN, rt, 2 h 52 
 
A complete switch of the reactivity was observed when the CF3 substituent was replaced by a methyl group 
(compound 83). 2-methyl-azetidine 83 was reacted with one equivalent of benzyl bromide to form the 
intermediate azetidinium salt 84 which was ring opened by the bromide to furnish compound 85 in 52% 
yield. Attack of the nucleophile occurred at the C2 under thermodynamic control (Scheme 13) in line with 
some literature reports regarding 2-substituted aziridinium salts ring opening.
41-42
 The strong 
electrowithdrawing nature of the CF3 group disfavours the attack at the more substituted carbon, 






Scheme 13. 2-methyl azetidinium ring opening 
 
1.1.3 Application of azetidines as ligands in catalysis 
In 2001, Hermsen and co-workers studied the addition of diethylzinc to aldehydes 86 using chiral N,O-
ligands containing azetidine fragments (Table 12).
44
 1-phenylpropan-1-ol and 1-(4-methoxyphenyl)propan-1-
ol 87 were obtained in good yields and ee up to >99% when ligand 88 was used (entry 1 and 5, Table 12). 
Use of ligand 90 improved the ee to 95% (entry 3, Table 12), whereas when ligand 89 was employed the ee 
decreased to 35% (entry 2, Table 12) due to a case of match/mismatch. One can see that when pyrrolidine 91 
was used the ee resulted to be lower (entry 4 & 6, Table 12) than when azetidine analogue 88 was used 
(entry 1 & 5, Table 12). This shows that the four membered ring allows a more effective chiral environment 
compared to the five membered ring.  
  
Table 12. Chiral N,O-ligands containing azetidine fragments for the addition of diethylzinc to aldehydes 
entry Aldehyde ligand yield of 87 (%) ee of 87 (%) configuration of 87 
1 Benzaldehyde 88 62 88 R 
2 Benzaldehyde 89 75 35 S 
3 Benzaldehyde 90 85 95 R 
4 Benzaldehyde 91 92 72 S 
5 Anisaldehyde 88 91 >99 R 
6 Anisaldehyde 91 94 79 S 
 
The ligand 88, which was found to be the best in terms of ee in the addition of diethylzinc to aromatic 
aldehydes, was also used with aliphatic aldehydes showing good yields and ee. In particular when 
25 
 
cyclohexanecarboxyaldehyde was used, the corresponding alcohol was obtained in 80% yield and 97% ee 
with (R) configuration. In 2008, Wang et al. reported a slightly modified version of the Hermsen ligand. A 
ferrocenylmethyl group was attached to the nitrogen. The yield and the ee were improved respectively up to 
97% and 98.4% when diethylzinc was added to benzaldehyde 86 in presence of ligand 92. Ligand load was 
also decreased to 3% mol against the 20% mol previously used with Hermsen ligand (Scheme 14).
45
   
 
Scheme 14. Chiral N,O-ligands containing ferrocenylmethyl azetidine fragments for the addition of diethylzinc to aldehydes 
 
The same reaction employing a chiral ferrocenyl aziridino alcohol as ligand was already tested by the same 
group.
46
 The improvement in the ee, from 92.6%, when the aziridine based catalyst was used, to 98.4% when 
the azetidine based catalyst was used, was explained by considering the more pronounced steric interactions 
between the hydrogen and the phenyl group in the smaller 3-membered ring as shown in (Figure 5).  
 
Figure 5. More pronounced steric interactions in the aziridine based catalyst compared to the azetidine based catalyst 
 
2,3-substituted azetidines have been used as catalysts for addition of diethylzinc to benzaldehyde to furnish 
1-phenylpropan-1-ol (Henry reaction) in good yield and ee (Table 13). Ligand 95 (entry 3, Table 13) 
produced the best yield 93% with an excellent ee = 97%. 
47-48
 Changing the R group from hydroxyl to amino 
(ligand 93) the ee drops down to 53% (entry 1, Table 13) and even more (ee = 1.4%) with a bulky group on 




Table 13. Amino azetidines and hydroxyl azetidine as catalyst for Henry reaction 
entry solvent Ar ligand yield of 87 (%) ee of 87 (%) (config) 
1 toluene Ph 93 100 53 (R) 
2 toluene Ph 94 47 1.4 (S) 
3 toluene Ph 95 93 97 (R) 
 
In 2005, Keller and co-workers used azetidines as ligands for the first time in Suzuki cross-coupling 
reactions. This catalytic system based on palladium and amino azetidine derivative ligands showed good 
efficiency in aromatic bromide substrates. 1-bromo-4-nitrobenzene 96 and (3,4-dimethoxyphenyl)boronic 
acid 97 were reacted in the presence of 2.5 equivalents of potassium carbonate and 1% mol of palladium 
amino-azetidine catalyst to yield the product 98 in 87% yield. It was also found that a very low catalyst 
loading 0.1% mol still shows a good conversion of 87% (Scheme 15).
49
 If one considers that according to the 
literature the general amount of catalyst loaded in Suzuki cross-coupling reactions is between 0.1 and 1% 
mol,
50
 it is clear that this new palladium amino-azetidine complex catalyst proved to be very suitable for this 
type of reaction. 
 




In 2010, Couty and Menguy reported the use of amino-azetidines and amino-pyrrolidines as organocatalysts 
for a Michael addition reaction.
51
 2,3,4-substituted amino-azetidines 99-106 and 2,3,4,5-substituted amino-
pyrrolidines 107-109 (Figure 6) were initially screened to find the best catalyst in terms of yield and ee in the 
addition of diethyl malonate 111 to -nitrostyrene 110 (Scheme 16).  
 
Figure 6. 2,3,4-substituted Amino azetidines and 2,3,4,5-substituted amino pyrrolidines as precatalyst for Michael addition 
 
The catalyst was prepared in situ by stirring the corresponding amino-azetidine or amino-pyrrolidine with 
3,5-bis trifluoromethyl isothiocyanate in toluene at room temperature for 15 minutes. No formation of the 
product was observed when amino-pyrrolidines 107-109 were used. The best result was obtained when 
azetidine 100 was employed yielding the product 112 in 77% yield and 68:32 (S:R) enantiomeric ratio (er). 
 
Scheme 16. Michael addition of diethyl malonate to -nitrostyrene 
 
Different nucleophiles such as malononitrile, acetylacetone and Meldrum’s acid were added to -nitrostyrene 
110 and the best result was achieved when acetylacetone was used. The product was obtained in 63% yield 
and 12:88 (S:R) er (entry 1, Table 14). The enantiomeric ratio (S:R) increased to 90:10 (entry 2, Table 14) 
28 
 
when (E)-1-(2-nitrovinyl)naphthalene was used as Michael acceptor. The presence of ortho-substituted 
benzene rings in the Michael acceptor also increased the enantiomeric ratio (S:R) to 8:92 (entry 3, Table 14) 
and 7:93 (entry 4, Table 14) despite the electronic nature of the substituents. This improvement in the 
enantiomeric ratio might be explained by considering possible steric interactions caused by the substituent  in 
the ortho position. Such interactions might perhaps disfavour the formation of the (R) enantiomer. The 
presence of para-substituted or meta-substituted benzene rings in the Michael acceptor slightly decreased the 
enantiomeric ratio (S:R) to 17:83 (entry 5 and 6, Table 14). 
 
Table 14. Addition of acetylacetone to different nitrostyrenes 
entry Ar time (h) yield (%) er (S:R) 
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1.1.4 Azetidines: Biological applications 
 
The azetidine core has played an important role in the design of novel molecules with potential uses in 
medicinal chemistry. Activation of metabotropic glutamate receptors is responsible for an increase in level of 
calcium ions in the extracellular area.
52-53





 In 1993, a study of trans-azetidines-2,4-dicarboxylic acid and their N-methyl derivatives as 
activators of metabotropic receptors was reported by Kozikowsky et al.
55
 Hydrolysis of phosphoinositide 
(PI), which is activated by glutamate and so related to the glutamate receptors, was measured to investigate 
the activity of the azetidines. It was found that the (2S,4S)-trans azetidine 116a produced an increase in 
phosphoinositide hydrolysis whereas the (2R,4R)-trans isomer 116b proved to be inactive. The N-methyl 
azetidines derivatives 117a, 117b and the racemic trans-pyrrolidine-2,5-dicarboxylic acid 118 were inactive 
(Figure 7). 
 
Figure 7. trans-azetidines-2,4-dicarboxylic acid, their N-methyl derivatives and trans-pyrrolidine-2,5-dicarboxylic acid as activators 
of metabotropic receptors 
   
In 2005, Navarro et al. published the synthesis of 2-azetidinones and 2-substituted azetidines which were 
screened against human cytomegalovirus (HCMV) protease.
56
 HCMV proved to be responsible for birth 
defects and it was also found that kidney, liver, bone marrow and heart/lung transplant recipients are affected 
by HCMV hepatitis and pneumonia.
57
 To investigate the activity against HCMV, the 2-azetidinones and 2-







Figure 8. Human cytomegalovirus (HCMV) protease inhibitors 
 
Azetidines showed a better activity than azetidinones which proves non covalent inhibition works 
successfully. This result was in line with the literature considering that for serine protease inhibitors, it was 
accepted that non covalent inhibitors are preferred to the covalent ones.
59
 Among all the molecules tested, 
compounds 119 and 120 showed the best activity against HCMV. It was claimed that the presence of the 
NHMe group instead of NH2 resulted in an enhancement of the activity, probably due to the increase in the 
hydrophobic nature of the molecule (Figure 8). Depressive disorder is caused by an insufficiency of 
monoamine neurotransmitters in the brain and  inhibition of the reuptake could maintain the concentration of 
neurotransmitters at the right level. In 2012, Han and co-workers reported a study of novel 3-substituted 
azetidine derivatives as triple reuptake inhibitors.
60
 All the azetidines synthesised were screened against 
dopamine, noripenephrine and serotonine transporters (HEK-hDAT, HEK-hNET, HEK-hSERT) and 
compared to the commercially available fluoxetine, nisoxetine and vanoxerine (GBR12909). The biological 
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screening revealed some important aspects: the bulkiness of the substituent at the oxygen (R
2
) and the 
napthyl as R
1
 seemed to have an effective role. In particular it is worth noting that activity increased 
significantly when R
1 
= C6H4(4-Cl) was replaced with R
1 





= C6H5 exhibited even higher activity than the commercially available inhibitors . 
 
Figure 9. Triple reuptake inhibitors 
 
1.1.5 Ring expansion 
In 2003 Couty and co-workers showed a stereoselective rearrangement of azetidine into pyrrolidine. Chloro-





Scheme 17. Stereoselective ring expansion of iodo-azetidine into iodo-pyrrolidine 
 
  
A ring transformation from azetidines to pyrrolidines was reported by Van Brabandt et al. in 2006.
62
 2,3- 
substituted chloro-azetidines 123a-e were converted into the corresponding 2,3,4-substituted pyrrolidines 
124a-e with inversion of stereochemistry in moderate yields (44-52%). Several nucleophiles were used to 









conditions Nu yield of 124 (%) 
a allyl Bn , CH3CN, 18 h Cl 46 
b allyl Me , CH3CN, 18 h Cl 44 
c t-Bu Bn 10 eq. NaOH, 100 
o
C, 18 h, DMSO OH 46 
d allyl Bn 10 eq. KCN, 100 
o
C, 18 h, DMSO CN 44 
e allyl Bn 10 eq. NaN3, 100 
o
C, 18 h, DMSO N3 52 
 
To understand the mechanism of this transformation, compounds 123a and 124a were both reacted with six 
equivalents of AlH2Cl in diethyl ether under reflux for 18 hours. Only the chloro-azetidine 123a yielded the 
product 126 showing that the formation of an aziridinium intermediate 125 is necessary to allow ring 
expansion of chloro-azetidines 123a to produce pyrrolidine 126 (Scheme 18). This experiment suggested that 
all the transformations of azetidines 123a-e into pyrrolidines 124a-e occur via the formation of an 
aziridinium intermediate. 
 
Scheme 18. Conversion of 123a into 126 via aziridinium intermediate 125 
 
In 2008 Durrat and co-workers reported a stereoselective ring expansion of 2-( -chloroalkyl)azetidines 127 
into the corresponding chloro-pyrrolidines 128.
2
 cis-2,3-azetidines and trans-2,3-azetidines were refluxed in 
DMF for 12 hours to afford cis-3,4-pyrrolidine and trans-3,4-pyrrolidine in 39% and 75% yields. Ring 
expansion in the presence of an external nucleophile was also investigated. Hydroxide, cyanide, azide and 
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acetate were added to 2-( -chloroalkyl)azetidines 127 to afford pyrrolidines 128 in moderate to good yields 
(39-87%). 
 
Table 16. Stereoselective ring expansion of 2-(a-chloroalkyl)azetidines 






































































Another example of azetidine ring expansion was illustrated by Bott and co-workers in 2009.
63
 2-substituted 
azetidine 129 was reacted with diazocarbonyl compound 130 in the presence of a catalytic amount of 
Cu(acac)2 to produce the intermediate azetidinium ylide 131 which could rearrange to the pyrrolidine 132 via 
Stevens [1,2]-shift (Scheme 19).
64-66
 No stereoselectivity was observed and the product was obtained in 71% 
yield. 
 
Scheme 19. Azetidine ring expansion via Stevens [1,2]-shift 
 
N-vinyl aziridines 133 can be converted to substituted 3,4-dihydro-2H-pyrrole-4,4-dicarboxylates 135 in 
very good to excellent yields (81-93%) via ring expansion promoted by sodium iodide.
67
 Iodide can ring 
open the aziridine to produce the intermediate 134 which can displace iodine to afford the product 135 
(Scheme 20). It was observed that the reaction rate decreased when an aryl group with electrowithdrawing 
groups was present at the -carbon (R = Ar) as opposed to an alkyl group. This could be explained by 
considering that the presence of electrowithdrawing groups might reduce electron density on the methylene 
carbon of diethyl malonate. 
 




A ring expansion of vinyl aziridine was studied by Mack et al. in 2012. 1-tosyl-2-vinylaziridine 136 was 
converted to 1-tosyl-2,5-dihydro-1H-pyrrole 139 in 69% yield using 5% of Cu(hfacac)2 and 5% of 
Zn(hfacac)2 in benzene at 100 
o
C for four hours. It was postulated that the copper is chelated in a tethraedral 
mode to form an -allyl four-membered ring copper(III) metallocyclic intermediate 137 which is able to 
isomerise to six-membered ring 138 and finally undergo reductive elimination process to produce the 




Scheme 21. Ring expansion of 1-tosyl-2-vinylaziridine to 1-tosyl-2,5-dihydro-1H-pyrrole 
 
Ring expansion of pyrrolidine 140 to piperidine 142 was published by Kim and co-workers in 1996. 1-
benzyl-2-(methyl-sulfonyloxymethyl)pyrrolidine 140 was refluxed in DMF for 30 minutes in the presence of 
acetate to afford a mixture of compounds 142 and 143 in 52 and 34% yields, respectively.
69
 It was speculated 
that aziridinium salt 141 might be the possible intermediate which could be ring expanded via a SN2-type 




Scheme 22. Ring expansion of through aziridinium formation to piperidine reported by Kim and co-workers 
 
Davies et al. reported a five (pyrrolidine) to six (piperidine) membered ring expansion reaction which 
involves an aziridinium salt formation. Iodo-pyrrolidine 144 was reacted with silver tetrafluoroborate to 
produce the intermediate 145 which was first isolated and characterised by single crystal X-ray diffraction, 




Scheme 23. Ring expansion of through aziridinium formation to piperidine reported by Davies et al. 
 
Jarvis and co-workers utilised an aziridinium ring expansion to synthesise enantiopure substituted 
piperidines 150.
71
 Pyrrolinol 148 was reacted with triflic anhydride to produce the aziridinium salt 
intermediate 149 which could undergo ring expansion via nucleophilic attack by different nucleophiles. The 
piperidine 150 was the only product observed and the possible pyrroline product 151 was not detected. It was 
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theorised that the double bond might be capable of activating the allylic position (path a) reducing the attack 
at the least hindered position (path b) (Scheme 24). 
 
Scheme 24. Ring expansion of aziridinium salt by selective nucleophilic attack at the homoallylic carbon 
 
1.2 Pyrrolidine 
The pyrrolidine core is found naturally in the leaves of tobacco and carrots. The pyrrolidine fragment is also 
present in many alkaloyds such as nicotine, hygrine and racetam compounds such as piracetam and 





Figure 10. Molecules with pyrrolidine fragment 
 
Nicotine has many pharmacological applications such as pain relief, relief of anxiety and depression; 
improvement in concentration and performance in those with attention deficit hyperactivity disorders; relief 
of some of the symptoms of acute schizophrenia; relief of some of the symptoms of Tourette's syndrome; 
relief of some of the symptoms of Parkinson's disease; and relief of some of the symptoms of Alzheimer's 





1.2.1 Synthesis of pyrrolidine derivatives 
There are many examples in the literature of homoallylic amines 152 as good starting reagents to prepare 
pyrrolidine derivatives 153, via a 5-endo-trig ring cyclisation (Scheme 25). 
 
Scheme 25. Homoallylic amines as starting reagents to synthesise pyrrolidines derivatives 
 
According to Baldwin’s rules, the 5-endo-trig cyclisation is a geometrically disfavoured process and 4-exo-
trig is a favourable process.
75-78
 However, there are some ways to make this reaction possible such as: 
nucleophile-driven, electrophile-driven, and radical-initiated cyclisations. In 1998, Lee and co-workers 
reported a synthesis of pyrrolidine derivatives 155a-h via diastereoselective iodoamidation of 3-
acetyloxybut-1-enylamines 154a-h.
79
 The homoallylic amine 154a was reacted with three equivalents of 
iodine at room temperature with different solvents such as THF, MeOH, CH2Cl2, MeCN. In all cases 
formation of pyrrolidine 155a was observed but starting material was still present at the end of the reaction 
(entry 1,2,3,4, Table 17). Complete conversion to the product 155a in 92% yield was obtained in three hours 
when a 2:1:1 mixture of NaHCO3, THF and Et2O was used (entry 5, Table 17). 
 





aNaHCO3-THF-Et2O = 2:1:1, Pf = 9-phenyl-fluoren-9-yl 
A substrate scope was also investigated and several homoallylic amines 154b-g were exposed to the 
iodoamidation reaction, affording the corresponding iodo-pyrrolidines 155b-g in good yields (66-92%) and 
entry solvent time (h) yield of 155a (%) 
1 THF 15 48 
2 MeOH 18 45 
3 CH2Cl2 6 50 






good diastereomeric ratios (Table 18). Single diastereoisomers were obtained when substrates 154b and 
154g were used (entry 1,7, Table 18). 
Table 18. Diastereoselective iodoamidation of 3-acetyloxybut-1-enylamines: Substrate scope 
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In 2007, a 5-endo-trig cyclisation of 2-trifluoromethyl-1-alkenes 156 was reported by Ichikawa et al.
80
 where 
4-methylbenzenesulfonamide (tosylamide: TsNH–) was used as a protecting group on the nitrogen. The 
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nitrogen anion attacks the alkene as in a SN2 reaction, promoting the elimination of a fluoride ion. The 
trifluoromethyl group activates the double bond allowing a 5-endo-trig rather than a 5-exo-tet ring closure 
(Scheme 26). It was claimed that the preference for the 5-endo-trig product 157 is due to the reduced steric 
and electrostatic repulsions between the sulfonamidate and the halogens. 
 
Scheme 26. 5-endo-trig cyclisation of 2-trifluoromethyl-1-alkenes 
 
  
A 5-endo-trig ring closure was accomplished treating -amino-sulphone 158 with a catalytic amount of 
potassium hydride yielding the product 161 in 65% yield (Scheme 27). Deprotonation of the NH of 
compound 158 leads to cyclic carbanion 160, which after proton exchange with another molecule of 158, 







Scheme 27. 5-endo-trig ring closure of a -amino-sulphone 
1.2.2 Synthesis of Nicotine and Nornicotine: known methods 
Several methods to synthesise nicotine have been developed using different approaches. The pyrrolidine ring 
of nicotine can be accessed using a chiral catalyst or a chiral ligand. Direct modification of L-proline to make 
optically active nicotine was reported in 1982 by Chavdarian and co-workers. The ee was only 24%. 
However, this was the first example of synthesis of enantioenriched nicotine (Scheme 28).
82
 L-proline was 
first reacted with formic acid and acetic anhydride to form (-)-1-formylprolyne intermediate 162, which was 
reduced with LiAlH4 to afford L-prolinol 163 in 57% yield. Compound 163 was then treated with thionyl 
chloride in chloroform to produce (-)-1-methyl-2-(chloromethyl)-pyrrolidine hydrochloryde 164 in 88% 
yield. Neutralisation of compound 164 with aqueous sodium bicarbonate followed by halogen displacement 
by sodium cyanide afforded (-)-1-methyl-2-(cyanomethyl)-pyrrolidine 165 in 51% yield. Compound 165 was 




after which, 3-ethoxyacrolein was added to afford 
compound 166 in 40% yield. Compound 166 was finally converted to (S)-(-)-nicotine in 55% yield via ring 




Scheme 28. Synthesis of nicotine via direct modification of L-proline 
In 1999, Loh and co-workers reported a four-step stereoselective synthesis of (S)-nornicotine. Reaction 
between 3-bromopyridine 167 and lactone 168 in the presence of n-BuLi produced the hydroxyketone (82% 
yield) 169, which was converted to aldehyde 170 in 82% yield via Swern oxidation. Aldehyde 170 was then 
reacted with 2,3,4,6-tetra-O-pivaloyl-13-D-galactosylamine in the presence of sodiumcyanoborohydride to 
afford compound 171 diastereoselectively in 45% yield. Hydrolysis of single diastereomer 171 yielded 
optically pure (S)-nornicotine in 95% yield. It was speculated that hydride transfer to the front re-face might 
be the explanation for the high diastereoselectivity. The si-face is, in fact, shielded by the bulky pivaloyl 
group in the favoured iminium intermediate, where steric interactions between the aromatic group and the 






Scheme 29. Four-step stereoselective synthesis of (S)-nornicotine 
In 2005, Helmchen and co-workers reported the synthesis of nicotine in greater than 99% ee. The key steps 
of this method were an asymmetric iridium-catalysed allylic amination and a ring-closing metathesis.
84
 
Asymmetric allylic substitution of 3-(3-pyridyl)allyl carbonate 172 afforded N-allyl derivative 173 in 87% 
yield and >99% ee when the phosphorus amidite ligand was used. Compound 173 was first protected at the 
nitrogen with Cbz and then reacted with Grubbs second generation catalyst to furnish compound 174 in 75% 
yield. A first reduction with TsNHNH2 followed by a second reduction with LAH provided (-)-(S)-nicotine 




Scheme 30. Synthesis of (-)-(S)-nicotine via iridium-catalysed allylic amination and RCM 
 
1.2.3 Applications of Pyrrolidines 
Pyrrolidines have found extensive applications as catalysts for several organic transformations, showing very 
good yields and enantioselectivities.
85-93
 Perhaps one of the most popular pyrrolidine containing 
organocatalysts is the amino acid L-proline. In 2002, Nirthrup and MacMillan published a direct and 
enantioselective cross-aldol reaction.
88
 Propionaldehyde was added to several non-enolisable aldehydes 175 
(aromatic and aliphatic) in the presence of a catalytic amount of proline (10 mol%) to afford -hydroxy 
aldehydes 176 in very good yield (75-91%) and excellent ee (91->99%) (Scheme 31). Addition of 
propionaldehyde to aldehydes 175 was performed by using a syringe pump to avoid homodimerisation. The 
best diastereoselectivity (24:1 anty:syn) and the best enantioselectivity (ee = >99%) were observed when the 
propionaldehyde was added to isobutyraldehyde.   
 
Scheme 31. Enantioselective cross-aldol reaction using L-proline as catalyst 
 
Diastereoselectivity is controlled by the formation of a six-membered ring in the transition state proposed by 
List in 2000,
94








Figure 11. Transition state proposed by List  
  
In 2001, Betancort et al. compared L-proline with different 2-substituted amino-pyrrolidines as catalysts for 
the Michael addition of aldehydes to nitro olefins.
93
 Ten equivalent of 3-methylbutanal were added to (E)-(2-
nitrovinyl)benzene to produce aldehyde 177. Amino-pyrrolidines 178 and 179 were screened as catalysts 
(Table 19) and (S)-2-(morpholinomethyl)-pyrrolidine 179 gave the second best diastereoselectivity (syn:anti 
92:8) and good enantioselectivity (ee = 72%) (entry 3, Table 19). L-proline deemed to be the best catalyst in 
terms of diastereoselectivity (syn:anti 93:7) but ee was only 25% and yield <5% (entry 1, Table 19). The best 
enantioselectivity (ee = 75%) was obtained when (S)-1-(pyrrolidin-2-ylmethyl)pyrrolidine 178 was used but 
diastereoselectivity (syn:anti = 80:20) (entry 2, Table 19) was not as good as (S)-2-(morpholinomethyl)-
pyrrolidine. 
 
Table 19. Michael addition of aldehydes to nitro olefins. Screening of catalysts 
entry cat yield of 177 (%) dr (syn:anti) ee of 177 (%) 
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To investigate the limitations and scope of the reaction several substituted aldehydes 180 were reacted with 
several nitro olefins 181 in the presence of 20 mol % of (S)-2-(morpholinomethyl)-pyrrolidine 179 (Scheme 
32). In general, better enantioselectivity was seen with increasing bulkiness of the substituent on the 





Scheme 32. Michael addition of aldehydes to nitro olefins using (S)-2-(morpholinomethyl)-pyrrolidine as catalyst 
   
A possible transition state, where favourable electrostatic interactions between the nitro group and the 
pyrrolidine nitrogen are involved, was proposed. Stereoselectivity could be explained by a less hindered si-
face approach of the nitro olefin (Figure 12). 
 
Figure 12. Transition state: favourable electrostatic interactions between the nitro group and the pyrrolidine nitrogen 
 
In 2006, Cao and co-workers developed a new pyrrolidine based catalyst, which proved to be very effective 
in the Michael addition of cyclohexanone to nitroolefines 183.
92
 The products 184 were obtained in moderate 
to very good yield (63-95%) and the ee (88-98%) was very good in all cases (Scheme 33). The 
diastereoselectivity was also very high and the syn diastereoisomer was always the main product. The 
electronic nature of the substituents on the aromatic ring did not effect the yield, the enantioselectivity and 
the diastereoselectivity. In fact, only a slight difference was observed when R = 4-OCH3Ph (yield = 95%, ee 





Scheme 33. Michael addition of cyclohexanone to nitroolefines 
 
1.3 Aim of the project 
The aim of this project is to make multifunctionalised pyrrolidines via an alkyne hydroamination cascade to 
obtain the intermediate enamine 185, which could then access the desired pyrrolidines 186 with a ring 
closure metathesis (RCM), followed by reduction of the double bond (Scheme 34).
95-96
 Hydroamination of 
alkyne is a well known reaction in the literature. Several metals such as copper, tantalum, zinc, palladium, 




Scheme 34. Alkyne hydroamination cascades and RCM as key steps for the synthesis of multifunctionalised pyrrolidines 
 
We were particularly inspired by an intramolecular alkyne hydroamination cascades involving 2(1-
alkynyl)arylaldimine 187 and allyltributylstannane, where indium triflate was chosen to activate both the 
imine and the triple bond. 1,2-dihydroisoquinoline 188 was obtained in 92% yield when 0.2 equivalents of 








An intermolecular version of the methodology shown above (Scheme 35) will be attempted for the first time 
as starting point of the research reported in this thesis. (E)-N-benzylidene-1-phenylmethanamine 189a was 
first obtained in >99% yield by condensation of benzaldehyde and benzylamine and then reacted with 1.2 
equivalents of allyltributylstannane, 1.2 equivalents of 1,2-diphenylethyne and 0.2 equivalents of indium 
triflate in toluene at 120 
o
C. Activation of the imino group of compound 189a by indium triflate followed by 
allylation, would produce the intermediate 190, which could then attack the triple bond activated by another 
molecule of indium triflate (Scheme 36). The reaction was monitored by TLC every 30 minutes and after 
three days starting material was still present. Analysis of the crude 
1
H NMR spectrum showed no product 
191 was formed, however, it was found that homoallylic amine 192a was obtained in 5% yield after flash 
chromatography (Scheme 36).  
 
Scheme 36. Hydroamination cascade using (E)-N-benzylidene-1-phenylmethanamine, allyltributylstannane and 1,2-diphenylethyne 
 
It has been reported in the literature that homoallylic amines are suitable starting materials to make 
azetidines and pyrrolidines via electro-induced cyclisations as it is illustrated in the introduction section. 
Although the synthesis of compound 191 had failed after many attempts, the possibility to access the 
homoallylic amine 192a would still be a good starting point to make pyrrolidines. The new aim of the project 
49 
 
is to develop a new methodology for the synthesis of multifunctionalised azetidines and pyrrolidines using 
homoallylic amines as starting materials. Iodine will be used as cyclisation promoter. All the new molecules 
synthesised will be used in medicinal chemistry applications. Asymmetric synthesis of azetidines will be also 
investigated by exploiting asymmetric synthesis of homoallylic amines. The enantioenriched azetidines 
obtained will be tested as organocatalysts for some organic chemistry reactions.  
2 Results and Discussion 
2.1 Synthesis of Azetidines 
2.1.1 Iodine-mediated Cyclisation of Homoallylic Amines 
There are many procedures in the literature regarding allylation of imines. Different Lewis acid such as 
boron trifluoride, palladium, indium, stannane chloride, magnesium and zinc have been used to activate 
imines.
107-115
 Allylation of imine 189a with allyltributylstannane was attempted using 1.5 equivalents of 
In(OTf3) as catalyst (Scheme 37). 
 
Scheme 37. Allylation of (E)-N-benzylidene-1-phenylmethanamine with allyltributylstannane and In(OTf)3  
 
The product 192a was formed in very low yield (10%), however, compound 192a was obtained in 86% yield 
when 1.5 equivalents of allyltributylstannane and three equivalents of BF3·Et2O were used in CH2Cl2 at room 




Scheme 38. Allylation of (E)-N-benzylidene-1-phenylmethanamine with allyltributylstannane and BF3·Et2O 
 
As described above in the introduction section, homoallylic amines have been largely used as starting 
materials for the synthesis of azetidines and pyrrolidines. Since iodine has already been shown to deliver 
pyrrolidines in a 5-exo fashion,
22
 and this sterically encumbered halide could perhaps offer high 
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stereodefinition, it was selected as the cyclisation promoter. Cyclisation of compound 192a would access 
azetidine 194a or pyrrolidine 195a via halonium species intermediate 193a. According to Baldwin,
75-78
 when 
a three membered ring is opened to form a cyclic structure, the rules lie between those for tetrahedral and 
trigonal systems, however, exo modes are generally preferred. If one considers that 5-endo-trig and 5-endo-
tet are unfavoured processes whereas 4-exo-trig and 4-exo-tet are favoured processes, it might be expected 
that azetidine 194a is the favoured product in the ring closing reaction of 192a with iodine (Scheme 39). 
 
Scheme 39. Iodine mediated cyclisation: azetidine formation versus pyrrolidine formation 
 
Compound 192a was treated with three equivalents of molecular iodine at room temperature in acetonitrile 
for 16 hours. Analysis of the crude 
1
H NMR spectrum showed only 44% conversion of the starting material. 
Nonetheless, when a three-fold excess of iodine was used at room temperature in acetonitrile accompanied 
by a five-fold excess of NaHCO3, only azetidine cis-194a could be obtained, albeit in 45% isolated yield, but 
most of the starting amine (192a) had been consumed (Scheme 40). Purification of compound 194a by silica 
gel flash chromatography proved to be not particularly efficient in terms of yield, in fact, different other 
fractions were collected and analysed suggesting that a possible decomposition of the product 194a had 
occurred. 
 
Scheme 40. Iodine mediated cyclisation of homoallylic amine 192a  
 
The structure of 194a was confirmed by 2D-NMR spectroscopy, in particular the HMBC experiment, where 
a 
3
J coupling between carbon one and the CH rather than a CH2 (Figure 13), showed clearly that the four 
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Figure 13. 2D-NMR spectroscopy to assign structure of azetidine cis-194a: irradiating H3 nOe has been seen with   
H5, H2a, H2b ,H4b 
 
The reaction was then studied under different temperatures to probe the best reaction conditions. 
Homoallylic amine 192a was stirred with three equivalents of iodine and five equivalents of sodium 
bicarbonate for 16 hours in acetonitrile affording 2,4-cis-azetidine 194a (entry 1, Table 20) at 20 
o
C and 3,5-
trans-pyrrolidine 195a (entry 2, Table 20) at 50 
o
C. Post-work-up azetidine and pyrrolidine were obtained in 
96% and 82% yield and the 
1
H NMR spectra were relatively clean compared to the spectra obtained after 
further purification by flash chromatography. One can note that further purification of compounds 194a and 
195a by silica flash chromatography resulted in a dramatic loss in yields 45 and 42% (Table 20). 
 











 >99:1 96 45 99:1 
2 50
o 
>99:1 82 42 1:99 
a Conversion to 194a + 195a based on consumption of 1 by 1H NMR spectroscopy. 
byield after work up. cyield after flash chromatography. 
c cis-(194a:195a) Ratio obtained by inspection of the 1H NMR spectrum post aqueous work-up. 
 
The formation of the pyrrolidine core was confirmed by 2D-NMR spectroscopy, in particular a 
3
J between 
carbon one and the CH2 (2) with the HMBC technique was used to assign the structure of cis-195a. The 
relative stereochemistry of cis-195a was corroborated by nOe studies. Irradiating H
3













 as proof they are on the same 
side  (Figure 14).
116
   
 
Figure 14. 2D-NMR spectroscopy to assign structure of pyrrolidine cis-195a: Irradiating H3 nOe has been seen with H5, H2b, H4b, 
irradiating H5 nOe has been seen with H3, H2b, H4b 
 
The cis configuration was the only one observed, there was no evidence for the formation of the trans 
product. If one considers that the azetidine has a puckered conformation with pseudo-axial and pseudo-
equatorial positions, the formation of the cis-azetidine as single product, could be explained by the favoured 
transition state where the iodine and the phenyl group are in the pseudo-equatorial positions. The disfavoured 




Figure 15. Disfavoured and favoured transition state for the formation of azetidine 
 
A solvent and base screening was tried to find the best conditions for the synthesis of the azetidine 194a. A 
control reaction using three equivalents of iodine but no base was attempted. After 16 hours the reaction was 
worked up and  analysis of the crude 
1
H NMR spectrum showed azetidine and the starting material were in a 
44:56 ratio, (entry 1, Table 21). Using sodium bicarbonate as base and acetonitrile as solvent, was found to 
be the best condition for this reaction. The desired azetidine 194a was formed as the only product with 
complete conversion of the starting material (entry 7, Table 21). When three equivalents of iodine and five 
equivalents of sodium bicarbonate were used it required 16 hours for the reaction to reach completion. The 
reaction time can, however, be reduced to six hours by using five equivalents of iodine. It is interesting to 
note that oxidation of homoallylic amine 192a to the imine 196a was observed when K2CO3, Cs2CO3 or 
KOAc were used as bases with acetonitrile as solvent (entry 4,5,12, Table 21). Formation of compound 196a 




Table 21. Iodine mediated cyclisation: Base and solvent screening 










1 - CH3CN 56.0 44.0 - - - 
2 Li2CO3 CH3CN 25.0 75.0 - - - 
3 Na2CO3 CH3CN - 61.0 39.0 - - 
4 K2CO3 CH3CN - 35.5 - 64.5 - 
5 Cs2CO3 CH3CN - - - 82 18 
6 LiOH CH3CN 48.5 33.0 18.5 - - 
7 NaHCO3 CH3CN - >99.5 - - - 
8 NaOH CH3CN - 60.0 40.0 - - 
9 KOH CH3CN - 53.0 47.0 - - 
10 LiOAc CH3CN - 73.0 27.0 - - 
11 NaOAc CH3CN - 68.5 31.5 - - 
12 KOAc CH3CN - 50.0 20.0 30.0 - 
13 NaHCO3 THF 63.0 37.0 - - - 
14 NaHCO3 MeOH - 50.0 21.0 29.0 - 
15 NaHCO3 CH2Cl2 58.0 42.0 - - - 
16 NaHCO3 THF:Et2O 69.0 31.0 - - - 
17 NaHCO3 DMSO - 12.0 55.0 33.0 - 
anumbers show ratio of the starting material and the products in the 1HNMR spectra 
To corroborate the nature of this reaction N-(4-methylbenzyl)-1-phenylbut-3-en-1-amine (192c), derived 
from p-tolyl benzaldehyde, was exposed to the same reaction conditions. The corresponding p-tolyl imine 
(196c) was isolated in 74% yield and the structure of 196c was determined by COSY, HSQC and HMBC 
(Scheme 41). 
 
Scheme 41. Oxidation of homoallylic amine 192c with iodine and caesium carbonate 
 
The cyclisation of homoallylic amine 192a was also tried with different reagents. NIS, NBS and Br2 were 
used instead of iodine. Analysis of the crude 
1
H NMR spectra showed a mixture of products in all cases 
proving molecular iodine to be the best halide source of those tried for this reaction. Different imines 189a-y 
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were prepared using a standard literature protocol.
117
 Aldehydes and amines were refluxed for four hours in 
ethanol to afford the corresponding imines in moderate to excellent yields (40-99%) (Table 22). 
 





 yield of 189 (%)
 
 ratio (E/Z) 
1 a Ph Bn 99  99.3/0.7
 c
 
2 b Ph PMB 99  99.3/0.7
 b
 
3 c Ph PTB 99  99.3/0.7
 c
 
4 d 3-Py Bn 99  99.8/0.2
b 
5 e 4-Py Bn 99  99.7/0.3
 b
 
6 f PNP Bn 99  89.4/10.6
 c
 
7 g 2-Br-Ph Bn 99  98.7/1.3
 b
 
8 h t-Bu Bn 83  98.6/1.4
 c
 
9 i 3-OMe-Ph Bn 99  99.4/0.6
 c
 
10 j 3-furyl Bn 99  99.2/0.8
 c
 
11 l Ph PNB 42  99.3/0.7
 b
 
12 k Cy Bn -
a 
 - 
13 m ONP PMB 99  99.4/0.6
 c
 
14 n Ph (S)-CH(Me)Ph 81  99.2/0.8
 c
 
15 o Fc Bn 40  97.2/2.8
 c
 
16 p Ph Cy 92  99.4/0.6
 c
 




 4-OMe-Ph Bn 95  98.3/0.7
c 
19 s 2-Py Bn 99  99.1/0.9
 b
 
20 t Ph (CH2)2NHC=OMe 52  98.9/1.1
 c
 
21 u 9-anthracenyl Bn 69  100/0 
22 v Ph t-Bu 46  99.4/0.6
 c
 
23 w 2-thiophenyl Bn 99  99.4/0.6
 c
 
24 x 3-1H-indolyl Bn 94  99.3/0.7
 b
 
25 y Me Bn -
a 
 - 
aimpurities were still present after purification, 
b
the resonance for CH=NCH2 in the 
1H NMR spectrum was used to elaborate the 
(E/Z) ratio, 
c
the resonance for CH=NCH2 in the 
1H NMR spectrum was used to elaborate the (E/Z) ratio 
 
The synthesised imines were freshly used and converted into homoallylic amines using two different 
methods reported in the literature.
113, 115, 118
 Boron trifluoride as Lewis acid and allyltributylstannane as allyl 
species were used in method a, whereas an in situ preformed allyl-Grignard, using magnesium and 
allylbromide, was employed in method b (Table 23). In general, method b proved to be more efficient than 
method a in terms of yields but in one case, homoallylic amine 192f could not be obtained with method b. 











yield of 192 (%) 
method a
 
yield of 192 (%) 
method b 
1 a Ph Bn 86 99 
2 b Ph PMB 99 99 
3 c Ph PTB 42 99 
4 d 3-Py Bn 98 99 
5 e 4-Py Bn 92 99 
6 f PNP Bn 81 - 
7 g 2-Br- Ph Bn 56 96 
8 h t-Bu Bn 89 71 
9 i 3-OMe-Ph Bn * 99 
10 j 3-furyl Bn 21 90 
11 k Cy Bn * 96 
12 l Ph PNB 57 88 
13 m ONP PMB 45 * 
14 n Ph (S)-CH(Me)Ph   
15 o Fc Bn 13 * 
16 p Ph Cy * 99 
17 q Ph n-Pr 92 99 
18 r
 4-OMe-Ph Bn 34 90 
19 s 2-Py Bn * 93 
20 t Ph (CH2)2NHC=OMe 30 * 
21 u 9-anthracenyl Bn - - 
22 v Ph t-Bu * 68 




24 x 3-1H-indolyl Bn - 
 
* 
25 y Me Bn * 65
 




2.1.2 Synthesis of Azetidines: Scope and Limitations 
With satisfactory reaction conditions in hand, the homoallylic amines 192b-o were also cyclised, with iodine, 
to the corresponding azetidines cis-194b-o (entry1-15, Table 24). Purification by column chromatography 
gave only around 45% isolated yield in all cases. Analysis of the crude materials’ proton NMR spectra 
revealed some pyrrolidine had formed when 192d, e, f, g, I, l, m and n, were used as starting materials but 
azetidines cis-194 were always the major products. The cyclisation of the 2-pyridyl analogue was also 
attempted but failed to give the desired product(s).
 
 









1 a Ph Bn >99 >99:1
  
2 b Ph PMB >99 >99:1 
3 c Ph PTB >99 >99:1
 
 
4 d 3-Py Bn >99     5:1 
5 e 4-Py Bn >99     6:1 
6 f PNP Bn >99     3:1 
7 g 2-Br- Ph Bn >99     3:1 
8 h t-Bu Bn >99 >99:1
 
 
9 i 3-OMe-Ph Bn >99     6:1 
10 j 3-furyl Bn >99 >99:1 
11 k Cy Bn >99 >99:1 
12 l Ph PNB >99     7:1
c 
13 m ONP PMB >99     3:1 
14 n Ph (S)-CH(Me)Ph >99     3:1 
15 o Fc Bn >99 >99:1 
16 p Ph Cy   38     1:>99
c 




4-OMe-Ph Bn    -      - 
PMB = para-methoxybenzyl. PTB = para-tolylbenzyl. PNP = para-nitro-phenyl. 
PNB = para-nitro-benzyl. ONP = ortho-nitrophenyl. Fc = ferrocenyl. a 194 + 195 
consumption of the starting material 192 by 1H NMR spectroscopy. b cis-(194:195) 
ratio obtained by inspection of the 1H NMR spectrum post aqueous work-up. c 
Sodium carbonate was used as base. d 192r suffered loss of allyl group and 
oxidation to corresponding imine. 
 
The X-ray crystal structure of 194b (Figure 16), solved by Dr Louise Male, along with inspection of nOe 






Figure 16. X-ray crystal structures with ellipsoids drawn at the 50% probability level of cis-194b. Most of the hydrogen atoms have 
been omitted for clarity and cis-stereochemistry is confirmed 
 
Homoallylic amine 192l was converted to the corresponding azetidine using sodium carbonate as base (entry 
12, Table 24). No reaction occurred when sodium bicarbonate was used. When R
2 
= cyclohexyl or propyl 
(entry 16 and 17, Table 24) no product was obtained under these conditions, suggesting that a benzylic group 
is crucial for the reaction to happen. However, when 192p and 192q were treated with sodium carbonate and 
iodine at room temperature for 16 hours, pyrrolidines cis-195p and cis-195q were obtained in poor yields 
(38% and 33%) and more than 50% of starting material was recovered (entry 16 and 17, Table 24). 
Cyclisations of 192p and 192q were also performed at room temperature for three days and at 50 
o
C for 16 
hours but no improvement in terms of yields was observed, starting material was still more than 50%. It was 
clear after these experiments that only homoallylic amines with R
2 
= aryl or benzyl could be converted to the 
corresponding azetidines under the iodo-mediated cyclisation conditions, in fact, homoallylic amines 192p 
and 192q did not convert to the azetidines. Ring closing of compound 192r failed but complete conversion to 
(E)-N-(4-methoxybenzylidene)-1-phenylmethanamine 189r, the only product detected in the 
1
H NMR 
spectrum, was observed. This might be explained with a different pathway of the reaction where loss of allyl 
group occurs due to the formation of the highly conjugated intermediate 197, which can convert to imine 
169r after treatment with sodium bicarbonate (Scheme 42).  
 
Scheme 42. Different pathway for ring closing of homoallylic amine 192r 
 
Homoallylic amine 192i with the methoxy group in the meta position was also exposed to the cyclisation 
conditions resulting in complete conversion to the corresponding azetidine cis-194i and pyrrolidine cis-195i 
in a 6:1 ratio (entry 9, Table 24).  
59 
 
2.1.1 Ring expansion: Conversion of Iodo-Azetidines to Iodo-Pyrrolidines 
It was rapidly discovered that storage of iodo-azetidines cis-194a (even at 4 
o
C) resulted in the formation of 
some of the corresponding pyrrolidines cis-195a. In order to confirm isomerisation of iodo-azetidines to 
iodo-pyrrolidines, thermal ring-expansion, in accordance with the literature,
2, 61-62 
was confirmed, heating cis-





Scheme 43. Thermal isomerisation of azetidines cis-194c-e to pyrrolidines cis-195c-e 
 
A possible mechanism for the ring expansion might be explained by an intramolecular halogen displacement 
by the nitrogen to give the intermediate aziridinium salt 198c, which could then be attacked by the iodide to 
afford the corresponding pyrrolidine cis-195c with inversion of stereochemistry (Scheme 44). Attack by the 
iodide to the less hindered carbon (reversible process) would reform azetidine cis-194c, whereas attack to the 
more hindered carbon (irreversible process) would produce the more thermodynamically favoured 
pyrrolidine cis-195c. It might be speculated that release of tortional strain is the driving force of this ring 
expansion. 
 
Scheme 44. Possible mechanism for the ring expansion of cis-azetidine into cis-pyrrolidine 
 
X-ray crystal structure analysis of compound 195c, solved by Dr Louise Male, also confirmed cis iodo-






Figure 17. X-ray crystal structure with ellipsoids drawn at the 50% probability level of cis-195c. Most of the hydrogen atoms have 
been omitted for clarity and cis-stereochemistry is confirmed. 
 
2.1.2 Attempts to isolate aziridinium salt 198a 
 
Several attempts were tried to isolate aziridinium salt 198a following the procedure reported by Davies and 
co-workers.
70
 Iodo-azetidine 194a was reacted with two equivalents of silver tetrafluoroborate at room 
temperature in dichloromethane (Scheme 45).  
 
Scheme 45. Attempt to isolate aziridinium tetrafluoroborate salt 198a 
 
The reaction was carried out multiple times but with different purification procedures. Unfortunately 
although there was evidence for starting material consumption, as monitored by TLC, the product could not 
be accurately characterised due to the presence of broad resonances in the 
1
H NMR spectra.   
2.1.3 Synthesis of Amino-Azetidines: Replacement of Iodine with Amines 
With the new azetidines synthesised (entry 1-15, Table 24), bearing in mind that iodo-azetidines are not 
thermally stable and that analysis of the crude 
1
H NMR showed that only the product could be detected, with 
starting material completely consumed, just after the work-up, no flash chromatography was applied and the 
post-work-up azetidine cis-194a was readily converted to the corresponding amino-azetidine cis-199ab with 
a simple nucleophilic substitution to displace iodine. The iodo-azetidine cis-194a was initially exposed to ten 
equivalents of propylamine in DMSO at room temperature for 48 hours and unexpectedly afforded amino-
pyrrolidine derivative cis-200ab in 78% yield (over two steps from 192a) as single diastereoisomer. Amino-
azetidine cis-199ab was then synthesised in 87% yield (over two steps from 192a) by stirring cis-194a in a 
61 
 
neat propylamine for 48 hours at room temperature. It was vital that liquid amines were used neat (as 
solvent) in the iodine displacement step, when co-solvent were used isomerisation to the corresponding 
pyrrolidine cis-200ab became problematic, however this feature can be exploited (as discussed later) in 
pyrrolidine synthesis. The formation of amino-azetidine cis-199ab, could be explained by considering the 
competition between intramolecular and intermolecular nucleophilic substitution. Aziridinium salt 198a 
could be formed with iodine displacement by intramolecular nitrogen attack, followed by attack with an 
external amine to afford the more thermodynamically stable pyrrolidine cis-200ab (pathway a, Scheme 46). 
Using amine as solvent allowed the intermolecular nucleophilic substitution to be the favoured pathway in 
order to access amino-azetidine derivative cis-199ab (pathway b, Scheme 46).  
 
Scheme 46. Intramolecular versus intermolecular nucleophilic substitution 
 
Iodo-cyclisation of 192a was repeated, after aqueous work-up the obtained material cis-194a was dissolved 
in neat p-methoxy benzylamine, and stirred at room temperature for 48 hours to give the corresponding 
amino-azetidine cis-199ah in 78% yield (over two steps from 192a) (Scheme 47). Thus, demonstrating 
derivitisation of material obtained from the cyclisation reactions may be performed without purification, to 
give higher yields than would be possible otherwise (Table 20). In fact, iodo-azetidine cis-194a could be 
obtained in only 45% yield after flash chromatography (Table 20), whereas the amino-azetidine cis-199ah 
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was synthesised in much higher yield (78% over two steps from 192a) after flash chromatography when the 




Scheme 47. Synthesis of amino-azetidine cis-199ah  
 
Next 192d was exposed to an analogous two step cyclisation-derivatisation sequence. Derivatives of cis-
194d (and cis-195d) are especially attractive owing to the 3-pyridyl motif, allowing access to a potentially 
useful class of azetidine (and pyrrolidine) nicotine analogues and derivatives. The pharmacological activity 
of such analogues is an area of persistent interest.
8-9, 74, 119-122
 In the case of the cyclisation of 192d, it had 
already been shown a 5:1 mixture of cis-194d:cis-195d in high conversion was obtained, yet only 42% of 
cis-194d could be isolated by column chromatography (entry 4, Table 24). Pleasingly, purification post 
derivatisation gave the corresponding amino azetidine cis-199da as a single diastereoisomer in 72% overall 




Scheme 48. Synthesis of amino-azetidine cis-199da  
 
Displacement of iodide with nitrogen nucleophiles gave thermally stable azetidines. In order to confirm 
thermal stability of azetidines, samples of cis-199ah and cis-199da were each heated in refluxing DMSO for 
four hours. Solvent removal in vacuo gave materials with unchanged proton NMR spectra, confirming the 
robustness of the azetidine motif in the absence of iodide.
116
 With this robust methodology that provides 
iodo-azetidine in hand, a small library of amino-azetidines with potential biological activity was obtained. 
Most of the iodo-azetidines (cis-194a-m) synthesised were converted to different amino-azetidines (cis-
199aa-mb) via halogen displacement by a range of primary and secondary aromatic and aliphatic amines 
(Table 25). Analysis of the 
1
H NMR spectra of the reaction mixture after work-up, showed complete 
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conversion from iodo-azetidines cis-194a-m to amino-azetidine cis-199aa-mb after 24 hours. Simple flash 
chromatography afforded the products with moderate to good overall yields 65-87% as shown in Table 25.  
Stereochemistry of most of the new amino-azetidines was confirmed by nOe correlations. nOe enhancements 








 when proton H
3
 was irradiated, confirming the expected cis 
configuration (Figure 18). 
 
Figure 18. nOe correlations to assign relative stereochemistry of amino-azetidines cis-199aa-mb: Irradiating H3 






























Table 25. Synthesis of amino-azetidines cis-199aa-mb 
     
cis-199aa 86% cis-199ab 87% cis-199ac 83% cis-199ad 69% cis-199ae 83% 
     
cis-199af 71% cis-199ag 81% cis-199ah 78% cis-199bb 74% cis-199ca 75% 
    
 
cis-199da 72% cis-199di 82% cis-199dj 76% cis-199ea 71% cis-199fa 76% 
     
cis-199ga 65% cis-199ha 86% cis-199ib 85% cis-199ja 79% cis-199kb 81% 
   
 





2.1.4 Synthesis of Azetidine-Triazoles: Replacement of Iodine with NaN3, Click Chemistry 
Displacement of iodine was attempted with a different nucleophile to access a new class of azetidines. 
Addition of 1.5 equivalents of sodium azide to the in situ generated cis-194a and cis-194d at room 
temperature in DMF, followed by addition of two equivalents of copper(I) iodide and one equivalent of 
phenyl acetylene or 1-pentyne, gave azetidine triazole derivatives cis-202aa, ab, da
116
 in respectively 53%, 
59% and 46 % isolated yield from 192 (Scheme 49). It is noteworthy that only 1.5 equivalents of sodium 
azide were enough to displace iodine to produce the azido-azetidine intermediates 201a,d showing the higher 
nucleophilicity of azide compared to the amine nucleophiles. The fact that no formation of pyrrolidine 203 
was observed is proof that intermolecular nucleophilic substitution is favoured compared to the 
intramolecular nucleophilic substitution when 1.5 equivalents of azide are used (Scheme 49).  
 
Scheme 49. Synthesis of triazole-azetidine cis-201aa,ab,da 
 
2.1.4.1 Asymmetric Synthesis of Azetidines using a Chiral Catalyst 
Allylation of imines has always been a very challenging reaction, whereas several procedures can be found 
in the literature for the synthesis of enantioenriched homoallylic alcohol. In particular asymmetric allylation 
of aldehydes
123-131
 and asymmetric reduction of ketones
132-134
 proved to be very successful procedures in 
terms of yields and ee. Homoallylic alcohol 204 might be converted to the desired enantioenriched amine 
192a by transforming the OH in a good leaving group followed by displacement with benzylamine (Scheme 
66 
 
50). Enantioenriched alcohol 204 could also be obtained by an asymmetric reduction of ketone 185 (Scheme 
50). 
 
Scheme 50. Retrosynthesis of homoallylic amine 192a 
 
Homoallylic alcohol 204 was prepared with the same procedure as shown previously in (Table 23). 
Benzaldehyde was added to an in situ prepared allyl-Grignard to afford compound 204 in 99% yield. The 
homoallylic alcohol 204 prepared, was then oxidised to the corresponding ketone 205 with PCC in CH2Cl2 in 




Scheme 51. Synthesis of homoallylic alcohol 204 and ketone 205 
 
Asymmetric allylation of benzaldehyde was attempted with two equivalents of allyltributylstannane in the 
presence of (S)-binol (22% mol), indium chloride (20% mol) and 4Å MS in dichloromethane for 48 hours at 
-78 
o
C to afford compound (S)-204 in 79% yield.
136
 Specific rotation of compound (S)-204 ([ ]D
20
 = -40.7) 




 to determine the ee, which was 88%. Limit 
of accuracy for the enantiomeric excess calculation  from the specific rotation values must be considered. In 
1968, Krow and Hill reported that the specific rotation of (S)-2-ethyl-2-methyl succinic acid with an 
enantiomeric excess of 85% changes with the concentration showing non linear correlations between specific 
rotation and enantiomeric excess.
138
 Tosylation of compound (S)-204 to transform the OH in a better living 





However a different literature procedure was attempted and compound (S)-204 was converted to compound 
(R)-206, which could now be exposed to a nucleophilic substitution with benzylamine to access the 
enantioenriched homoallylic amine 192a. The homoallylic alcohol (S)-204 was reacted with 0.5 equivalents 




Scheme 52. Synthesis of enantioenriched alcohol (S)-204 via asymmetric allylation of benzaldehyde and functional group 
interconversion 
 
Compound (R)-206 was then exposed to two equivalents of benzylamine and three equivalents of sodium 
bicarbonate in DMF at room temperature for 16 hours to obtain the desired homoallylic amine (S)-192a in 
43% yield (Scheme 53). Unfortunately there were two problems related to this halogen displacement: the 
formation of the highly conjugated product 207 and loss of enantiopurity, which decreased to 23% ee, of 
compound (S)-192a confirmed by comparison with the literature value (ee = 91%, [ ]D
20





Scheme 53. Halogen displacement by benzylamine 
 
The loss of enantiopurity might be explained by the possible stabilisation of the carbocation 208 by the 
benzylic group, which does not allow the reaction to proceed via a pure SN2, resulting in a mixture of SN1 
and SN2 (Scheme 54). 
 




2.1.4.2 Enzimatic Kinetic Resolution  
It has been previously reported that racemic alcohols and amines can be resolved by enzymatic kinetic 
resolution.
142-146
 Candida antarctica lipase A was chosen as suitable enzyme to access the desired 
homoallylic amine (S)-192a needed for the synthesis of enantiopure azetidines. The homoallylic amine 192a 
was acylated with two equivalents of acetic anhydride, 0.1 equivalents of DMAP and two equivalents of 




Scheme 55. Acylation of homoallylic amine 192a 
 
Kinetic resolution of compound 209 to obtain enantiopure homoallylic amine 192a was attempted. 
Compound 209 was stirred with the enzyme CAL-A in 0.1 M phosphate buffer pH 7.5. The reaction was 
monitored every 30 minutes by TLC for three days after which a crude 
1
H NMR spectrum was obtained and 
analysed. Unfortunately, starting material 209 was recovered as a racemate, confirmed by lack of any optical 
rotation (Scheme 56).  
 
Scheme 56. Kinetic resolution of compound 209 
 
Compound 192a was then stirred for two days with CAL-A and methyl 2-methoxyacetate in MTBE at 50 
o
C 
but unreacted racemic amine 192a  was quantitatively recovered (Scheme 57). 
 




2.1.4.3 Chiral Auxiliary Approach 
2.1.4.3.1 Ellman’s Chiral Sulfinamides 
 
Asymmetric synthesis of azetidines proved to be unsuccessfull when a functional group interconversion 
strategy was applied (Scheme 53). Also the kinetic resolution approach did not furnish the desired products 
(Scheme 56, Scheme 57) so a chiral auxiliary approach was investigated. Ellman’s chiral sulfinamides
148
 
(Figure 19) were chosen as the most suitable auxiliaries for the asymmetric synthesis of 192a.  
 
Figure 19. Ellman’s chiral sulfinamides 
 
Several papers regarding the asymmetric synthesis of enantioenriched homoallylic amines using Ellman’s 
chiral auxiliaries have already been published
149
 and in particular the synthesis of homoallylic amine (R)-210 
in excellent ee (up to >99%) have also been reported.
111, 150
 A simple reductive amination of compound (R)-
210 would furnish the desired homoallylic amine (R)-192a in high yield and enantioselectivity. 
 
Scheme 58. Proposed reductive amination of compound (R)-211 to access the desired homoallylic amine (R)-192a 
 
(S)-N-tert-butylsulfinylamine (S)-211 was prepared in 90% yield by using a literature procedure.
151
 
Benzaldehyde was stirred for 16 hours in dichloromethane with (S)-N-tert-butylsulfinylamine, PPTS and 
anhydrous magnesium sulphate (Scheme 59). 
 




The (S)-N-tert-butylsulfinyl aldimines (S)-211 was stirred with allylbromide (1.3eq) and indium (powder, -
100 mesh) (1.3 eq) in dry THF for 16 hours to afford homoallylic amine (S,R)-212 in 90% yield and 96:4 dr, 
confirmed by analysis of 
1




Scheme 60. Asymmetric allylation of (S)-211   
 
Removal of the chiral auxiliary under acidic conditions yielded the homoallylic amine (R)-210 in 79% yield 




 (Scheme 61).  
 
Scheme 61. Removal of the chiral auxiliary under acidic conditions 
 
Non racemic homoallylic amine (R)-210 was converted to the non racemic homoallylic amine (R)-192a with 
a reductive amination in >99% yield and 92% ee. The enantiomeric eccess was confirmed by comparison of 
the specific rotation value with the literature value ([ ]D
20 
= 52.9; 91% ee).
152
 Compound (R)-210 and 
benzaldehyde were refluxed in methanol for four hours and, after cooling to 20 
o
C, the imine thus formed 




Scheme 62. Reductive amination of compound (R)-210 to access the desired homoallylic amine (R)-192a 
 
No loss of enantiopurity was observed and the homoallylic synthesised was exposed to the conditions 
described above (Scheme 47) to afford the amino-azetidine (2S,4R)-199ab in 76% yield over two steps and 




Scheme 63. Synthesis of enantioenriched amino-azetidine (2S,4R)-199ab 
 
Allylation of compound (R)-211 was attempted with a different method. Indium triflate, zinc and 
allylbromide were used to afford the homoallylic amine (R)-192a in 99% yield. Only one diastereoisomer 
was detected by analysis of 
1




Scheme 64. Asymmetric allylation of (S)-211 with a different method   
 
The chiral auxiliary group was removed as shown above (Scheme 61) to afford compound (R)-210 in 75% 
yield and >99% ee. The enantiomeric excess was confirmed by comparison of the specific rotation value 




 (Scheme 65).  
 
Scheme 65. Removal of the chiral auxiliary under acidic conditions 
 
Compound (R)-210 was reacted with benzaldehyde to form the corresponding imine, which was readily 
reduced with NaBH4 in methanol for 16 hours to produce the homoallylic amine (R)-192a in 99% yield and 
>99% ee. The enantiomeric excess of (R)-192a was confirmed by comparison of the specific rotation value 
with the literature value ([ ]D
20 




Scheme 66. Reductive amination of compound (R)-210 to access the desired homoallylic amine (R)-192a 
 
The enantioenriched homoallylic amine (R)-192a was exposed to previously optimised iodine cyclisation 
followed by halogen displacement with benzylamine to afford the enantioenriched amino-azetidine (2S,4R)-
199aa in 84% yield over two steps and 99.5% ee confirmed by chiral HPLC (Scheme 67). 
 
Scheme 67. Synthesis of enantioenriched amino-azetidine (2S,4R)-199aa 
2.1.4.3.2 (S)-1-Phenylethanamine Chiral Auxiliary 
 
Synthesis of enantioenriched amino-azetidine was also tried using a different chiral auxiliary. The post-
work-up iodo-azetidine 194a was reacted with (S)-1-phenylethanamine for 24 hours at room temperature 
neat to obtain a 1:1 mixture of diastereoisomers 199ai and 199ah in 64% yield over two steps. Different 
flash chromatography conditions were tried to separate the diastereoisomers with no success (Scheme 68).   
 
Scheme 68. Halogen displacement with the chiral (S)-1-phenylethanamine auxiliary group  
 
The chiral auxiliary group (S)-1-phenylethanamine could also be used in an earlier stage of the synthesis. 
Allylation of (S,E)-N-benzylidene-1-phenylethanamine 189n with magnesium and allylbromide in dry THF 
afforded the homoallylic amine 192n in 99% yield and 1:1 diastereomeric ratio. The two different 
diastereoisomers were exposed to several flash chromatography conditions but the diastereomeric ratio could 




Scheme 69. Allylation of (S,E)-N-benzylidene-1-phenylethanamine 189n 
 
However the allylation was repeated and the 1:1 mixture of diastereoisomers prepared was treated with the 
cyclisation conditions to afford a 3:1 mixture of iodo-azetidines 194n and iodo-pyrrolidines 195n elaborated 
by analysis of the crude 
1
H NMR spectrum. The isomers were successfully exposed to preparative HPLC 
separation and only one single enantiomer cis-amino-azetidine could be obtained pure in 23% yield  (Scheme 
70). 
 
Scheme 70. Iodine mediated cyclisation of homoallylic amine 192n 
2.1.5 Synthesis of Azetidine Metal Complexes 
There are only few examples of amino-azetidine metal complexes as catalysts in the literature.
49, 154
 Herein 
the synthesis of new palladium and platinum amino-azetidine complexes is illustrated. These new racemic 
azetidine metal complexes were synthesised with the purpose of obtaining and analysing the X-ray structures 
in order to design new enantioenriched amino-azetidines metal complexes to be used as catalysts.   
Amino-azetidine 199aa (1.1 eq) was stirred with one equivalent of K2PtCl4 in refluxing MeOH for 16 hours 
to afford Pt(II)-amino-azetidine complex 213aaa in 65% yield (Scheme 71).
155
 The product was purified by 
flash chromatography and crystallisation with acetonitrile and diethyl ether. The structure of compound 
74 
 
213aaa was confirmed by 2D-NMR spectroscopy techniques. X-ray crystal structure analysis of compound 
213aaa, solved by Dr Louise Male, also confirmed Pt(II)-amino-azetidine complex was formed (Figure 20). 
 
Scheme 71. Synthesis of Pt(II)-amino-azetidine complex 213aaa 
 
 
Figure 20. X-ray crystal structure with ellipsoids drawn at the 50% probability level of Pt(II)-amino-azetidine complex 213aaa. 
Most of the hydrogen atoms have been omitted for clarity  
 
Amino-azetidine 199ah (1.1 eq) was stirred with one equivalent of Na2PdCl4 in MeOH for 16 hours at room 
temperature to afford Pd(II)-amino-azetidine complex 213aha.
155
 The product was obtained in 57% yield 
after purification by flash chromatography and crystallisation with acetonitrile and diethyl ether (Scheme 
72). X-ray crystal structure, solved by Dr Louise Male, along with 2D-NMR spectra analysis of compound 
213aha confirmed Pd(II)-amino-azetidine complex was formed (Figure 21). 
 




Figure 21. X-ray crystal structure with ellipsoids drawn at the 50% probability level of Pd(II)-amino-azetidine complex 213aha. 
Most of the hydrogen atoms have been omitted for clarity  
 
Amino-azetidine 199ga was refluxed with two equivalents of Pd2(dba)2 in toluene for 16 hours to afford the 
C,N,N Pd(II)-amino-azetidine complex 213gaa. The product was purified by flash chromatography and 
crystallisation with acetonitrile and diethyl ether in 73% yield (Scheme 73).
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 Analysis of 
1
H NMR 
spectrum of compound 213gaa proved to be inefficient in order to assign the structure of compound 213gaa 
due to the presence of too many broad peaks. However, X-ray crystal structure analysis of compound 
213gaa, solved by Dr Louise Male, showed the actual structure of C,N,N Pd(II)-amino-azetidine complex 
213gaa (Figure 22). 
 
Scheme 73. Synthesis of C,N,N Pd(II)-amino-azetidine complex 213gaa 
 
Figure 22. X-ray crystal structure with ellipsoids drawn at the 50% probability level of C,N,N Pd(II)-amino-azetidine complex 




Analysis of the X-ray structures of compounds 213aaa, 213aha and 213gaa revealed that the metal 
(palladium or platinum) is completely shielded by the two phenyl groups on the bottom face, whereas the top 
face is shielded only by one phenyl with the possibility to approach one side of the top face. This shielding 
effect of the phenyl groups would create a very good chiral environment around the metals making these 





Scheme 74. Suitable reactions for asymmetric Lewis-Acid catalysis with azetidine complexes 
2.2 Synthesis of Pyrrolidines 
It was already proved (Scheme 46) that cis-amino-pyrrolidines can be synthesised by reacting iodo-azetidine 
with ten equivalents of propylamine in DMSO at room temperature for 48 hours. Two different post-work-up 
iodo-azetidine cis-194a,k were reacted with ten equivalents of propylamine or pyrrolidine in DMSO at room 
temperature for 48 hours affording amino-pyrrolidines cis-200aj,kb as single diastereoisomers (no trans 















d.r. yield (%) (from 192) 
cis-200ab Ph Bn 
n
Pr >99:1 78 
cis-200aj Ph Bn pyr >99:1 81 
cis-200kb Cy Bn 
n
Pr >99:1 82 
Cy = cyclohexyl, pyr = pyrrolidine 
A similar approach was attempted with a different nucleophile such as hydroxide to probe whether cis-
hydroxyl-pyrrolidines could also be obtained. Post-work-up iodo-azetidine cis-194a,b,d were reacted with a 
solution of sodium hydroxide 2N in DMSO for 48 hours at room temperature to afford hydroxyl-pyrrolidines 
(cis)-214a,b,d as single diastereoisomers in respectively 82%, 79% and 72% yields (Table 27).  
 





 d.r. yield (%) (from 192) 
cis-214a Ph Bn >99:1 82 
cis-214b Ph Bn >99:1 79 
cis-214d Cy Bn >99:1 72 
78 
 
As reported in the literature, the possible mechanism for the formation of the alcohol might be via 
aziridinium salt formation as described in the introduction (Scheme 18).
62
 To support the hypothesis of an 
aziridinium salt formation iodo-pyrrolidine cis-195a was stirred for 48 hours with a solution of NaOH 2N in 
DMSO for 48 hours but the expected hydroxyl-pyrrolidine trans-214a was not obtained and starting material 
was fully recovered. Such experiment might perhaps suggest that the formation of an aziridinium salt 
intermediate is necessary for the synthesis of hydroxyl-pyrrolidines (Scheme 75). 
 
Scheme 75. Reaction of iodo-pyrrolidine cis-195a with NaOH 
 
Iodo-pyrrolidine cis-195a was then exposed to the same reaction conditions as shown above in (Scheme 75) 
but the temperature was changed to 80 
o
C and the desired hydroxyl-pyrrolidine trans-214a could still not be 
obtained. However, amino-pyrrolidines trans-200ab,aj,kb or triazole-pyrrolidines trans-215aa,ca,da were 
synthesised, when two different nucleophiles such as amine or azide, where used to displace iodine. Amino-
pyrrolidines trans-200ab,aj,kb were synthesised in 74-79% overall yields (from homoallylic amine 192) by 
treating iodo-pyrrolidines cis-195a,k with ten equivalents of the corresponding amines in DMSO at 80 
o
C for 
16 hours. The ratio of diastereoisomers was very good in all cases (>99:1) and only the trans 
diastereoisomers were detected from the analysis of the crude 
1















d.r. yield (%) (from 192) 
trans-200ab Ph Bn 
n
Pr >99:1 74 
trans-200aj Ph Bn pyr >99:1 78 
trans-200kb Cy Bn 
n
Pr >99:1 79 
Cy = cyclohexyl, pyr = pyrrolidine 
To synthesise triazole-pyrrolidines, iodo-pyrrolidines cis-195a,c,d were reacted with NaN3 at room 
temperature in DMF for 16 hours, at which point they were treated with copper iodide and phenylacetylene 
at 120 
o
C for four hours to afford triazole-pyrrolidines trans-215aa,ca,da as single diastereoisomers in 
respectively 65%, 61% and 57% yields (Table 29). The structures of the triazole-pyrrolidines were all 
assigned by 2D-NMR spectroscopy techniques and X-ray crystal structure analysis of compound trans-
215da, solved by Dr Louise Male, also confirmed the trans-stereochemistry (Figure 23). 
 





 d.r. yield (%) (from 192) 
trans-215aa Ph Bn >99:1 65 
trans-215ca Ph PTB >99:1 61 
trans-215da 3-Py Bn >99:1 57 
 
                                                                    
Figure 23. X-ray crystal structure with ellipsoids drawn at the 50% probability level of trans-215da. Most of the hydrogen atoms 




2.3 Oxidation of Secondary and Tertiary amines 
 
Oxidation of amines is a very important reaction for the synthesis of imines which are useful intermediates to 
access biological active nitrogen-containing compounds or nitrogen-containing molecules which could be 
used as catalysts. Oxidation of secondary benzylic amines to imines could also be a good method for N-
dibenzylation of secondary amines. Different procedures for oxidation of amines and N-debenzylation have 
already been reported in the literature
160-167
 and most of them involve the use of metals such as palladium, 
ruthenium and gold. Herein, a new methodology for the oxidation of secondary and tertiary amines and 
selective N-benzyl deprotection of secondary amines over N-benzyl deprotection of tertiary amines with 
commercially available reagents such as iodine and caesium carbonate is illustrated. This is the first time 
iodine and caesium carbonate have been reported as a very powerful tool for oxidation of amines affording 
excellent yields with no need of purification. Some of the needed secondary amines were prepared by 
condensation of different amines and aldehydes followed by reduction with NaBH4. Primary amines 216a-f 
were reacted with aldehydes 217a-f in refluxing methanol for four hours to produce the corresponding 
imines intermediate (218a-f), which were directly reduced with 1.5 equivalents of NaBH4 at room 
temperature for 16 hours to afford secondary amines 219a-f in 99% yield (Table 30). 
 





yield of 219 (%) 
a PMB Ph 99 
b PNB Ph 99 
c 
n
Pr Ph 99 
d CH2CH2OH Ph 99 
e Bn 2-Th 99 
f CH2(CH3)Ph Ph 99 
PMB = para-methoxy benzyl, PNB = para-nitro benzyl, Th = thiophene 
 
In order to establish optimum reaction conditions for oxidation of secondary amines, N-benzyl-1-
phenylethanamine was reacted with three equivalents of iodine under different base and solvent conditions. 
Caesium carbonate (entry 2, Table 31) and potassium carbonate (entry 5, Table 31) with acetonitrile as 
solvent, proved to be the best bases, affording the product (E)-N-benzylidene-1-phenylethanamine 189n in 
99% yield. When the reaction was tried without the base, starting material was completely recovered (entry 
81 
 
1, Table 31), showing the crucial role of the base. Benzaldehyde was formed as side product when sodium 
bicarbonate, sodium acetate and lithium acetate (entry 3, 4 and 8, Table 31) with acetonitrile as solvent, were 
used. (E)-N-benzylidene-1-phenylethanamine 189n was the main product in most of the cases suggesting 
that the less hindered proton was abstracted by the base. Acetonitrile and THF (entry 2 and 12, Table 31) 
proved to be the best solvents when caesium carbonate was used as base, yielding the product 189n in >99%, 
whereas the use of DMSO favoured the formation of 1-phenyl-N-(1-phenylethylidene)methanamine 220f 




Table 31. Oxidation of secondary amines: Base and solvent screening 
entry solvent base ratio of 219f (%) 
a 
ratio of 189n (%) 
a 
ratio of 220f (%) 
a 
ratio of PhCHO (%) 
a 
1 CH3CN - 100 - - - 
2 CH3CN Cs2CO3 - >99 - - 
3 CH3CN NaHCO3 81 13 - 6 
4 CH3CN NaOAc 49 35 - 16 
5 CH3CN K2CO3 - >99 - - 
6 CH3CN Li2CO3 65 27 - 8 
7 CH3CN LiOH 50 50 - - 
8 CH3CN LiOAc 74 7 - 19 
9 MeOH Cs2CO3 75 25 - - 
10 Et2O Cs2CO3 42 58 - - 
11 DMSO Cs2CO3 - 46 54 - 
12 THF Cs2CO3 - >99 - - 
13 DMF Cs2CO3 - 75 25 - 
a ratio elaborated by analysis of 1H NMR spectrum  
With the best conditions in hand, a screening of the oxidation reaction under different equivalents of iodine 
and caesium carbonate was also studied. One equivalent of iodine and three equivalents of caesium 
carbonate were deemed to be the best conditions (entry 6, Table 32). Only 8% of product 189n was obtained 
when 0.1 equivalents of caesium carbonate with one equivalent of iodine were used, showing no catalytic 
activity of the base (entry 1, Table 32). Iodine did not show catalytic activity either. In fact, the product 189n 
was obtained in only 20% yield when 0.1 equivalents of iodine and three equivalents of caesium carbonate 
were used (entry2, Table 32). It is of interest to note that by increasing the equivalents of iodine three-fold, 






Table 32. Screening of iodine and caesium carbonate equivalents. 
entry eq of I2 eq of Cs2CO3 conversion 189n (%) 
a 
1 1 0.1 8 
2 0.1 3 21 
3 1 1 41 
4 1 1.5 86 
5 1 2 88 
6 1 3 >99 
7 3 5 >99 
a ratio elaborated by analysis of 1H NMR spectrum. 
Several secondary amines were exposed to the optimised reaction conditions to understand the scope and 
limitation of this oxidation. A simple work-up with sodium thiosulfate, furnished the imines in very high 
yield (99%) and no further purification was needed (Table 33). The regioselective formation of the imine 
189f (entry 3, Table 33) suggested a possible mechanism where the most acidic proton reacts with the base 
(Scheme 76). A mixture of four isomers was detected by analysis of the 
1
H NMR spectrum when amine 219a 
was exposed to the reaction conditions, due to hydrolysis and recondensation of the two possible isomers 
189b and 189r. Nonetheless, only the two isomers 189b and 189r were obtained when five equivalents of 
anhydrous magnesium sulphate were added to the reaction mixture (entry 2, Table 33). The formation of 















Table 33. Oxidation of secondary amines with one equivalent of iodine and three equivalents of Cs2CO3 in CH3CN at rt. 







































40  99 
a isolated yield with no chromatography needed; b 5 equivalent of MgSO4 were added to the reaction conditions; 
c ratio elaborated by analysis of 1H NMR spectrum. 
 
Dibenzylamine 221 was reacted with one equivalent of iodine and three equivalents of caesium carbonate in 
acetonitrile for 90 minutes in the dark and product (E)-N-benzylidene-1-phenylmethanamine 189a (entry 1, 
Table 33) was formed in >99 % yield. The reaction proceeded with essentialy the same yield and selectivity 




Scheme 76. Most acidic proton is abstracted by the base 
 
To prove that this oxidation reaction might be completely selective between nitrogen and oxygen, 
dibenzylamine 221 and dibenzyl ether 226 were mixed together with one equivalent of iodine and three 
equivalents of caesium carbonate in acetonitrile for 16 hours. After work-up compound 226 was completely 
recovered unchanged, whereas compound 223 was completely converted to imine 189a in 99% (Scheme 77). 




Scheme 77. Oxidation of dibenzylamine in the presence of dibenzyl either  
 
The oxidation was tried on diamine 227 to show whether selective oxidation of secondary amine over 
tertiary amine could be possible. Diamine 227, prepared in 60% yield by condensation of the commercially 
available 1-benzylpiperidin-4-amine with benzaldehyde, followed by reduction with NaBH(OAc)3, was 
exposed to the oxidation reaction conditions. The imine 228 obtained in 99%, was hydrolised with a 3M 
solution of HCl at 60 
o
C to afford compound 229 in 99% yield. This experiment shows that N-benzyl 






Scheme 78. Benzylic deprotection of secondary amine over tertiary amine 
 
N-benzyl deprotection of secondary amine over tertiary amine was also attempted on amino-azetidine cis-
199aa. Compound cis-199aa was reacted with one equivalent of iodine and three equivalents of caesium 
carbonate in acetonitrile for two hours to produce the intermediate imine cis-230 (confirmed by mass spec), 
which was hydrolised with HCl 3M at 60 
o
C to deliver the unprotected amino-azetidine cis-231 in 89% 




Scheme 79. Benzylic deprotection of secondary amine over tertiary amine applied to amino-azetidine cis-199aa   
 
Different oxidising agent sources such as bromine, NBS and NIS were compared to iodine. Dibenzylamine 
221 was exposed to one equivalent of oxidising agent. Caesium carbonate was used as base and acetonitrile 
was the solvent of choice. When the reaction was left stirring for 1.5 hours, molecular iodine exhibited the 
best result (entry 2, Table 34). When the reaction was left stirring overnight, NIS proved to be a good 
oxidant showing complete conversion to the product although molecular iodine was still the best reagent due 
to the more straightforward purification. Molecular bromine and NBS did not allow the reaction to reach 







Table 34. Oxidation of dibenzylamine: Comparison between different oxidising agent sources 
  conversion after 
entry oxidant 1.5 h % 
a 
16 h % 
a 





3 NBS 62 70 
4 NIS 63 >99 
a ratio elaborated by analysis of 1H NMR spectrum.; b isolated yield with no chromatography needed. 
 
With the best conditions in hand, a solvent and base screening was investigated on the tertiary amine 232, 
which was prepared in 99% by reductive amination of compound 219f with acetaldehyde in the presence of 




Scheme 80. Preparation of tertiary amine 232 
 
Compound 232 was initially reacted with one equivalent of iodine and three equivalents of caesium 
carbonate in acetonitrile, and unfortunately, it was fully recovered unchanged after 24 hours. However, when 
three equivalents of iodine were used, secondary amine 219f was obtained in 83% yield. Imine 220f (11%) 
and benzaldehyde (6%) were also detected along with compound 219f through the analysis of the crude 
1
H 
NMR spectrum. The best conditions for this retro-alkylation of tertiary benzylamine 232 reaction were 
achieved when DMSO:H2O (5:1) as solvent and caesium carbonate as base were used. Starting material 232 
was completely converted to secondary amine 219f in 99% yield after work-up with no need of further 
purification (entry 9, Table 35). It is noteworthy that loss of benzyl group was observed when sodium acetate 
and CH3CN:H2O (5:1) were used, affording compound 233 in 38% yield against the most favoured product 






Table 35. Oxidation of tertiary amine 232: Base and solvent screening 
entry Solvent:H2O 
5:1 
base ratio of 232 
(%)
a 
ratio of 219f 
(%)
a 
ratio of 220f 
(%)
a 








1 CH3CN Cs2CO3 - 83 11 6 - 
1 CH3CN NaHCO3 - 73 - - 27 
2 CH3CN Na2CO3 - 56 39 5 - 
3 CH3CN NaOAc - 62 - - 38 
4 CH3CN K2CO3 - 59 34 7 - 
5 CH3CN Li2CO3 - 59 33 8 - 
6 CH3CN LiOH 50 50 - - - 
7 CH3CN LiOAc - 56 39 5 - 
8 DMF  Cs2CO3 - 74 26 - - 
9 DMSO Cs2CO3 - 99
b 
- - - 
10 THF Cs2CO3 58 28 12 2 - 
11 MeOH Cs2CO3 - 89 - - 11 
a ratio elaborated by analysis of 1H NMR spectrum; b isolated yield with no chromatography needed. 
 
Loss of alkyl group via iminium salt formation, followed by hydrolysis, occurred with a E2 elimination 
process where the base and the leaving group are in an antiperiplanar conformation ( 
Scheme 81).  
 
 








2.4 Azetidine as Organocatalyst for a Michael Addition Reaction 
 
The amino-azetidine (2S,4R)-199aa was exposed to the oxidation conditions previously described (Scheme 
79). Compound (2S,4R)-199aa was first reacted with one equivalent of iodine and three equivalents of 
caesium carbonate in acetonitrile for two hours, after which, it was treated with a 3M solution of HCl at 60 
o





Scheme 82. N-benzyl deprotection of enantioenriched amino-azetidine (2S,4R)-199aa 
 
Compound (2S,4R)-231 was tested as organocatalyst for a Michael addition reaction. As shown in the 
introduction (Scheme 16), azetidines with structure similar to (2S,4R)-231 had already been used in a 
Michael addition reaction.
51
 Dimethyl malonate (2 eq) was added to nitrostyrene in toluene for 24 hours, 
with 10% mol of the catalyst previously formed by stirring compound (2S,4R)-231 with 3-(-
bis(trifluoromethyl)phenyl isothiocyanate for 30 minutes (Scheme 83). Although the Michael adduct (S)-
dimethyl 2-(2-nitro-1-phenylethyl)malonate 234 was obtained in only 20% yield, the 89% ee showed 
azetidine (2S,4R)-231 is an active precatalyst for this reaction. Absolute stereochemistry (S) and ee of 







Scheme 83. Amino-azetidine (2S,4R)-231 as organocatalyst for a Michael addition reaction 
 
A possible transition state is shown below (Figure 24). The si-face attack might be speculated as favourable, 




Figure 24. Possible transition state for the Michael addition of malonate to nitrostyrene using amino-azetidine (2S,4R)-231 as 
precatalyst 
2.5 Biological Activity 
2.5.1 Exploration of Activity in a Zebrafish Assay with Selected Amino-Azetidines 
 
Zebrafish is an important vertebrate model organism for scientific research. It has been largely used for 
several biological screenings in the field of drug discovery.
171
 There are many advantages for the use of 
zebrafish. First of all, they are 1-1.5 inches long when they reach the adult stage, which means housing space 
is effectively reduced compared to when rats are used. Moreover, zebrafish embryos are transparent and this 
allows for easy identification of phenotypic traits. In addition to the optical clarity, there are many 
histochemical markers for zebrafish to be used with immunochemistry techniques. The rapid maturation of 
these organisms also allows easy experimentation for mutagenesis screenings.
172
  
Six different amino-azetidines were selected to be tested in a zebrafish assay (Figure 25). The biological 
screenings were conducted by Sundeep Dhillon under the supervision of Dr Ferenc Mueller from the 
Medical School at the University of Birmingham. The transgenic zebrafish were obtained by injecting the 
zebrafish’s embryos with a green fluorescent protein (GFP) and they were visualised with a fluorescent 




Figure 25. Azetidines selected for preliminary biological screening 
2.5.1.1 Morphology  
 
Table 36 shows images of the development of zebrafish embryos treated with the six selected azetidines at 
24 hrs post fertilization (hpf) (added as DMSO solutions) against a control and a DMSO blank. Three 
different concentration regimes were tested (10, 25 and 30 μM). Compound 199ae was found to cause 
morphological effects over the whole exposure period and 199ga was found to cause morphological effects 
at later time points. 
Table 36. Observation of zebrafish treated with DMSO solutions of chosen azetidines over 5 days: A) 10 μM, B) 25 μM and C) 30 
μM (24 hpf start).  
Additive A: 10 µM B: 25 µM C: 30 µM (24 hpf start) 
 









Control: DMSO added (xx mol.dm
-3











Table 37. Summary of effects of chosen azetidines on zebrafish embryos after 5 days.  


















/ blood clots 
199ae ++++ ++++ ++++ ++++ ++++ ++++ ++++ +++ ++++ 
199ja + - + - ++ - ++ - ++ 
199ga +++ - + - +++ - +++ - +++ 
199ac + - +/- - + - + - + 
199di +/- - - - +/- - +/- - +/- 
199ad +/- +/- +/- - + - + - + 
Control +/- - +/- - +/- - +/- - +/- 
Blank - - - - +/- - +/- - +/- 
++++ = very severe effect (75-100%); +++ = severe effect 50-75%); ++ moderate effect (25-50%); 













Figure 26. Specific characterisation of compound 199ae showed that it caused various effects. Compound 199ae at a concentration 
of 20 µM was found to significantly reduce movement of 6dpf zebrafish compared to controls (A), (n=60, p=<0.05). Analysis of 4dpf 
FLI fish that were treated with 50 μM 199ae at 2dpf showed no difference in vascular development when compared to their 
respective control, but they did present with delayed development. Analysis of 2dpf FLIGATA zebrafish treated at 8hpf with 50 μM 
199ae (C) under the green channel showed severely delayed growth with the tip of the tail not fully formed and the beginning of tail 
necrosis evident. Tail necrosis was found to occur in all embryos treated with 50 µM 199ae (D), (n=40). Analysis of 2dpf FLIGATA 
zebrafish treated at 8hpf with 50 μM 199ae (E) under the red channel showed reduced circulation with the formation of blood clots. 












2.5.2 Herbicide, Insecticide and Fungicide Screening of Azetidines and Pyrrolidines 
 
Nine azetidines and four pyrrolidines were provided to Syngenta to be tested as potential herbicide, fungicide 
or insecticide leads. Syngenta conducted the experiments and elaborated the following results.  
2.5.2.1 Results 
 
Test compounds- the results of the DES screening are given in Tables 42-45 (experimental section). 
Fungicide: Numerous compounds produced consistent weak activity against Septoria tritici, but this was not 
sufficient to warrant further testing, except for compound trans-200ab, which showed strong activity against 
two replicates. 
Herbicide: compound trans-200ab was also herbicidal against the dicotyledon Arabidopsis thaliana. No 
other compounds produced interesting activity. 
Insecticide: Only compound cis-199mb showed interesting activity being active against Diabrotica balteata 
on two replicates. Compound cis-199lb was active on one replicate against Plutella xylostella. This was not 
interesting enough to investigate further. No other compounds produced any activity. 
Positive controls- The positive control compounds performed as expected. 
3 Conclusion and Future Work 
 
A new methodology for the synthesis of cis iodo-azetidines and cis iodo-pyrrolidines employing iodine has 
been developed. Iodine displacement with different nucleophiles has furnished a new library of amino-
azetidines and amino-pyrrolidines with potential biological activity. Some of the amino-azetidine synthesised 
have shown biological activity in a zebrafish assay and herbicide, fungicide or insecticide assays. Compound 
trans-200ab proved to be active against Septoria tritici on two out of three replicates and it is currently under 
investigation in higher tier screening. This compound also showed herbicide activity against Arabidopsis 
thaliana and it is currently under investigation in the soil based glasshouse herbicide studies. Compound cis-
199mb proved to be active against the insect Diabrotica balteata on two out of three replicates and it is 
currently under investigation in higher tier insecticide screens. No other compounds were of interest. None of 
the compounds progressed to higher tier testing were active enough on these platforms to be of further 
interest to Syngenta. Synthesis of new azetidines and pyrrolidines as potential drugs is currently under 
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investigation in Dr John Fossey’s research group. Synthesis of enantioenriched amino-azetidines has also 
been achieved (Figure 27).  
 
Figure 27. Enantioenriched amino-azetidines (2S,4R)-199aa and (2S,4R)-199ab   
 
Amino-azetidine (2S,4R)-231 was used as organocatalyst for a Michael addition reaction, affording the 
product in 89% ee (Scheme 83). Work on the amino azetidines as organocatalysts is currently in progress in 
Dr John Fossey’s research group in order to improve yield and ee of the products.  
A successful oxidation of secondary and tertiary amines using iodine and caesium carbonate has been 
discovered. Such reaction has also been investigated as a method for N-debenzyl deprotection of secondary 
amines over N-debenzyl deprotection of tertiary amines (Scheme 79). N-benzyl deprotection of compound 
199 to access a new class of azetidines as catalysts is also under investigation in Dr John Fossey’s research 
group (Scheme 84). 
 
Scheme 84. N-benzyl deprotection of amino-azetidines 199 
 
Racemic amino-azetidines metal complexes have been synthesised. Asymmetric synthesis to afford 
enantioenriched 213aaa, 213aha, 213gaa and their uses as chiral Lewis acid catalysts is under investigation 
in Dr John Fossey’s research group (Figure 28). 
 




4 Experimental Section 
Commercially available solvents and reagents were used without further purification.  
1
H NMR spectra were 
recorded at 300 MHz on a Bruker AVIII300 NMR spectrometer, at 400 MHz on a AV400 NMR 
spectrometer and at 500 MHz on a DRX500 spectrometer, 
13
C NMR spectra at 100 MHz on a Bruker 
AVIII400 NMR spectrometer are proton decoupled and were recorded at room temperature unless otherwise 
stated, data was processed with Mestrec version 5.2.5-4731 and Topspin 2.0 (Version of: Nov 9th 2006). 
Chemical shifts (δ) are reported in ppm relative to TMS (δ 0.00) for the 
1
H NMR and to chloroform (δ 77.0) 
for the 
13
C NMR measurements, coupling constant J are expressed in Hertz, pendant technique was used for 
13
C NMR assignment. Mass spectra were recorded with electrospray MS Waters LCT Time of Flight Mass 
Spectrometer and with EI (GC/MS) Waters GCT Premier Time of Flight Mass Spectrometer. Enantiomeric 
excesses of compounds have been calculated by comparison of the specific rotation values  
4.1 General procedures 
4.1.1 General procedure A: synthesis of imine 
Amine (1.1 eq) was added to a solution of aldehyde (1eq) in ethanol (25 mL) and the mixture was stirred for 
four hours at 60 
o
C. Ethanol was removed in vacuo and the product was purified by quick filtration through a 
silica plug (EtOAc). 
4.1.2 General procedure B: synthesis of homoallylic amine (method a) 
Boron trifluoride diethyl etherate (3 eq) was added to a solution of imine (1 eq) in chloroform (25 mL) for 30 
minutes at rt, allyltributylstannane (1.5 eq) was added and the mixture was left stirring for 16 hours at rt. 
Chloroform was removed in vacuo, diethyl ether and H2O were added, the aqueous layer was neutralised 
with a solution of sodium bicarbonate and the product was extracted three times with ethyl acetate which was 
removed in vacuo to afford the product. 
4.1.3 General procedure C: synthesis of homoallylic amine (method b) 
Magnesium (2 eq) and allylbromide (1.5 eq) were added to dry THF (25 mL) at 0 
o
C and stirred for 15 
minutes after which imine (1 eq) was added. The mixture was left stirring at 0 
o
C for 15 minutes before it 
was left for 16 hours at rt. A saturated solution of sodium bicarbonate and ethylacetate were added. The 
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product was extracted from the aqueous layer with ethylacetate three times. Flash chromatography was used 
for further purification of the product in some cases.   
4.1.4 General procedure D: synthesis of cis-iodoazetidine 
Sodium bicarbonate (5 eq) iodine (3 eq) were added to homoallylamine (1 eq) in acetonitrile (25 mL). The 
mixture was stirred at rt for 16 hours and was monitored by TLC. When the reaction was completed solvent 
was removed in vacuo. To the residue thus obtained a solution of sodium thiosulfate was added, the 
compound was extracted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate and 
dried in vacuo to deliver “post-work-up” material.  
4.1.5 General procedure E: ring expansion of cis-iodoazetidine to cis-iodopyrrolidine 
Azetidines were refluxed for four hours in acetonitrile (20 mL). At which point the reactions were judged to 
be complete (by TLC), the solvent was removed in vacuo to deliver isomerised product.  
4.1.6 General procedure F: synthesis of cis-aminoazetidine 
Sodium bicarbonate (5 eq) and iodine (3 eq) were added to the homoallylamine (1 eq) in acetonitrile (50 
mL). The mixture was stirred at rt for 16 hours and it was monitored by TLC. When the reaction was 
completed, the solvent was removed in vacuo. To the residue thus obtained a solution of sodium thiosulfate 
was added, the compound was extracted with ethyl acetate, washed with water, dried over anhydrous 
magnesium sulfate and dried in vacuo to deliver “post-work-up” material. Post-work-up azetidine was stirred 
at rt for 24 hours in the corresponding neat amine, after which time sodium bicarbonate was added and the 
product was extracted with ethyl acetate. Unreacted amine was removed in vacuo and the residue was 
purified by flash chromatography. 
4.1.7 General procedure G: synthesis of cis-triazoleazetidine 
 
Post-work-up azetidine (1 eq) and sodium azide (2eq) were dissolved in DMF (20 mL) and were stirred at rt 
for 16 hours. Alkyne (1 eq) and copper(I) iodide (2 eq) were added and the reaction mixture was stirred at rt 
for 16 hours. The solvent was removed in vacuo, ethyl acetate was added and the resulting suspension was 
filtered through Celite to remove the inorganic salts. The filtrate was concentrated under reduced pressure 
and the product was purified by flash chromatography. 
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4.1.8 General procedure H: synthesis of cis-aminopyrrolidine 
Post-work-up iodo-azetidine (1 eq) was stirred with amine (10 eq) in DMSO (25 mL) for 48 hours at rt. 
Diethyl ether was added and the organic layer washed with a saturated solution of sodium bicarbonate and 
H2O three times. The solvent was removed in vacuo and the product purified by flash chromatography. 
4.1.9 General procedure J: synthesis of trans-aminopyrrolidine 
Post-work-up iodo-azetidine (1 eq) was heated at 50 °C in acetonitrile (20 mL) for four hours. The solvent 
was removed in vacuo, amine (10 eq) was added and the mixture was stirred at 80 
o
C for 16 hours in DMSO. 
Diethyl ether was added and the organic layer was washed with a saturated solution of sodium bicarbonate 
and H2O three times. The residue was concentrated under reduced pressure and the product was purified by 
flash chromatography. 
4.1.10 General procedure I: synthesis of cis-hydroxypyrrolidine 
Post-work-up iodo-azetidine was stirred in a 2N solution of NaOH (25 mL) and DMSO (25 mL) for 48 hours 
rt. Diethyl ether was added and the organic layer was washed with H2O three times. The solvent was 
removed in vacuo and the product purified by flash chromatography. 
4.1.11 General procedure L: synthesis of trans-triazolepyrrolidine 
Post-work-up iodo-azetidine was heated at 70 oC in DMSO (20 mL) for four hours, after cooling down, 
sodium azide (1.5 eq) was added and the mixture was stirred at rt for 16 hours. Ethynylbenzene (1eq) and 
copper (I) iodide (2eq) were added and the reaction mixture was heated at 80 °C for 4 hours. The solvent was 
removed in vacuo, ethyl acetate was added and the resulting suspension was filtered through Celite to 
remove the inorganic salts. The filtrate was concentrated under reduced pressure and the product was 
purified by flash chromatography. 
4.1.12 General procedure M: reductive amination (method a) 
 
Amine (1.1 eq) was added to a solution of aldehyde (1 eq) in methanol (25 mL) and the mixture was stirred 
for four hours at 60 
o
C after which it was cooled to rt. NaBH4 (2 eq) was added and the reaction was left 
stirring for 16 hours. The solvent was removed in vacuo and diethyl ether and a solution of HCl 1N were 
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added. The aqueous layer was basified with a saturated solution of sodium bicarbonate and the product was 
extracted with ethyl acetate three times and purified by flash chromatography in some cases. 
4.1.13 General procedure N: oxidation of secondary amine to imine 
Caesium carbonate (3 eq) and iodine (1 eq) were added to amine in acetonitrile (10 mL). Consumption of 
starting material was monitored by TLC. When the reaction was completed solvent was removed in vacuo. 
To the residue thus obtained a solution of sodium thiosulfate was added. The residue was extracted with ethyl 
acetate, washed with water, dried over anhydrous magnesium sulfate and dried in vacuo to deliver the 
corresponding imine.  
4.1.14 General procedure O: reductive amination (method b) 
 
Amine (1.1 eq) was added to a solution of aldehyde (1 eq) in dichloroethane (25 mL) after NaBH(OAc)3 (1.5 
eq) was added slowly. The mixture was stirred for 16 hours at rt. The solvent was removed in vacuo and 
diethyl ether and a solution of HCl 1N were added. The aqueous layer was basified with a saturated solution 
of  sodium bicarbonate and the product extracted with ethyl acetate three times and purified by flash 
chromatography in some cases. 
4.1.15 General procedure P: hydrolysis of imine 
The imine was stirred at 60 
o
C in HCl 3 M (15 mL) for one hour. Diethyl ether was added and the aqueous 
layer was neutralised with a solution of NaOH 2 M after which the product was extracted with chloroform 
three times. The solvent was removed in vacuo and the product was obtained with no need of further 
purification. 
4.1.16 (189a) (E)-N-benzylidene-1-phenylmethanamine 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), benzylamine 
(10.36 mmol, 1.11 g). Yellow oil, 1.83 g, 99%. IR 3062, 3027, 2871, 2839, 1642, 
1580, 1495, 1451, 1378, 1292; 
1
H NMR ( ; 300 MHz, CDCl3);
 
4.67 (2H, s, PhCH2), 7.13-7.31 (8H, m, PhH), 




H} NMR ( ; 100 MHz, CDCl3), 65.23 (CH2), 127.25 
(CH), 128.26 (CH), 128.59 (CH), 128.78 (CH), 128.86 (CH), 131.00 (CH), 136.53 (C), 139.75 (C), 162.04 
(CH). M/z: (ES
+





4.1.17 (189b) (E)-N-benzylidene-1-(4-methoxyphenyl)methanamine 
 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), (4-
methoxyphenyl)methanamine (10.36 mmol, 1.42 g). Yellow oil, 2.11 g, 99% 
.
1
H NMR ( ; 300 MHz, CDCl3);
 
3.77 (3H, s, OCH3), 4.75 (2H, s, PhCH2), 6.87 (2H, d, J = 8.7, ArH), 7.24 





( ; 100 MHz, CDCl3), 55.31 (CH3), 64.52 (CH2), 113.97 (CH), 128.29 (CH), 128.61 (CH), 129.23 (CH), 
130.73 (CH), 131.42 (C), 136.26 (C), 158.74 (C), 161.60 (CH). M/z: (ES
+
) 226.1 [M + H]
+
. 
4.1.18 (189c) (E)-N-benzylidene-1-(p-tolyl)methanamine 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), p-
tolylmethanamine (10.36 mmol, 1.26 g). Yellow oil, 1.96 g, 99%. 
1
H NMR ( ; 
300 MHz, CDCl3);
 
2.23 (3H, s, CH3), 4.66 (2H, s, NCH2), 7.06 (2H, d, J = 8.0, ArH), 7.17 (2H, d, J = 8.0, 




H} NMR ( ; 100 MHz, 
CDCl3), 21.39 (CH3), 65.03 (CH2), 128.25 (CH), 128.56 (CH), 128.81 (CH), 129.45 (CH), 130.90 (CH), 
136.60 (C), 136.67 (C), 161.67 (CH). M/z: (ES
+
) 210.1 [M + H]
+
. 
4.1.19 (189d) (E)-1-phenyl-N-(pyridin-3-ylmethylene)methanamine 
General procedure A was used: nicotinaldehyde (9.34 mmol, 1.00 g), benzylamine 
(10.27 mmol, 1.10 g). Yellow oil, 1.82 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
4.70 (2H, s, PhCH2), 7.11-7.29 (6H, m, ArH), 8.00 (1H, dt, J = 7.9 & 1.8, ArH), 8.19 (1H, s, CH=NCH2), 




H} NMR ( ; 100 MHz, CDCl3), 64.93 
(CH2), 123.50 (CH), 127.02 (CH), 127.91 (CH), 128.45 (CH), 131.56 (C), 134.39 (CH), 138.94 (C), 150.13 
(CH), 151.35 (CH), 158.78 (CH). M/z: (ES
+
) 197.1 [M + H]
+
.  
4.1.20 (189e) (E)-1-phenyl-N-(pyridin-4-ylmethylene)methanamine 
General procedure A was used: isonicotinaldehyde (9.34 mmol, 1.00 g), 
benzylamine (10.27 mmol, 1.10 g). Yellow oil, 1.82 g, 99%. 
1
H NMR ( ; 300 
MHz, CDCl3);
 
4.88 (2H, s, PhCH2), 7.28-7.41 (5H, m, ArH), 7.65 (2H, dd, J = 4.5 & 1.6, ArH), 8.38 (1H, s, 




H} NMR ( ; 100 MHz, CDCl3), 65.13 (CH2), 122.03 
99 
 
(CH), 127.29 (CH), 128.05 (CH), 128.63 (CH), 138.42 (C), 142.86 (C), 150.43 (CH), 159.88 (CH). M/z: 
(ES
+
) 197.1 [M + H]
+
.  
4.1.21 (169f) (E)-N-(4-nitrobenzylidene)-1-phenylmethanamine 
 
General procedure A was used: 4-nitrobenzaldehyde (6.62 mmol, 1.00 g), 
benzylamine (7.28 mmol, 780 mg). Yellow solid, 1.48 g, 99%. IR 3000, 
2934, 2904, 2835, 1636 1509, 1372, 1342, 1243; 
1
H NMR ( ; 300 MHz, CDCl3);
 
4.75 (2H, s, PhCH2), 7.13-





NMR ( ; 100 MHz, CDCl3), 65.19 (CH2), 123.85 (CH), 127.32 (CH), 128.10 (CH), 128.67 (CH), 128.95 
(CH), 138.57 (C), 141.67 (C), 149.08 (C), 159.49 (CH). M/z: (ES
+
) 241.1 [M + H]
+
. 
4.1.22 (189g) (E)-N-(2-bromobenzylidene)-1-phenylmethanamine 
General procedure A was used: 2-bromobenzaldehyde (5.40 mmol, 1.00 g), 
benzylamine (5.94 mmol, 637 mg). Brown oil, 1.47 g, 99%. 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
4.82 (2H, s, PhCH2), 7.17-7.34 (7H, m, ArH), 7.63 (m, 1H, ArH), 8.06 




H} NMR ( ; 100 MHz, CDCl3), 65.23 (CH2), 125.22 (C), 
127.16 (CH), 127.67 (CH), 128.09 (CH), 128.62 (CH), 129.05 (CH), 131.95 (CH), 133.08 (CH), 134.63 (C), 
139.12 (C), 160.96 (CH). M/z: (ES
+
) 274.02 [M + H]
+
.  
4.1.23 (189h) (E)-N-(2,2-dimethylpropylidene)-1-phenylmethanamine  
General procedure A was used: pivalaldehyde (11.61 mmol, 1.00 g), benzylamine 
(12.77 mmol, 1.37 g). Yellow oil, 1.69 g, 83%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.11 
(9H, s, tert-butyl),
  




H} NMR ( ; 100 
MHz, CDCl3), 27.01, 3 x (CH3), 64.58 (CH2), 126.75 (CH), 127.59 (CH), 128.36 (CH), 139.73 (C), 173.35 
(CH). M/z: (ES
+
) 176.1 [M + H]
+
. 
4.1.24  (189j) (E)-N-(furan-3-ylmethylene)-1-phenylmethanamine 
 
General procedure A was used: furan-3-carbaldehyde (10.41 mmol, 1.00 g), 
benzylamine (11.45 mmol, 1.23 g). Yellow oil, 1.92 g, 99%. 
1





4.56 (2H, s, PhCH2), 6.70 (1H, d, J= 2.1, ArH), 7.05-7.22 (6H, m, ArH), 7.52 (1H, s, ArH), 




H} NMR ( ; 100 MHz, CDCl3), 65.22 (CH2), 108.12 (CH), 125.69 (C), 127.11 
(CH), 128.12 (CH), 128.61 (CH)  139.39 (C), 144.12 (CH), 145.45 (CH), 153.65 (CH). M/z: (ES
+




4.1.25 (189m) (E)-1-(4-methoxyphenyl)-N-(2-nitrobenzylidene)methanamine 
 
General procedure A was used: 2-nitrobenzaldehyde (6.62 mmol, 1.00 g), 
(4-methoxyphenyl)methanamine (7.28 mmol, 998 mg). Yellow oil, 1.77 g, 
99%.
1
H NMR ( ; 300 MHz, CDCl3);
 
3.80 (3H, s, OCH3), 4.83 (2H, s, 
NCH2), 6.92 (2H, d, J = 8.7, ArH), 7.30 (2H, d, J = 8.7, ArH), 7.54 (1H, t, J = 8.1, ArH), 7.64 (1H, t, J = 7.5, 





NMR ( ; 100 MHz, CDCl3), 55.27 (CH3), 64.70 (CH2), 114.04 (CH), 124.28 (CH), 129.39 (CH), 129.84 
(CH), 130.62 (C), 130.70 (CH), 131.28 (C), 133.45 (CH), 148.88 (C), 157.35 (CH), 158.88 (C). M/z: (ES
+
) 
271.1 [M + H]
+
. 
4.1.26 (189n) (S,E)-N-benzylidene-1-phenylethanamine 
 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), (S)-1-
phenylethanamine (10.36 mmol, 1.26 g). Yellow oil, 1.60 g, 81%. 
1
H NMR ( ; 300 
MHz, CDCl3);
 
1.64 (3H, d, J = 6.0, CH3), 4.61 (1H, q, J = 6.0, CHCH3), 7.30 (1H, m,  PhH), 7.45 (7H, m, 




H} NMR ( ; 100 MHz, CDCl3), 24.92 (CH3), 69.78 
(CH), 126.67 (CH), 126.86 (CH), 128.30 (CH), 128.46 (CH), 128.56 (CH), 130.60 (CH), 136.47 (C), 145.25 
(C), 159.46 (CH). M/z: (ES
+
) 210.1 [M + H]
+
. 
4.1.27 (189o) (E)-(3-((benzylimino)methyl)cyclopent-3-en-1-yl)(cyclopent-3-en-1-yl)iron 
 
General procedure A was used: cyclopent-3-en-1-yl(3-formylcyclopent-3-en-1-
yl)iron (2.34 mmol, 500 mg), benzylamine (2.80 mmol, 302 mg). Black oil, 289 mg, 
40%. 
1
H NMR ( ; 300 MHz, CDCl3); 3.87 (3H, m, PhCH2N & FcH), 4.28 (2H, t, J 
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H} NMR ( ; 100 
MHz, CDCl3), 65.15 (CH2), 68.66 (CH), 69.12 (CH), 69.70 (CH), 70.53 (CH), 73.27 (CH), 80.59 (C), 126.91 
(CH), 127.90 (CH), 128.51 (CH), 139.70 (C), 162.24 (CH). M/z: (ES
+
) 308.1 [M + H]
+
.  
4.1.28 (189p) (E)-N-benzylidene-1-cyclohexylmethanamine 
 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), 
cyclohexylmethanamine (10.36 mmol, 1.17 g). Colourless oil, 1.84 g, 97%. 
1
H 
NMR ( ; 300 MHz, CDCl3);
 
0.81-0.92 (2H, m), 1.02-1.23 (3H, m),
 
1.53-1.68 (6H, m), 3.33 (2H, d, J = 6.3, 




H} NMR ( ; 100 MHz, 
CDCl3), 26.17 (CH2), 26.66 (CH2), 31.52 (CH2), 39.04 (CH), 68.71 (CH2), 128.05 (CH), 128.52 (CH), 
130.36 (CH), 136.45 (C), 160.67 (CH). M/z: (ES
+
) 202.1 [M + H]
+
. 
4.1.29 (189q) (E)-N-benzylidenepropan-1-amine 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), propylamine 
(10.36 mmol, 612 mg). Yellow oil, 1.21 g, 87%. IR 2962, 2931, 2874, 1645, 1580, 
1451, 1379, 1338; 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.85 (3H, t, J = 7.4, CH3), 1.56-1.68 (2H, m, CH2CH3),
 




H} NMR ( ; 100 MHz, CDCl3), 11.88 (CH3), 24.10 (CH2), 65.33 (CH2), 128.03 (CH), 128.55 (CH), 
130.43 (CH), 136.40 (C), 160.74 (CH). M/z: (EI
+
) 146.1 [M + H]
+
. 
4.1.30 (189r) (E)-N-(4-methoxybenzylidene)-1-phenylmethanamine 
 
General procedure A was used: 4-methoxybenzaldehyde (7.34 mmol, 1.00 
g), benzylamine (8.08 mmol, 868 mg). Yellow oil, 1.57 g, 95%. 
1
H NMR ( ; 
300 MHz, CDCl3);
 
3.74 (3H, s, OCH3), 4.74 (2H, s, PhCH2), 6.88 (2H, d, J = 9.0, ArH), 7.19-7.26 (1H, m, 




H} NMR ( ; 100 MHz, 
CDCl3), 55.36 (CH3), 65.02 (CH2), 114.06 (CH), 126.97 (CH), 128.02 (CH), 128.53 (CH), 129.25 (C), 
129.91 (CH), 139.73 (C), 161.31 (CH), 161.79 (C). M/z: (ES
+






4.1.31 (189s) (E)-1-phenyl-N-(pyridin-2-ylmethylene)methanamine 
General procedure A was used: picolinaldehyde (9.34 mmol, 1.00 g), benzylamine 
(10.27 mmol, 1.10 g). Yellow oil, 1.82 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
4.82 (2H, s, PhCH2), 7.15-7.25 (2H, m, ArH), 7.27-7.35 (4H, m, ArH), 7.59 (1H, t, J = 8.1, ArH), 8.02 (1H, 




H} NMR ( ; 100 MHz, CDCl3), 
64.83 (CH2), 121.22 (CH), 124.73 (CH), 127.10 (CH), 128.14 (CH), 128.52 (CH), 136.38 (CH), 138.82 (C), 
149.33 (CH), 154.55 (C), 162.73 (CH). M/z: (ES
+
) 176.1 [M + H]
+
. 
4.1.32  (189t) (E)-N-(2-(benzylideneamino)ethyl)acetamide 
 
General procedure A was used: benzaldehyde (9.42 mmol, 1.00 g), N-(2-
aminoethyl)acetamide (10.36 mmol, 1.06 g). Yellow oil, 932 mg, 52%. 
1
H NMR 
( ; 300 MHz, CDCl3);
 
1.98 (3H, s, CH3), 3.59 (2H, t, J = 5.8, CH2NH), 3.70-





H} NMR ( ; 100 MHz, CDCl3), 23.22 (CH3), 40.36 (CH2), 60.35 (CH2) 128.15 (CH), 128.68 
(CH), 130.97 (CH), 135.85 (C), 162.71 (CH), 170.19 (C). M/z: (ES
+
) 191.1 [M + H]
+
. 
4.1.33 (189u) (E)-N-(anthracen-9-ylmethylene)-1-phenylmethanamine 
General procedure A was used: anthracene-9-carbaldehyde (4.85 mmol, 1.00 g), 
benzylamine (5.33 mmol, 571 mg). Orange solid, 988 mg, 69%. 
1
H NMR ( ; 300 
MHz, CDCl3);
 
5.18 (2H, s, PhCH2), 7.31-7.57 (9H, m, ArH), 8.05 (2H, dd, J = 7.3 & 




H}NMR ( ; 100 MHz, 
CDCl3), 57.66 (C), 66.80 (CH2), 124.82 (CH), 125.26 (CH), 126.76 (CH), 127.18 (CH), 128.25 (CH), 128.69 
(CH), 128.89 (CH), 129.51 (CH), 130.11 (C), 131.30 (C), 139.20 (C), 161.18 (CH). M/z: (ES
+




4.1.34 (189v) (E)-N-benzylidene-2-methylpropan-2-amine 
General procedure A was used: benzaldehyde (4.71 mmol, 500 mg), 2-methylpropan-2-
amine (5.18 mmol, 379 mg). Colourless Oil, 349 mg, 46%. 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
1.29 (9H, s, tert-butyl), 7.34-7.38 (3H, m, PhH), 7.72-7.75 (2H, m, PhH), 8.25 
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H} NMR ( ; 100 MHz, CDCl3), 29.79 3x(CH3), 127.95 (CH), 128.53 (CH), 130.18 
(CH), 137.25 (C), 155.07 (CH). M/z: (ES
+
) 162.1 [M + H]
+
. 
4.1.35  (189w) (E)-1-phenyl-N-(thiophen-2-ylmethylene)methanamine 
 
General procedure A was used: thiophene-2-carbaldehyde (8.92 mmol, 1.00 g), 
benzylamine (9.81 mmol, 1.05 g). Yellow oil, 1.78 g, 99%. 
1
H NMR ( ; 300 MHz, 
CDCl3);
 





H} NMR ( ; 100 MHz, CDCl3), 64.54 (CH2), 127.13 (CH), 127.50 (CH), 128.14 (CH), 128.62 
(CH), 129.15 (CH), 130.79 (CH), 139.24 (C), 142.60 (C), 155.27 (CH). M/z: (ES
+
) 202.1 [M + H]
+
. 
4.1.36 (189x) (E)-N-((1H-indol-3-yl)methylene)-1-phenylmethanamine 
 
General procedure A was used: 1H-indole-3-carbaldehyde (6.89 mmol, 1.00 g), 
benzylamine (7.58 mmol, 812 mg). Yellow solid, 1.52 g, 94%. 
1
H NMR ( ; 300 
MHz, CDCl3);
 




H} NMR ( ; 100 MHz, CDCl3), 65.44 (CH2), 111.46 (CH), 115.36 (C), 121.38 (CH), 121.58 (CH), 
123.28 (CH), 125.53 (C), 126.83 (CH), 127.90 (CH), 128.50 (CH), 128.85 (CH), 136.80 (C), 140.39 (C), 
156.76 (CH). M/z: (ES
+
) 235.1 [M + H]
+
. 
4.1.37  (192a) N-benzyl-1-phenylbut-3-en-1-amine 
 
General procedure B was used: (E)-N-benzylidene-1-phenylmethanamine (5.63 
mmol, 1.10 g), allyltributylstannane (8.44 mmol, 2.80 g), boron trifluoride diethyl 
etherate (16.89 mmol, 2.34 g). Yellow oil, 1.15 g, 86%. General procedure C was 
used: (E)-N-benzylidene-1-phenylmethanamine (5.12 mmol, 1.00 g), allylbromide (7.68 mmol, 929 mg), 
magnesium (10.24 mmol, 249 mg). Yellow oil, 1.21 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.86 (1H, br, 
NH), 2.26-2.36 (2H, m, NHCHCH2), 3.49 (2H, ABq, JAB = 13.3, PhCH2), 3.56-3.60 (1H, m, NHCH), 4.96 
(1H, ddt, J = 10.3, 2, 2, CH=CHH), 5.01, (1H, ddt, J = 17.1, 2, 2, CH=CHH), 5.59 (1H, ddt, J = 17.1, 10.3, 




H} NMR ( ; 100 MHz, CDCl3), 43.28 (CH2), 51.57 (CH2), 
61.76 (CH), 117.63 (CH2), 126.93 (CH), 127.17 (CH), 127.41 (CH), 128.22 (C), 128.44 (CH), 128.51 (CH), 
135.58 (CH), 140.76 (C), 143.96 (C). High-resolution MS calcd for C17H20N: 238.1595; found: 238.1584.  
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= 57.8 (c 11.4, CHCl3). 
1




H} NMR same as 172a. M/z: 
(ES
+




4.1.39 (192b) N-(4-methoxybenzyl)-1-phenylbut-3-en-1-amine 
 
General procedure B was used: (E)-N-benzylidene-1-(4-
methoxyphenyl)methanamine (4.44 mmol, 1.00 g), allyltributylstannane 
(6.66 mmol, 2.20 g), boron trifluoride diethyl etherate (13.32 mmol, 1.89 g). 
Yellow oil, 1.18 g, 99%. General procedure C was used: (E)-N-benzylidene-1-(4-
methoxyphenyl)methanamine (4.44 mmol, 1.00 g), allylbromide (6.66 mmol, 805 mg), magnesium (8.88 
mmol, 216 mg). Yellow oil, 1.21 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
2.13 (1H, br, NH), 2.38-2.43 (2H, 
m, NHCHCH2), 3.54 (2H, ABq, JAB = 13.0, NHCH2), 3.68 (1H, apt.t, obs.J = 6.8, NHCH), 3.77 (3H, s, CH3), 
5.01-5.09 (2H, m, CH=CH2), 5.68 (1H, ddt, J = 16.2, 10.1, 6.5, CH=CH2), 6.83 (2H, d, J = 8.6, ArH), 7.16 




H} NMR ( ; 100 MHz, CDCl3), 42.99 (CH2), 50.80 
(CH2), 55.27 (CH3), 61.57 (CH), 113.79 (CH), 117.61 (CH2), 127.14 (CH), 127.37 (CH), 128.35 (CH), 
129.36 (CH), 132.44 (C), 135.38 (CH), 143.58 (C), 158.76 (C). M/z: (ES
+
) 268.3 [M + H]
+
. 
4.1.40 (192c) N-(4-methylbenzyl)-1-phenylbut-3-en-1-amine 
General procedure B was used: (E)-N-benzylidene-1-(p-tolyl)methanamine (4.78 
mmol, 1.00 g), allyltributylstannane (7.17 mmol, 2.37 g), boron trifluoride 
diethyl etherate (14.34 mmol, 2.03 g). Yellow oil, 505 mg, 42%. General 
procedure C was used: (E)-N-benzylidene-1-(p-tolyl)methanamine (8.74 mmol, 1.83 g), allylbromide (13.12 
mmol, 1.59 g), magnesium (17.48 mmol, 425 mg). Yellow oil, 2.18 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.70 (1H, br, NH), 2.32 (3H, s, CH3), 2.37-2.43 (2H, m, NHCHCH2), 3.55 (2H, ABq, JAB = 13.2, NHCH2), 
3.68 (1H, dd, J = 7.6 & 6.2, NHCH), 5.00-5.09 (2H, m, CH=CH2), 5.76 (1H, ddt, J = 17.1, 10.3, 7.1, 




H} NMR ( ; 100 MHz, CDCl3), 21.13 (CH3), 43.17 (CH2), 51.17 
(CH2), 61.56 (CH), 117.53 (CH2), 127.05 (CH), 127.36 (CH), 128.11 (CH), 128.40 (CH), 129.05 (CH), 
135.53 (CH), 136.37 (C), 137.60 (C), 143.91 (C). M/z: (ES
+





4.1.41 (192d) N-benzyl-1-(pyridin-3-yl)but-3-en-1-amine 
 
General procedure B was used: (E)-1-phenyl-N-(pyridin-3-
ylmethylene)methanamine (7.64 mmol, 1.50 g), allyltributylstannane (11.46 mmol, 
3.80 g), boron trifluoride diethyl etherate (22.92 mmol, 3.25 g). Yellow oil, 1.78 g, 
98%. General procedure C was used: (E)-1-phenyl-N-(pyridin-3-ylmethylene)methanamine (5.09 mmol, 1.00 
g), allylbromide (7.63 mmol, 925 mg), magnesium (10.18 mmol, 247 mg). Yellow oil, 1.21 g, 99%. 
1
H NMR 
( ; 300 MHz, CDCl3);
 
2.10 (1H, br, NH),  2.39-2.44 (2H, m, NHCHCH2), 3.60 (2H, ABq, JAB = 13.3, 
NHCH2), 3.74 (1H, apt.t, obs.J = 6.8, NHCH), 5.05-5.12 (2H, m, CH=CH2), 5.63-5.77 (1H, m, CH=CH2), 7.22-





H} NMR ( ; 100 MHz, CDCl3), 42.86 (CH2), 51.46 (CH2), 59.20 (CH), 118.34 (CH2), 123.53 
(CH), 127.02 (CH), 128.06 (CH), 128.43 (CH), 134.53 (CH), 134.81 (CH), 139.02 (C), 140.07 (C), 148.66 
(CH), 149.49 (CH). M/z: (ES
+
) 239.1 [M + H]
+
. 
4.1.42 (192e) N-benzyl-1-(pyridin-4-yl)but-3-en-1-amine 
General procedure B was used: (E)-1-phenyl-N-(pyridin-4-
ylmethylene)methanamine (5.09 mmol, 1.00 g), allyltributylstannane (7.63 mmol, 
2.53 g), boron trifluoride diethyl etherate (15.27 mmol, 2.17 g). Yellow oil, 1.12 g, 
92%. General procedure C was used: (E)-1-phenyl-N-(pyridin-4-ylmethylene)methanamine (5.09 mmol, 1.00 
g), allylbromide (7.63 mmol, 925 mg), magnesium (10.18 mmol, 247 mg). Yellow oil, 1.21 g, 99%. 
1
H NMR 
( ; 300 MHz, CDCl3);
 
2.32-2.48 (2H, m, NHCHCH2), 3.62 (2H, ABq, JAB = 13.3, NHCH2), 3.67-3.75 (1H, 
m, NHCH), 4.97-5.11 (2H, m, CH=CH2), 5.61-5.75 (1H, m, CH=CH2), 7.25-7.42 (7H, m, ArH), 8.56 (2H, d, 




H} NMR ( ; 100 MHz, CDCl3), 42.37 (CH2), 51.50 (CH2), 60.70 (CH), 118.57 (CH2), 
122.67 (CH), 127.22 (CH), 128.10 (CH), 128.47 (CH), 134.16 (CH), 139.65 (C), 149.74 (CH), 152.96 (C). 
M/z: (ES
+
) 239.1 [M + H]
+
. 
4.1.43 (192f) N-benzyl-1-(4-nitrophenyl)but-3-en-1-amine 
 
General procedure B was used: (E)-N-(4-nitrobenzylidene)-1-
phenylmethanamine (4.16 mmol, 1.00 g), allyltributylstannane (6.24 mmol, 
106 
 
2.07 g), boron trifluoride diethyl etherate (12.48 mmol, 1.77 g). Yellow oil, 951 mg, 81%. 
1
H NMR ( ; 300 
MHz, CDCl3); 1.88 (1H, br, NH), 
 
2.30-2.45 (2H, m, NHCHCH2), 3.61 (2H, ABq, JAB = 13.5, NHCH2), 3.82 
(1H, dd, J = 7.8 & 5.8), 5.03-5.10 (2H, m, CH=CH2), 5.61-5.75 (1H, m, CH=CH2), 7.22-7.36 (5H, m, ArH), 




H} NMR ( ; 100 MHz, CDCl3), 42.94 (CH2), 
51.61 (CH2), 61.16 (CH), 118.60 (CH2), 123.72 (CH), 126.97 (CH), 128.01 (CH), 128.13 (CH), 128.47 
(CH), 134.23 (CH), 139.92 (C), 147.20 (C), 151.83 (C). M/z: (ES
+
) 283.1 [M + H]
+
. 
4.1.44 (192g) N-benzyl-1-(2-bromophenyl)but-3-en-1-amine 
 
General procedure B was used: (E)-N-(2-bromobenzylidene)-1-
phenylmethanamine (2.70 mmol, 740 mg), allyltributylstannane (4.05 mmol, 1.34 
g), boron trifluoride diethyl etherate (8.10 mmol, 1.15 g). Yellow oil, 478 mg, 
56%. General procedure C was used: (E)-N-(2-bromobenzylidene)-1-phenylmethanamine (4.33 mmol, 1.37 
g), allylbromide (6.50 mmol, 786 mg), magnesium (8.66 mmol, 210 mg). Brown oil, 1.31 g, 96%. 
1
H NMR 
( ; 300 MHz, CDCl3);
 
1.85 (1H, br, NH),  2.19-2.30 (1H, m, NHCHCHH), 2.46-2.56 (1H, m, NHCHCHH), 
3.58 (2H, ABq, JAB = 13.1, NHCH2), 4.22 (1H, dd, J = 8.5 & 4.5), 5.05-5.12 (2H, m, CH=CH2), 5.70-5.84 
(1H, m, CH=CH2), 7.10 (1H, td,  J = 7.5 & 1.8, ArH), 7.20-7.36 (6H, m, ArH), 7.54 (1H, dd, J = 8.0 & 1.2, 




H} NMR ( ; 100 MHz, CDCl3), 41.41 (CH2), 51.64 (CH2), 
59.94 (CH), 117.92 (CH2), 124.15 (C), 126.91(CH), 127.66 (CH), 128.16 (CH), 128.37 (CH), 132.87 (CH), 
135.09 (CH), 140.45 (C), 142.32 (C). M/z: (ES
+
) 316.1 [M + H]
+
. 
4.1.45 (192h) N-benzyl-2,2-dimethylhex-5-en-3-amine 
General procedure B was used: (E)-N-(2,2-dimethylpropylidene)-1-
phenylmethanamine (3.99 mmol, 700 mg), allyltributylstannane (5.99 mmol, 1.98 g), 
boron trifluoride diethyl etherate (11.97 mmol, 1.70 g). Yellow oil, 771 mg, 89%. 
General procedure C was used: (E)-N-(2,2-dimethylpropylidene)-1-phenylmethanamine (7.36 mmol, 1.29 g), 
allylbromide (11.04 mmol, 1.33 g), magnesium (14.72 mmol, 358 mg). Purified by flash chromatography 
(Hexane : EtOAc 95:5 Rf 0.3), coulourless oil, 1.14 g, 71%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.93 (9H, s, tert-
butyl), 1.94 (1H, dt, J = 14.2 & 8.7, NHCHCHH), 2.22 (1H, dd, J = 9.0 & 3.4, NHCH), 2.39-2.48 (1H, m, 
NHCHCHH), 3.77 (2H, ABq, JAB = 12.6, NHCH2), 5.00-5.10 (2H, m, CH=CH2), 5.81-5.94 (1H, m, 
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H} NMR ( ; 100 MHz, CDCl3), 26.91 (CH3), 35.62 (C), 36.07 
(CH2), 54.93 (CH2), 66.28 (CH), 116.48 (CH2), 126.99 (CH), 128.30 (CH), 128.45 (CH), 137.65 (CH), 
140.52 (C). M/z: (ES
+
) 218.1 [M + H]
+
. 
4.1.46 (192i) N-benzyl-1-(3-methoxyphenyl)but-3-en-1-amine 
 
General procedure C was used: (E)-N-(3-methoxybenzylidene)-1-
phenylmethanamine (4.40 mmol, 1.00 g), allylbromide (6.60 mmol, 798 
mg), magnesium (8.80 mmol, 214 mg). Yellow oil, 1.17 g, 99%. 
1
H NMR 
( ; 300 MHz, CDCl3);
 
1.79 (1H, br, NH), 2.38-2.43 (2H, m, NHCHCH2), 3.61 (2H, ABq, JAB = 13.3, 
NHCH2), 3.67 (1H, apt.t, obs.J = 6.8, NHCH), 3.86 (3H, s, CH3), 5.04-5.15 (2H, m, CH=CH2), 5.68-5.81 (1H, 




H} NMR ( ; 100 
MHz, CDCl3), 44.21 (CH2), 51.58 (CH2), 55.32 (CH3), 61.08 (CH), 112.62 (CH), 113.81 (CH), 117.47 
(CH2), 121.02 (CH), 126.85 (CH), 128.17 (CH), 128.36 (CH), 135.67 (CH), 135.86 (C), 140.75 (C), 158.72 
(C). M/z: (ES
+
) 268.1 [M + H]
+
. 
4.1.47 (192j) N-benzyl-1-(furan-3-yl)but-3-en-1-amine 
 
General procedure B was used: (E)-N-(furan-3-ylmethylene)-1-phenylmethanamine 
(5.40 mmol, 1.00 g), allyltributylstannane (8.10 mmol, 2.68 g), boron trifluoride 
diethyl etherate (16.20 mmol, 2.30 g). Yellow oil, 258 mg, 21%. General procedure 
C was used: (E)-N-(furan-3-ylmethylene)-1-phenylmethanamine (3.72 mmol, 690 mg), allylbromide (5.59 
mmol, 676 mg), magnesium (7.44 mmol, 181 mg). Yellow oil, 761 mg, 90%. 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
2.32 (2H, dd, J = 9.8 & 4.0, NHCHCH2), 3.58 (2H, ABq, JAB = 13.2, NHCH2), 3.58 (1H, apt.t, obs.J = 
6.7, NHCH), 4.97 (1H, ddt, J = 10.2, 2.2, 2.0, CH=CHH), 5.49 (1H, ddt, J = 17.1, 2.2, 2.0, CH=CHH) 5.62 




H} NMR ( ; 100 
MHz, CDCl3), 45.05 (CH2), 51.67 (CH2), 57.34 (CH), 111.65 (CH), 116, 73 (CH2), 126.84 (CH), 128.07 
(CH), 128.18 (CH), 136.75 (CH), 131.52 (C), 138.14 (CH), 140.62 (C), 142.24 (CH). M/z: (ES
+







4.1.48 (192k) N-benzyl-1-cyclohexylbut-3-en-1-amine 
 
General procedure C was used: (E)-N-benzylidene-1-cyclohexylmethanamine (5.46 
mmol, 1.10 g), allylbromide (8.26 mmol, 1.00 g), magnesium (11.06 mmol, 269 
mg). Colourless oil, 1.26 g, 96%. 
1
H NMR ( ; 300 MHz, CDCl3); 
 
0.96-1.75 (11H, 
m), 2.05-2.42 (3H,  m), 3.74 (2H, s, NHCH2Ph), 5.03-5.15 (2H, m, CH=CH2), 5.65-5.94 (1H, m, CH=CH2), 




H} NMR ( ; 100 MHz, CDCl3), 26.28 (CH2), 26.69 (CH2), 26.84 (CH2), 28.92  
(CH2), 29.61 (CH2), 35.44 (CH2), 41.58 (CH), 52.49 (CH2), 61.67 (CH), 116.86 (CH2), 126.86 (CH), 128.18 
(CH), 128.28 (CH), 136.84 (CH), 142.29 (C). M/z: (ES
+
) 244.2 [M + H]
+
. 
4.1.49 (192l) N-(4-nitrobenzyl)-1-phenylbut-3-en-1-amine 
 
General procedure B was used: (E)-N-benzylidene-1-(4-
nitrophenyl)methanamine (3.99 mmol, 960 mg), allyltributylstannane (5.99 
mmol, 1.98 g), boron trifluoride diethyl etherate (11.97 mmol, 1.70 g). 
Yellow oil, 642 mg, 57%. General procedure C was used: (E)-N-benzylidene-1-(4-nitrophenyl)methanamine 
(3.01 mmol, 723 mg), allylbromide (4.51 mmol, 546 mg), magnesium (6.02 mmol, 146 mg). Yellow oil, 748 
mg, 88%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.78 (1H, br, NH), 2.26-2.42 (2H, m, NHCHCH2), 3.57 (1H, dd, J 
= 12.3 & 5.2 NHCH), 3.73 (2H, ABq, JAB = 14.5, NHCH2), 4.97-5.05 (2H, m, CH=CH2), 5.58-5.71 (1H, m, 




H} NMR ( ; 
100 MHz, CDCl3), 43.07 (CH2), 50.70 (CH2), 61.84 (CH), 117.84 (CH2), 123.53 (CH), 127.18 (CH), 127.32 
(CH), 128.54 (CH), 128.65 (CH), 135.22 (CH), 143.27 (C), 146.94 (C), 148.52 (C). M/z: (ES
+




4.1.50 (192m) N-(4-methoxybenzyl)-1-(2-nitrophenyl)but-3-en-1-amine 
 
General procedure B was used: (E)-1-(4-methoxyphenyl)-N-(2-
nitrobenzylidene)methanamine (3.70 mmol, 1.00 g), allyltributylstannane 
(5.55 mmol, 1.84 g), boron trifluoride diethyl etherate (11.10 mmol, 1.57 g). 
Yellow oil, 520 mg, 45%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
2.29-2.43 (2H, m, NHCHCHH), 2.61-2.69 (1H, 
m, NHCHCHH), 3.49 (2H,  ABq, JAB = 8.4, NHCH2), 3.80 (3H, s, CH3), 4.25-4.31 (1H, m, NHCH),  5.10-
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5.15 (2H, m, CH=CH2), 5.74-5.88 (1H, m, CH=CH2), 6.85 (2H, d, J = 8.7, ArH), 7.15 (2H, d, J = 8.7, ArH), 




H} NMR ( ; 100 MHz, CDCl3), 42.26 (CH2), 51.19 (CH2), 55.23 (CH3), 56.20 (CH), 113.81 (CH), 
118.36 (CH2), 123.96 (CH), 127.60 (CH), 128.99 (CH), 129.20 (CH), 132.11 (C), 132.81 (CH), 134.76 (CH), 
138.85 (C), 150.13 (C), 158.68 (C). M/z: (ES
+
) 313.1 [M + H]
+
. 
4.1.51 (192o) (3-(1-(benzylamino)but-3-en-1-yl)cyclopent-3-en-1-yl)(cyclopent-3-en-1-yl)iron 
 
General procedure B was used: (E)-(3-((benzylimino)methyl)cyclopent-3-en-1-
yl)(cyclopent-3-en-1-yl)iron (0.65 mmol, 200 mg), allyltributylstannane (0.97 
mmol, 323 mg), boron trifluoride diethyl etherate (1.3 mmol, 184 mg). Purified by 
flash chromatography (CHCl3 : MeOH 9:1, Rf 0.4), yellow oil, 29 mg, 13%. 
1
H 
NMR ( ; 300 MHz, CDCl3); 2.44-2.68 (1H, m, NHCHCHH), 2.59-2.68 (1H, m, NHCHCHH), 3.51 (dd, 1H, 
J = 7.3 & 5.0, NHCHCH2), 3.83 (2H, s, NHCH2Ph), 4.10-4.23 (7H, m), 5.08-5.16 (2H, m, CH=CH2), 5.81-




H} NMR ( ; 100 MHz, CDCl3), 40.29 (CH2), 51.25 
(CH2), 55.75 (CH), 66.70 (CH), 67.18 (CH), 67.24 (CH), 67.4 (CH), 68.45 (CH), 92.3 (C), 116.67 (CH2), 
126.95 (CH), 128.23 (CH), 128.45 (CH), 135.89 (CH), 140.53 (C). M/z: (ES
+
) 350.1 [M + H]
+
. 
4.1.52 (192p) N-(cyclohexylmethyl)-1-phenylbut-3-en-1-amine 
 
General procedure C was used: (E)-N-benzylidene-1-cyclohexylmethanamine (4.97 
mmol, 1.00 g), allylbromide (7.45 mmol, 901 mg), magnesium (9.94 mmol, 242 
mg). Yellow oil, 1.20 g, 99%.
1
H NMR ( ; 300 MHz, CDCl3);
 
0.81-0.94 (2H, m), 
1.09-1.33 (3H, m), 1.33-1.49 (1H, m),
 
1.69-1.79 (6H, m), 2.30 (2H,  dd, J = 6.6 & 3.9), 2.40-2.45 (2H, m), 
3.64 (1H, dd, J = 7.6 & 6.1, NHCH), 5.07-5.16 (2H, m, CH=CH2), 5.69-5.83 (1H, m, CH=CH2), 7.23-7.36 




H} NMR ( ; 100 MHz, CDCl3), 26.08 (CH2), 26.73 (CH2), 31.44 (CH2), 38.08 (CH), 
43.19 (CH2), 54.49 (CH2), 62.67 (CH), 117.41 (CH2), 128.86 (CH), 127.18 (CH), 128.26 (CH), 135.64 (CH), 
144.29 (C). M/z: (ES
+








4.1.53 (192q) 1-phenyl-N-propylbut-3-en-1-amine 
 
General procedure B was used: (E)-N-benzylidenepropan-1-amine (7.47 mmol, 1.10 
g), allyltributylstannane (11.21 mmol, 3.71 g), boron trifluoride diethyl etherate (22.41 
mmol, 3.18 g). Yellow oil, 1.30 g, 92%. General procedure C was used: (E)-N-
benzylidenepropan-1-amine (8.15 mmol, 1.20 g), allylbromide (12.23 mmol, 1.48 g), magnesium (16.30 
mmol, 396 mg). Yellow oil, 1.53 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.75 (3H, t, J = 7.4, CH3), 1.40 
(2H, sextet, CH2CH3), 2.28-2.43 (4H, m, NHCH2 & NHCHCH2), 3.63 (1H, apt.t, obs.J = 7.0, NHCH), 4.90-




H} NMR ( ; 100 MHz, 
CDCl3), 11.65 (CH3)  22.59 (CH2), 42.26 (CH2), 49.34 (CH), 62.76 (CH), 117.81 (CH2), 127.38 (CH), 
128.50 (CH), 134.87 (CH), 142.38 (C). M/z: (ES
+
) 190.2 [M + H]
+
. 
4.1.54 (192r) N-benzyl-1-(4-methoxyphenyl)but-3-en-1-amine 
 
General procedure B was used: (E)-N-(4-methoxybenzylidene)-1-
phenylmethanamine (6.66 mmol, 1.50 g), allyltributylstannane (9.99 mmol, 
3.31 g), boron trifluoride diethyl etherate (19.98 mmol, 2.84 g). Yellow oil, 
600 mg, 34%. General procedure C was used: (E)-N-(4-methoxybenzylidene)-1-phenylmethanamine (7.28 
mmol, 1.64 g), allylbromide (14.56 mmol, 1.75 g), magnesium (21.84 mmol, 531 mg). Yellow oil, 1.75 g, 
90%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.76 (1H, br, NH), 2.36-2.41 (2H, m, NHCHCH2), 3.58 (2H,  ABq, JAB 
= 13.3, NHCH2), 3.64 (1H, apt.t, obs.J = 6.8, NHCH), 3.80 (3H, s, CH3), 5.07 (1H, ddt, J = 10.2, 2.0, 2.0, 
CH=CHH), 5.11 (1H, ddt, J = 16.2, 2.0. 2.0, CH=CHH), 5.69 (1H, ddt, J = 16.2, 10.2, 7.2, CH=CH2), 6.89 




H} NMR ( ; 100 MHz, CDCl3), 43.19 (CH2), 51.38 
(CH2), 55.25 (CH3), 60.97 (CH), 113.77 (CH), 117.42 (CH2), 126.80 (CH), 128.13 (CH), 128.32 (CH), 
135.61 (CH), 135.82 (C), 140.70 (C), 158.67 (C). M/z: (ES
+
) 268.1 [M + H]
+
. 
4.1.55 (192s) N-benzyl-1-(pyridin-2-yl)but-3-en-1-amine 
 
General procedure C was used: (E)-1-phenyl-N-(pyridin-2-
ylmethylene)methanamine (2.64 mmol, 519 mg), allylbromide (3.97 mmol, 480 
mg), magnesium (5.28 mmol, 128 mg). Yellow oil, 585 mg, 93%. 
1
H NMR ( ; 300 
111 
 
MHz, CDCl3);  2.43-2.62 (2H, m, NHCHCHH), 2.65 (1H, br, NH), 3.67 (2H, ABq, JAB = 13.2, PhCHH), 
3.89 (1H, dd, J = 7.4 & 6.1, NHCH), 5.03-5.10 (2H, m, CH=CH2), 5.67-5.81 (1H, m, CH=CH2), 7.17-7.40 




H} NMR ( ; 100 MHz, 
CDCl3), 41.41 (CH2), 51.66 (CH2), 62.85 (CH), 118.02 (CH2), 122.04 (CH), 122.13(CH), 126.89 (CH), 
128.23 (CH), 128.39 (CH), 134.94 (CH), 136.41 (CH), 139.88 (C), 149.41 (CH), 162.63 (C). M/z: (ES
+
) 
239.1 [M + H]
+
. 
4.1.56 (192t) N-(2-((1phenylbut-3-en-1-yl)amino)ethyl)acetamide 
 
General procedure B was used: (E)-N-(2-(benzylideneamino)ethyl)acetamide 
(3.10 mmol, 590 mg), allyltributylstannane (4.65 mmol, 1.54 g), boron 
trifluoride diethyl etherate (9.30 mmol, 1.32 g). Yellow oil, 216 mg, 30%. 
1
H 
NMR ( ; 300 MHz, CDCl3);
 
1.94 (3H s, CH3), 2.36-2.44 (3H, m, NHCHCHH & CHNHCH2), 2.63-2.70 (1H, 
m, NHCHCHH), 3.14-3.30 (2H, m, CH2NHC=O), 3.64 (1H, apt.t, obs.J = 7.2, NHCH), 5.05-5.12 (2H, m, 




H} NMR ( ; 100 MHz, CDCl3), 23.22 (CH3), 39.34 (CH2), 42.69 (CH2), 46.35 (CH2), 62.29 (CH), 
117.72 (CH2), 127.07 (CH), 127.27 (CH), 128.47 (CH), 135.20 (CH), 143.47 (C), 170.30 (C). M/z: (ES
+
) 
233.1 [M + H]
+
. 
4.1.57 (192v) N-(tert-butyl)-1-phenylbut-3-en-1-amine 
 
General procedure C was used: (E)-N-benzylidene-2-methylpropan-2-amine (1.71 mmol, 
276 mg), allylbromide (2.57 mmol, 311 mg), magnesium (3.42 mmol, 83.14 mg). Yellow 
oil, 236 mg, 68%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.97 (9H, s, tert-butyl), 2.18-2.28 (1H, 
m, NHCHCHH), 2.33-2.42 (1H, m, NHCHCHH), 3.81 (1H, dd, J = 8.4 & 5.5, NHCH), 5.03-5.10 (2H, m, 




H} NMR ( ; 100 MHz, CDCl3), 
30.13 (CH3), 45.189 (CH2), 51.20 (C), 56.78 (CH), 117.48 (CH2), 126.39 (CH), 127.01 (CH), 128.09 (CH), 
136.16 (CH), 147.71 (C). M/z: (ES
+







4.1.58 (192w) N-benzyl-1-(thiophen-2-yl)but-3-en-1-amine 
 
General procedure B was used: (E)-1-phenyl-N-(thiophen-2-
ylmethylene)methanamine (4.97 mmol, 1.00 g), allyltributylstannane (7.45 mmol, 
2.47 g), boron trifluoride diethyl etherate (14.91 mmol, 2.12 g). Yellow oil, 701 mg, 
58%.
1
H NMR ( ; 300 MHz, CDCl3);
 
2.78-3.02 (2H, m, NHCHCH2), 3.91-4.00 (2H, m, NHCH2), 4.46 (1H, 
dd, J = 9.7 & 4.4, NHCH), 5.01-5.13 (2H, m, CH=CH2), 5.43-5.57 (1H, ddt, J = 16.1, 10.0, 6.9, CH=CH2), 




H} NMR ( ; 100 MHz, CDCl3), 43.40 
(CH2), 51.18 (CH2), 56.95 (CH), 117.92 (CH2), 124.10 (CH), 124.30 (CH), 126.22 (CH), 126.94 (CH),  
128.20 (C), 128.40 (CH), 134.80 (CH), 140.30 (C), 150.17 (C). M/z: (ES
+
) 244.1 [M + H]
+
.  
4.1.59 (192y) N-benzylpent-4-en-2-amine 
 
General procedure A and C were used: crude (E)-N-ethylidene-1-phenylmethanamine 
(20.86 mmol, 2.78 g), allylbromide (31.28 mmol, 3.78 g), magnesium (41.72 mmol, 1.01 
g). Yellow oil, yield over 2 steps = 259 mg, 65%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.08 
(3H, d, J = 6.3 CH3), 2.08-2.29 (2H, m, NHCHCHH & NHCH), 2.68-2.79 (1H, m, NHCHCHH), 3.76 (1H, 





H} NMR ( ; 100 MHz, CDCl3), 20.30 (CH3), 41.47 (CH2), 51.41 (CH2), 51.81 (CH), 117.22 
(CH2), 126.87 (CH), 128.13 (CH), 128.42 (CH), 135.75 (CH), 140.78 (C). M/z: (ES
+
) 176.1 [M + H]
+
. 
4.1.60  (194a) cis-1-Benzyl-2-(Iodomethyl)-4-phenylazetidine.  
General procedure D was used: homoallylamine 192a (500 mg, 2.1 mmol), iodine 
(1.60 g, 6.3 mmol), sodium bicarbonate (885 mg, 11.00 mmol) and acetonitrile (50 
mL). Yellow oil, yield (post-work up) 732 mg, 96%; after flash chromatography 
(Hexane/CH2Cl2/Et3N = 5.5/4/0.5 Rf 0.4) 343 mg, 45%. 
1
H NMR ( ; 300 MHz, 
CDCl3); 1.74 (1H, dt, J = 12.0 & 9.0, PhCHCHH), 2.65 (1H, dt, J = 9.0 & 6.0, PhCHCHH), 2.91 (1H, dd, J 
= 10.5 & 3.0, CHHI), 2.98 (1H, apt.t, obs.J = 9.0, CHHI), 3.28 (1H, m, NCHCH2I), 3.80 (2H, ABq, JAB = 15.0, 




H} NMR ( ; 100 
MHz, CDCl3), 12.77 (CH2),  35.65 (CH2), 60.75 (CH2), 62.96 (CH), 63.00 (CH), 126.94 (CH), 127.37 (CH), 
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128.29 (CH), 128.34 (CH), 129.37 (CH), 138.16(C), 143.02 (C). High-resolution MS calcd for C17H18NI: 
363.0484; found: 363.0485.  
4.1.61 (194b) cis-2-(Iodomethyl)-1-(4-methoxybenzyl)-4-phenylazetidine.  
General procedure D was used: homoallylamine 192b (644 mg, 2.54 mmol), iodine 
(1.94 g, 7.63 mmol), sodium bicarbonate (1.07 g, 12.70 mmol) and acetonitrile (50 
mL). Yellow oil, yield (post-work up) 849 mg, 85%; after flash chromatography 
(Hexane/CH2Cl2/Et3N = 5.5/4/0.5 Rf 0.4) 409 mg, 41%. 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
1.68 (1H, dt, J = 12.0 & 9.0, PhCHCHH), 2.60 (1H, dt, J = 9.0 & 6.0, PhCHCHH), 2.86 (1H, dd, J = 
9.0 & 6.0, CHHI), 2.93 (1H, apt.t, obs.J = 9.0, CHHI), 3.21 (1H, m, NCHCH2I), 3.70 (2H, ABq, JAB = 12.0, 
NCHHAr), 3.82 (3H, s, OMe), 3.95 (1H, apt.t, obs.J = 9.0, NCHPh), 6.86 (2H, d, J = 9.0, ArH), 7.29 (3H, m, 




H} NMR ( ; 100 MHz, CDCl3)  12.89 
(CH2), 35.56 (CH2), 55.28 (CH3), 59.95 (CH2), 62.68 (CH), 62.76 (CH), 113.65 (CH), 126.89 (CH), 127.29 
(CH), 128.31 (CH), 130.20 (C), 130.44(CH), 143.08 (C), 158.91 (C). High-resolution MS calcd for formula 
C18H21NOI: 394.0668; found: 394.0674. 
4.1.62 (194c) cis-2-(Iodomethyl)-1-(4-methylbenzyl)-4-phenylazetidine. 
General procedure D was used: homoallylamine 192c (1.0 g, 3.98 mmol), iodine (3.02 
g, 11.90 mmol), sodium bicarbonate (1.67 g, 19.90 mmol) and acetonitrile (50 mL). 
Yellow oil, yield (post-work up) 1.40 g, 93%; after flash chromatography 
(Hexane/CH2Cl2/Et3N = 5.5/4/0.5 Rf 0.4) 615 mg, 45%. 
1
H NMR ( ; 300 MHz, 
CDCl3); 1.72 (1H, dt, J = 12.0 & 9.0, PhCHCHH), 2.40 (3H, s, tolyl-Me), 2.64 (1H, dt, J = 9.0 & 6.0, 
PhCHCHH),  2.90 (1H, dd, J = 9.0 & 6.0, CHHI), 2.96 (1H, apt.t, obs.J = 9.0, CHHI), 3.26 (1H, m, NCHCH2I), 
3.75 (2H, ABq, JAB = 12.0, NCH2Ar), 3.99 (1H, t, J = 9.0, NCHPh), 7.17 (2H, d, J = 9.0, ArH), 7.32 (3H, m, 




H} NMR ( ; 100 MHz, CDCl3), 12.94 
(CH2),  21.25 (CH3), 35.63 (CH2), 60.29 (CH2), 62.79 (CH), 126.91 (CH), 127.31 (CH), 128.33 (CH), 128.98 
(CH), 129.30(CH), 135.04 (C), 136.90 (C), 143.09 (C). High-resolution MS calcd for formula C18H21NI: 
378.0718; found: 378.0725. 
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4.1.63 (194d) 3-cis-1-Benzyl-4-(iodomethyl)azetidin-2-yl)pyridine. 
 
General procedure D was used: homoallylamine 192d (1.50 g, 6.29 mmol), iodine (4.80 
g, 19.00 mmol), sodium bicarbonate (2.64 g, 31.50 mmol), and acetonitrile (50 mL). 
Yellow oil, yield (post-work up), 2.08 g, 91%; after flash chromatography (EtOAc/ 
Hexane = 8/2 Rf 0.4) 961 mg, 42%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.68 (1H, dt, J = 
12.0 & 9.0, PyCHCHH), 2.60 (1H, dt, J = 9.0 & 6.0, PyCHCHH), 2.93 (2H, d, J = 9.0, CH2I ), 3.24 (1H, m, 
J = 6.0, NCHCH2I), 3.73 (2H, ABq, JAB = 12.0, NCH2Ph), 3.98 (1H, apt.t, obs.J = 9.0, NCHPy), 7.26 (6H, m, 




H} NMR ( ; 100 
MHz, CDCl3), 12.32 (CH2), 35.22 (CH2), 60.72 (CH2), 60.76 (CH), 62.84 (CH), 123.30 (CH), 127.45 (CH), 
128.24 (CH), 129.27 (CH), 134.68 (CH), 137.31 (C), 138.14 (C), 148.71 (CH). High-resolution MS calcd for 
formula C16H17N2Na: 387.0334; found: 387.0349. 
4.1.64 (194e) 4-(cis-1-Benzyl-4-(iodomethyl)azetidin-2-yl)pyridine. 
General procedure D was used:  homoallylamine 192e (1.00 g, 4.20 mmol), iodine 
(3.30 g, 13.00 mmol), sodium bicarbonate (1.76 g, 21.00 mmol) and acetonitrile (50 
mL). Yellow oil, yield (post-work up), 1.45 g, 95%; after flash chromatography 
(EtOAc/ Hexane = 8/2 Rf 0.4) 642 mg, 51%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.60 
(1H, dt, J = 12.0 & 9.0, PyCHCHH), 2.59 (1H, dt, J = 9.0 & 6.0, PyCHCHH), 2.89 (2H, d, J = 9.0, CH2I), 
3.23 (1H, m, NCHCH2I), 3.71 (2H, ABq, JAB = 12.0, NCH2Ph), 3.93 (1H, apt.t, obs.J = 9.0, NCHPy), 7.25 (7H, 




H} NMR ( ; 100 MHz, CDCl3), 12.29 (CH2), 34.76 (CH2), 60.89 
(CH2), 61.70 (CH), 62.75 (CH),  121.62 (CH), 127.53 (CH), 128.29 (CH), 129.29 (CH), 137.36 (C), 149.74 
(CH), 151.53 (C). High-resolution MS calcd for formula C16H17N2NaI: 387.0334; found: 387.0341. 
4.1.65 (194f) cis-1-Benzyl-2-(iodomethyl)-4-(4-nitrophenyl)azetidine. 
General procedure D was used: homoallylamine 192f (350 mg, 1.24 mmol), 
iodine (944 mg, 3.72 mmol), sodium bicarbonate (520 mg, 6.20 mmol) and 
acetonitrile (50 mL). Yellow oil, yield (post-work up) 459 mg, 90%; after flash 
chromatography 233 mg, 46%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.65 (1H, dt, J = 
12.0 & 9.0, ArCHCHH), 2.66 (1H, m, ArCHCHH), 2.96 (2H, m, CH2I), 3.28 (1H, m, NCHCH2I), 3.76 (2H, 
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ABq, JAB = 12.0, NCH2Ph), 4.07 (1H, apt.t, obs.J = 9.0, NCHAr), 7.28 (5H, m, ArH), 7.58 (2H, d, J = 6.0, 




H} NMR ( ; 100 MHz, CDCl3), 11.96 (CH2), 35.29 (CH2), 60.90 
(CH2), 62.37 (CH), 62.63 (CH), 123.50 (CH), 127.39 (CH), 127.55 (CH), 128.27 (CH), 129.28(CH), 137.18 
(C), 147.12 (C), 150.56 (C). High-resolution MS calcd for formula C17H17N2O2I: 408.0335; found: 408.0318. 
4.1.66 (194g) cis-1-Benzyl-2-(2-bromophenyl)-4-(iodomethyl)azetidine.  
General procedure D was used: homoallylamine 192g (750 mg, 2.40 mmol), iodine 
(1.81 g, 7.14 mmol), sodium bicarbonate (1.00 g, 12.00 mmol), and acetonitrile (50 
mL). Yellow oil, yield (post-work up), 881 mg, 83%; after flash chromatography 
(EtOAc/ Hexane/Et3N = 98/1.5/0.5 Rf 0.4) 445 mg; 42%. 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
1.51 (1H, dt, J = 12.0 & 9.0, ArCHCHH), 2.85 (3H, m, ArCHCHH and CH2I ), 3.30 (1H, m, 
NCHCH2I), 3.77 (2H, ABq, JAB = 12.0, NCH2Ph), 4.29 (1H, apt.t, obs.J = 9.0, NCHAr), 7.12 (1H, td, J = 9.0 & 





NMR ( ; 100 MHz, CDCl3), 12.88 (CH2), 34.37 (CH2), 60.92 (CH2), 62.04 (CH), 62.87 (CH), 121.85 (C), 
127.43 (CH), 127.45 (CH), 128.23 (CH), 128.33(CH), 129.28 (CH), 132.22 (CH), 137.97 (C), 142.04 (C). 
High-resolution MS calcd for formula C17H18NBrI: 441.9667; found: 441.9660. 
4.1.67 (194h) cis-1-Benzyl-2-(tert-butyl)-4-(iodomethyl)azetidine.  
General procedure D was used: homoallylamine 192h (900 mg 4 mmol), iodine (3.00 g, 
12.00 mmol), sodium bicarbonate (1.74 g, 21.00 mmol) and acetonitrile (50 mL). Yellow 
oil, yield (post-work up) 1.20 g, 87%; after flash chromatography (Hexane/CH2Cl2/Et3N = 
6/3.5/0.5 Rf 0.4) 563 mg, 41%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.91 (9H, s, tert-Bu), 1.45 (1H, dt, J = 12.0 
& 9.0, tert-BuCHCHH), 2.17 (1H, dt, J = 9.0 & 6.0, tert-BuCHCHH), 2.60 (1H, dd, J = 9.0 & 3.0, CHHI), 
2.75 (2H, m, CHHI and tert-BuCH), 3.04 (1H, m, NCHCH2I), 3.73 (2H, ABq, JAB = 12.0, NCH2Ph), 7.32 




H} NMR ( ; 100 MHz, CDCl3), 12.75 (CH2), 25.92 (CH3), 26.52 (CH2), 26.52 (CH2), 
33.44 (C), 63.28 (CH2), 69.40 (CH), 127.15 (CH), 128.21 (CH), 128.94 (CH), 139.41 (C). High-resolution 




4.1.68 (196a) (E)-N-benzylidene-1-phenylbut-3-en-1-amine 
Five equivalents of caesium carbonate (1.37 g, 4.20 mmol) and three equivalents 
of iodine (640 mg, 2.52 mmol) were added to 192a (200 mg, 0.84 mmol) in 
acetonitrile (25 mL), the mixture was stirred at room temperature for 16 hours and 
was monitored by TLC. When the reaction was completed solvent was removed in vacuo. To the residue 
thus obtained a solution of sodium thiosulfate was added, the compound was extracted with ethyl acetate for 
three times, washed with water, dried over magnesium sulfate and dried in vacuo, the crude product was 
purified by distillation. Yellow oil, 157 mg, 79%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
2.69 (2H, apt.t, obs.J = 7.5, 
PhCHCH2), 4.33 (1H, apt.t, obs.J = 7.5, PhCHCH2), 4.98-5.07 (2H, m, CH=CH2 ), 5.64-5.78 (1H, m, 





H} NMR ( ; 100 MHz, CDCl3) 43.26 (CH2), 75.39 (CH), 117.28 (CH2), 127.07 (CH), 127.16 (CH), 
128.39 (CH), 128.48 (CH), 128.58 (CH), 130.65 (CH), 135.53 (CH), 136.39 (C), 143.93 (C), 160.08 (CH). 
High-resolution MS calcd for C17H17N: 235.1361; found: 235.1355.  
4.1.69 (196c) (E)-N-(4-methylbenzylidene)-1-phenylbut-3-en-1-amine 
Five equivalents of caesium carbonate (3.26 g, 10.00 mmol) and three 
equivalents of iodine (1.50 g, 6.00 mmol) were added to 192c (500 mg, 2.0 
mmol) in acetonitrile (25 mL), the mixture was stirred at rt for 16 hours and was 
monitored by TLC. When the reaction was completed solvent was removed in vacuo. To the residue thus 
obtained a solution of sodium thiosulfate was added, the compound was extracted with ethylacetate three 
times, washed with water, dried over anhydrous magnesium sulfate and dried in vacuo, the crude product 
was purified by distillation. Yellow oil, 367 mg, 74%. 
1
H NMR ( ; 400 MHz, CDCl3); 
 
2.47 (3H, s, Me), 
2.83 (2H, apt.t, obs.J = 8, PhCHCH2), 4.46 (1H, apt.t, obs.J = 7.2, PhCHCH2), 5.12-5.21 (2H, m, CH=CH2 ), 5.81-
5.92 (1H, m, CH=CH2), 7.28-7.38 (3H, m, ArH), 7.46 (2H, t, J = 8, ArH), 7.58 (2H, d, J = 7.2 ArH), 7.80 




H} NMR ( ; 100 MHz, CDCl3) 21.59 (CH3), 43.36 (CH2), 
75.36 (CH), 117.22 (CH2), 127.19 (CH), 128.38 (CH), 128.42 (CH), 128.48 (CH), 129.32 (CH), 133.89 (C), 
135.64 (CH), 140.97 (C), 144.11 (C), 159.90 (CH).  High-resolution MS calcd for C18H19NNa: 272.1415; 
found: 272.1425.  
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4.1.70 (195c) cis-4-Iodo-1-(4-methylbenzyl)-2-phenylpyrrolidine.  
General procedure E was used: 194c (20 mg, 0.05 mmol) and acetonitrile (20 mL), 
yellow oil, 19 mg, 97%. 
1
H NMR ( ; 500 MHz, CDCl3); 2.35 (s, 3H, Me), 2.41 
(m, 1H, PhCHCHH), 2.76 (1H, dd, J = 10.0 & 5.0, NCHHCHI), 2.94 (1H, dt, J = 
15.0 & 10.0, PhCHCHH), 3.43 (1H, dd, J = 10.0 & 5.0, NCHHCHI), 3.52 (2H, 
ABq, JAB = 15.0, NCH2Ar), 3.57 (1H, apt.t, obs.J = 10.0, PhCHCH2), 4.40 (1H, m, NCH2CHI), 7.14 (2H, d, J = 
10.0, ArH), 7.23 (2H, d, J = 10.0, ArH), 7.30 (1H, t, J = 5.0, ArH), 7.39 (2H, t, J = 10.0, ArH), 7.57 (2H, d, J 




H} NMR ( ; 100 MHz, CDCl3), 17.97 (CH), 21.07 (CH3), 48.85 (CH2), 56.32 (CH2), 
64.29 (CH2), 69.28 (CH), 127.44 (CH), 127.78 (CH), 128.26 (CH), 128.33 (CH), 128.54 (CH), 128.59 (CH), 
128.89 (CH), 128.94 (CH), 128.96 (CH), 129.22 (CH), 135.73 (C), 136.41(C), 141.92 (C). High-resolution 
MS calcd for formula C18H21NNaI: 400.0538; found: 400.0542. 
4.1.71 (195d) 3-(cis-1-Benzyl-4-iodopyrrolidin-2-yl)pyridine.  
General procedure E was used: 194d (50 mg, 0.14 mmol) and acetonitrile (20 mL), 
yellow oil, 47 mg, 95%. 
1
H NMR ( ; 300 MHz, CDCl3); 2.36 (1H, m, PyCHCHH), 
2.77 (1H, dd, J = 12.0 & 6.0, NCHHCHI), 2.99 (1H, dt, J = 15.0 & 12.0, 
PyCHCHH), 3.42 (1H, dd, J = 12.0  & 6.0, NCHHCHI), 3.55 (2H, ABq, JAB = 12.0, 
NCH2Ph), 3.64 (1H, t, J = 9.0, PyCHCH2), 4.40 (1H, m, NCH2CHI), 7.14 (2H, d, J = 10.0, ArH), 7.28 (6H, 




H} NMR ( ; 100 
MHz, CDCl3), 17.41 (CH), 48.44 (CH2), 56.73 (CH2), 64.38 (CH2), 66.60 (CH), 123.88 (CH), 126.96 (CH), 
128.03 (CH), 128.24(CH), 128.32 (CH), 135.40 (CH), 138.32 (C), 147.60(C), 149.14 (CH), 149.74 (CH). 
High-resolution MS calcd for formula C16H17N2I: 364.0436; found: 364.0440. 
4.1.72 (195e) 4-(cis-1-Benzyl-4-iodopyrrolidin-2-yl)pyridine.  
General procedure E was used: 194e (50 mg, 0.14 mmol) and acetonitrile (20 mL), 
yellow oil, 49 mg, 98%. 
1
H NMR ( ; 300 MHz, CDCl3); 2.36 (1H, m, PyCHCHH), 
2.80 (1H, dd, J = 12.0 & 6.0, NCHHCHI), 2.99 (1H, dt, J = 15.0 & 9.0, PyCHCHH), 
3.43 (1H, dd, J = 12.0 & 6.0, NCHHCHI), 3.59 (2H, ABq, JAB = 15.0, NCH2Ph), 
3.65 (1H, apt.t, obs.J = 9.0, PyCHCH2), 4.40 (1H, m, NCH2CHI), 7.30 (5H m, ArH), 7.52 (2H, d, J = 6.0, PyH), 
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H} NMR ( ; 100 MHz, CDCl3), 17.23 (CH), 48.17 (CH2), 56.98 (CH2), 
64.31 (CH2), 67.94 (CH), 122.78 (CH), 127.17 (CH), 128.25 (CH), 128.37(CH), 138.21 (C), 150.15 (CH), 
151.47 (C). High-resolution MS calcd for formula C18H21NI: 364.0436; found 364.0440. 
4.1.73 (199aa) N-benzyl-1-((cis)-1-benzyl-4-phenylazetidin-2-yl)methanamine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash 
chromatography (Hexane/EtOAc = 1/1 Rf 0.4), yellow oil, yield (from 
192a) = 248 mg, 86%. IR 3316, 2983, 1645, 1494, 1453, 1373, 1242, 1158; 
1
H NMR ( ; 300 MHz, CDCl3);
 
2.00 (1H, apt.q, obs.J= 9.9, PhCHCHH), 2.35-
2.45 (2H, m, PhCHCHH and NCHCHHNH), 2.53 (1H, dd, J = 12.0 & 4.5, 
NCHCHHNH), 3.28-3.36 (1H, m, CHCH2NH), 3.58 (2H, s, NHCH2Ph), 3.67 (2H, ABq, JAB = 12.9, 





NMR ( ; 100 MHz, CDCl3), 31.12 (CH2), 53.75 (CH2), 54.14 (CH2), 61.49 (CH2), 62.72 (CH), 65.24 (CH), 
126.67 (CH), 126.85 (CH), 127.05 (CH), 127.93 (CH), 128.14 (CH), 128.18 (CH), 128.23 (CH), 128.49 
(CH), 129.11 (CH),138.88 (C), 140.58 (C), 143.54 (C). High-resolution MS calcd for formula C24H27N2: 
343.2174; found: 343.2163.  
4.1.74 (199aa) N-benzyl-1-((2S,4R)-1-benzyl-4-phenylazetidin-2-yl)methanamine 
General procedure F was used: (R)-192a (200 mg, 0.84 mmol), flash 
chromatography (Hexane/EtOAc = 1/1 Rf 0.4), yellow oil, yield (from (R)-
192a) = 242 mg, 84%. HPLC: Chiralpak AD column, detected at 210 nm, 
eluent: n-hexane/iso-propanol 99/1, flow rate: 0.250 ml/min. [α]D
20 
= +96.8 
(c 0.32, CHCl3), 99.5% ee. IR 3061, 3027, 2821, 1672, 1603, 1494, 1453, 1353, 1206, 1157; 
1




H} NMR same as 199aa. High-resolution MS calcd for formula C24H26N2Na: 365.1994; found: 
365.1999. Several chiral columns were tried under different conditions but a clear baseline separation of the 
enantiomers (2S,4R)-199aa and (2R,4S)-199aa was not possible when the racemate was analysed (Table 38). 
However, when the enantioenriched (2S,4R)-199aa was used, a clear separation was obtained and the 





Table 38. HPLC data for racemate 199aa 
No. Ret.Time Peak Name   Height Area Rel.Area Amount Type 
 min  mAU mAU*min %   
1 24.00       n.a. 665.968 774.560 42.53     n.a. BM * 
2                                                  25.90       n.a. 824.818 1046.813 57.47     n.a. MB* 
Total:   1490.786 1821.373 100.00     0.000  
 
Table 39. HPLC data for (2S,4R)-199aa 
No. Ret.Time Peak Name   Height Area Rel.Area Amount Type 
 min  mAU mAU*min %   
1 25.40 n.a. 4.710 3.538 0.23     n.a. BM * 
2                                                  27.38           n.a. 939.967 1503.597 99.77     n.a. MB* 
Total:   944.677 1507.134 100.00     0.000  
4.1.75  (199ab) N-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)propan-1-amine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 
216 mg, 87%. IR 3313, 2944, 2832, 1449, 1115; 
1
H NMR ( ; 300 MHz, 
CDCl3); 0.84 (3H, t, J = 7.5, Me), 1.30-1.42 (2H, m,CH2CH3), 1.91-2.00 (1H, 
m, PhCHCHH), 2.26-2.50 (5H, m, NHCH2CH2, PhCHCHH, NCHCHHNH, NH), 2.57 (1H, dd, J = 12.3 & 
4.2, NCHCHHNH), 3.29-3.37 (1H, m, NCHCH2NH), 3.68 (2H, ABq, JAB = 12.6, NCH2Ph), 4.03 (1H, apt.t, 































H} NMR ( ; 100 MHz, 
CDCl3), 11.68 (CH3), 22.61 (CH2), 31.27 (CH2), 51.84 (CH2), 54.03 (CH2), 61.44 (CH2), 62.32 (CH), 65.30 
(CH), 126.84 (CH), 127.13 (CH), 128.22 (CH), 129.14 (CH), 138.92 (C), 143.31 (C). High-resolution MS 
calcd for formula C20H27N2: 295.2174; found: 295.2162.  
4.1.76 (199ab) N-(((2S,4R)-1-benzyl-4-phenylazetidin-2-yl)methyl)propan-1-amine 
General procedure F was used: (R)-192a (400 mg, 1.68 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from (R)-
192a) = 377 mg, 76%. HPLC: Chiralpak AD column, detected at 210 nm, 
eluent: n-hexane/iso-propanol 95/5, flow rate: 0.250 ml/min. [α]D
20 
= +97.2 (c 
1.17, CHCl3), 92.5% ee. IR 3029, 2960, 2933, 2873, 1654, 1493, 1454, 1382, 1156; 
1





NMR same as 199ab. High-resolution MS calcd for formula C20H27N2: 295.2174; found: 295.2179. Several 
chiral columns were tried under different conditions but a clear baseline separation of the enantiomers 
(2S,4R)-199ab and (2R,4S)-199ab was not possible when the racemate was analysed (Table 40). However, 
when the enantioenriched (2S,4R)-199ab was used, a clear separation was obtained and the enantiomeric 
excess could be calculated (Table 41). 
 
Table 40. HPLC data for racemate 199ab 
No. Ret.Time Peak Name   Height Area Rel.Area Amount Type 
 min  mAU mAU*min %   
1 19.61       n.a. 367.958 321.959 45.15     n.a. BM * 
2                                                  21.50       n.a. 308.704 391.150 54.85     n.a. MB* 
Total:   676.662 713.109 100.00     0.000  
        
 















Table 41. HPLC data for (2S,4R)-199ab 
No. Ret.Time Peak Name   Height Area Rel.Area Amount Type 
 min  mAU mAU*min %   
1 18.75       n.a. 53.655 38.600 3.73     n.a. BM * 
2                                                  20.29       n.a. 882.679 996.706 96.27     n.a. MB* 
Total:   936.334 1035.306 100.00     0.000  
 
             
4.1.77 (199ac) N-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)propan-2-amine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash chromatography 
(CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 206 mg, 83%. IR 
3661, 3300, 3062, 3027, 2927, 2969, 1649, 1603, 1494, 1454, 1382, 1250, 1172, 
1066; 
1
H NMR ( ; 300 MHz, CDCl3); 0.87 (3H, d, J = 6, Me), 0.96 (3H, d, J = 6, 
Me), 1.96 (1H, apt.q, obs.J= 8.4, PhCHCHH),  2.35 (1H, dd, J = 11.7 & 4.8, NCHCHHNH), 2.41-2.52 (2H, m, 
PhCHCHH & NHCH(CH3)2), 2.58 (1H, dd, J = 11.7 & 4.8, NCHCHHNH), 3.31-3.38 (1H, m, NCHCH2NH),  
3.67 (2H, ABq, JAB = 12.9, NCH2Ph), 4.04 (1H, apt.t, obs.J = 8.1, PhCHCH2), 7.25-7.38 (8H, m,  PhH), 7.48 




H} NMR ( ; 100 MHz, CDCl3), 21.63 (CH3), 22.21 (CH3), 31.24 (CH2), 49.27 
(CH), 51.64 (CH2), 61.40 (CH2), 62.30 (CH), 65.33 (CH), 126.84 (CH), 127.20 (CH), 127.27 (CH), 128.26 
(CH), 128.34 (CH), 129.21 (CH), 139.00 (C), 143.11 (C). High-resolution MS calcd for formula C20H27N2: 



















4.1.78 (199ad) 1-((cis)-1-benzyl-4-phenylazetidin-2-yl)-N-(pyridin-2-ylmethyl)methanamine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) 
= 199 mg, 69%. IR 3311, 3061, 3029, 2926, 2820, 1671, 1590, 1570, 1493, 
1474, 1454, 1433, 1356, 1289, 1210, 1149; 
1
H NMR ( ; 300 MHz, CDCl3); 
 
2.00 (1H, apt.q, obs.J = 8.4, PhCHCHH), 2.39-2.49 (2H, m, PhCHCHH and 
NCHCHHNH), 2.55 (1H, dd, J = 12.3 & 4.2, NCHCHHNH), 2.92 (1H, br, NH), 3.29-3.37 (1H, m, 
CHCH2NH), 3.67 (2H, ABq, JAB = 12.9, NCH2Ph), 3.74 (2H, s, NHCH2Py), 4.02 (1H, apt.t, obs.J = 8.1, 
PhCHCH2),  7.10-7.35 (13H, m, PhH), 7.46-7.48 (1H, m, PhH), 7.60 (1H, td; J= 7.8 & 1.8, PyH), 8.52-8.54 




H} NMR ( ; 100 MHz, CDCl3), 31.13 (CH2), 53.69 (CH2), 55.29 (CH2), 61.42 (CH2), 
62.28 (CH), 65.26 (CH), 121.78 (CH), 121.91 (CH), 126.86 (CH), 127.05 (CH), 128.10 (CH), 128.17 (CH), 
129.18 (CH), 136.35 (CH), 138.65 (C), 143.47 (C),149.30 (CH), 159.83 (C). High-resolution MS calcd for 
formula C23H26N3: 344.2126; found: 344.2118.  
4.1.79 (192ae) 1-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)piperidine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash chromatography 
(Hexane/EtOAc = 1/1 Rf 0.3), yellow oil, yield (from 192a) = 229 mg, 85%. IR 
3062, 3027, 2933, 2852, 2799, 1676, 1603, 1521, 1493, 1453, 1382, 1353, 1324, 
1273, 1252, 1209, 1156, 1122; 
1
H NMR ( ; 300 MHz, CDCl3); 1.37-1.42 (2H, 
m, NCH2CH2CH2),  1.50-1.57 (4H, m, NCH2CH2), 1.79 (1H, dt, J = 9.9 & 8.7, PhCHCHH), 2.23-2.35 (6H, 
m, NCH2CH2 & NCHCH2N), 2.57 (1H, dt, J = 9.9 & 8.7, PhCHCHH), 3.28-3.37 (1H, m,  NCHCH2N), 3.70 
(2H, ABq, JAB = 12.9, NCH2Ph), 4.00 (1H, apt.t, obs.J = 8.1, PhCHCH2), 7.19-7.32 (8H, m,  PhH), 7.39-7.42 




H} NMR ( ; 100 MHz, CDCl3), 24.21 (CH2), 25.89 (CH2), 35.57 (CH2), 55.16 (CH2), 
60.92 (CH), 61.25 (CH2), 65.36 (CH2), 65.90 (CH), 126.78 (CH), 126.88 (CH), 127.89 (CH), 128.04 (CH), 




4.1.80 (192af) 4-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)morpholine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash 
chromatography (Hexane/EtOAc = 1/1 Rf 0.3), yellow oil, yield (from 192a) = 
192 mg, 71%. IR 3061, 3028, 2954, 2853, 2807, 1641, 1603, 1566, 1493, 1454, 
1357, 1327, 1302, 1277, 1241, 1207, 1139; 
1
H NMR ( ; 300 MHz, CDCl3); 1.83 
(1H, dt, J = 9.9 & 8.7, PhCHCHH), 2.26-2.44 (6H, m, NCHCH2N & NCH2CH2O), 2.55 (1H, dt, J= 9.9 & 
8.7, PhCHCHH), 3.27-3.36 (1H, m, NCHCH2N), 3.66 (4H, t, J = 4.8, CH2O), 3.71 (2H, ABq, JAB = 12.9, 




H} NMR ( ; 100 MHz, CDCl3), 34.71 (CH2), 54.29 (CH2), 60.54 (CH), 61.35 (CH2), 64.74 (CH2), 
65.79 (CH), 66.91 (CH2), 126.77 (CH), 126.93 (CH), 127.01 (CH), 127.96 (CH), 128.12 (CH), 129.45 (CH), 
138.39 (C), 143.52 (C). High-resolution MS calcd for formula C21H26N2ONa: 345.1943; found: 345.1939.  
4.1.81 (192ag) 1-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)-4-methylpiperazine 
General procedure F was used: 192a (200 mg, 0.84 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 
228 mg, 81%. IR 3675, 3391, 2988, 2972, 2901, 2800, 1634, 1603, 1565, 
1493, 1453, 1406, 1394, 1381, 1264, 1231, 1165, 1066, 1056; 
1
H NMR ( ; 
300 MHz, CDCl3); 1.80 (1H, dt, J = 9.9 & 8.7, PhCHCHH), 2.27 (3H, s, Me), 2.30-2.49 (10H, m, 
NCHCH2N & NCH2CH2N), 2.55 (1H, dt, J = 9.9 & 8.7, PhCHCHH), 3.27-3.36 (1H, m,  NCHCH2N), 3.69 
(2H, ABq, JAB = 12.9, NCH2Ph), 4.00 (1H, apt.t, obs.J = 8.1, PhCHCH2), 7.18-7.33 (8H, m, PhH), 7.41 (2H, dd, 




H} NMR ( ; 100 MHz, CDCl3), 35.05 (CH2), 45.05 (CH3), 53.69 (CH2), 55.03 
(CH2), 60.69 (CH), 61.31 (CH2), 64.30 (CH2), 65.85 (CH), 126.75 (CH), 126.89 (CH), 126.94 (CH), 127.93 
(CH), 128.08 (CH), 129.45 (CH), 138.38 (C), 143.56 (C). High-resolution MS calcd for formula C22H30N3: 






4.1.82 (199ah) 1-((cis)-1-benzyl-4-phenylazetidin-2-yl)-N-(4-methoxybenzyl)methanamine.  
General procedure F was used: 192a (200 mg, 0.84 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield 
(from 192a) = 245 mg, 78%. IR 3300, 2926, 1611, 1584, 1512, 
1496, 1454, 1349, 1304, 1250, 1178, 1073; 
1
H NMR ( ; 400 MHz, 
CDCl3);
 
1.61 (1H, br, NH), 1.88 (1H, m, PhCHCHH), 2.27 (2H, m, 
PhCHCHH and NCHCHHNH), 2.40 (1H, dd, J = 12.0 & 6.0, NCHCHHNH), 3.19 (1H, m, CHCH2NH), 3.53 
(2H, ABq, JAB = 9.0, NCH2Ph), 3.61 (2H, ABq, JAB = 3.0, NHCH2Ar), 3.69 (3H, s, OMe), 3.89 (1H, apt.t, obs.J 
= 12.0, PhCHCH2), 6.70 (2H, d, J = 6.0, ArH), 7.00 (2H, d, J = 9.0, ArH), 7.12 (8H, m, PhH), 7.34 (2H, d, J 




H} NMR ( ; 100 MHz, CDCl3), 30.78 (CH2), 53.15 (CH2), 53.96 (CH2), 61.48 (CH2), 
62.52 (CH), 62.96 (CH), 123.29 (CH), 126.96 (CH), 127.30 (CH), 128.10 (CH), 128.24 (CH), 129.16 (CH), 
134.66 (CH), 138.10 (C), 138.58 (C), 139.80 (C), 148.52 (CH), 148.74 (CH). High-resolution MS calcd for 
formula C25H29N2O: 373.2280; found: 373.2277.  
4.1.83 (199bb) N-(((cis)-1-(4-methoxybenzyl)-4-phenylazetidin-2-yl)methyl)propan-1-amine 
General procedure F was used, 192b (760 mg, 2.84 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192b) = 
682 mg, 74%. IR 3315, 2936, 1625, 1544, 1426, 1319, 1273, 1178; 
1
H NMR 
( ; 300 MHz, CDCl3); 0.85 (3H, t, J = 7.5, Me), 1.32-1.44 (2H, m, CH2CH3), 
1.95 (1H, apt.q, obs.J = 8.7, PhCHCHH), 2.27-2.50 (4H, m, NHCH2CH2, 
PhCHCHH, NCHCHHNH), 2.57 (1H, dd, J = 12.1 & 4.5  NCHCHHNH), 3.28-3.36 (1H, m, NCHCH2NH), 
3.62 (2H, ABq, JAB = 12.9, NCH2Ar), 3.80 (3H, s, OCH3),  4.01 (1H, apt.t, obs.J = 8.1, PhCHCH2), 6.84 (2H, d, 





( ; 100 MHz, CDCl3), 11.68 (CH3), 22.66 (CH2), 31.18 (CH2), 51.91 (CH2), 54.15 (CH2), 55.26 (CH3), 60.66 
(CH2), 62.00 (CH), 65.09 (CH), 113.65 (CH), 126.81 (CH), 127.12 (CH), 128.23 (CH), 130.24 (CH), 130.95 




4.1.84 (199ca) N-benzyl-1-((cis)-1-(4-methylbenzyl)-4-phenylazetidin-2-yl)methanamine 
General procedure F was used: 192c (530 mg, 2.11 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192c) 
= 564 mg, 75%. IR 3653, 3284, 2956, 2878, 2753, 2528, 1596, 1496, 1476, 
1467, 1382, 1345, 1289, 1215, 1112; 
1
H NMR ( ; 500 MHz, CDCl3);
 
2.01 
(1H, apt.q, obs.J = 10.0, PhCHCHH), 2.33 (3H, s, Me), 2.41-2.48 (2H, m, 
PhCHCHH and NCHCHHNH), 2.58 (1H, dd, J = 12.0 & 4.5, NCHCHHNH), 3.32-3.37 (1H, m, 
NCHCH2NH), 3.61 (2H, ABq, JAB = 13.0, NHCH2Ph), 3.66 (2H, ABq, JAB = 13.0, NCH2Ar), 4.03 (1H, apt.t, 




H} NMR ( ; 125 MHz, CDCl3), 21.12 (CH3), 31.08 (CH2), 53.68 (CH2), 53.97 (CH2), 61.02 (CH2), 
62.28 (CH), 65.07 (CH), 126.80 (CH), 126.85 (CH), 127.07 (CH), 128.02 (CH), 128.22 (CH), 128.26 (CH), 
128.90 (CH), 129.07 (CH), 135.73 (C), 136.66 (C), 140.01 (C), 143.49 (C). High-resolution MS calcd for 
formula C25H28N2Na: 379.2150; found: 379.2144.  
4.1.85 (199da) N-Benzyl-1-(cis-1-benzyl-4-(pyridin-3-yl)azetidin-2-yl)methanamine.  
General procedure F was used: 192d (328 mg, 1.37 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192d) 
= 340 mg, 72%. IR 3302, 3027, 2819, 1643, 1578, 1494, 1479, 1453, 1427, 
1356, 1314, 1207, 1156; 
1
H NMR ( ; 400 MHz, CDCl3); 1.31 ( 1H, br, NH),
 
2.16 (1H, apt.q, obs.J = 8.0, PyCHCHH), 2.52 (2H, m, PyCHCHH and NCHCHHNH), 2.83 (1H, dd, J = 12.0 
& 4.0, NCHCHHNH), 3.56 (1H, m, NCHCH2NH), 3.68 (2H, ABq, JAB = 12.0, NCH2Ph), 3.92 (2H, ABq, JAB 
= 12.0, NHCH2Ph), 4.08 (1H, apt.t, obs.J = 8.0, PyCHCH2), 7.16 (1H, t, J = 8.0, ArH), 7.21 (1H, t, J = 8.0, 
ArH), 7.23 (2H, t, J = 8.0, ArH), 7.28 (1H, d, J = 8.0, ArH), 7.29 (2H, d, J = 8.0, ArH), 7.34 (2H, m, ArH), 





H} NMR ( ; 100 MHz, CDCl3), 30.78 (CH2), 53.15 (CH2), 53.96 (CH2), 61.48 (CH2), 62.52 
(CH), 62.96 (CH), 123.29 (CH), 126.96 (CH), 127.30 (CH), 128.10 (CH), 128.24(CH), 129.16 (CH), 134.66 
(CH), 138.10 (C), 138.58 (C), 139.80 (C), 148.52 (CH), 148.74 (CH). High-resolution MS calcd for formula 
C23H25N3Na: 366.1946; found: 366.1949.  
126 
 
4.1.86 (199di) 2-((((cis)-1-benzyl-4-(pyridin-3-yl)azetidin-2yl)methyl)amino)ethanol 
General procedure F was used: 192d (410 mg, 1.72 mmol), flash 
chromatography (CHCl3/MeOH = 1/1 Rf 0.4), yellow oil, yield (from 192d) 
= 419 mg, 82%. IR 3333, 2939, 2829, 1639, 1596, 1580, 1495, 1454, 1359, 
1315, 1209, 1155; 
1
H NMR ( ; 300 MHz, CDCl3); 2.25 (1H, apt.q, obs.J = 9.3, 
PyCHCHH), 2.62-2.94 (7H, m, NCHCH2NH, PyCHCHH, CH2CH2OH, NH, OH), 3.59-3.67 (1H, m, 
NCHCH2NH), 3.79 (2H, t, J = 5.1, CH2OH),  3.95 (2H, ABq, JAB = 12.6, NCH2Ph), 4.32 (1H, apt.t, obs.J = 8.1, 
PyCHCH2), 7.49-7.56 (6H, m, ArH), 8.06 (1H, dd, obs.J = 7.8 & 1.2, PyH), 8.75 (1H, d, J = 4.5, PyH), 8.88 




H} NMR ( ; 100 MHz, CDCl3), 30.83 (CH2), 51.17 (CH2), 53.13 (CH2), 60.58 (CH2), 
61.53 (CH2), 62.68 (CH), 62.85 (CH), 123.32 (CH), 127.32 (CH), 128.22 (CH), 129.17 (CH), 134.56 (CH), 
138.14 (C), 138.54 (C), 148.50 (CH), 148.63 (CH). High-resolution MS calcd for formula C18H23N3ONa: 
320.1739; found: 320.1744.  
4.1.87 (199dj) 3-((cis)-1-benzyl-4-(pyrrolidin-1-ylmethyl)azetidin-2-yl)pyridine 
General procedure F was used: 192d (200 mg, 0.84 mmol), flash chromatography 
(CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192d) = 196 mg, 76%. IR 
3413, 3029, 2960, 2690, 2195, 1635, 1495, 1453, 1430, 1357, 1317, 1189, 1156; 
1
H NMR ( ; 300 MHz, CDCl3); 2.01- 2.08 (5H, m,  NCH2CH2 & PyCHCHH), 
2.75 (1H, dd, J = 12.3 & 3.0, NCHCHHN), 2.83 (1H, dt, J = 10.5 & 7.5, PyCHCHH), 2.94-3.02 (1H, m, 
NCHCHHN), 3.15 (4H, br, NCH2CH2), 3.71 (2H, ABq, JAB = 12.3, NCH2Ph), 3.77-3.84 (1H, m, 
NCHCH2N), 4.11 (1H, apt.t, obs.J = 8.1, PyCHCH2), 7.18-7.31 (6H, m,  ArH), 7.68 (1H, dt, J = 7.8 & 2.1, 




H} NMR ( ; 125 MHz, CDCl3), 23.26 
(CH2), 34.82 (CH2), 54.44 (CH2), 57.91 (CH), 59.70 (CH2) 60.98 (CH), 63.47 (CH), 123.31 (CH), 127.72 
(CH), 128.51 (CH), 129.65 (CH), 134.43 (CH), 136.85 (C), 137.37 (C), 148.48 (CH), 148.80 (CH). High-





4.1.88 (199ea) N-benzyl-1-((cis)-1-benzyl-4-(pyridin-4-yl)azetidin-2yl)methanamine 
General procedure F was used: 192e (600 mg, 2.52 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 
192e) = 615 mg, 71%. IR 3031, 2818, 1671, 1600, 1495, 1453, 1412, 
1311, 1356, 1206, 1156; 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.96 (1H, apt.q, 
obs.J = 9.0, PyCHCHH), 2.41-2.50 (2H, m, PyCHCHH and NCHCHHNH), 2.56 (1H, dd, J = 12.3 & 4.5, 
NCHCHHNH), 2.94 (1H, br, NH), 3.35-3.45 (1H, m, NCHCH2NH), 3.63 (2H, s, NHCH2Ph), 3.68 (2H, 





H} NMR ( ; 100 MHz, CDCl3), 30.39 (CH2), 53.14 (CH2), 53.91 (CH2), 61.68 (CH2), 62.52 
(CH), 63.92 (CH), 121.64 (CH), 126.93 (CH), 127.38 (CH), 128.03 (CH), 128.27(CH), 128.34 (CH), 129.15 
(CH), 138.03 (C), 139.87 (C), 149.56 (CH), 152.37 (C). High-resolution MS calcd for formula C23H26N3: 
344.2126; found: 344.2130.  
4.1.89 (199fa) N-benzyl-1-((cis)-1-benzyl-4-(4-nitrophenyl)azetidin-2-yl)methanamine 
General procedure F was used: 192f (200 mg, 0.71 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 
192f) = 208 mg, 76%. IR 3062, 3028, 2924, 2851, 1671, 1599, 1516, 
1494, 1453, 1343, 1287, 1213, 1157; 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.70 (1H, br, NH), 1.94-2.03(1H, apt.q, obs.J = 8.7, ArCHCHH), 2.46-2.54 (2H, m, ArCHCHH and 
NCHCHHNH), 2.59 (1H, dd, J = 12.0 & 4.2, NCHCHHNH), 3.38-3.45 (1H, m, NCHCH2NH), 3.67 (2H, s, 
NHCH2Ph), 3.70 (2H, ABq, JAB = 12.3, NCH2Ph),  4.13 (1H, apt.t, obs.J = 8.1, ArCHCH2), 7.20-7.37 (10H, m, 




H} NMR ( ; 100 MHz, CDCl3)  30.99 
(CH2), 53.35 (CH2), 54.11 (CH2), 61.73 (CH2), 62.65 (CH), 64.53 (CH), 123.47 (CH), 126.85 (CH), 127.37 
(CH), 127.95 (CH), 128.25 (CH), 137.98 (C), 140.39 (C), 146.95 (C), 151.22 (C). High-resolution MS calcd 





4.1.90 (199ga) N-benzyl-1-((cis)-1-benzyl-4-(2-bromophenyl)azetidin-2-yl)methanamine 
General procedure F was used: 192g (1.30 g, 4.11 mmol), flash 
chromatography (Hexane/EtOAc = 1/1 Rf 0.4), yellow oil, yield (from 
192g) = 1.26 g, 65%. IR 3675, 2988, 2901, 1406, 1394, 1250, 1075, 1066, 
1056; 
1
H NMR ( ; 300 MHz, CDCl3); 1.54 (1H, br, NH), 
 
1.81 (1H, dt, J = 
10.2 & 8.4, ArCHCHH), 2.36 (1H, dd, J = 12.0 & 4.5, NCHCHHNH), 2.50 (1H, dd, J = 12.0 & 4.5, 
NCHCHHNH), 2.70 (1H, dt, J = 10.2 & 8.4, ArCHCHH), 3.37-3.45 (1H, m, CHCH2NH), 3.58 (2H, apt.d, obs.J 
= 3.3, NHCH2Ph), 3.71 (2H, ABq, JAB = 12.9, NCH2Ph), 4.36 (1H, apt.t, obs.J = 8.1, ArCHCH2), 7.15 (1H, td, J 





H} NMR ( ; 100 MHz, CDCl3), 30.17 (CH2), 53.79 (CH2), 54.06 (CH2), 61.77 (CH2), 62.79 
(CH), 64.24 (CH), 121.94 (C), 126.69 (CH), 127.25 (CH), 127.39 (CH), 127.91 (CH), 128.12 (CH), 128.24 
(CH), 128.27 (CH), 129.13 (CH), 132.20 (CH), 138.74 (C), 140.49 (C), 142.60 (C). High-resolution MS 
calcd for formula C24H26N2Br: 421.1279; found: 421.1271.  
4.1.91 (199ha) N-benzyl-1-((cis)-1-benzyl-4-(tert-butyl)azetidin-2-yl)methanamine 
General procedure F was used: 192h (928 mg, 4.27 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192h) = 
1.18 g, 86%. IR 3675, 3214, 2987, 2969, 2901, 1664, 1603, 1494, 1476, 1453, 
1394, 1360, 1250, 1229, 1075, 1066, 1056; 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.00 (9H, s, tert-butyl), 1.89 (1H, dt, J = 10.5 & 8.4, tert-butylCHCHH), 2.04 (1H, dt, J = 10.5 & 8.4, tert-
butylCHCHH), 2.29 (1H, dd, J = 12.0 & 4.5, NCHCHHNH), 2.48 (1H, dd, J = 12.0 & 4.5, NCHCHHNH), 
2.93 (1H, apt.t, obs.J = 8.4, tert-butylCHCH2), 3.17 (1H, m, CHCH2NH), 3.59 (2H, s, NHCH2Ph), 3.77 (2H, 




H} NMR ( ; 125 MHz, CDCl3),  22.13 (CH2), 
26.17 (CH3), 33.8 (C), 54.11 (CH2), 54.28 (CH2), 62.47 (CH), 64.22 (CH2), 71.88 (CH), 126.62 (CH), 127.0 
(CH), 127.87 (CH), 128.23 (CH), 128.82 (CH), 140.28 (C), 140.73 (C). High-resolution MS calcd for 




4.1.92 (199ib) N-(((cis)-1-benzyl-4-(3-methoxyphenyl)azetidin-2-yl)methyl)propan-1-amine 
General procedure F was used: 192i (700 mg, 2.62 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 
192i) = 723 mg, 85%. IR 3290, 2966, 2937, 2876, 1654, 1602, 1549, 
1454, 1372, 1239, 1155; 
1
H NMR ( ; 300 MHz, CDCl3); 0.86 (3H, t, J= 
7.5, Me), 1.37-1.49 (2H, m,CH2CH3), 2.05-2.21 (2H, m, J = 8.7, PhCHCHH, NHCHHCH2CH3), 2.26 (1H, 
dd, J = 12.3 & 4.8, NCHCHHNH), 2.40-2.54 (2H, m, PhCHCHH & NHCHHCH2CH3), 2.70 (1H, dd, J = 
12.3 & 4.8, NCHCHHNH), 3.38-3.45 (1H, m, NCHCH2NH), 3.69 (2H, ABq, JAB = 12.6, NCH2Ph), 3.85 
(3H, s, OCH3), 4.08 (1H, apt.t, obs.J = 8.1, PhCHCH2), 6.83 (1H, dd, J = 8.2 & 2.7, ArH), 7.01-7.05 (2H, m, 




H} NMR ( ; 100 MHz, CDCl3), 11.47 (CH3), 21.96 (CH2), 30.68 (CH2), 
51.38 (CH2), 52.87 (CH2), 55.33 (CH3), 61.21 (CH2), 65.33 (CH), 112.20 (CH), 112.84 (CH), 119.05 (CH), 
127.50 (CH), 128.13 (CH), 128.56 (CH), 129.21 (CH), 129.40 (CH), 138.69 (C), 144.41 (C), 159.78 (C). 
High-resolution MS calcd for formula C21H29N2O: 325.2280; found: 325.2270.  
4.1.93 (199ja) N-benzyl-1-((cis)-1-benzyl-4-(furan-3-yl)azetidin-2-yl)methanamine 
General procedure F was used: 192j (758 mg, 3.30 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192j) 
= 867 mg, 79%. IR 3197, 3027, 2934, 2858, 2797, 1642, 1594, 1544, 1523, 
1495, 1453, 1416, 1380, 1338, 1265, 1227, 1197, 1166; 
1
H NMR ( ; 300 
MHz, CDCl3);
 
1.76 (1H, br, NH), 2.09 (1H, apt. q, obs. J = 9.0, ArCHCHH), 2.32-2.40 (1H, m, ArCHCHH), 
2.41 (1H, dd, J = 12.0 & 4.2, NCHCHHNH), 2.55 (1H, dd, J = 12.0 & 4.2, NCHCHHNH), 3.25-3.33 (1H, 
m, CHCH2NH), 3.62 (2H, s, NHCH2Ph), 3.68 (2H, ABq, JAB = 12.9, NCH2Ph), 3.95 (1H, apt.t, obs.J = 9.0, 




H} NMR ( ; 100 MHz, CDCl3) 29.58 (CH2), 
53.48 (CH2), 54.19 (CH2), 56.96 (CH), 61.45 (CH2), 62.87 (CH), 109.41 (CH), 126.72 (CH), 127.10 (CH), 
127.94 (CH), 128.10 (C), 128.14 (CH), 128.26 (CH), 129.13 (CH), 138.75 (C), 139.28 (CH), 140.08 (C), 
142.91 (CH). High-resolution MS calcd for formula C22H25N2O: 333.1964; found: 333.1962.  
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4.1.94 (199kb) N-(((cis)-1-benzyl-4-cyclohexylazetidin-2-yl)methyl)propan-1-amine 
General procedure F was used: 192k (840 mg, 3.50 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192k) = 
852 mg, 81%. IR 2922, 2850, 1641, 1494, 1449, 1351, 1260, 1073; 
1
H NMR 
( ; 300 MHz, CDCl3); 0.82 (3H, t, J = 7.5, Me), 0.89-0.96 (2H, m, 
NCHCHCHH), 1.23-1.35 (5H, m, NHCH2CH2CH3, NCHCHCH2CHH, NCHCHCH2CH2CHH, NCHCH), 
1.61-1.75 (6H, m, NCHCHCHH, NCHCHCH2CHH, NCHCHCH2CH2CHH, NHCH2CH2), 2.06-2.35 (4H, m, 
NHCH2CHCHH, NHCH2CH2CH3, NCHCHHNH), 2.40 (1H, dd, J = 12.0 & 4.2, NCHCHHNH), 2.78 (1H, 
apt.q, obs.J = 8.4, NCHCH), 3.05-3.15 (1H, m, NCHCH2NH), 3.65 (2H, ABq, JAB = 12.6, NCH2Ph), 7.25-7.36 




H} NMR ( ; 100 MHz, CDCl3), 11.68 (CH3), 22.70 (CH2), 22.51 (CH2), 25.95 (CH2), 
26.64 (CH2), 28.12 (CH2), 29.57 (CH2), 29.70 (CH2), 44.38 (CH), 51.91 (CH2), 54.31 (CH2), 62.45 (CH), 
63.55 (CH2), 67.67 (CH) ,127.08 (CH), 128.22 (CH), 129.05 (CH), 139.60 (C). High-resolution MS calcd for 
formula C20H33N2: 301.2643; found: 301.2636.  
4.1.95 (199lb) N-(((cis)-1-(4-nitrobenzyl)-4-phenylazetidin-2-yl)methyl)propan-1-amine 
General procedure F was used: 192l (279 mg, 0.99 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192l) = 
275 mg, 82%. IR 3387, 2925, 2851, 1604, 1518, 1493, 1456, 1344, 1261, 1159; 
1
H NMR ( ; 300 MHz, CDCl3); 0.89 (3H, t, J = 7.2, Me), 1.50-1.63 (2H, 
m,CH2CH3), 2.00 (1H, dt, J = 10.8 & 8.4, PhCHCHH), 2.57-2.72 (4H, m, NHCH2CH2, PhCHCHH, 
NCHCHHNH), 2.79 (1H, dd, J = 12.4 & 3.9, NCHCHHNH), 3.45-3.54 (1H, m, NCHCH2NH), 3.80 (2H, 
ABq, JAB = 13.2, NCH2Ar), 4.03 (1H, apt.t, J = 8.1, PhCHCH2),  7.26-7.37 (5H, m, PhH), 7.44 (2H, d, J = 8.4, 




H} NMR ( ; 100 MHz, CDCl3), 11.32 (CH3), 20.57 (CH2), 32.43 
(CH2), 50.37 (CH2), 52.09 (CH2), 60.30 (CH), 60.56 (CH2), 66.28 (CH), 123.40 (CH), 126.81 (CH), 127.68 
(CH), 128.35 (CH), 129.77 (CH), 141.93 (C), 145.86 (C), 147.18 (C). High-resolution MS calcd for formula 





General procedure F was used: 192m (200 mg, 0.64 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192m) = 
163 mg, 69%. IR 2959, 2932, 2874, 1611, 1584, 1523, 1513, 1463, 1346, 
1248, 1176, 1109; 
1
H NMR ( ; 300 MHz, CDCl3); 0.77 (3H, t, J= 7.5, Me), 
1.22-1.32 (2H, m, CH2CH3), 1.73 (1H, dt, J = 10.5 & 8.4, ArCHCHH), 2.22-
2.37 (3H, m, NHCH2CH2, NCHCHHNH), 2.46 (1H, dd, J = 12.2 & 4.8, NCHCHHNH), 2.73 (1H, dt, J = 
10.5 & 8.4, ArCHCHH), 3.29-3.36 (1H, m, NCHCH2NH), 3.53 (2H, ABq, JAB = 12.6, NCH2Ar), 3.72 (3H, s, 
OCH3), 4.47 (1H, apt.t, obs.J = 8.4, ArCHCH2), 6.76 (2H, d, J = 8.7,  ArH), 7.18 (2H, d, J = 8.7, ArH), 7.30 




H} NMR ( ; 100 MHz, CDCl3) 11.71 (CH3), 22.94 (CH2), 31.18 (CH2), 51.98 (CH2), 54.63 (CH2), 
55.26 (CH3), 61.14 (CH2), 61.50 (CH), 62.32 (CH), 113.71 (CH), 124.33 (CH), 127.40 (CH), 128.91 (CH), 
130.24 (CH), 130.52 (C), 133.56 (CH), 139.55 (C), 147.31 (C), 158.92 (C). High-resolution MS calcd for 
formula C21H27N3O3Na: 392.1950; found: 392.1951.  
4.1.97 (199nb) N-((4-phenyl-1-((S)-1-phenylethyl)azetidin-2-yl)methyl)propan-1-amine 
General procedure F was used, yellow oil, [α]D
20 
= -19.0, (c 0.5 , CH2Cl2). IR 
2969, 2872, 1656, 1491, 1454, 1372, 1283, 1156; 
1
H NMR ( ; 300 MHz, 
CDCl3); 0.86 (3H, t, J = 7.4, Me), 1.00 (3H, d, J = 6.6, PhCHMe), 1.28-1.40 
(2H, m, NHCH2CH3), 1.84 (1H, apt.q, obs.J = 10.2, PhCHCHH), 1.94 (1H, dd, J = 
12.0 & 5.0, NCHCHHNH),  2.12-2.30 (3H, NCHCHHNH & NHCH2CH2 ), 2.42 (1H, dt, J = 10.2 & 8.7, 
PhCHCHH), 3.14-3.23 (1H, m, NCHCH2NH), 3.51 (1H, q, J = 6.6, NCHCH3), 4.03 (1H, apt.t, obs.J = 8.2, 




H} NMR ( ; 100 MHz, CDCl3) 11.79 
(CH3), 21.66 (CH3), 23.02 (CH2), 31.14 (CH2), 52.06 (CH2), 54.06 (CH2), 61.91 (CH), 65.03 (CH), 68.60 
(CH), 126.75 (CH), 126.84 (CH), 127.34 (CH), 127.60 (CH), 128.17 (CH), 128.28 (CH), 144.92 (C), 145.83 
(C). High-resolution MS calcd for formula C21H29N2: 309.2330; found: 309.2339.  
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4.1.98 (202aa) 1-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)-4-phenyl-1H-1,2,3-triazole 
General procedure G was used: post-work up iodo-azetidine 194a (1.00 g, 2.70 
mmol), sodium azide (357 mg, 5.50 mmol), DMF (20 mL), ethynylbenzene (276 
mg, 2.70 mmol), copper (I) iodide (1.05 g, 5.50 mmol), flash chromatography 
(Hexane/EtOAc = 6/4 Rf 0.4), yellow oil, yield (from 192a) = 680 mg, 53%. IR 
3675, 2971, 2901, 2163, 1493, 1453, 1406, 1393, 1066, 1056; 
1
H NMR ( ; 300 MHz, CDCl3); 1.72 (1H, dt, J 
= 10.8 & 8.4, PhCHCHH), 2.48 (1H, dt, J = 10.8 & 8.4 , PhCHCHH), 3.62-3.70 (1H, m, NCHCH2N), 3.71 
(2H, ABq, JAB = 12.3, NCH2Ph), 3.94 (1H, dd, J = 14.2 & 3.6, NCHCHHN), 4.06 (1H, apt.t, obs.J = 8.1, 
PhCHCH2), 4.29 (1H, dd, J = 14.2 & 3.6, NCHCHHN), 7.21-7.40 (11H, m, PhH), 7.48 (2H, t, J = 7.8, PhH), 




H} NMR ( ; 100 MHz, CDCl3), 30.18 (CH2), 53.53 
(CH2), 61.21 2X(CH), 64.97 (CH2), 121.41 (CH), 125.71 (CH), 126.73 (CH), 127.43 (CH), 127.67 (CH), 
127.97 (CH), 128.29 (CH), 128.57 (CH), 128.81 (CH), 129.54 (CH), 130.90 (C), 137.87 (C), 142.27 (C), 
147.26 (C). High-resolution MS calcd for formula C25H25N4: 381.2079; found 381.2078.  
4.1.99 (202ab) 1-(((cis)-1-benzyl-4-phenylazetidin-2-yl)methyl)-4-propyl-1H-1,2,3-triazole 
General procedure G was used: post-work up iodo-azetidine 194a (895 mg, 2.50 
mmol), sodium azide (320 mg, 5.00 mmol), DMF (20 mL), 1-pentyne (170 mg, 
2.50 mmol), copper (I) iodide (952 mg, 5.00 mmol), flash chromatography 
(Hexane/EtOAc = 6/4 Rf 0.4), yellow oil, yield (from 192a) = 516 mg, 59%. IR 
3062, 3029, 2958, 2927, 2870, 1673, 1603, 1551, 1494, 1383, 1358, 1287, 1214, 1157; 
1
H NMR ( ; 300 
MHz, CDCl3); 1.01 (3H, t, J = 7.2, Me), 1.62-1.77 (3H, m, PhCHCHH & CH2CH3), 2.42 (1H, dt, J = 10.8 & 
7.2, PhCHCHH), 2.68-2.74 (2H, m, N=NCCH2), 3.58 (1H, m, NCHCH2N), 3.66 (2H, ABq, JAB = 12.6, 
NCH2Ph), 3.85 (1H, dd, J = 14.2 & 3.6, NCHCHHN), 4.01 (1H, apt.t, obs.J = 8.1, PhCHCH2), 4.20 (1H, dd, J = 




H} NMR ( ; 100 MHz, 
CDCl3), 13.85 (CH3), 22.83 (CH2), 27.70 (CH2),  30.28 (CH2), 53.31 (CH2), 61.13 2x(CH), 64.89 (CH2), 
122.32 (CH), 126.72 (CH), 127.37 (CH), 127.55 (CH), 128.19 (CH), 128.46 (CH), 128.88 (C), 129.53 (CH), 
137.79 (C), 142.38 (C). High-resolution MS calcd for formula C22H26N4Na: 369.2055; found 369.2039.  
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4.1.100 (202da) 3-(cis-1-Benzyl-4-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)azetidin-2-yl)pyridine. 
General procedure G was used: post-work up iodo-azetidine 194d (500 mg, 1.37 
mmol) and sodium azide (178 mg, 2.74 mmol) DMF (20 mL), ethynylbenzene 
(140 mg, 1.37 mmol), copper (I) iodide (521 mg, 2.74 mmol), flash 
chromatography (CHCl3/MeOH = 95/5 Rf 0.4), yellow oil, yield (from 192d) = 
303 mg, 46%. IR 3029, 2915, 2850, 1578, 1454, 1427, 1383, 1311, 1222, 1178; 
1
H NMR ( ; 500 MHz, 
CDCl3); 1.82 (1H, apt.q, obs.J = 10.0, PyCHCHH), 2.56 (1H, apt.q, obs.J = 10.0, PyCHCHH), 3.68 (2H, ABq, JAB 
= 10.0, NCH2Ph), 3.74 (1H, m, NCHCH2N), 4.08 (1H, dd, J = 12.5 & 5.0, NCHCHHN), 4.15 (1H, m, 
PyCHCH2), 4.36 (1H, d, J = 15.0, NCHCHHN), 7.10 (1H, m, PyH), 7.27 (1H, t, J = 10.0, PhH), 7.29 (2H, d, 
J = 5.0, PhH), 7.31 (2H, t, J = 10.0, PhH), 7.37 (1H, t, J = 10.0, PhH), 7.47 (2H, t, J = 10.0, PhH), 7.59 (1H, 




H} NMR ( ; 100 
MHz, CDCl3), 28.97 (CH2), 52.54 (CH2), 60.75 (CH), 60.75 (CH2), 61.75 (CH), 121.84 (CH), 123.64 (CH), 
125.20 (CH), 125.22 (CH), 127.77 (CH), 128.03 (CH), 128.58 (CH), 128.83 (CH), 129.39 (CH), 130.06 (C), 
137.00 (C), 137.20 (C), 146.70 (C), 147.80 (CH), 148.40 (CH). High-resolution MS calcd for formula 
C24H23N5Na: 404.1851; found 404.1839.  
4.1.101  (204) 1-phenylbut-3-en-1-ol 
Magnesium (37.69 mmol, 916 mg) and allylbromide (28.27 mmol, 3.42 g) were added to 
dry THF (50 mL) at 0 
o
C and stirred for 15 minutes after which benzaldehyde (18.85 mmol, 
2.00 g) was added. The mixture was left stirring at 0 
o
C for 15 minutes before stirring the 
reaction for 16 hours at rt. A saturated solution of sodium bicarbonate and ethyl acetate were 
added. The product was extracted from the aqueous layer with ethyl acetate three times. Ethyl acetate was 
removed in vacuo to afford the homoallylic alcohol 204 with no need of further purification. Yellow oil, 2.78 
g, >99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
2.32-2.37 (2H, m, OHCHCH2), 2.58 (1H, br, OH), 4.52 (1H apt.t, J 





NMR ( ; 100 MHz, CDCl3), 43.77 (CH2), 73.44 (CH), 118.15 (CH2), 125.96 (CH), 127.53 (CH), 128.42 




4.1.102 (204) (S)-1-phenylbut-3-en-1-ol 
 
Indium (III) chloride (1.90 mmol, 420 mg) and (S)-Binol (2.07 mmol, 592 mg) were stirred 
for two hours at rt under nitrogen atmosphere in dry dichloromethane in presence of 4Å 
molecular sieve (50 mg). Allyltributylstannane (19.00 mmol, 6.24 g) was added and the 
mixture was stirred for ten minutes after which it was cooled to -78 
o
C for 15 minutes followed by slow 
addition of benzaldehyde (9.40 mmol, 1.00 g). The reaction mixture was left stirring at -78 
o
C for four hours 
and then for 48 hours at rt. A saturated solution of sodium bicarbonate was added and the product was 
extracted with dichloromethane three times. The solvent was removed in vacuo and the homoallylic alcohol 
(S)-204 was purified by flash chromatography using hexane:ethyl acetate (8:2) as solvent. Colourless oil, 
1.10 g, 79%. [α]D
20 
= -40.7 (c 32.7, CHCl3). 
1




H} NMR and High-resolution MS same as 
204.  
4.1.103 (205) 1-phenylbut-3-en-1-one 
 
Celite (1.00 g) was added to a suspension of PCC (3.71 g, 17.00 mmol) in CH2Cl2 (15mL). 
The resultant slurry was stirred vigorously for 5 min before being cooled to 0 
o
C. A solution 
of homoallylic alcohol 204 (1.70 g, 11.50 mmol) in CH2Cl2 (5 mL) was then added in one 
portion. The resulting solution was allowed to warm to rt and stirred for further four hours. Sodium 
thiosulfate, sodium bicarbonate and diethyl ether were added and the mixture was stirred vigorously for 15 
min before being filtered though a silica plug, washed with diethyl ether and dried over anhydrous 
magnesium suflate.  The solvent was removed in vacuo to yield the crude product as a yellow oil, which was 
purified by flash column chromatography (Hexane:EtOAc, 98:2 Rf 0.3) to afford the ketone 205 (1.5 g, 
89%). 
1
H NMR ( ; 300 MHz, CDCl3);
 
3.69 (1H, t, J = 1.4, C=OCHH), 3.71 (1H, t, J = 1.4, C=OCHH), 




H} NMR ( ; 100 MHz, CDCl3), 43.69 (CH2), 118.73 (CH2), 128.29 (CH), 128.63 (CH), 131.07 (CH), 





4.1.104 (206) (R)-(1-bromobut-3-en-1-yl)benzene  
 
PBr3 (1.35 mL, 1.35 mmol) was added to a stirred solution of compound (S)-204 (400 mg, 
1.70 mmol) in diethyl ether (20 mL) cooled to 0 
o
C. The resulting solution was stirred for a 
further 60 min before being quenched with a saturated aqueous solution containing sodium 
bicarbonate (20 mL) and diluted with diethyl ether (10 mL). The organic layer was separated and the 
aqueous layer extracted with diethyl ether (3 x 10 mL). The combained organic layers were washed with 
brine and dried over anhydrous magnesium sulfate before the solvent was removed in vacuo to give 
compound (R)-206 as a colourless oil (378 mg, 66%). [α]D
20 
= +33.7 (c 32.2, CHCl3). 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
2.74-2.94 (2H m, BrCHCH2), 4.84 (1H, apt.t, obs.J = 7.5, BrCH),  4.95-5.03 (2H, m, CH=CH2), 5.54-




H} NMR ( ; 400 MHz, CDCl3), 42.95 (CH2), 52.98 
(CH), 117.03 (CH2), 126.27 (CH), 127.29 (CH), 127.56 (CH), 133.63 (CH), 140.5 (C). M/z: (ES
+




4.1.105 (209) N-benzyl-N-(1-phenylbut-3-en-1-yl)acetamide 
 
N-benzyl-1-phenylbut-3-en-1-amine 192a (2.11 mmol, 500 mg), acetic anhydride 
(4.22 mmol, 430 mg), DMAP (0.21 mmol, 26 mg) and triethylamine (4.22 mmol, 427 
mg) were stirred for 16 hours at rt in DCM. When the starting material was consumed 
(monitored by TLC) the reaction was quenched with methanol and the solvents 
removed in vacuo. Ethyl acetate and water were added to the residue and the water layer extracted with ethyl 
acetate three times. Ethyl acetate was removed in vacuo and the crude product purified by flash 
chromatography (CH2Cl2 Rf 0.4). Yellow oil, 424 mg, 72%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.87 (3H, s, 
CH3), 2.68 (2H, t, J = 13.1 & 6.2, NCHCH2), 4.19 (2H, ABq, JAB = 17.7, NCH2Ph), 4.87-4.99 (2H, m, 
CH=CH2), 5.37-5.70 (1H, m, CH=CH2), 6.00 (1H, apt.t, obs.J = 7.9, NCH), 6.82 (2H, d, J= 6.6, PhH), 6.97-




H} NMR ( ; 100 MHz, CDCl3), 22.74 (CH3), 35.27 (CH2), 48.08 (CH2), 56.16 
(CH), 117.38 (CH2), 126.18 (CH), 127.07 (CH), 127.74 (CH), 128.10 (CH), 128.49 (CH), 128.65 (CH), 
135.00 (CH), 137.86 (C), 139.25 (C), 171.95 (C). High-resolution MS calcd for C19H21NONa: 302.1521; 
found: 302.1512.  
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4.1.106 (211) (S,E)-N-benzylidene-2-methylpropane-2-sulfinamide  
(R)-2-methylpropane-2-sulfinamide (16.50 mmol, 2.00 g) was stirred for 24 hours in 
dichloromethane with PPTS (0.82 mmol, 207 mg), anhydrous magnesium sulphate 
(82.50 mmol, 9.93 g) and benzaldehyde (49.50 mmol, 5.25 g) after which the 
suspension was filtered and the solvent was removed in vacuo. The crude obtained was purified by flash 
chromatography using hexane:ethyl acetate (10:1) as solvent. Yellow oil, 3.11 g, 90%. 
1
H NMR ( ; 300 
MHz, CDCl3); 
 
1.29 (9H, s, tert-butyl), 7.45-7.58 (3H, m, PhH), 7.87 (2H, dd,  J = 7.8 & 1.8, PhH), 8.61 




H} NMR ( ; 100 MHz, CDCl3), 22.61 (CH3)x3, 57.77 (C),  128.94 (CH), 129.39 (CH), 
132.41 (CH),  134.14 (C), 162.79 (CH). M/z: (ES
+
) 210.1 [M + H]
+
. 
4.1.107 (212) (S)-2-methyl-N-((R)-1-phenylbut-3-en-1-yl)propane-2-sulfinamide 
 
Procedure a: (S)-N-tert-butylsulfinyl aldimines (S)-211 (13.10 mmol, 2.75 g) was added 
to allylbromide (17.10 mmol, 2.07 g) and indium (powder, -100 mesh)  (17.10 mmol, 
1.96 g) in dry THF at rt. The mixture was heated to 60 
o
C and left stirring for 16 hours 
after which it was quenched with brine and the product was extracted with ethyl acetate three times. The 
solvent was removed in vacuo to afford (S,R)-212 in 90% yield (2.94 g). Procedure b: allyl bromide (18.2 
mmol, 2.20 g) was added to a suspension of activated zinc powder (27.3 mmol, 1.78 g), indium triflate (18.2 
mmol, 10.20 g) and (S)-N-tert-butylsulfinyl aldimines (S)-211 (9.10 mmol, 1.90 g) in dry THF under 
nitrogen atmosphere. The mixture was stirred at rt for 24 hours after which it was quenched with brine and 
the product was extracted with ethyl acetate three times. The solvent was removed in vacuo to afford (S,R)-
212 in 99% yield (2.30 g). [α]D
25 
= +121.6 (c 9.7, CHCl3). 
1
H NMR ( ; 300 MHz, CDCl3); 1.19 (9H, s, tert-
butyl), 2.44-2.62 (2H, m, PhCHCH2), 4.49 (1H, br, NH) 4.68 (1H, apt.t, obs.J = 6.0, PhCHNH), 5.01-5.11 (2H, 




H} NMR ( ; 100 MHz, CDCl3), 
22.94 (CH3)x3, 42.75 (CH2), 57.59 (C),  58.00 (CH), 119.40 (CH2), 127.85 (CH), 128.14 (CH),  128.44 
(CH), 133.75 (CH), 140.48 (C). M/z: (ES
+







4.1.108 (210) (R)-1-phenylbut-3-en-1-amine 
 
A solution of HCl 3N in methanol (20 mL) was added to compound (S)-211 (7.90 mmol, 2.00 
g) and the mixture was left stirring was 16 hours at rt. Methanol was removed in vacuo, diethyl 
ether was added and the HCl salt of (R)-210 was extracted with water three times. The aqueous 
layer was basified with a solution of NaOH 2M till pH 14 and compound (R)-210 was extracted with 
dichloromethane three times. The product (R)-210 was obtained as a yellow oil in 75% yield (878 mg). [α]D
20 
= +58.5 (c 8.2, CHCl3). 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.60 (1H, br, NH), 2.30-2.51 (2H, m, PhCHCH2), 
3.98 (1H, dd, J = 8.0 & 5.4, PhCHCH2), 5.06-5.15 (2H, m, CH=CH2), 5.68-5.81 (1H, m, CH=CH2), 7.21-




H} NMR ( ; 100 MHz, CDCl3), 44.20 (CH2), 55.40 (CH), 117.59 (CH2), 126.32 
(CH), 126.96 (CH), 128.40 (CH), 135.45 (CH), 145.85 (C). M/z: (ES
+
) 148.1 [M + H]
+
. 
4.1.109 Pt(II)-amino-azetidine metal complex 213aaa 
 
Under nitrogen atmosphere, K2PtCl4 (0.26 mmol, 110 mg) was added to a 
solution of methanol and compound 199ah (0.29 mol, 100 mg). The mixture 
was left stirring for 16 hours at 60 
o
C after which the solvent was removed 
in vacuo and the product purified by crystallisation (CH3CN:Et2O). Yellow 
crystals, 115 mg, 65%. 
1
H NMR ( ; 400 MHz, CDCl3), 1.16-1.27 (1H), 1.95-2.16 (3H, m), 3.04 (2H, s), 3.48 
(1H, dd, J = 11.9 & 9.0), 3.75 (1H, t, J = 11.6), 3.91-3.99 (2H, m), 4.84 (2H, ABq, JAB = 15.0), 4.84 (2H, s), 




H} NMR ( ; 100 MHz, CDCl3), 29.69 (CH2), 49.95 (CH2), 52.45 (CH2), 54.0 
(CH2), 56.49 (CH), 58.07 (CH), 126.18 (CH), 127.63 (CH) 128.24 (CH), 128.45 (CH), 128.77 (CH), 128.84 








4.1.110 Pd(II)-amino-azetidine metal complex 213aha 
 
Under nitrogen atmosphere, Na2PdCl4 (0.15 mmol, 43 mg) was added 
to a solution of methanol and compound 199ah (0.16 mmol, 60 mg). 
The mixture was left stirring for 16 hours at rt after which the solvent 
was removed in vacuo and the product purified by crystallisation 
(CH3CN:Et2O). Yellow crystals, 50 mg, 57%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.21-1.31 (1H, m), 1.75 (1H, 
138 
 
dd, J = 13.9 & 5.3), 2.02-2.10 (1H, m), 3.11 (1H, dd, J = 13.6 & 9.6), 3.23 (1H, d, J = 11.0), 3.37 (1H, d, J = 
11.7), 3.45-3.53 (1H, m), 3.70 (3H, s), 4.19 (1H, dd, J = 10.9 & 7.2), 5.00 (2H, ABq, JAB = 11.7), 5.29 (1H, 
br), 6.67 (2H, d, J = 8.6), 6.91-6.93 (3H, m), 7.05 (2H, d, J = 8.6), 7.50-7.53 (3H, m), 7.74-7.77 (2H, m), 




H} NMR ( ; 100 MHz, CDCl3), 24.42 (CH2), 55.09 (CH2), 55.28 (CH3), 57.80 
(CH2), 66.38 (CH2), 67.26 (CH), 75.83 (CH), 114.19 (CH), 115.40 (C), 126.23 (C), 128.37 (CH), 128.78 








4.1.111 C,N,N Pd(II)-amino-azetidine metal complex 213gaa 
 
Under nitrogen atmosphere, Pd2(dba)2 (0.24 mmol, 136 mg) was added to amino-
azetidine 199ga (0.12 mmol, 50 mg), the mixture was left stirring for 16 hours in toluene 
at 100
 o
C. The solvent was removed in vacuo and the product purified by crystallisation 




H} NMR ( ; 100 MHz, CDCl3), 
45.20 (CH2), 62.57 (CH2), 65.82 (CH), 67.55 (CH2), 72.50 (CH), 117.27 (CH2), 122.28 (CH), 123.21 (CH), 
125.25 (CH), 125.65 (CH), 127.64 (CH), 128.35 (CH), 128.45 (CH), 128.89 (CH), 128.99 (CH), 129.04 
(CH), 130.22 (C), 130.43 (CH), 131.12 (CH), 131.77 (C), 134.20 (C), 135.02 (C), 137.68 (CH), 142.63 
(CH). High-resolution MS calcd for formula C24H25N2Pd: 447.1053; found: 447.1060.  
4.1.112 (200ab) (cis)-1-benzyl-5-phenyl-N-propylpyrrolidin-3-amine 
 
General procedure H was used: homoallylic amine 192a (100 mg, 0.42 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 96 mg, 
78%. IR 3662, 2923, 2852, 1641, 1494, 1451, 1379, 1256, 1066; 
1
H NMR ( ; 300 
MHz, CDCl3); 0.90 (3H, t, J = 7.5, Me), 1.47-1.59 (2H, m, CH2CH2CH3), 1.61-1.71 
(1H, m, PhCHCHH), 2.39 (1H, dd, J = 10.1 & 7.3, NCHHCHNH), 2.48-2.60 (3H, m, 
J = 7.5, PhCHCHH  & NHCH2), 3.06 (1H, dd, obs.J = 10.1 & 1.8, NCHHCHNH), 3.28-3.35 (1H, m, 
NCH2CHNH), 3.41 (1H, dd, J = 9.6 & 7.0, PhCHCH2), 3.45 (2H, ABq, JAB = 13.2, NCH2Ph), 7.23-7.39 (8H, 




H} NMR ( ; 125 MHz, CDCl3), 11.77 (CH3), 22.74 (CH2), 43.12 
(CH2), 49.33 (CH2), 55.61 (CH), 57.53 (CH2), 58.46 (CH2), 68.80 (CH), 126.75 (CH), 127.25 (CH), 127.49 
139 
 
(CH), 128.13 (CH), 128.53 (CH), 129.19 (CH), 139.14 (C), 142.62 (C). High-resolution MS calcd for 
formula C20H27N2: 295.2174; found: 295.2171.  
4.1.113 (200ab) (trans)-1-benzyl-5-phenyl-N-propylpyrrolidin-3-amine 
General procedure J was used: homoallylic amine 192a (50 mg, 0.21 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 46 mg, 
74%. IR 3675, 3391, 2966, 2930, 2796, 1602, 1493, 1453, 1376, 1288, 1241, 1075, 
1066; 
1
H NMR ( ; 300 MHz, CDCl3); 0.92 (3H, t, J = 7.5, Me), 1.56-1.68 (2H, m, 
CH2CH2CH3), 2.03-2.23 (3H, m, PhCHCHH, PhCHCHH, NCHHCHNH), 2.50 (2H, 
t, J = 7.5, NHCH2), 3.39-3.53 (2H, m, NCHHCHNH & NCH2CHNH), 3.45 (2H, ABq, JAB = 12.9, NCH2Ph), 





H} NMR ( ; 125 MHz, CDCl3), 11.69 (CH3), 22.53 (CH2), 41.95 (CH2), 49.85 (CH2), 55.53 
(CH), 57.66 (CH2), 59.50 (CH2), 67.82 (CH), 126.83 (CH), 127.24 (CH), 127.56 (CH), 128.16 (CH), 128.52 
(CH), 128.59 (CH), 139.21 (C), 142.88 (C). High-resolution MS calcd for formula C20H27N2: 295.2174; 
found: 295.2155.  
4.1.114 (200aj) (cis)-1'-benzyl-5'-phenyl-1,3'-bipyrrolidine 
General procedure H was used: homoallylic amine 192a (100 mg, 0.42 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 104 
mg, 81%. IR 3414, 3061, 3028, 2962, 2790, 1602, 1493, 1453, 1331, 1289, 1208, 
1154; 
1
H NMR ( ; 300 MHz, CDCl3); 1.86-1.96 (5H, m, NCH2CH2 & PhCHCHH), 
2.42-2.51 (1H, m, NCHHCHN & PhCHCHH), 2.77 (4H, br, NCH2CH2), 3.22 (1H, 
dd, J = 10.95 & 3.0, NCHHCHN), 3.24 (1H, br, NCH2CHN), 3.46 (2H, ABq, JAB = 13.5, NCH2Ph), 3.52 




H} NMR ( ; 125 
MHz, CDCl3), 23.75 (CH2), 40.77 (CH2), 51.55 (CH2), 56.40 (CH), 57.80 (CH2), 60.93 (CH), 69.05 (CH2), 
126.93 (CH), 127.40 (CH), 127.59 (CH), 128.26 (CH), 128.37 (CH), 128.66 (CH), 138.89 (C), 141.85 (C). 





4.1.115 (200aj) (trans)-1'-benzyl-5'-phenyl-1,3'-bipyrrolidine 
General procedure J was used: homoallylic amine 192a (400 mg, 1.68 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192a) = 403 
mg, 78%. IR 3402, 3028, 2875, 2793, 1453, 1374, 1154; 
1
H NMR ( ; 300 MHz, 
CDCl3); 1.87 (4H, br, NCH2CH2), 2.00 (1H, dt, J = 13.3 & 9.0 PhCHCHH), 2.35-
2.45 (2H, m, PhCHCHH & NCHHCHN), 2.66-2.68 (4H, m, NCH2CH2), 3.00-3.09 
(1H, m, NCH2CHN), 3.16 (1H, dd, J = 8.7 & 6.6, NCHHCHN), 3.47 (2H, ABq, JAB = 12.9, NCH2Ph), 3.76 




H} NMR ( ; 100 MHz, 
CDCl3), 23.26 (CH2), 40.53 (CH2), 53.07 (CH2), 57.60 (CH2), 58.34 (CH2), 62.71 (CH), 68.07 (CH2), 126.86 
(CH), 127.23 (CH), 127.52 (CH), 128.18 (CH), 128.53 (CH), 128.63 (CH), 139.20 (C), 143.18 (C). High-
resolution MS calcd for formula C21H27N2: 307.2174; found: 307.2159.  
4.1.116 (200ka) (cis)-1-benzyl-5-cyclohexyl-N-propylpyrrolidin-3-amine 
General procedure H was used: homoallylic amine 192k (17 mg, 0.07 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192k) = 17 mg, 
82%. IR 3408, 2925, 2853, 1643, 1495, 1450, 1373, 1241; 
1
H NMR ( ; 300 MHz, 
CDCl3); 0.94 (3H, t, J = 7.5, Me), 1.05-1.26 (5H, m, NCHCHCHH, 
NCHCHCH2CHH, NCHCHCH2CH2CHH), 1.72-1.90 (8H, m, NCHCH, 
NCHCHCHH, NCHCHCH2CHH, NCHCHCH2CH2CHH, NHCH2CH2), 1.96-2.05 (1H, m, NCHCHHCH), 
2.20-2.30 (1H, m, NCHCHHCH), 2.36-2.49 (2H, m, NCHCH2CH, NCHHCHNH), 2.79-2.95 (2H, m, 
NHCH2CH2), 3.10-3.14 (2H, m, NCHHCHNH), 3.59 (2H, ABq, JAB = 13.2, NCH2Ph), 3.71-3.78 (1H, m, 




H} NMR ( ; 100 MHz, CDCl3), 11.42 (CH3), 20.20 (CH2), 
25.86 (CH2), 26.12 (CH2), 26.68 (CH2), 26.71 (CH2), 30.17 (CH2), 30.80 (CH2), 38.09 (CH), 46.84 (CH2), 
54.86 (CH), 55.62 (CH2), 57.03 (CH2), 67.45 (CH), 127.38 (CH), 128.51 (CH), 128.64 (CH), 137.95 (C). 





4.1.117 (200ka) (trans)-1-benzyl-5-cyclohexyl-N-propylpyrrolidin-3-amine 
General procedure J was used: homoallylic amine 192k (67 mg, 0.27 mmol), flash 
chromatography (CHCl3/MeOH = 9/1 Rf 0.4), yellow oil, yield (from 192k) = 65 mg, 
79%. IR 3376, 3027, 2923, 2851, 2792, 2505, 2422, 1586, 1494, 1451, 1375, 1326, 
1147; 
1
H NMR ( ; 300 MHz, CDCl3); 0.93 (3H, t, J= 7.5, Me), 1.00-1.27 (5H, m, 
NCHCHCHH, NCHCHCH2CHH, NCHCHCH2CH2CHH), 1.64-1.84 (8H, m, 
NCHCH, NCHCHCHH, NCHCHCH2CHH, NCHCHCH2CH2CHH, NHCH2CH2), 1.97-2.19 (2H, m, 
NCHCH2CH & NCHCHHCH), 2.32-2.41 (1H, m, NCHCH2CH), 2.68-2.73 (2H, m, NHCH2CH2), 2.76-2.83 
(1H, m,  NCHHCHNH), 3.17-3.25 (2H, m, NCHHCHNH), 3.35-3.41 (1H, m, NCH2CHNH), 3.63 (2H, ABq, 




H} NMR ( ; 100 MHz, CDCl3), 11.53 (CH3), 21.25 
(CH2), 25.74 (CH2), 26.28 (CH2), 26.82 (CH2), 26.92 (CH2), 30.76 (CH2), 39.11 (CH), 49.48 (CH2), 55.44 
(CH), 58.19 (CH2), 66.98 (CH2), 126.89 (CH), 128.27 (CH), 128.51 (CH), 139.53 (C). High-resolution MS 
calcd for formula C20H33N2: 301.2643; found: 301.2630.  
4.1.118 (214a) (cis)-1-benzyl-5-phenylpyrrolidin-3-ol 
General procedure I was used: homoallylic amine 192a (100 mg, 0.42 mmol), flash 
chromatography (Hexane/EtOAc = 2/1 Rf 0.3), yellow oil, yield (from 192a) = 87 
mg, 82%. IR 3370, 2970, 2906, 2794, 1493, 1453, 1408, 1376, 1250, 1229, 1144; 
1
H 
NMR ( ; 300 MHz, CDCl3); 1.71-1.79 (1H, m, PhCHCHH), 2.09 (1H, br, OH), 2.33 
(1H, dd, J = 10.3 & 4.8, NCHHCHOH), 2.61-2.70 (1H, m, PhCHCHH), 3.02-3.07 (1H, m, NCHHCHOH), 
3.36 (1H, apt.t, obs.J = 8.4, PhCHCH2), 3.45 (2H, ABq, JAB = 13.2, NCH2Ph), 4.20-4.29 (1H, m, CH2CHOH), 




H} NMR ( ; 100 MHz, 
CDCl3), 45.97 (CH2), 57.16 (CH2), 62.13 (CH2), 68.28 (CH), 70.12 (CH), 126.90 (CH), 127.29 (CH), 127.55 
(CH), 128.20 (CH), 128.62 (CH), 128.67 (CH), 138.83 (C), 142.84 (C). High-resolution MS calcd for 





4.1.119 (214b) (cis)-1-(4-methoxybenzyl)-5-phenylpyrrolidin-3-ol 
General procedure I was used: homoallylic amine 192b (100 mg, 0.37 mmol), 
flash chromatography (Hexane/EtOAc = 2/1 Rf 0.3), yellow oil, yield (from 
192b) = 83 mg, 79%. IR 3346, 2925, 1682, 1611, 1512, 1454, 1302, 1248, 
1178, 1106; 
1
H NMR ( ; 500 MHz, CDCl3); 1.72-1.77 (1H, m, PhCHCHH), 
2.11 (1H, br, OH), 2.33 (1H, dd, J = 10.5 & 5.0, NCHHCHOH),  2.59-2.67 (1H, m, PhCHCHH), 2.99-3.03 
(1H, m, NCHHCHOH), 3.34 (1H, apt.t, obs.J = 8.5, PhCHCH2), 3.40 (2H, ABq, JAB = 13.0, NCH2Ph), 3.78 
(3H, s, OMe), 4.23-4.25 (1H, m, CH2CHOH), 6.82 (2H, d, J = 8.5, ArH), 7.15 (2H, d, J = 8.5, ArH), 7.27 




H} NMR ( ; 125 MHz, 
CDCl3), 45.90 (CH2), 55.19 (CH3), 56.29 (CH2), 61.89 (CH2), 68.17 (CH), 69.95 (CH), 113.53 (CH), 127.26 
(CH), 127.60 (CH), 128.56 (CH), 129.92 (CH), 130.61 (C), 142.63 (C), 158.61 (C). High-resolution MS 
calcd for formula C18H21NO2Na: 306.1470; found: 306.1464.  
4.1.120 (214d) (cis)-1-benzyl-5-(pyridin-3-yl)pyrrolidin-3-ol 
General procedure I was used: homoallylic amine 192d (100 mg, 0.42 mmol), flash 
chromatography (EtOAc Rf 0.4), yellow oil, yield (from 192d) = 77 mg, 72%. IR 
3298, 3028, 2925, 2793, 1579, 1495, 1480, 1453, 1428, 1373, 1318, 1217, 1149; 
1
H 
NMR ( ; 300 MHz, CDCl3); 1.68-1.75 (1H, m, PyCHCHH), 2.20 (1H, br, OH), 2.36 
(1H, dd, J = 10.5 & 4.8, NCHHCHOH), 2.58-2.68 (1H, m, PyCHCHH), 3.01-3.10 (1H, m, NCHHCHOH), 
3.42 (2H, ABq, JAB = 13.2, NCH2Ph), 3.39 (1H, apt.t, obs.J = 8.4, PyCHCH2), 3.42 (2H, ABq, JAB = 13.2, 
NCH2Ph), 4.23-4.28 (1H, m, CH2CHOH), 7.13-7.27 (6H, m, ArH), 7.84 (1H, d, J = 8.1, PyH), 8.46 (1H, d, J 




H} NMR ( ; 100 MHz, CDCl3), 45.86 (CH2), 57.20 (CH2), 62.38 
(CH2), 66.08 (CH), 70.02 (CH), 124.02 (CH), 127.47 (CH), 128.34 (CH), 128.75 (CH), 135.36 (CH), 137.83 
(C), 138.02(C), 148.92 (CH), 149.60 (CH). High-resolution MS calcd for formula C16H18N2ONa: 277.1317; 





4.1.121 (215aa) 1-((trans)-1-benzyl-5-phenylpyrrolidin-3-yl)-4-phenyl-1H-1,2,3-triazole 
General procedure L was used: post-work up  iodo-azetidine 194a (71 mg, 0.19 
mmol), DMSO (20 mL), sodium azide (25 mg, 0.38 mmol), ethynylbenzene (20 
mg, 0.19 mmol), copper (I) iodide (36 mg, 0.19 mmol), flash chromatography 
(Hexane/EtOAc = 7/3 Rf 0.3), yellow oil, yield (from 192a) = 52 mg, 65% . IR 
3063, 3028, 2925, 2853, 1603, 1494, 1454, 1216, 1156; 
1
H NMR ( ; 300 MHz, 
CDCl3); 2.39 (1H, dt, J = 13.8 & 9.6, PhCHCHH), 2.61-2.69 (1H, m, PhCHCHH), 2.72 (1H, dd, J = 9.7 & 
7.4, NCHHCHN3), 3.49 (2H, ABq, JAB = 12.9, NCH2Ph), 3.61 (1H, dd, J = 9.7 & 7.4, NCHHCHN3), 3.92 
(1H, apt.t, obs.J = 7.8, PhCHCH2), 5.09-5.19 (1H, m, CH2CHN3), 7.17-7.28 (7H, m, PhH), 7.31-7.38 (4H, m, 




H} NMR ( ; 100 
MHz, CDCl3), 42.38 (CH2), 57.11 (CH2), 57.88 (CH), 59.44 (CH2), 67.90 (CH), 118.68 (CH), 125.70 (CH), 
127.17 (CH), 127.61 (CH), 127.76 (CH), 128.17 (CH), 128.33 (CH), 128.69 (CH), 128.77 (CH), 128.83 
(CH), 130.58 (C), 138.42 (C), 141.68 (C), 147.81 (C). High-resolution MS calcd for formula C25H24N4Na: 
403.1899; found: 403.1917.  
4.1.122 (215ca) (1-((trans)-1-(4-methylbenzyl)-5-phenylpyrrolidin-3-yl)-4-phenyl-1H-1,2,3-triazole 
General procedure L was used: post-work up iodo-azetidine 194c (70 mg, 0.18 
mmol) DMSO (20 mL), sodium azide (24 mg, 0.37 mmol), ethynylbenzene (18 
mg, 0.18 mmol), copper (I) iodide (68 mg, 0.37 mmol), (Hexane/EtOAc = 7/3 Rf 
0.3), yellow oil, yield (from 192c) = 48 mg, 61%. IR 3356, 3070, 3026, 1674, 
1600, 1523, 1493, 1456, 1341, 1170; 
1
H NMR ( ; 500 MHz, CDCl3); 2.33 (3H, s, 
Me), 2.44 (1H, dt, J = 13.8 & 9.5, PhCHCHH), 2.69-2.74 (1H, m, PhCHCHH), 2.80 (1H, dd, J = 9.9 & 7.5, 
NCHHCHN3), 3.53 (2H, ABq, JAB = 13.0, NCH2Ar), 3.69 (1H, dd, J = 9.9 & 7.5, NCHHCHN3), 3.97 (1H, 
apt.t, obs.J = 8.0, PhCHCH2), 5.17-5.23 (1H, m, CH2CHN3), 7.11 (2H, d, J = 8.0, ArH), 7.15 (2H, d, J = 8.0, 
ArH), 7.30-7.34 (2H, m, ArH), 7.39-7.44 (4H, m, ArH), 7.52 (2H, d, J = 7.0, ArH), 7.71 (1H, s, CHN3), 7.81 




H} NMR ( ; 125 MHz, CDCl3), 21.08 (CH3), 42.49 (CH2), 56.65 (CH2), 57.94 
(CH), 59.23 (CH2), 67.76 (CH), 118.61 (CH), 125.69 (CH), 127.59 (CH), 127.70 (CH), 128.14 (CH), 128.69 
(CH), 128.74 (CH), 128.82 (CH), 129.00 (CH), 130.68 (C), 135.19 (C), 136.80 (C), 141.63 (C), 147.90 (C). 
High-resolution MS calcd for formula C26H26N4Na: 417.2055; found: 417.2054.  
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4.1.123 (215da) 3-(trans-1-Benzyl-4-(4-phenyl-1H-1,2,3-triazol-1-yl)pyrrolidin-2-yl)pyridine.  
General procedure L was used: post-work up iodo-azetidine 194d (110 mg, 0.30 
mmol), DMSO (20 mL), sodium azide (30 mg, 0.45 mmol), ethynylbenzene (32 
mg, 0.30 mmol), copper (I) iodide (115 mg, 0.60 mmol), (EtOAc Rf 0.4), yellow 
oil, yield (from 192d) = 86 mg, 57%. IR 3127, 3026, 2920, 2822, 1579, 1495, 1481, 
1455, 1428, 1375, 1322, 1289, 1229, 1178, 1160; 
1
H NMR ( ; 300 MHz, CDCl3); 
2.43(1H, dt,  J = 15.0 & 9.0, PyCHCHH), 2.78 (1H, m, PyCHCHH), 2.86 (1H, dd, J = 9.0 & 6.0, CHHN3), 
3.57 (2H, ABq, JAB = 15.0, NCH2Ph), 3.71 (1H, t, J = 9.0, CHHN3), 4.07 (1H, t, J = 9.0, PyCHCH2), 5.21 
(1H, m, NCHCH2N3), 7.33 (9H, m, ArH), 7.75 (1H, s, CHN3), 7.81 (2H, d, J = 9.0, ArH), 7.87 (1H, d, J = 




H} NMR ( ; 100 MHz, CDCl3), 42.30 (CH2), 56.20 
(CH2), 57.82 (CH), 59.42 (CH2), 65.45 (CH), 118.87 (CH), 125.71(CH), 127.36 (CH), 128.25 (CH), 128.45 
(CH), 128.65 (CH), 128.87 (CH), 130.47 (C), 135.15 (CH), 137.93(C), 147.87(C), 149.29(CH), 149.57(CH) 
(quat C=Ctriazole not observed). High-resolution MS calcd for formula C24H23N5Na: 404.1851; found: 
404.1867. 
To confirm stereochemistry nOe experiments were performed, revealing a trans substitution arrangement 
about the pyrrolidine ring, suggesting compound 195d, formed in situ is cleanly converted via an SN2 
mechanism to the corresponding azide which is subsequently converted to the corresponding triazole: 





4.1.124 (219a) N-benzyl-1-(4-methoxyphenyl)methanamine 
 
General procedure M was used: (4-methoxyphenyl)methanamine (10.35 
mmol, 1.42 g), benzaldehyde (9.42 mmol, 1.00 g), sodium borohydride 
(18.84 mmol, 713 mg), yellow oil, 2.13 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.87 (1H, s, NH), 3.85 (2H, 





H} NMR ( ; 100 MHz, CDCl3); 52.66 (CH2), 53.16 (CH2), 55.27 (CH3), 113.92 (CH), 127.04 
(CH), 128.51 (CH), 129.47 (CH), 132.58 (C), 140.56 (C), 158.81 (C). M/z: (ES
+
) 228.1 [M + H]
+
. 
4.1.125 (219b) N-benzyl-1-(4-nitrophenyl)methanamine 
 
General procedure M was used: benzylamine (1.02 mmol, 109 mg), 4-
nitrobenzaldehyde (0.93 mmol, 140 mg), sodium borohydride (1.86 mmol, 
70 mg), yellow oil, 224 mg, 99%. 
1
H NMR ( ; 300 MHz, CDCl3); 
 
3.73 (2H, s, CH2Ph-p-NO2), 3.83 (2H, s, 




H} NMR ( ; 
100 MHz, CDCl3); 52.29 (CH2), 53.26 (CH2), 123.62 (CH), 127.24 (CH), 128.14 (CH), 128.54 (CH), 128.69 
(CH), 139.75 (C), 147.07 (C), 148.29 (C). High-resolution MS calcd for C14H15N2O2: 243.1134; found: 
243.1135.  
4.1.126 (219c) N-benzylpropan-1-amine 
 
General procedure M was used: propylamine (10.36 mmol, 612 mg), benzaldehyde 
(9.42 mmol, 1.00 g), sodium borohydride (18.84 mmol, 713 mg), yellow oil, 1.39 g, 
99%. 
1
H NMR ( ; 300 MHz, CDCl3); 
 
0.96 (3H, t, J = 7.4, CH3CH2CH2), 1.39 (1H, br, NH), 1.57 (2H, 





H} NMR ( ; 100 MHz, CDCl3); 11.81 (CH3), 23.24 (CH2), 51.40 (CH2), 54.05 (CH2), 126.84 
(CH), 128.11 (CH), 128.36 (CH), 140.64 (C). M/z: (ES
+
) 150.1 [M + H]
+
. 
4.1.127 (219d) 2-(benzylamino)ethanol 
 
General procedure M was used: 2-aminoethanol (17.98 mmol, 1.10 g), 
benzaldehyde (16.35 mmol, 1.83 g), sodium borohydride (32.70  mmol, 6.94 g), 
yellow oil, 2.46 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3); 
 
2.67 (2H, t, J = 5.4, CH2CH2OH), 3.03 (2H, br, OH 
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H} NMR ( ; 
100 MHz, CDCl3) 50.63 (CH2), 53.48 (CH2), 60.68 (CH2), 127.20 (CH), 128.26 (CH), 128.51 (CH), 139.57 
(C). High-resolution MS calcd for C9H14NO: 152.1075; found: 152.1080.  
4.1.128 (219e) N-benzyl-1-(thiophen-2-yl)methanamine 
 
General procedure M was used: benzylamine (4.91 mmol, 526 mg), thiophene-2-
carbaldehyde (4.46 mmol, 500 mg), sodium borohydride (8.92 mmol, 337 mg), 
yellow oil, 901 mg, 99%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.84 (1H, br, NH), 3.77 (2H, s, PhCH2NH), 3.93 





H} NMR ( ; 100 MHz, CDCl3) 47.51 (CH2), 52.74 (CH2), 124.44 (CH), 124.98 (CH), 126.64 (CH), 
127.07 (CH), 128.24 (CH), 128.45 (CH), 139.89 (C), 144.03 (C). High-resolution MS calcd for C12H14NS: 
204.0847; found: 204.0840.  
4.1.129 (219f) N-benzyl-1-phenylethanamine 
 
General procedure M was used: 1-phenylethanamine (20.72 mmol, 2.51 g), 
benzaldehyde (18.84 mmol, 2.00 g), sodium borohydride (37.69 mmol, 1.42 g), 
yellow oil, 3.96 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3); 
 
1.47 (3H, d, J = 6.6, Me), 1.73 (1H, br, NH), 3.73 





( ; 100 MHz, CDCl3) 24.65 (CH3), 51.79 (CH2), 57.63 (CH), 126.83 (CH), 126.96 (CH), 127.06 (CH), 
128.26 (CH), 128.48 (CH), 128.60 (CH), 140.79 (C), 145.72 (C). High-resolution MS calcd for C15H17N: 
211.1361; found: 211.1360.  
4.1.130 (189a) (E)-N-benzylidene-1-phenylmethanamine 
 
General procedure N was used: dibenzylamine (0.25 mmol, 50 mg), caesium 
carbonate (0.76 mmol, 248 mg,), I2 (0.25 mmol, 63 mg,), CH3CN (10 mL), yellow 
oil, 49 mg, 99%. IR 3062, 3027, 2871, 2839, 1642, 1580, 1495, 1451, 1378, 1292; 
1
H NMR ( ; 300 MHz, 
CDCl3);
 





NMR ( ; 100 MHz, CDCl3), 65.23 (CH2), 127.25 (CH), 128.26 (CH), 128.59 (CH), 128.78 (CH), 128.86 
(CH), 131.0 (CH), 136.53 (C), 139.75 (C), 162.04 (CH). M/z: (ES
+





4.1.131  (189f) (E)-N-(4-nitrobenzylidene)-1-phenylmethanamine 
General procedure N was used: N-benzyl-1-(4-nitrophenyl)methanamine 
(0.16 mmol, 40 mg), caesium carbonate (0.49 mmol, 160 mg,), I2 (0.16 
mmol, 41 mg,), CH3CN (10 mL), yellow solid, 38 mg, 99%. IR 3000, 2934, 2904, 2835, 1636 1509, 1372, 
1342, 1243; 
1
H NMR ( ; 300 MHz, CDCl3);
 
4.75 (2H, s, PhCH2), 7.13-7.28 (5H, m, PhH), 7.80 (2H, d, J = 




H} NMR ( ; 100 MHz, CDCl3), 65.19 
(CH2), 123.85 (CH), 127.32 (CH), 128.10 (CH), 128.67 (CH), 128.95 (CH), 138.57 (C), 141.67 (C), 149.08 
(C), 159.49 (CH). M/z: (ES
+
) 241.1 [M + H]
+
. 
4.1.132 (189q) (E)-N-benzylidenepropan-1-amine 
General procedure N was used: N-benzylpropan-1-amine (0.67 mmol, 100 mg), 
caesium carbonate (2.01 mmol, 656 mg), I2 (0.67 mmol, 170 mg), magnesium 
sulphate (3.35 mmol, 400 mg), CH3CN (15 mL), yellow oil, 98 mg, 99 %. IR 2962, 2931, 2874, 1645, 1580, 
1451, 1379, 1338; 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.85 (3H, t, J = 7.4, CH3), 1.56-1.68 (2H, m, CH2CH3),
 




H} NMR ( ; 100 MHz, CDCl3), 11.88 (CH3), 24.10 (CH2), 65.33 (CH2), 128.03 (CH), 128.55 (CH), 
130.43 (CH), 136.40 (C), 160.74 (CH). M/z: (EI
+
) 146.1 [M + H]
+
. 
4.1.133 (223) (E)-2-(benzylideneamino)ethanol 
 
General procedure N was used: 2-(benzylamino)ethanol (0.44 mmol, 67 mg), 
caesium carbonate (1.33 mmol, 434 mg), I2 (0.44 mmol, 112 mg), CH3CN (10 mL), 
yellow oil, 65 mg, 99%. IR 3345, 3062, 3029, 2878, 1645, 1450, 1382, 1294; 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
3.75-3.78 (2H, m, CH2OH), 3.91-3.94 (2H, m, NCH2CH2), 4.53 (1H, br, OH), 7.40-7.45 (3H, m, 




H} NMR ( ; 100 MHz, CDCl3), 62.33 (CH2), 
63.32 (CH2), 128.21 (CH2), 128.64 (CH), 130.90 (CH), 135.81 (C), 163.27 (CH). M/z: (ES
+
) 149.1 [M + H]
+
. 
4.1.134  (189n) (E)-N-benzylidene-1-phenylethanamine 
General procedure N was used: N-benzyl-1-phenylethanamine (0.24 mmol, 50 mg), 
caesium carbonate (0.71 mmol, 237 mg), I2 (0.24 mmol, 61 mg), CH3CN (10 mL), 
148 
 
colourless oil, 49 mg, 99%. IR 3061, 3026, 2971, 2926, 2866, 1645, 1492, 1450, 1380, 1292; 
1
H NMR ( ; 
300 MHz, CDCl3);
 
1.51 (3H, d, J = 6.6, Me), 4.45 (1H, q, J = 6.6, PhCHCH3), 7.11-7.36 (8H, m, PhH), 7.68-




H} NMR ( ; 100 MHz, CDCl3), 24.93 (CH3), 69.78 (CH), 
126.69 (CH), 126.87 (CH), 128.31 (CH), 128.47 (CH), 128.57 (CH), 130.61 (CH), 136.48 (C), 145.26 (C), 
159.48 (CH). High-resolution MS calcd for C15H15N: 209.1204; found: 209.1199.  
4.1.135 (225) 5-(pyrrolidin-1-yl)-3,4-dihydro-2H-pyrrole 
General procedure N was used: pyrrolidine (1.41 mmol, 100 mg), caesium carbonate (4.22 
mmol, 1.38 g), I2 (358 mg, 1.41 mmol), CH3CN (15 mL), yellow oil, 97 mg, 99%. IR 3392, 
2973, 2920, 1677, 1503, 1454, 1421, 1343, 1300, 1259; 
1
H NMR ( ; 300 MHz, CDCl3); 2.01-2.08 (4H, m, 
N=CNCH2CH2), 2.25 (2H, quintet, J = 7.6, N=CCH2CH2), 2.94 (2H, t, J = 7.6, N=CCH2), 3.62 (2H, t, J = 




H} NMR ( ; 100 MHz, CDCl3), 20.68 
(CH2), 25.24 (CH2), 25.30 (CH2), 31.95 (CH2), 47.44 (CH2), 51.13 (CH2), 51.86 (CH2), 165.51 (C). M/z: 
(ES
+
) 139.1 [M + H]
+
. 
4.1.136 (227) N,1-dibenzylpiperidin-4-amine 
 
General procedure O was used: 1-benzylpiperidin-4-amine (2.60 mmol, 500 mg), benzaldehyde 
(2.60 mmol, 291 mg), sodium acethoxyborohydride (3.94 mmol, 835 mg), yellow oil, 435 mg, 
60%. 
1
H NMR ( ; 300 MHz, CDCl3); 1.44 (1H, br, NH),
 
1.44-1.55 (2H, m, NHCHCH2), 1.91-
1.94 (2H, m, NHCHCH2), 2.06 (2H, td, J = 11.6 & 2.0, NCH2CH2NH2), 2.53-2.60 (1H, m, 





H} NMR ( ; 100 MHz, CDCl3) 32.84 (CH2), 50.91 (CH2), 52.45 (CH2), 54.32 (CH), 63.18 
(CH2) 126.92 (CH), 126.97 (CH), 128.13 (CH), 128.23 (CH), 128.47 (CH), 129.14 (CH), 138.75 (C), 140.87 






4.1.137 (228) (E)-1-benzyl-N-benzylidenepiperidin-4-amine 
General procedure N was used: N,1-dibenzylpiperidin-4-amine (100 mg, 0.36 mmol), caesium 
carbonate (348 mg, 1.07 mmol), I2 (91 mg, 0.36 mmol), CH3CN (15 mL), yellow oil, 98 mg, 
99%. IR 3060, 3026, 2937, 2804, 2760, 1639, 1450, 1389, 1293; 
1
H NMR ( ; 400 MHz, 
CDCl3);
 
1.67-1.70 (2H, m, CH=NCHCH2), 1.79-1.88 (2H, m, CH=NCHCH2), 2.12 (2H, t, J = 
10.8, NCH2CH2), 2.87-2.91 (2H, m, NCH2CH2), 3.18 (1H, m, CH=NCH), 3.50 (2H, s, 





NMR ( ; 100 MHz, CDCl3) 33.49 (CH2), 52.08 (CH2), 63.16 (CH2), 67.54 (CH), 126.99 (CH), 128.12 (CH), 
128.22 (CH), 128.56 (CH), 129.15 (CH), 130.48 (CH), 136.51 (C), 138.56 (C), 159.11 (CH). High-resolution 
MS calcd for C19H23N2: 279.1861; found: 279.1869.  
4.1.138 (229) 1-benzylpiperidin-4-amine 
General procedure P was used: (E)-1-benzyl-N-benzylidenepiperidin-4-amine (0.09 mmol, 25 
mg), yellow oil, 17 mg, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
1.33-1.45 (2H, m, NH2CHCH2), 
1.59 (2H, br, NH2) 1.76-1.81 (2H, m, NH2CHCH2), 2.02 (2H, td, J = 11.7 & 2.4, 
NCH2CH2NH2), 2.60-2.70 (1H, m, CHNH2), 2.80- 2.86 (2H, m, NCH2CH2NH2), 3.49 (2H, s, 




H} NMR ( ; 100 MHz, CDCl3) 35.94 (CH2), 48.77 (CH), 52.43 
(CH2), 63.08 (CH2), 126.91 (CH), 128.14 (CH), 129.10 (CH), 138.56 (C). M/z: (EI
+
) 190.1 [M + H]
+
.  
4.1.139 (231) ((cis)-1-benzyl-4-phenylazetidin-2-yl)methanamine 
Procedures N and P were used: caesium carbonate (0.82 mmol, 268 mg) and I2 (0.27 
mmol, 70 mg), were added to N-benzyl-1-((cis)-1-benzyl-4-phenylazetidin-2-
yl)methanamine (0.27 mmol, 89 mg), in CH3CN (15 mL). Yellow oil, 61 mg, 89%. 
IR 3393, 2924, 1603, 1493, 1453, 1356, 1215, 1157; 
1
H NMR ( ; 300 MHz, CDCl3);
 
2.15 (1H, apt.q, obs.J = 11.1, PhCHCHH), 2.40-2.52 (2H, m, PhCHCHH and NCHCHHNH2), 2.90 (1H, dd, J = 
13.2 & 1.8, NCHCHHNH2), 3.60-3.61 (1H, m, CHCH2NH), 3.71 (2H, ABq, JAB = 12.3, NCH2Ph), 4.19 (1H, 




H} NMR ( ; 100 MHz, 
CDCl3), 29.80 (CH2), 40.99 (CH2), 57.74 (CH), 59.91 (CH2), 65.40 (CH), 127.02 (CH), 127.99 (CH), 128.54 
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(CH), 128.63 (CH), 129.27 (CH), 129.51 (CH), 135.73 (C), 140.13 (C). High-resolution MS calcd for 
formula C17H21N2: 253.1704; found: 253.1696.  
4.1.140 (232) N-benzyl-N-ethyl-1-phenylethanamine 
 
General procedure O was used: N-benzyl-1-phenylethanamine (7.18 mmol, 1.50 g), 
acetaldehyde (7.18 mmol, 316 mg), sodium acethoxyborohydride (10.77 mmol, 
2.28 g), yellow oil, 1.72 g, 99%. 
1
H NMR ( ; 300 MHz, CDCl3);
 
0.91 (3H, t, J = 
7.1, CH3CH2), 1.28 (3H, d, J = 6.8, CH3CH), 2.34 (1H, m, CH3CHHN), 2.51 (1H, m, CH3CHHN), 3.45 (2H, 




H} NMR ( ; 
100 MHz, CDCl3) 12.21 (CH3), 16.20 (CH3), 43.09 (CH2), 53.92 (CH2), 58.06 (CH), 126.60 (CH), 126.64 
(CH), 127.80 (CH), 128.10 (CH), 128.17 (CH), 128.54 (CH), 141.23 (C), 144.59 (C). High-resolution MS 
calcd for C17H22N: 240.1752; found: 240.1755.  
4.1.141  (219f) N-benzyl-1-phenylethanamine 
Procedure: caesium carbonate (0.63 mmol, 205 mg) and I2 (0.63 mmol, 159 mg), 
were added to amine N-benzyl-N-ethyl-1-phenylethanamine (0.21 mmol, 50 mg), 
in DMSO:H2O (10:2 mL). Consumption of starting material was monitored by 
TLC. When the reaction was completed diethyl ether and a solution of sodium thiosulfate  were added, the 
organic layer was washed with water three times and dried in vacuo to deliver the corresponding amine. 
Yellow oil, 44 mg, 99%. IR 3062, 3026, 2974, 1493, 1451, 1372, 1302, 1238; 
1
H NMR ( ; 300 MHz, 
CDCl3);
 
1.47 (3H, d, J = 6.6, Me), 1.73 (1H, br, NH), 3.73 (2H, ABq, JAB = 13.2, NHCH2Ph), 3.91 (1H, q, J 




H} NMR ( ; 100 MHz, CDCl3), 24.65 (CH3), 51.79 (CH2), 
57.63 (CH), 126.83 (CH), 126.96 (CH), 127.06 (CH), 128.26 (CH), 128.48 (CH), 128.60 (CH), 140.79 (C), 
145.72 (C). High-resolution MS calcd for C15H17N: 211.1361; found: 211.1360.  
4.1.142 (231) ((2S,4R)-1-benzyl-4-phenylazetidin-2-yl)methanamine 
 
Procedures N and P were used: caesium carbonate (0.87 mmol, 283 mg) and I2 
(0.29 mmol, 74 mg), were added to N-benzyl-1-((2S,4R)-1-benzyl-4-
phenylazetidin-2-yl)methanamine 199aa (0.29 mmol, 100 mg), in CH3CN (15 mL). 
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Yellow oil, 73 mg, 99%. [α]D
20 
= +107.8 (c 1.4, CHCl3). IR 3061, 3027, 2019, 2851, 1601, 1493, 1454, 1353, 
1303, 1209, 1157; 
1
H NMR ( ; 300 MHz, CDCl3); 1.22 (2H, br, NH2),
 
1.76 (1H, apt.q, obs.J = 8.7, 
PhCHCHH), 2.26-2.35 (3H, m, PhCHCHH and NCHCH2NH2), 3.07-3.15 (1H, m, NCHCH2NH2), 3.59 (2H, 





( ; 100 MHz, CDCl3), 29.79 (CH2), 45.60 (CH2), 61.45 (CH2), 64.59 (CH), 64.89 (CH), 126.70 (CH), 127.05 
(CH), 127.08 (CH), 128.17 (CH), 128.21 (CH), 129.12 (CH), 138.97 (C), 143.56 (C). High-resolution MS 
calcd for formula C17H21N2: 253.1704; found: 253.1717.  
4.1.143 (234) (S)-dimethyl 2-(2-nitro-1-phenylethyl)malonate 
 
1-isothiocyanato-3,5-bis(trifluoromethyl)benzene (0.04 mmol, 11 mg) was stirred 
with (2S,4R)-231 (0.04 mmol, 10 mg) for 30 minutes in dry toluene under argon 
atmosphere after which (E)-(2-nitrovinyl)benzene (0.40 mmol, 59 mg) and dimethyl 
malonate (0.80 mmol, 106 mg) were added and the mixture was left stirring at rt temperature for 48 hours. 
Toluene was removed in vacuo and the product was purified by flash chromatography using hexane:ethyl 
acetate (7:3) as solvent. Yield = 23 mg, 20%. [a]D
25
= +5.5 (c 1.0, CHCl3). 
1
H NMR ( ; 300 MHz, CDCl3); 
3.49 (3H, s, OCH3), 3.70 (3H, s, OCH3), 3.80 (1H, d, J = 9.0, MeO(O)CCH), 4.14-4.22 (1H, m, 




H} NMR ( ; 100 MHz, CDCl3), 
45.34 (CH), 53.69 (CH3), 54.01 (CH3), 56.46 (CH), 79.41 (CH2), 129.92 (CH), 130.11 (CH), 130.39 (CH), 





4.2 Syngenta screening: materials and methods 
  
Methodology Herbicide assays: The compound was tested for herbicidal activity against 
Arabidopsis thaliana at 10 ppm and Poa annua at 32ppm. Test plates were 
stored for seven days in a controlled environment cabinet. They were scored 
as 0 or 99, where 99 = significant herbicidal effect, and 0 = no effect.  




Poa annua Pre-emergence 32 
 





Insecticide assays:  The compound was tested for activity against an aphid 
species at 1000ppm on a leaf-piece based assay, and against Plutella 
xylostella and Diabrotica balteata at 500ppm in artificial diet assays. 
Chemicals were applied to feeding aphids, or prior to infestation with P. 
xylostella and D. balteata larvae. The compound was also screened against 
the nematode Caernorhabditis elegans at 50ppm in a liquid culture medium. 
Mortality was assessed relative to control wells using a 2 band system (0 or 
99 where 99 = significant mortality, 0 = no effect), 5-9d after the treatments 
depending on the assay.  
Test species Treatment type Media Rate (ppm) 
Aphid species Feeding/contact Leaf disc 1000 
















Fungicide assays: The compound was evaluated in mycelial growth tests in 
artificial media against Pythium dissimile, Alternaria solani, Botryotinia 
fuckeliana and Gibberella zeae, at rates of 20ppm and 2ppm. 
Test species Media Rate (ppm) 
Pythium dissimile Semi-solid 20 and 2 








Semi-solid 20 and 2 
 
The compound was also evaluated against several pathogens on leaf-piece 
assays, at the rate of 100ppm for Septoria tritici on wheat and Uromyces 
viciae-fabae on bean, and rates of 200ppm and 60ppm for Phytophthora 
153 
 
infestans on tomato.  The compound was applied prior to inoculation with the 
pathogens.  
Test species Host Rate (ppm) 
Septoria tritici  Wheat 100 
Phytophthora 
infestans  





Mycelial growth or disease inhibition was assessed visually and scored using 
a three band system (0, 55 and 99 where 99 = total inhibition of hyphal 
growth/disease development, 55 = partial inhibition, 0 = no inhibition), 4-14d 
after inoculation depending on the assay. 
Positive controls: In addition to the test compounds, positive control 
compounds were included in each test azoxystrobin and prochloraz for 
fungicide assays, thiamethoxam, indoxacarb and levamisole for insecticide 



















Table 42. Scores are given average scores for the replicates (avg); Scores are 99 any herbicide effect (Herbicide assays); >70% mortality (Insecticide 


































































































































Table 43 Scores are given average scores for the replicates (avg); Scores are 99 any herbicide effect (Herbicide assays); >70% mortality (Insecticide 
























































































































0 0 0 
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Table 44. Scores are given average scores for the replicates (avg); Scores are 99 any herbicide effect (Herbicide assays); >70% mortality (Insecticide 
assays); complete control of pathogen in that replicate (Fungicide assays), 55- Partial control of pathogen (Fungicide assays only), 0-no activity. 
compound 
name 



























































































































Table 45. Scores are given average scores for the replicates (avg); Scores are 99 any herbicide effect (Herbicide assays); >70% mortality (Insecticide 
assays); complete control of pathogen in that replicate (Fungicide assays), 55- Partial control of pathogen (Fungicide assays only), 0-no activity. 
compound 
name 




























































































































































4.3 X-Ray Crystallographic Information (All the following X-ray structures have been solved by Dr 
Louise Male). 




Table 46.  Crystal data and structure refinement for (cis)-194b. 
Identification code  (cis)-194b 
Empirical formula  C18 H20 I N O 
Formula weight  393.25 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 10.6159(3) Å = 81.7569(15)°. 
 b = 12.3314(3) Å = 74.4479(14)°. 
 c = 13.4921(3) Å  = 81.2906(14)°. 
Volume 1672.13(7) Å3 
Z 4 
Density (calculated) 1.562 Mg/m3 
Absorption coefficient 1.914 mm-1 
F(000) 784 
Crystal size 0.70 x 0.45 x 0.12 mm3 
Theta range for data collection 3.02 to 27.50°. 
Index ranges -13<=h<=13, -16<=k<=16, -17<=l<=17 
Reflections collected 35064 
Independent reflections 7664 [R(int) = 0.0341] 
Completeness to theta = 27.50° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8028 and 0.3476 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7664 / 0 / 381 
Goodness-of-fit on F2 1.149 
Final R indices [I>2sigma(I)] R1 = 0.0366, wR2 = 0.0983 
R indices (all data) R1 = 0.0444, wR2 = 0.1022 
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Largest diff. peak and hole 1.500 and -1.591 e.Å-3 
 
Notes: The structure is a racemate, and contains two crystallographically independent molecules per asymmetric unit.  
Hydrogen atoms were fixed as riding models. 
 
Table 47.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for (cis)-194b.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 517(3) 952(3) 1602(3) 35(1) 
C(2) 418(3) -114(2) 2305(2) 29(1) 
C(3) 1582(3) -1030(2) 2137(2) 29(1) 
C(4) 511(3) -1819(2) 2326(2) 26(1) 
C(5) -1766(3) -831(3) 2622(2) 29(1) 
C(6) -2600(3) 201(2) 2324(2) 25(1) 
C(7) -3441(3) 811(3) 3085(2) 27(1) 
C(8) -4243(3) 1738(3) 2834(2) 31(1) 
C(9) -4226(3) 2088(2) 1804(2) 26(1) 
C(10) -3381(3) 1516(3) 1033(2) 29(1) 
C(11) -2588(3) 580(3) 1301(2) 32(1) 
C(12) -4975(4) 3501(3) 616(3) 42(1) 
C(13) 753(3) -2783(2) 1707(2) 24(1) 
C(14) 652(3) -2648(3) 694(2) 31(1) 
C(15) 930(4) -3549(3) 125(3) 39(1) 
C(16) 1316(3) -4580(3) 569(3) 39(1) 
C(17) 1412(3) -4724(3) 1564(3) 37(1) 
C(18) 1126(3) -3839(3) 2142(2) 30(1) 
N(1) -396(2) -856(2) 2042(2) 26(1) 
O(1) -5085(2) 3008(2) 1651(2) 35(1) 
I(1) 2006(1) 1826(1) 1864(1) 39(1) 
C(101) 3053(3) 4085(3) 5380(2) 32(1) 
C(102) 2021(3) 5024(2) 5729(2) 26(1) 
C(103) 1617(3) 5897(3) 4901(2) 28(1) 
C(104) 1712(3) 6759(2) 5594(2) 26(1) 
C(105) 2296(3) 5874(3) 7235(2) 28(1) 
C(106) 3081(3) 4872(3) 7646(2) 26(1) 
C(107) 2500(3) 3941(3) 8131(2) 29(1) 
C(108) 3232(3) 2983(3) 8444(2) 30(1) 
C(109) 4587(3) 2960(3) 8254(2) 28(1) 
C(110) 5188(3) 3893(3) 7783(2) 31(1) 
C(111) 4447(3) 4836(3) 7482(2) 28(1) 
C(112) 4871(4) 1046(3) 8852(3) 42(1) 
C(113) 2324(3) 7780(2) 5096(2) 25(1) 
C(114) 3656(3) 7726(3) 4599(2) 32(1) 
C(115) 4208(3) 8670(3) 4099(2) 35(1) 
C(116) 3427(4) 9672(3) 4087(2) 35(1) 
C(117) 2118(4) 9740(3) 4569(3) 37(1) 
C(118) 1561(3) 8804(3) 5077(2) 31(1) 
N(101) 2528(2) 5897(2) 6111(2) 25(1) 
O(101) 5412(2) 2064(2) 8515(2) 36(1) 










Table 48.  Bond lengths [Å] and angles [°] for (cis)-194b. 
_____________________________________________________ 
C(1)-C(2)  1.507(4) 
C(1)-I(1)  2.170(3) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-N(1)  1.486(4) 
C(2)-C(3)  1.534(4) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.553(4) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-N(1)  1.485(4) 
C(4)-C(13)  1.501(4) 
C(4)-H(4)  1.0000 
C(5)-N(1)  1.454(4) 
C(5)-C(6)  1.506(4) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(11)  1.389(4) 
C(6)-C(7)  1.394(4) 
C(7)-C(8)  1.377(5) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.391(4) 
C(8)-H(8)  0.9500 
C(9)-O(1)  1.372(4) 
C(9)-C(10)  1.379(4) 
C(10)-C(11)  1.386(5) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-O(1)  1.422(4) 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-C(14)  1.384(4) 
C(13)-C(18)  1.395(4) 
C(14)-C(15)  1.391(5) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.378(5) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.358(5) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.382(5) 
C(17)-H(17)  0.9500 
C(18)-H(18)  0.9500 
C(101)-C(102)  1.502(4) 
C(101)-I(101)  2.161(3) 
C(101)-H(10A)  0.9900 
C(101)-H(10B)  0.9900 
C(102)-N(101)  1.483(4) 
C(102)-C(103)  1.537(4) 
C(102)-H(102)  1.0000 
C(103)-C(104)  1.543(4) 
C(103)-H(10C)  0.9900 
C(103)-H(10D)  0.9900 
C(104)-N(101)  1.484(4) 
C(104)-C(113)  1.493(4) 
C(104)-H(104)  1.0000 
C(105)-N(101)  1.466(4) 
C(105)-C(106)  1.506(4) 
C(105)-H(10E)  0.9900 
C(105)-H(10F)  0.9900 
C(106)-C(107)  1.381(4) 
C(106)-C(111)  1.403(4) 
C(107)-C(108)  1.390(5) 
C(107)-H(107)  0.9500 
C(108)-C(109)  1.388(4) 
C(108)-H(108)  0.9500 
C(109)-O(101)  1.368(4) 
C(109)-C(110)  1.389(4) 
C(110)-C(111)  1.377(5) 
C(110)-H(110)  0.9500 
C(111)-H(111)  0.9500 
C(112)-O(101)  1.424(4) 
C(112)-H(11A)  0.9800 
C(112)-H(11B)  0.9800 
C(112)-H(11C)  0.9800 
C(113)-C(114)  1.390(4) 
C(113)-C(118)  1.395(4) 
C(114)-C(115)  1.387(5) 
C(114)-H(114)  0.9500 
C(115)-C(116)  1.380(5) 
C(115)-H(115)  0.9500 
C(116)-C(117)  1.363(5) 
C(116)-H(116)  0.9500 
C(117)-C(118)  1.383(5) 
C(117)-H(117)  0.9500 



























































































































































Symmetry transformations used to generate equivalent atoms
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Table 49. Anisotropic displacement parameters (Å2x 103)for (cis)-194b. The anisotropic  
displacement factor exponent takes the form: -2 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 39(2)  30(2) 38(2)  -4(1) -13(1)  -2(1) 
C(2) 33(2)  25(2) 29(1)  -7(1) -9(1)  -2(1) 
C(3) 30(2)  28(2) 31(2)  -11(1) -11(1)  1(1) 
C(4) 28(2)  28(2) 23(1)  -5(1) -8(1)  1(1) 
C(5) 27(2)  28(2) 30(2)  -3(1) -2(1)  -2(1) 
C(6) 22(1)  25(1) 29(1)  -6(1) -4(1)  -5(1) 
C(7) 28(2)  31(2) 23(1)  -4(1) -5(1)  -3(1) 
C(8) 32(2)  35(2) 27(1)  -10(1) -5(1)  0(1) 
C(9) 27(2)  24(1) 29(1)  -4(1) -7(1)  -5(1) 
C(10) 33(2)  30(2) 24(1)  -2(1) -5(1)  -6(1) 
C(11) 34(2)  32(2) 26(1)  -8(1) 0(1)  -2(1) 
C(12) 47(2)  37(2) 37(2)  8(2) -11(2)  -1(2) 
C(13) 20(1)  28(2) 26(1)  -6(1) -4(1)  -5(1) 
C(14) 38(2)  32(2) 24(1)  -1(1) -6(1)  -8(1) 
C(15) 49(2)  45(2) 26(2)  -13(1) -4(1)  -14(2) 
C(16) 33(2)  33(2) 49(2)  -17(2) 1(2)  -9(1) 
C(17) 30(2)  26(2) 55(2)  -9(2) -10(2)  -2(1) 
C(18) 30(2)  31(2) 31(2)  -3(1) -12(1)  -3(1) 
N(1) 25(1)  26(1) 26(1)  -7(1) -5(1)  0(1) 
O(1) 42(1)  29(1) 31(1)  -2(1) -13(1)  4(1) 
I(1) 49(1)  26(1) 45(1)  -4(1) -12(1)  -13(1) 
C(101) 31(2)  34(2) 31(2)  -9(1) -7(1)  0(1) 
C(102) 27(2)  29(2) 23(1)  -5(1) -4(1)  -4(1) 
C(103) 25(1)  31(2) 29(1)  -4(1) -10(1)  -2(1) 
C(104) 24(1)  29(2) 24(1)  -4(1) -5(1)  0(1) 
C(105) 31(2)  31(2) 21(1)  -3(1) -5(1)  -4(1) 
C(106) 32(2)  30(2) 16(1)  -5(1) -5(1)  -5(1) 
C(107) 26(2)  37(2) 24(1)  -1(1) -6(1)  -8(1) 
C(108) 29(2)  36(2) 25(1)  2(1) -5(1)  -11(1) 
C(109) 31(2)  31(2) 24(1)  -2(1) -10(1)  -4(1) 
C(110) 26(2)  37(2) 32(2)  -5(1) -8(1)  -9(1) 
C(111) 31(2)  30(2) 25(1)  -2(1) -7(1)  -10(1) 
C(112) 42(2)  35(2) 45(2)  7(2) -11(2)  -5(2) 
C(113) 28(2)  25(1) 21(1)  -4(1) -7(1)  1(1) 
C(114) 31(2)  28(2) 33(2)  -2(1) -3(1)  2(1) 
C(115) 33(2)  38(2) 32(2)  1(1) -3(1)  -6(1) 
C(116) 51(2)  26(2) 31(2)  3(1) -18(1)  -7(1) 
C(117) 49(2)  26(2) 42(2)  -5(1) -24(2)  4(2) 
C(118) 30(2)  31(2) 35(2)  -9(1) -13(1)  5(1) 
N(101) 28(1)  24(1) 22(1)  -3(1) -7(1)  -2(1) 
O(101) 32(1)  34(1) 43(1)  1(1) -13(1)  -2(1) 
I(101) 38(1)  37(1) 50(1)  -22(1) -7(1)  -1(1) 
______________________________________________________________________________ 
 
Table 50. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for (cis)-194b. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1A) -345 1417 1740 42 
H(1B) 752 796 871 42 
H(2) 104 24 3049 34 
H(3A) 2087 -1141 2670 34 
H(3B) 2170 -988 1430 34 
H(4) 215 -2071 3081 31 
H(5A) -1816 -882 3370 35 
H(5B) -2126 -1482 2501 35 
H(7) -3461 582 3791 33 
H(8) -4809 2140 3366 38 
H(10) -3343 1761 326 35 
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H(11) -2017 184 767 38 
H(12A) -4074 3682 310 63 
H(12B) -5594 4177 615 63 
H(12C) -5180 2984 210 63 
H(14) 392 -1936 386 38 
H(15) 854 -3453 -569 47 
H(16) 1515 -5193 177 46 
H(17) 1678 -5438 1864 44 
H(18) 1184 -3950 2840 36 
H(10A) 3273 3625 5988 38 
H(10B) 3864 4377 4941 38 
H(102) 1235 4754 6246 32 
H(10C) 718 5878 4827 33 
H(10D) 2269 5924 4221 33 
H(104) 836 6952 6078 31 
H(10E) 1347 5852 7568 33 
H(10F) 2560 6550 7399 33 
H(107) 1574 3956 8255 34 
H(108) 2812 2355 8782 36 
H(110) 6113 3879 7668 37 
H(111) 4866 5471 7161 34 
H(11A) 4214 1104 9515 62 
H(11B) 5575 454 8938 62 
H(11C) 4451 878 8337 62 
H(114) 4194 7036 4601 39 
H(115) 5121 8628 3765 42 
H(116) 3804 10318 3741 42 
H(117) 1586 10432 4556 45 
H(118) 649 8861 5417 37 
________________________________________________________________________________ 
 































































































4.3.2 X-ray Crystallographic Information for Iodo-Pyrrolidine (cis)-195c 
 
Table 52. Crystal data and structure refinement for (cis)-195c. 
Identification code  (cis)-195c 
Empirical formula  C18 H20 I N 
Formula weight  377.25 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 2(1)/n 
Unit cell dimensions a = 6.9828(2) Å = 90°. 
 b = 9.0924(5) Å = 93.829(3)°. 
 c = 25.8129(12) Å  = 90°. 
Volume 1635.21(13) Å3 
Z 4 
Density (calculated) 1.532 Mg/m3 
Absorption coefficient 1.949 mm-1 
F(000) 752 
Crystal size 0.32 x 0.16 x 0.03 mm3 
Theta range for data collection 2.98 to 27.48°. 
Index ranges -8<=h<=9, -11<=k<=11, -33<=l<=33 
Reflections collected 18336 
Independent reflections 3720 [R(int) = 0.0551] 
Completeness to theta = 27.48° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9438 and 0.5743 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3720 / 0 / 182 
Goodness-of-fit on F2 1.057 
Final R indices [I>2sigma(I)] R1 = 0.0503, wR2 = 0.1088 
R indices (all data) R1 = 0.0875, wR2 = 0.1240 




Table 53.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for (cis)-195c.  U(eq) is defined as one third of 
the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 2565(6) 2456(5) 858(2) 34(1) 
C(2) 3957(7) 1389(5) 618(2) 38(1) 
C(3) 4671(6) 376(5) 1073(2) 28(1) 
C(4) 2539(7) 1998(5) 1422(2) 36(1) 
C(5) 3556(6) -139(5) 1932(2) 30(1) 
C(6) 1780(6) -286(5) 2235(2) 27(1) 
C(7) 1568(6) 505(5) 2687(2) 28(1) 
C(8) -50(6) 328(5) 2965(2) 32(1) 
C(9) -1508(6) -626(5) 2795(2) 31(1) 
C(10) -1308(6) -1396(5) 2339(2) 35(1) 
C(11) 312(6) -1221(5) 2062(2) 31(1) 
C(12) -3232(7) -856(6) 3109(2) 45(1) 
C(13) 5101(6) -1175(5) 910(2) 25(1) 
C(14) 3605(6) -2107(5) 742(2) 30(1) 
C(15) 3978(7) -3521(5) 584(2) 37(1) 
C(16) 5845(8) -4022(5) 587(2) 41(1) 
C(17) 7340(7) -3101(6) 750(2) 39(1) 
C(18) 6976(6) -1670(5) 909(2) 33(1) 
N(1) 3065(5) 443(4) 1414(1) 26(1) 




Table 54. Bond lengths [Å] and angles [°] for (cis)-195c. 
C(1)-C(4)  1.514(7) 
C(1)-C(2)  1.534(6) 
C(1)-I(1)  2.154(4) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.549(6) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-N(1)  1.472(5) 
C(3)-C(13)  1.507(6) 
C(3)-H(3)  1.0000 
C(4)-N(1)  1.461(5) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(1)  1.459(5) 
C(5)-C(6)  1.515(6) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(11)  1.383(6) 
C(6)-C(7)  1.386(6) 
C(7)-C(8)  1.387(6) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.386(6) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.383(6) 
C(9)-C(12)  1.511(6) 
C(10)-C(11)  1.388(6) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-C(18)  1.384(6) 
C(13)-C(14)  1.392(6) 
C(14)-C(15)  1.379(6) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.381(7) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.382(7) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.393(7) 
C(17)-H(17)  0.9500 




















































































Table 55. Anisotropic displacement parameters (Å2x 103) for (cis)-195c.  The anisotropic displacement factor exponent takes the form: -2 2[ 
h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 28(2)  31(3) 42(3)  3(2) 1(2)  0(2) 
C(2) 35(3)  37(3) 43(3)  11(2) 12(2)  7(2) 
C(3) 26(2)  26(2) 34(2)  3(2) 3(2)  2(2) 
C(4) 31(2)  34(3) 42(3)  -4(2) -3(2)  9(2) 
C(5) 25(2)  36(3) 29(2)  0(2) 2(2)  4(2) 
C(6) 29(2)  26(2) 24(2)  1(2) -3(2)  5(2) 
C(7) 29(2)  27(2) 27(2)  -1(2) -1(2)  -2(2) 
C(8) 36(2)  37(3) 22(2)  3(2) 1(2)  4(2) 
C(9) 24(2)  38(3) 31(2)  10(2) 2(2)  2(2) 
C(10) 29(2)  35(3) 40(3)  1(2) -6(2)  1(2) 
C(11) 32(2)  34(3) 27(2)  -8(2) -4(2)  6(2) 
C(12) 36(3)  64(4) 36(3)  12(3) 5(2)  -2(2) 
C(13) 28(2)  29(2) 18(2)  2(2) 5(2)  4(2) 
C(14) 30(2)  33(3) 25(2)  4(2) 2(2)  5(2) 
C(15) 51(3)  29(3) 29(2)  1(2) 0(2)  0(2) 
C(16) 68(4)  30(3) 24(2)  -3(2) 6(2)  16(2) 
C(17) 44(3)  44(3) 28(3)  6(2) 6(2)  17(2) 
C(18) 31(2)  40(3) 28(2)  7(2) 4(2)  5(2) 
N(1) 28(2)  25(2) 25(2)  1(2) 3(2)  6(2) 
I(1) 33(1)  109(1) 34(1)  6(1) 4(1)  15(1) 
______________________________________________________________________________ 
 
Table 56. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for (cis)-195c. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 3079 3480 839 41 
H(2A) 5041 1927 477 45 
H(2B) 3292 811 335 45 
H(3) 5843 814 1256 34 
H(4A) 3480 2570 1643 43 
H(4B) 1247 2131 1551 43 
H(5A) 4484 528 2120 36 
H(5B) 4172 -1113 1904 36 
H(7) 2541 1176 2807 33 
H(8) -160 868 3276 38 
H(10) -2293 -2053 2215 42 
H(11) 415 -1753 1748 38 
H(12A) -4265 -1320 2891 68 
H(12B) -3672 96 3234 68 
H(12C) -2877 -1493 3406 68 
H(14) 2317 -1766 736 35 
H(15) 2947 -4152 472 44 
H(16) 6101 -4997 478 49 
H(17) 8625 -3446 753 46 


































































Table 58. Crystal data and structure refinement for 2193aaa. 
Identification code  213aaa 
Empirical formula  C24H26Cl2N2Pt, C2H3N 
Formula weight  649.51 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 2(1) 
Unit cell dimensions a = 10.6958(2) Å = 90°. 
 b = 10.4600(2) Å = 93.9630(10)°. 
 c = 43.9267(10) Å  = 90°. 
Volume 4902.68(17) Å3 
Z, Z’ 8, 4 
Density (calculated) 1.760 Mg/m3 
Absorption coefficient 5.961 mm-1 
F(000) 2544 
Crystal size 0.16 x 0.12 x 0.10 mm3 
Theta range for data collection 2.92 to 25.03°. 
Index ranges -12<=h<=12, -12<=k<=12, -52<=l<=52 
Reflections collected 44832 
Independent reflections 16268 [R(int) = 0.1064] 
Completeness to theta = 25.03° 97.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5871 and 0.4489 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 16268 / 277 / 1165 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0623, wR2 = 0.0856 
R indices (all data) R1 = 0.0871, wR2 = 0.0908 
Absolute structure parameter 0.041(7) 
Largest diff. peak and hole 1.236 and -1.882 e.Å-3 
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Notes: The structure contains four crystallographically-independent platinum complexes with one acetonitrile molecule per platinum complex.  
The hydrogen atoms bonded to N(2), N(102), N(202) and N(302) (one per crystallographically-independent platinum complex) were located in the 
electron density and their positions refined subject to suitable distance restraints, (N-H = 0.91 (2) Å and Pd … H = 2.48 (4) Å and C(104)-H(12C) = 
C(112)-H(12C) = 1.92 (4) Å). The isotropic thermal parameters (Uiso) of these hydrogen atoms were set at 1.2 times the equivalent isotropic thermal 
parameter (Ueq) of the parent nitrogen atom. All remaining hydrogen atoms were fixed as riding models. The hydrogen bonding is detailed in Table 7, 
page 33 of this document. 
 
Table 59. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 213aaa.  U(eq) is defined as one third of the 
trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 4373(10) 1349(10) 4311(2) 24(2) 
C(2) 4417(10) 2692(10) 4176(2) 27(2) 
C(3) 3934(9) 2097(9) 3869(2) 22(2) 
C(4) 4454(8) 2506(10) 3573(2) 21(2) 
C(5) 3592(9) -336(10) 3927(2) 23(2) 
C(6) 3359(9) -760(10) 3599(3) 24(2) 
C(7) 2369(11) -234(11) 3425(3) 38(3) 
C(8) 2076(12) -718(13) 3140(3) 45(3) 
C(9) 2752(13) -1712(13) 3016(3) 47(3) 
C(10) 3747(12) -2219(12) 3197(3) 42(3) 
C(11) 4045(10) -1746(10) 3489(3) 28(3) 
C(12) 6385(10) 2546(10) 3294(2) 26(2) 
C(13) 5763(10) 1802(10) 3029(2) 29(2) 
C(14) 5900(11) 505(11) 2994(2) 38(3) 
C(15) 5379(13) -131(12) 2743(3) 50(3) 
C(16) 4645(11) 482(14) 2522(3) 47(3) 
C(17) 4538(14) 1797(13) 2549(3) 60(4) 
C(18) 5077(11) 2434(12) 2803(2) 45(3) 
C(19) 5241(9) 865(9) 4566(2) 20(2) 
C(20) 5029(9) -339(9) 4688(2) 21(2) 
C(21) 5781(10) -815(10) 4933(2) 28(2) 
C(22) 6736(11) -71(11) 5062(3) 32(3) 
C(23) 6952(10) 1112(12) 4950(3) 35(3) 
C(24) 6217(9) 1582(11) 4697(2) 29(3) 
N(1) 4432(7) 792(8) 3982(2) 24(2) 
N(2) 5836(7) 2299(9) 3598(2) 22(2) 
Cl(1) 6644(2) -1248(2) 4098(1) 22(1) 
Cl(2) 8233(2) 506(3) 3661(1) 23(1) 
Pt(1) 6231(1) 612(1) 3828(1) 18(1) 
C(101) 8463(9) 1280(11) 684(2) 23(2) 
C(102) 7203(9) 1239(12) 828(2) 23(2) 
C(103) 7907(9) 1661(10) 1127(2) 20(2) 
C(104) 7656(10) 1083(11) 1427(3) 24(3) 
C(105) 10241(9) 2079(10) 1043(3) 24(3) 
C(106) 10727(10) 2330(12) 1369(2) 26(3) 
C(107) 10204(10) 3265(12) 1541(3) 31(3) 
C(108) 10681(12) 3548(13) 1831(3) 46(4) 
C(109) 11707(14) 2872(13) 1948(3) 48(4) 
C(110) 12296(13) 1988(12) 1785(3) 42(3) 
C(111) 11791(11) 1662(11) 1497(3) 30(3) 
C(112) 7735(9) -922(10) 1724(3) 26(3) 
C(113) 8519(11) -301(11) 1983(3) 35(3) 
C(114) 9816(10) -463(13) 2007(3) 33(3) 
C(115) 10502(13) 72(13) 2252(3) 47(4) 
C(116) 9906(14) 759(14) 2473(3) 50(3) 
C(117) 8646(14) 898(13) 2456(3) 52(4) 
C(118) 7936(12) 348(13) 2204(3) 46(3) 
C(119) 8776(9) 454(11) 425(2) 24(2) 
C(120) 9948(10) 538(13) 311(2) 31(2) 
C(121) 10247(13) -155(13) 53(3) 44(3) 
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C(122) 9379(13) -889(12) -95(3) 42(3) 
C(123) 8158(14) -979(11) 9(3) 43(3) 
C(124) 7889(12) -328(10) 271(3) 32(3) 
N(101) 9140(7) 1207(9) 1007(2) 19(2) 
N(102) 7885(8) -311(8) 1416(2) 23(2) 
Cl(11) 11247(2) -933(2) 925(1) 24(1) 
Cl(12) 9695(2) -2689(3) 1372(1) 25(1) 
Pt(11) 9460(1) -628(1) 1182(1) 18(1) 
C(201) 10235(9) 6385(9) 4329(2) 21(2) 
C(202) 10125(9) 7742(9) 4193(2) 22(2) 
C(203) 10465(9) 7148(9) 3887(2) 20(2) 
C(204) 9800(9) 7546(10) 3593(2) 25(2) 
C(205) 10859(10) 4721(10) 3951(2) 26(3) 
C(206) 10967(9) 4322(12) 3628(3) 27(3) 
C(207) 10290(10) 3250(10) 3506(3) 27(3) 
C(208) 10498(12) 2819(11) 3215(3) 38(3) 
C(209) 11370(12) 3405(11) 3043(3) 38(3) 
C(210) 12030(11) 4483(13) 3157(3) 41(3) 
C(211) 11818(10) 4906(11) 3454(3) 29(3) 
C(212) 7764(9) 7516(10) 3288(2) 24(2) 
C(213) 8259(9) 6793(11) 3033(2) 26(2) 
C(214) 8107(10) 5459(12) 3012(3) 34(3) 
C(215) 8533(14) 4787(13) 2770(3) 50(4) 
C(216) 9143(13) 5462(18) 2543(3) 59(4) 
C(217) 9278(15) 6752(17) 2556(3) 65(4) 
C(218) 8825(10) 7419(12) 2801(3) 36(3) 
C(219) 9506(8) 5875(9) 4575(2) 20(2) 
C(220) 9776(9) 4686(10) 4706(2) 26(2) 
C(221) 9156(10) 4170(11) 4944(3) 31(3) 
C(222) 8256(11) 4937(13) 5070(3) 39(3) 
C(223) 7985(10) 6138(13) 4956(2) 33(3) 
C(224) 8584(10) 6617(11) 4709(2) 29(3) 
N(201) 10011(7) 5842(7) 4002(2) 19(2) 
N(202) 8438(7) 7286(9) 3601(2) 21(2) 
Cl(21) 7889(2) 3754(2) 4099(1) 22(1) 
Cl(22) 6077(2) 5499(3) 3654(1) 23(1) 
Pt(21) 8162(1) 5625(1) 3833(1) 17(1) 
C(301) 3462(9) 5499(12) 688(2) 21(2) 
C(302) 2201(8) 5561(14) 834(2) 26(2) 
C(303) 2923(9) 5114(10) 1134(2) 21(2) 
C(304) 2658(8) 5689(11) 1430(2) 17(2) 
C(305) 5271(9) 4732(10) 1048(3) 26(3) 
C(306) 5777(9) 4509(11) 1373(2) 22(2) 
C(307) 6754(10) 5227(12) 1503(3) 36(3) 
C(308) 7255(14) 5001(13) 1789(3) 50(4) 
C(309) 6758(14) 3980(13) 1967(3) 50(4) 
C(310) 5765(13) 3288(14) 1840(3) 47(4) 
C(311) 5274(12) 3518(12) 1535(3) 38(3) 
C(312) 2719(10) 7685(11) 1731(2) 26(3) 
C(313) 3536(9) 7139(10) 1986(2) 21(2) 
C(314) 4823(10) 7403(13) 2031(3) 35(3) 
C(315) 5571(12) 6879(12) 2274(3) 39(3) 
C(316) 5066(12) 6087(13) 2477(3) 46(3) 
C(317) 3815(12) 5783(14) 2432(3) 47(3) 
C(318) 3067(11) 6317(14) 2195(3) 40(3) 
C(319) 3806(10) 6380(10) 435(2) 24(3) 
C(320) 4997(11) 6275(12) 318(2) 32(3) 
C(321) 5268(12) 6945(12) 63(3) 36(3) 
C(322) 4336(14) 7717(12) -91(3) 46(4) 
C(323) 3178(13) 7787(12) 16(3) 41(3) 
C(324) 2891(12) 7112(10) 276(3) 33(3) 
N(301) 4155(7) 5613(10) 1010(2) 20(1) 
N(302) 2888(8) 7111(9) 1424(2) 24(2) 
Cl(31) 6230(2) 7767(2) 924(1) 23(1) 
Cl(32) 4663(2) 9527(2) 1372(1) 25(1) 
Pt(31) 4451(1) 7448(1) 1187(1) 18(1) 
C(401) 3472(11) 1302(14) 642(3) 31(3) 
N(401) 3093(11) 2284(11) 690(3) 52(3) 
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C(402) 3953(11) 74(12) 576(3) 33(3) 
C(501) 4321(11) 6358(11) 4315(2) 28(3) 
C(502) 5562(9) 6008(10) 4441(3) 29(3) 
N(501) 3349(10) 6666(11) 4220(3) 52(3) 
C(601) 8457(10) 5490(13) 639(2) 25(2) 
C(602) 8921(11) 6786(10) 583(3) 32(3) 
N(601) 8061(10) 4483(11) 681(3) 49(3) 
C(701) 300(10) 1384(10) 4311(3) 26(2) 
C(702) -849(9) 1030(10) 4449(3) 28(3) 
N(701) 1207(9) 1620(10) 4211(3) 47(3) 
________________________________________________________________________________ 
 
Table 60. Bond lengths [Å] and angles [°] for 213aaa. 
_____________________________________________________ 
C(1)-C(19)  1.495(15) 
C(1)-C(2)  1.526(15) 
C(1)-N(1)  1.564(12) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.545(15) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.511(13) 
C(3)-N(1)  1.535(13) 
C(3)-H(3)  1.0000 
C(4)-N(2)  1.491(12) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(1)  1.492(13) 
C(5)-C(6)  1.513(15) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(11)  1.373(15) 
C(6)-C(7)  1.377(16) 
C(7)-C(8)  1.367(18) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.397(18) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.387(18) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.391(16) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.515(15) 
C(12)-N(2)  1.517(13) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-C(18)  1.363(12) 
C(13)-C(14)  1.374(13) 
C(14)-C(15)  1.374(13) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.365(14) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.385(14) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.390(14) 
C(17)-H(17)  0.9500 
C(18)-H(18)  0.9500 
C(19)-C(24)  1.378(14) 
C(19)-C(20)  1.392(13) 
C(20)-C(21)  1.392(15) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.375(16) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.359(16) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.403(16) 
C(23)-H(23)  0.9500 
C(24)-H(24)  0.9500 
N(1)-Pt(1)  2.092(7) 
N(2)-Pt(1)  2.062(9) 
N(2)-H(2C)  0.92(2) 
Cl(1)-Pt(1)  2.306(2) 
Cl(2)-Pt(1)  2.314(2) 
C(101)-C(119)  1.486(15) 
C(101)-C(102)  1.529(14) 
C(101)-N(101)  1.547(13) 
C(101)-H(101)  1.0000 
C(102)-C(103)  1.532(14) 
C(102)-H(10A)  0.9900 
C(102)-H(10B)  0.9900 
C(103)-C(104)  1.492(15) 
C(103)-N(101)  1.530(12) 
C(103)-H(103)  1.0000 
C(104)-N(102)  1.479(14) 
C(104)-H(10C)  0.9900 
C(104)-H(10D)  0.9900 
C(105)-N(101)  1.490(13) 
C(105)-C(106)  1.512(15) 
C(105)-H(10E)  0.9900 
C(105)-H(10F)  0.9900 
C(106)-C(107)  1.378(16) 
C(106)-C(111)  1.419(16) 
C(107)-C(108)  1.374(18) 
C(107)-H(107)  0.9500 
C(108)-C(109)  1.38(2) 
C(108)-H(108)  0.9500 
C(109)-C(110)  1.352(18) 
C(109)-H(109)  0.9500 
C(110)-C(111)  1.383(17) 
C(110)-H(110)  0.9500 
C(111)-H(111)  0.9500 
C(112)-C(113)  1.511(17) 
C(112)-N(102)  1.516(14) 
C(112)-H(11A)  0.9900 
C(112)-H(11B)  0.9900 
C(113)-C(118)  1.369(16) 
C(113)-C(114)  1.394(16) 
C(114)-C(115)  1.379(17) 
C(114)-H(114)  0.9500 
C(115)-C(116)  1.395(18) 
C(115)-H(115)  0.9500 
C(116)-C(117)  1.352(18) 
C(116)-H(116)  0.9500 
C(117)-C(118)  1.419(19) 
C(117)-H(117)  0.9500 
C(118)-H(118)  0.9500 
C(119)-C(120)  1.385(13) 
C(119)-C(124)  1.392(16) 
C(120)-C(121)  1.398(18) 
C(120)-H(120)  0.9500 
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C(121)-C(122)  1.339(19) 
C(121)-H(121)  0.9500 
C(122)-C(123)  1.416(19) 
C(122)-H(122)  0.9500 
C(123)-C(124)  1.382(16) 
C(123)-H(123)  0.9500 
C(124)-H(124)  0.9500 
N(101)-Pt(11)  2.088(9) 
N(102)-Pt(11)  2.060(9) 
N(102)-H(12C)  0.901(18) 
Cl(11)-Pt(11)  2.309(2) 
Cl(12)-Pt(11)  2.319(3) 
C(201)-C(219)  1.476(13) 
C(201)-C(202)  1.541(14) 
C(201)-N(201)  1.549(12) 
C(201)-H(201)  1.0000 
C(202)-C(203)  1.547(14) 
C(202)-H(20A)  0.9900 
C(202)-H(20B)  0.9900 
C(203)-C(204)  1.491(14) 
C(203)-N(201)  1.545(11) 
C(203)-H(203)  1.0000 
C(204)-N(202)  1.484(12) 
C(204)-H(20C)  0.9900 
C(204)-H(20D)  0.9900 
C(205)-C(206)  1.493(15) 
C(205)-N(201)  1.508(12) 
C(205)-H(20E)  0.9900 
C(205)-H(20F)  0.9900 
C(206)-C(211)  1.372(14) 
C(206)-C(207)  1.419(16) 
C(207)-C(208)  1.388(15) 
C(207)-H(207)  0.9500 
C(208)-C(209)  1.383(16) 
C(208)-H(208)  0.9500 
C(209)-C(210)  1.403(17) 
C(209)-H(209)  0.9500 
C(210)-C(211)  1.409(16) 
C(210)-H(210)  0.9500 
C(211)-H(211)  0.9500 
C(212)-C(213)  1.480(14) 
C(212)-N(202)  1.526(13) 
C(212)-H(21A)  0.9900 
C(212)-H(21B)  0.9900 
C(213)-C(218)  1.383(14) 
C(213)-C(214)  1.406(16) 
C(214)-C(215)  1.377(15) 
C(214)-H(214)  0.9500 
C(215)-C(216)  1.420(19) 
C(215)-H(215)  0.9500 
C(216)-C(217)  1.36(2) 
C(216)-H(216)  0.9500 
C(217)-C(218)  1.397(18) 
C(217)-H(217)  0.9500 
C(218)-H(218)  0.9500 
C(219)-C(220)  1.391(14) 
C(219)-C(224)  1.413(13) 
C(220)-C(221)  1.389(15) 
C(220)-H(220)  0.9500 
C(221)-C(222)  1.396(16) 
C(221)-H(221)  0.9500 
C(222)-C(223)  1.375(17) 
C(222)-H(222)  0.9500 
C(223)-C(224)  1.393(15) 
C(223)-H(223)  0.9500 
C(224)-H(224)  0.9500 
N(201)-Pt(21)  2.075(8) 
N(202)-Pt(21)  2.047(9) 
N(202)-H(22C)  0.91(2) 
Cl(21)-Pt(21)  2.308(2) 
Cl(22)-Pt(21)  2.317(2) 
C(301)-C(319)  1.508(15) 
C(301)-C(302)  1.532(12) 
C(301)-N(301)  1.554(12) 
C(301)-H(301)  1.0000 
C(302)-C(303)  1.556(14) 
C(302)-H(30A)  0.9900 
C(302)-H(30B)  0.9900 
C(303)-C(304)  1.476(13) 
C(303)-N(301)  1.552(12) 
C(303)-H(303)  1.0000 
C(304)-N(302)  1.508(14) 
C(304)-H(30C)  0.9900 
C(304)-H(30D)  0.9900 
C(305)-N(301)  1.508(13) 
C(305)-C(306)  1.512(15) 
C(305)-H(30E)  0.9900 
C(305)-H(30F)  0.9900 
C(306)-C(307)  1.377(16) 
C(306)-C(311)  1.387(16) 
C(307)-C(308)  1.352(18) 
C(307)-H(307)  0.9500 
C(308)-C(309)  1.448(19) 
C(308)-H(308)  0.9500 
C(309)-C(310)  1.37(2) 
C(309)-H(309)  0.9500 
C(310)-C(311)  1.426(18) 
C(310)-H(310)  0.9500 
C(311)-H(311)  0.9500 
C(312)-C(313)  1.489(15) 
C(312)-N(302)  1.496(13) 
C(312)-H(31A)  0.9900 
C(312)-H(31B)  0.9900 
C(313)-C(318)  1.376(15) 
C(313)-C(314)  1.404(15) 
C(314)-C(315)  1.401(17) 
C(314)-H(314)  0.9500 
C(315)-C(316)  1.357(17) 
C(315)-H(315)  0.9500 
C(316)-C(317)  1.376(17) 
C(316)-H(316)  0.9500 
C(317)-C(318)  1.386(17) 
C(317)-H(317)  0.9500 
C(318)-H(318)  0.9500 
C(319)-C(324)  1.393(16) 
C(319)-C(320)  1.411(15) 
C(320)-C(321)  1.369(16) 
C(320)-H(320)  0.9500 
C(321)-C(322)  1.417(19) 
C(321)-H(321)  0.9500 
C(322)-C(323)  1.356(18) 
C(322)-H(322)  0.9500 
C(323)-C(324)  1.395(16) 
C(323)-H(323)  0.9500 
C(324)-H(324)  0.9500 
N(301)-Pt(31)  2.087(10) 
N(302)-Pt(31)  2.061(9) 
N(302)-H(32C)  0.91(2) 
Cl(31)-Pt(31)  2.317(2) 
Cl(32)-Pt(31)  2.327(3) 
C(401)-N(401)  1.130(16) 
C(401)-C(402)  1.420(17) 
C(402)-H(40A)  0.9800 
C(402)-H(40B)  0.9800 
C(402)-H(40C)  0.9800 
C(501)-N(501)  1.140(14) 
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C(501)-C(502)  1.450(16) 
C(502)-H(50A)  0.9800 
C(502)-H(50B)  0.9800 
C(502)-H(50C)  0.9800 
C(601)-N(601)  1.154(16) 
C(601)-C(602)  1.470(16) 
C(602)-H(60A)  0.9800 
C(602)-H(60B)  0.9800 
C(602)-H(60C)  0.9800 
C(701)-N(701)  1.121(13) 
C(701)-C(702)  1.455(14) 
C(702)-H(70A)  0.9800 
C(702)-H(70B)  0.9800 





















































































































































































































































































































































































































































































Symmetry transformations used to generate equivalent atoms: 
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Table 61. Anisotropic displacement parameters (Å2x 103) for 213aaa. The anisotropic displacement factor exponent takes the form: -2 2[ 
h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 24(4)  28(4) 21(4)  -6(3) 9(4)  -4(4) 
C(2) 23(4)  29(4) 29(5)  -5(3) 7(4)  0(4) 
C(3) 20(4)  20(4) 27(4)  0(3) 6(4)  -1(4) 
C(4) 20(5)  21(5) 23(6)  -1(5) -1(4)  0(5) 
C(5) 23(5)  37(6) 10(5)  -5(4) 8(4)  -8(5) 
C(6) 18(5)  21(5) 31(6)  1(5) -4(5)  -8(5) 
C(7) 36(7)  29(6) 47(8)  7(6) -8(6)  2(5) 
C(8) 39(7)  50(8) 44(8)  13(7) -20(6)  -4(7) 
C(9) 55(8)  57(9) 29(7)  -1(6) -6(7)  -19(7) 
C(10) 43(7)  41(7) 40(8)  -9(6) -7(6)  -4(6) 
C(11) 26(6)  28(6) 29(6)  -4(5) 0(5)  -14(5) 
C(12) 35(6)  13(5) 32(6)  0(5) 11(5)  -2(5) 
C(13) 29(6)  32(5) 28(6)  10(5) 6(4)  10(5) 
C(14) 67(7)  22(5) 22(5)  9(5) -5(5)  4(6) 
C(15) 78(9)  48(7) 24(6)  -2(5) 11(6)  0(6) 
C(16) 51(6)  68(6) 23(5)  -12(5) 3(4)  5(6) 
C(17) 71(9)  82(7) 26(7)  -3(6) -18(6)  35(8) 
C(18) 69(8)  43(6) 23(6)  9(5) 2(5)  24(6) 
C(19) 21(5)  21(6) 20(5)  -2(4) 8(4)  10(4) 
C(20) 16(5)  23(5) 26(6)  -8(5) 12(4)  4(4) 
C(21) 33(6)  25(6) 25(6)  -4(5) 3(5)  1(5) 
C(22) 32(5)  46(6) 20(5)  6(5) 15(5)  1(5) 
C(23) 17(5)  56(8) 29(7)  -3(6) -4(5)  -5(5) 
C(24) 23(6)  43(7) 23(6)  -5(5) 16(5)  -2(5) 
N(1) 26(4)  22(4) 23(4)  1(3) 2(3)  1(4) 
N(2) 16(4)  29(5) 21(5)  -5(4) -1(4)  -4(4) 
Cl(1) 23(1)  21(1) 23(1)  3(1) 4(1)  5(1) 
Cl(2) 17(1)  24(1) 30(1)  -5(1) 9(1)  1(1) 
Pt(1) 15(1)  17(1) 21(1)  -1(1) 2(1)  0(1) 
C(101) 20(4)  24(4) 23(4)  0(4) -4(3)  5(4) 
C(102) 18(3)  26(4) 25(5)  2(4) -4(3)  2(4) 
C(103) 18(4)  20(4) 23(4)  4(4) -3(3)  6(4) 
C(104) 21(5)  29(6) 22(6)  -5(5) 4(5)  2(5) 
C(105) 16(5)  20(6) 37(7)  2(5) 16(5)  6(4) 
C(106) 31(6)  30(6) 19(6)  8(5) 1(5)  -13(6) 
C(107) 23(6)  40(7) 29(7)  -9(6) 6(5)  1(5) 
C(108) 41(8)  44(8) 55(9)  -21(7) 17(7)  1(7) 
C(109) 66(9)  57(9) 23(7)  -16(7) 7(7)  -18(8) 
C(110) 49(8)  40(7) 35(8)  2(6) -4(6)  -22(6) 
C(111) 33(7)  28(6) 28(7)  12(5) 2(5)  -7(5) 
C(112) 18(5)  23(6) 36(7)  11(5) 4(5)  -1(5) 
C(113) 37(7)  37(7) 31(7)  3(6) 6(6)  2(6) 
C(114) 21(6)  51(8) 25(6)  -4(6) 2(5)  7(6) 
C(115) 38(7)  54(8) 46(9)  1(7) -19(6)  -5(7) 
C(116) 84(7)  43(8) 22(6)  -6(7) -5(6)  -4(8) 
C(117) 79(6)  50(8) 29(6)  -8(5) 12(5)  11(6) 
C(118) 54(7)  60(10) 27(6)  -1(6) 13(5)  21(7) 
C(119) 24(5)  20(6) 28(6)  12(6) 8(4)  8(5) 
C(120) 41(6)  32(6) 22(5)  0(7) 6(5)  7(7) 
C(121) 43(8)  44(8) 44(9)  9(7) 4(7)  -1(7) 
C(122) 71(9)  36(8) 21(7)  4(6) 12(7)  14(7) 
C(123) 76(10)  28(7) 23(7)  -2(6) 1(6)  -11(7) 
C(124) 45(7)  29(7) 22(6)  -5(5) -2(5)  -1(6) 
N(101) 15(3)  22(4) 19(4)  -4(4) 1(3)  -1(3) 
N(102) 27(5)  18(5) 22(5)  -11(4) -2(4)  -10(4) 
Cl(11) 21(1)  25(2) 28(2)  2(1) 9(1)  6(1) 
Cl(12) 21(1)  22(1) 31(2)  5(1) 1(1)  2(1) 
Pt(11) 16(1)  20(1) 20(1)  0(1) 2(1)  0(1) 
C(201) 15(4)  24(4) 22(4)  -1(3) -5(4)  -3(4) 
C(202) 13(4)  20(4) 32(5)  -4(3) -2(4)  1(4) 
C(203) 18(4)  13(4) 30(4)  3(3) 4(4)  1(4) 
C(204) 32(6)  14(5) 30(6)  8(5) 4(5)  2(5) 
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C(205) 26(6)  28(6) 23(6)  -6(5) -8(5)  16(5) 
C(206) 20(5)  32(6) 30(6)  5(6) 6(5)  2(5) 
C(207) 31(6)  25(6) 23(6)  2(5) -2(5)  4(5) 
C(208) 56(8)  30(6) 26(6)  -11(5) -4(6)  -2(6) 
C(209) 52(8)  45(7) 20(6)  -10(6) 11(6)  0(6) 
C(210) 43(7)  57(8) 24(6)  14(6) 18(6)  -8(7) 
C(211) 25(6)  34(6) 30(6)  6(5) 6(5)  -7(5) 
C(212) 19(5)  18(5) 35(6)  6(5) -2(5)  7(5) 
C(213) 11(5)  43(7) 24(6)  0(5) -3(4)  -6(5) 
C(214) 39(6)  32(7) 32(6)  -3(6) 5(5)  0(6) 
C(215) 85(10)  42(7) 24(7)  -3(6) 13(7)  16(7) 
C(216) 70(9)  88(8) 19(6)  -7(8) 0(6)  28(10) 
C(217) 73(10)  100(9) 26(7)  19(7) 29(7)  13(9) 
C(218) 41(6)  39(6) 29(6)  18(5) 3(5)  -2(6) 
C(219) 15(5)  25(7) 18(5)  -1(4) -2(4)  5(4) 
C(220) 18(5)  41(7) 19(6)  -6(5) -6(4)  -3(5) 
C(221) 34(6)  29(6) 28(6)  -2(5) -7(5)  -11(5) 
C(222) 22(6)  64(8) 30(7)  3(6) -2(5)  0(6) 
C(223) 25(6)  58(8) 17(6)  0(6) 4(5)  9(6) 
C(224) 29(6)  33(6) 25(6)  1(5) -4(5)  1(5) 
N(201) 23(4)  19(4) 17(4)  3(3) 2(3)  -2(3) 
N(202) 13(4)  29(5) 22(5)  -4(4) 9(3)  9(4) 
Cl(21) 21(1)  20(1) 26(1)  2(1) 0(1)  -4(1) 
Cl(22) 15(1)  25(1) 30(1)  -3(1) -2(1)  0(1) 
Pt(21) 15(1)  17(1) 20(1)  -2(1) 1(1)  0(1) 
C(301) 28(4)  16(4) 20(3)  -6(4) 4(3)  4(4) 
C(302) 24(3)  25(4) 27(4)  0(5) -2(3)  -2(5) 
C(303) 21(4)  21(4) 22(4)  2(3) 2(3)  -5(4) 
C(304) 17(4)  9(4) 27(4)  4(4) 4(3)  6(4) 
C(305) 20(5)  24(6) 34(7)  -7(5) -7(5)  6(5) 
C(306) 11(5)  30(6) 25(6)  3(5) 3(4)  10(5) 
C(307) 27(6)  48(9) 31(7)  14(6) -4(5)  7(6) 
C(308) 56(9)  39(7) 51(10)  -1(7) -17(7)  9(7) 
C(309) 69(10)  53(9) 26(7)  -5(7) -3(7)  12(8) 
C(310) 45(8)  56(9) 40(8)  15(7) 13(7)  14(7) 
C(311) 40(7)  37(7) 37(8)  9(6) 5(6)  19(6) 
C(312) 26(6)  31(7) 23(6)  -6(5) 15(5)  3(5) 
C(313) 16(5)  29(6) 20(6)  -9(5) 5(4)  1(5) 
C(314) 29(6)  45(7) 32(7)  14(7) -1(5)  1(6) 
C(315) 33(7)  52(8) 30(7)  -6(6) -3(6)  9(6) 
C(316) 53(6)  45(8) 38(8)  6(6) -9(6)  15(6) 
C(317) 65(7)  58(9) 19(6)  13(6) 4(5)  -7(7) 
C(318) 33(6)  67(8) 21(6)  4(6) 9(5)  -4(6) 
C(319) 36(6)  23(6) 13(5)  -2(5) -7(5)  -2(5) 
C(320) 36(5)  47(6) 15(5)  -7(5) 9(4)  -4(5) 
C(321) 46(8)  41(7) 20(7)  -11(6) 7(6)  -19(6) 
C(322) 81(10)  28(7) 34(8)  1(6) 31(8)  -21(7) 
C(323) 64(9)  34(7) 25(7)  -1(6) -7(6)  8(7) 
C(324) 48(7)  33(7) 18(6)  -2(5) 0(5)  -8(6) 
N(301) 23(3)  15(3) 22(3)  -2(4) 4(3)  -2(4) 
N(302) 18(4)  30(6) 24(5)  -5(4) -7(4)  6(4) 
Cl(31) 20(1)  26(2) 26(1)  -4(1) 10(1)  -4(1) 
Cl(32) 24(1)  22(1) 30(2)  -5(1) 1(1)  -2(1) 
Pt(31) 16(1)  19(1) 20(1)  -1(1) 1(1)  0(1) 
C(401) 30(7)  36(7) 28(7)  5(6) 2(5)  -9(6) 
N(401) 60(7)  35(7) 66(9)  -1(7) 27(7)  -7(6) 
C(402) 36(7)  41(7) 24(7)  17(6) 8(5)  1(6) 
C(501) 39(7)  32(6) 13(5)  9(5) -1(5)  -9(6) 
C(502) 31(6)  30(6) 28(6)  6(5) 12(5)  4(5) 
N(501) 30(6)  65(8) 58(8)  26(6) -6(6)  -8(6) 
C(601) 38(6)  21(6) 16(5)  -1(6) 10(4)  5(6) 
C(602) 36(7)  27(6) 34(7)  2(6) 10(6)  -3(5) 
N(601) 55(7)  36(6) 61(8)  -4(6) 37(6)  14(6) 
C(701) 25(6)  23(6) 31(6)  3(5) 4(5)  1(5) 
C(702) 29(6)  29(6) 28(6)  0(5) 8(5)  -2(5) 





Table 62. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 213aaa. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 3500 1210 4372 29 
H(2A) 5271 3058 4177 32 
H(2B) 3827 3302 4262 32 
H(3) 2997 2096 3849 27 
H(4A) 4064 1998 3401 25 
H(4B) 4266 3420 3533 25 
H(5A) 2773 -134 4008 28 
H(5B) 3956 -1064 4047 28 
H(7) 1900 452 3501 45 
H(8) 1384 -366 3021 55 
H(9) 2540 -2027 2816 57 
H(10) 4228 -2895 3120 51 
H(11) 4721 -2105 3612 33 
H(12A) 6317 3470 3248 31 
H(12B) 7288 2325 3313 31 
H(14) 6367 36 3148 45 
H(15) 5534 -1020 2722 60 
H(16) 4228 29 2357 57 
H(17) 4089 2268 2393 72 
H(18) 4966 3332 2820 54 
H(20) 4358 -845 4601 25 
H(21) 5637 -1646 5010 33 
H(22) 7246 -385 5232 38 
H(23) 7606 1625 5042 42 
H(24) 6394 2399 4616 35 
H(2C) 6320(70) 2910(40) 3699(16) 26 
H(101) 8567 2180 614 27 
H(10A) 6830 374 836 28 
H(10B) 6585 1871 743 28 
H(103) 7902 2614 1143 24 
H(10C) 8213 1474 1591 28 
H(10D) 6777 1247 1473 28 
H(10E) 10010 2907 945 28 
H(10F) 10929 1709 931 28 
H(107) 9497 3725 1456 37 
H(108) 10312 4193 1948 55 
H(109) 12015 3032 2153 58 
H(110) 13047 1597 1867 50 
H(111) 12154 994 1386 36 
H(11A) 6842 -878 1769 31 
H(11B) 7968 -1836 1714 31 
H(114) 10220 -935 1858 39 
H(115) 11387 -28 2271 57 
H(116) 10394 1137 2638 60 
H(117) 8245 1353 2609 62 
H(118) 7049 430 2189 56 
H(120) 10563 1080 409 38 
H(121) 11067 -106 -16 52 
H(122) 9582 -1351 -271 51 
H(123) 7534 -1480 -99 51 
H(124) 7083 -416 347 39 
H(12C) 7260(30) -670(40) 1297(8) 27 
H(201) 11140 6244 4393 25 
H(20A) 10757 8352 4282 27 
H(20B) 9271 8107 4188 27 
H(203) 11393 7145 3871 24 
H(20C) 9936 8469 3559 30 
H(20D) 10139 7068 3422 30 
H(20E) 11708 4933 4041 32 
H(20F) 10555 3981 4065 32 
H(207) 9697 2831 3623 32 
H(208) 10035 2110 3133 45 
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H(209) 11522 3078 2847 46 
H(210) 12604 4915 3037 49 
H(211) 12278 5619 3536 35 
H(21A) 6868 7293 3299 29 
H(21B) 7807 8440 3241 29 
H(214) 7705 5017 3167 41 
H(215) 8421 3888 2756 60 
H(216) 9462 5004 2378 71 
H(217) 9676 7196 2401 78 
H(218) 8907 8323 2809 43 
H(220) 10426 4196 4626 32 
H(221) 9335 3333 5019 37 
H(222) 7825 4626 5237 47 
H(223) 7379 6648 5048 40 
H(224) 8374 7441 4630 35 
H(22C) 8120(90) 7960(30) 3702(15) 25 
H(301) 3574 4602 616 25 
H(30A) 1571 4941 748 31 
H(30B) 1844 6432 843 31 
H(303) 2931 4160 1149 26 
H(30C) 3203 5294 1595 21 
H(30D) 1775 5523 1472 21 
H(30E) 5952 5090 932 32 
H(30F) 5034 3895 955 32 
H(307) 7085 5901 1388 43 
H(308) 7931 5510 1872 60 
H(309) 7110 3794 2167 60 
H(310) 5398 2644 1958 56 
H(311) 4616 3004 1445 46 
H(31A) 2883 8615 1720 31 
H(31B) 1834 7574 1778 31 
H(314) 5198 7955 1891 43 
H(315) 6439 7081 2297 46 
H(316) 5563 5750 2646 55 
H(317) 3457 5195 2566 57 
H(318) 2200 6109 2176 48 
H(320) 5615 5737 417 39 
H(321) 6080 6892 -11 43 
H(322) 4522 8184 -268 56 
H(323) 2554 8302 -88 50 
H(324) 2069 7152 344 40 
H(32C) 2230(30) 7330(100) 1293(12) 29 
H(40A) 4072 12 357 50 
H(40B) 3361 -584 633 50 
H(40C) 4759 -52 692 50 
H(50A) 6029 5606 4283 44 
H(50B) 5489 5405 4610 44 
H(50C) 6007 6776 4517 44 
H(60A) 8209 7360 537 47 
H(60B) 9450 6768 409 47 
H(60C) 9413 7094 764 47 
H(70A) -1438 652 4293 43 
H(70B) -1226 1794 4534 43 






































































































































































































































































































Symmetry transformations used to generate equivalent atoms:  
  
Table 64. Hydrogen bonds for 213aaa [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(2)-H(2C)...Cl(21) 0.92(2) 2.50(3) 3.363(9) 156(4) 
 N(2)-H(2C)...Cl(22) 0.92(2) 2.73(4) 3.365(10) 127(4) 
 N(102)-H(12C)...Cl(31)#1 0.901(18) 2.52(2) 3.365(9) 157(4) 
 N(102)-H(12C)...Cl(32)#1 0.901(18) 2.83(3) 3.443(9) 127(3) 
 N(202)-H(22C)...Cl(1)#2 0.91(2) 2.57(4) 3.375(8) 148(5) 
 N(202)-H(22C)...Cl(2)#2 0.91(2) 2.68(4) 3.387(10) 136(4) 
 N(302)-H(32C)...Cl(11)#3 0.91(2) 2.60(5) 3.398(10) 146(7) 
 N(302)-H(32C)...Cl(12)#3 0.91(2) 2.75(4) 3.413(9) 130(4) 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x,y-1,z    #2 x,y+1,z    #3 x-1,y+1,z  
 




Table 65. Crystal data and structure refinement for 213aha. 
Identification code  213aha 
Empirical formula  C25H28Cl2N2OPd, 0.125(C4H10O) 
Formula weight  559.06 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 13.4719(2) Å = 94.4120(10)°. 
 b = 19.3528(2) Å = 106.4250(10)°. 
 c = 21.6914(3) Å  = 108.6670(10)°. 
Volume 5051.22(12) Å3 
Z, Z’ 8, 4 
Density (calculated) 1.470 Mg/m3 
Absorption coefficient 0.967 mm-1 
F(000) 2282 
Crystal size 0.24 x 0.12 x 0.07 mm3 
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Theta range for data collection 2.91 to 27.48°. 
Index ranges -17<=h<=17, -25<=k<=25, -28<=l<=28 
Reflections collected 105481 
Independent reflections 23160 [R(int) = 0.0436] 
Completeness to theta = 27.48° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9354 and 0.8012 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 23160 / 57 / 1155 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0387, wR2 = 0.0945 
R indices (all data) R1 = 0.0506, wR2 = 0.0999 
Largest diff. peak and hole 1.252 and -1.004 e.Å-3 
 
Notes: The structure contains four crystallographically-independent palladium complexes with 1/8th of a diethyl ether molecule per palladium 
complex (1/2 per asymmetric unit). It was not possible to refine the atoms of the diethyl ether molecule anisotropically.   
The hydrogen atoms bonded to N(2), N(102), N(202) and N(302) (one per crystallographically-independent palladium complex) were located in the 
electron density and their positions refined subject to suitable distance restraints, (N-H = 0.91 (2) Å and Pd … H = 2.48 (4) Å). The isotropic thermal 
parameters (Uiso) of these hydrogen atoms were set at 1.2 times the equivalent isotropic thermal parameter (Ueq) of the parent nitrogen atom. All 
remaining hydrogen atoms were fixed as riding models. The hydrogen bonding is detailed in Table 7, page 33 of this document. 
 
Table 66. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 213aha.  U(eq) is defined as one third of the 
trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 9419(3) 2088(2) 9344(2) 26(1) 
C(2) 10448(3) 2168(2) 9921(2) 29(1) 
C(3) 11017(3) 2075(2) 9414(2) 24(1) 
C(4) 11684(3) 1580(2) 9460(2) 21(1) 
C(5) 9771(3) 1984(2) 8256(2) 27(1) 
C(6) 10551(3) 1844(2) 7929(2) 28(1) 
C(7) 10270(4) 1167(2) 7527(2) 37(1) 
C(8) 11008(4) 1055(2) 7232(2) 48(1) 
C(9) 12034(4) 1601(3) 7340(2) 51(1) 
C(10) 12315(4) 2270(2) 7734(2) 44(1) 
C(11) 11573(3) 2392(2) 8026(2) 33(1) 
C(12) 11558(3) 277(2) 9435(2) 22(1) 
C(13) 11784(2) 155(2) 8800(2) 21(1) 
C(14) 11007(3) -371(2) 8263(2) 25(1) 
C(15) 11252(3) -521(2) 7703(2) 29(1) 
C(16) 12299(3) -140(2) 7669(2) 29(1) 
C(17) 13084(3) 390(2) 8194(2) 29(1) 
C(18) 12821(3) 531(2) 8753(2) 26(1) 
C(19) 13566(4) -54(3) 7076(2) 51(1) 
C(20) 8257(3) 1687(2) 9332(2) 25(1) 
C(21) 7387(3) 1831(2) 8902(2) 29(1) 
C(22) 6307(3) 1466(2) 8867(2) 33(1) 
C(23) 6071(3) 963(2) 9275(2) 32(1) 
C(24) 6924(3) 822(2) 9714(2) 31(1) 
C(25) 8010(3) 1184(2) 9742(2) 28(1) 
N(1) 9886(2) 1722(1) 8892(1) 22(1) 
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N(2) 10983(2) 818(1) 9485(1) 20(1) 
O(1) 12461(2) -325(2) 7092(1) 41(1) 
Cl(1) 7731(1) 359(1) 8061(1) 28(1) 
Cl(2) 8865(1) -658(1) 8970(1) 21(1) 
Pd(1) 9412(1) 583(1) 8848(1) 18(1) 
C(101) 5992(3) 1953(2) 6698(2) 35(1) 
C(102) 6128(3) 1221(2) 6853(2) 36(1) 
C(103) 7216(3) 1498(2) 6701(2) 35(1) 
C(104) 7591(3) 990(2) 6343(2) 35(1) 
C(105) 7545(4) 2766(2) 6329(2) 41(1) 
C(106) 8455(3) 2756(2) 6062(2) 43(1) 
C(107) 8311(4) 2749(3) 5404(2) 62(1) 
C(108) 9123(5) 2710(4) 5160(2) 95(2) 
C(109) 10103(4) 2670(4) 5567(3) 94(2) 
C(110) 10267(4) 2692(3) 6224(2) 69(2) 
C(111) 9457(4) 2741(2) 6464(2) 52(1) 
C(112) 7456(4) 516(2) 5236(2) 44(1) 
C(113) 8081(3) 12(2) 5483(2) 37(1) 
C(114) 7534(3) -687(2) 5585(2) 38(1) 
C(115) 8081(3) -1183(2) 5745(2) 34(1) 
C(116) 9191(3) -979(2) 5796(2) 30(1) 
C(117) 9754(3) -267(2) 5718(2) 35(1) 
C(118) 9205(3) 218(2) 5564(2) 40(1) 
C(119) 9224(3) -2162(2) 5982(2) 37(1) 
C(120) 4902(4) 2030(2) 6427(2) 44(1) 
C(121) 4838(6) 2729(3) 6519(2) 80(2) 
C(122) 3819(9) 2820(5) 6288(3) 118(3) 
C(123) 2873(7) 2215(6) 5980(3) 114(3) 
C(124) 2916(5) 1518(4) 5888(2) 82(2) 
C(125) 3922(4) 1421(3) 6105(2) 50(1) 
N(101) 6761(3) 2001(2) 6282(1) 32(1) 
N(102) 6837(2) 696(2) 5660(1) 28(1) 
O(101) 9797(2) -1431(1) 5916(1) 34(1) 
Cl(11) 5248(1) 2272(1) 4987(1) 35(1) 
Cl(12) 5255(1) 712(1) 4284(1) 28(1) 
Pd(11) 6044(1) 1417(1) 5332(1) 24(1) 
C(201) 3596(3) 2209(2) 3251(2) 23(1) 
C(202) 3226(3) 1389(2) 2950(2) 26(1) 
C(203) 4378(3) 1560(2) 2878(2) 22(1) 
C(204) 4511(3) 1283(2) 2255(2) 21(1) 
C(205) 5646(3) 2885(2) 3421(2) 24(1) 
C(206) 6590(3) 2788(2) 3228(2) 24(1) 
C(207) 6964(3) 3160(2) 2772(2) 30(1) 
C(208) 7792(3) 3025(2) 2573(2) 39(1) 
C(209) 8239(3) 2515(2) 2823(2) 42(1) 
C(210) 7876(3) 2145(2) 3282(2) 40(1) 
C(211) 7066(3) 2285(2) 3490(2) 31(1) 
C(212) 3965(3) 1284(2) 1071(2) 23(1) 
C(213) 5143(3) 1535(2) 1064(1) 21(1) 
C(214) 5624(3) 2205(2) 885(2) 26(1) 
C(215) 6710(3) 2436(2) 885(2) 28(1) 
C(216) 7338(3) 1997(2) 1076(2) 24(1) 
C(217) 6867(3) 1320(2) 1248(2) 26(1) 
C(218) 5784(3) 1095(2) 1234(2) 24(1) 
C(219) 8900(3) 2834(2) 889(2) 37(1) 
C(220) 2812(3) 2622(2) 3114(2) 25(1) 
C(221) 1888(3) 2404(2) 2559(2) 33(1) 
C(222) 1137(3) 2779(2) 2477(2) 42(1) 
C(223) 1330(4) 3371(2) 2941(2) 44(1) 
C(224) 2250(4) 3599(2) 3484(2) 45(1) 
C(225) 2986(3) 3224(2) 3572(2) 35(1) 
N(201) 4546(2) 2385(1) 2954(1) 20(1) 
N(202) 3847(2) 1536(1) 1712(1) 19(1) 
O(201) 8431(2) 2184(1) 1125(1) 30(1) 
Cl(21) 4534(1) 3878(1) 2438(1) 25(1) 
Cl(22) 3460(1) 2861(1) 978(1) 27(1) 
Pd(21) 4121(1) 2642(1) 2026(1) 17(1) 
C(301) 2467(3) 4755(2) 1948(2) 27(1) 
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C(302) 2002(3) 4149(2) 1337(2) 28(1) 
C(303) 2912(3) 4633(2) 1102(2) 26(1) 
C(304) 2697(3) 4706(2) 394(2) 27(1) 
C(305) 4080(3) 5877(2) 1901(2) 29(1) 
C(306) 4644(3) 6242(2) 1440(2) 27(1) 
C(307) 4463(3) 6856(2) 1204(2) 28(1) 
C(308) 4942(3) 7166(2) 758(2) 34(1) 
C(309) 5612(3) 6861(2) 535(2) 40(1) 
C(310) 5811(3) 6258(2) 771(2) 45(1) 
C(311) 5331(3) 5949(2) 1223(2) 38(1) 
C(312) 2225(3) 5585(2) -295(2) 26(1) 
C(313) 2255(3) 5171(2) -903(2) 24(1) 
C(314) 3089(3) 5485(2) -1168(2) 25(1) 
C(315) 3073(3) 5157(2) -1769(2) 26(1) 
C(316) 2224(3) 4496(2) -2101(2) 27(1) 
C(317) 1395(3) 4170(2) -1837(2) 30(1) 
C(318) 1401(3) 4506(2) -1248(2) 29(1) 
C(319) 2845(4) 4481(2) -3024(2) 46(1) 
C(320) 1764(3) 4919(2) 2323(2) 35(1) 
C(321) 622(4) 4711(2) 2041(2) 40(1) 
C(322) -22(5) 4801(3) 2412(3) 59(1) 
C(323) 437(6) 5108(3) 3046(3) 73(2) 
C(324) 1568(6) 5339(2) 3345(2) 69(2) 
C(325) 2259(4) 5235(2) 2981(2) 48(1) 
N(301) 2959(2) 5310(1) 1540(1) 23(1) 
N(302) 1932(2) 5122(1) 190(1) 19(1) 
O(301) 2108(2) 4125(1) -2694(1) 38(1) 
Cl(31) 1941(1) 6525(1) 1873(1) 28(1) 
Cl(32) 551(1) 6115(1) 297(1) 22(1) 
Pd(31) 1878(1) 5748(1) 984(1) 18(1) 
C(401) 3683(14) 5259(10) 5326(9) 125(6) 
C(402) 4449(14) 4936(9) 5742(8) 123(5) 
C(403) 2059(14) 5424(9) 5332(8) 112(5) 
C(404) 1175(18) 5472(12) 5636(11) 162(8) 
O(401) 2835(10) 5159(6) 5594(6) 126(4) 
________________________________________________________________________________ 
 
Table 67. Bond lengths [Å] and angles [°] for 213aha. 
_____________________________________________________ 
C(1)-C(20)  1.499(5) 
C(1)-C(2)  1.537(5) 
C(1)-N(1)  1.544(4) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.538(5) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.500(4) 
C(3)-N(1)  1.520(4) 
C(3)-H(3)  1.0000 
C(4)-N(2)  1.490(4) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(1)  1.491(4) 
C(5)-C(6)  1.501(5) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(11)  1.390(5) 
C(6)-C(7)  1.393(5) 
C(7)-C(8)  1.386(6) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.388(7) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.372(6) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.393(5) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-N(2)  1.502(4) 
C(12)-C(13)  1.510(4) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-C(18)  1.391(4) 
C(13)-C(14)  1.391(4) 
C(14)-C(15)  1.380(5) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.392(5) 
C(15)-H(15)  0.9500 
C(16)-O(1)  1.371(4) 
C(16)-C(17)  1.383(5) 
C(17)-C(18)  1.389(5) 
C(17)-H(17)  0.9500 
C(18)-H(18)  0.9500 
C(19)-O(1)  1.423(5) 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(20)-C(25)  1.392(4) 
C(20)-C(21)  1.397(5) 
C(21)-C(22)  1.377(5) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.388(5) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.387(5) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.386(5) 
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C(24)-H(24)  0.9500 
C(25)-H(25)  0.9500 
N(1)-Pd(1)  2.077(2) 
N(2)-Pd(1)  2.057(3) 
N(2)-H(2C)  0.900(17) 
Cl(1)-Pd(1)  2.3023(8) 
Cl(2)-Pd(1)  2.3347(7) 
C(101)-C(120)  1.480(6) 
C(101)-C(102)  1.535(5) 
C(101)-N(101)  1.542(5) 
C(101)-H(101)  1.0000 
C(102)-C(103)  1.529(5) 
C(102)-H(10A)  0.9900 
C(102)-H(10B)  0.9900 
C(103)-C(104)  1.499(5) 
C(103)-N(101)  1.533(4) 
C(103)-H(103)  1.0000 
C(104)-N(102)  1.484(4) 
C(104)-H(10C)  0.9900 
C(104)-H(10D)  0.9900 
C(105)-N(101)  1.495(5) 
C(105)-C(106)  1.502(6) 
C(105)-H(10E)  0.9900 
C(105)-H(10F)  0.9900 
C(106)-C(107)  1.383(6) 
C(106)-C(111)  1.395(6) 
C(107)-C(108)  1.363(7) 
C(107)-H(107)  0.9500 
C(108)-C(109)  1.395(8) 
C(108)-H(108)  0.9500 
C(109)-C(110)  1.373(7) 
C(109)-H(109)  0.9500 
C(110)-C(111)  1.360(7) 
C(110)-H(110)  0.9500 
C(111)-H(111)  0.9500 
C(112)-N(102)  1.494(5) 
C(112)-C(113)  1.516(5) 
C(112)-H(11A)  0.9900 
C(112)-H(11B)  0.9900 
C(113)-C(114)  1.387(5) 
C(113)-C(118)  1.392(5) 
C(114)-C(115)  1.394(5) 
C(114)-H(114)  0.9500 
C(115)-C(116)  1.387(5) 
C(115)-H(115)  0.9500 
C(116)-O(101)  1.368(4) 
C(116)-C(117)  1.394(5) 
C(117)-C(118)  1.376(5) 
C(117)-H(117)  0.9500 
C(118)-H(118)  0.9500 
C(119)-O(101)  1.419(4) 
C(119)-H(11C)  0.9800 
C(119)-H(11D)  0.9800 
C(119)-H(11E)  0.9800 
C(120)-C(121)  1.385(6) 
C(120)-C(125)  1.407(7) 
C(121)-C(122)  1.394(9) 
C(121)-H(121)  0.9500 
C(122)-C(123)  1.372(12) 
C(122)-H(122)  0.9500 
C(123)-C(124)  1.370(10) 
C(123)-H(123)  0.9500 
C(124)-C(125)  1.382(6) 
C(124)-H(124)  0.9500 
C(125)-H(125)  0.9500 
N(101)-Pd(11)  2.066(3) 
N(102)-Pd(11)  2.065(3) 
N(102)-H(12C)  0.901(18) 
Cl(11)-Pd(11)  2.3078(8) 
Cl(12)-Pd(11)  2.3212(8) 
C(201)-C(220)  1.498(4) 
C(201)-C(202)  1.532(5) 
C(201)-N(201)  1.545(4) 
C(201)-H(201)  1.0000 
C(202)-C(203)  1.535(4) 
C(202)-H(20A)  0.9900 
C(202)-H(20B)  0.9900 
C(203)-C(204)  1.495(4) 
C(203)-N(201)  1.528(4) 
C(203)-H(203)  1.0000 
C(204)-N(202)  1.484(4) 
C(204)-H(20C)  0.9900 
C(204)-H(20D)  0.9900 
C(205)-N(201)  1.497(4) 
C(205)-C(206)  1.507(4) 
C(205)-H(20E)  0.9900 
C(205)-H(20F)  0.9900 
C(206)-C(207)  1.384(5) 
C(206)-C(211)  1.400(5) 
C(207)-C(208)  1.393(5) 
C(207)-H(207)  0.9500 
C(208)-C(209)  1.382(6) 
C(208)-H(208)  0.9500 
C(209)-C(210)  1.380(6) 
C(209)-H(209)  0.9500 
C(210)-C(211)  1.385(5) 
C(210)-H(210)  0.9500 
C(211)-H(211)  0.9500 
C(212)-N(202)  1.504(4) 
C(212)-C(213)  1.508(4) 
C(212)-H(21A)  0.9900 
C(212)-H(21B)  0.9900 
C(213)-C(214)  1.391(4) 
C(213)-C(218)  1.395(4) 
C(214)-C(215)  1.387(5) 
C(214)-H(214)  0.9500 
C(215)-C(216)  1.386(4) 
C(215)-H(215)  0.9500 
C(216)-O(201)  1.370(4) 
C(216)-C(217)  1.391(4) 
C(217)-C(218)  1.373(5) 
C(217)-H(217)  0.9500 
C(218)-H(218)  0.9500 
C(219)-O(201)  1.419(4) 
C(219)-H(21C)  0.9800 
C(219)-H(21D)  0.9800 
C(219)-H(21E)  0.9800 
C(220)-C(225)  1.382(5) 
C(220)-C(221)  1.384(5) 
C(221)-C(222)  1.403(5) 
C(221)-H(221)  0.9500 
C(222)-C(223)  1.372(6) 
C(222)-H(222)  0.9500 
C(223)-C(224)  1.365(6) 
C(223)-H(223)  0.9500 
C(224)-C(225)  1.386(5) 
C(224)-H(224)  0.9500 
C(225)-H(225)  0.9500 
N(201)-Pd(21)  2.077(2) 
N(202)-Pd(21)  2.075(2) 
N(202)-H(22C)  0.901(18) 
Cl(21)-Pd(21)  2.3182(8) 
Cl(22)-Pd(21)  2.3210(7) 
C(301)-C(320)  1.497(5) 
C(301)-C(302)  1.533(5) 
C(301)-N(301)  1.549(4) 
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C(301)-H(301)  1.0000 
C(302)-C(303)  1.527(5) 
C(302)-H(30A)  0.9900 
C(302)-H(30B)  0.9900 
C(303)-C(304)  1.508(4) 
C(303)-N(301)  1.530(4) 
C(303)-H(303)  1.0000 
C(304)-N(302)  1.494(4) 
C(304)-H(30C)  0.9900 
C(304)-H(30D)  0.9900 
C(305)-N(301)  1.496(4) 
C(305)-C(306)  1.507(5) 
C(305)-H(30E)  0.9900 
C(305)-H(30F)  0.9900 
C(306)-C(307)  1.392(5) 
C(306)-C(311)  1.393(5) 
C(307)-C(308)  1.382(5) 
C(307)-H(307)  0.9500 
C(308)-C(309)  1.393(5) 
C(308)-H(308)  0.9500 
C(309)-C(310)  1.382(6) 
C(309)-H(309)  0.9500 
C(310)-C(311)  1.392(6) 
C(310)-H(310)  0.9500 
C(311)-H(311)  0.9500 
C(312)-N(302)  1.491(4) 
C(312)-C(313)  1.507(4) 
C(312)-H(31A)  0.9900 
C(312)-H(31B)  0.9900 
C(313)-C(314)  1.394(4) 
C(313)-C(318)  1.398(5) 
C(314)-C(315)  1.396(4) 
C(314)-H(314)  0.9500 
C(315)-C(316)  1.386(5) 
C(315)-H(315)  0.9500 
C(316)-O(301)  1.364(4) 
C(316)-C(317)  1.394(5) 
C(317)-C(318)  1.386(5) 
C(317)-H(317)  0.9500 
C(318)-H(318)  0.9500 
C(319)-O(301)  1.419(4) 
C(319)-H(31C)  0.9800 
C(319)-H(31D)  0.9800 
C(319)-H(31E)  0.9800 
C(320)-C(325)  1.387(5) 
C(320)-C(321)  1.392(6) 
C(321)-C(322)  1.378(6) 
C(321)-H(321)  0.9500 
C(322)-C(323)  1.337(8) 
C(322)-H(322)  0.9500 
C(323)-C(324)  1.379(8) 
C(323)-H(323)  0.9500 
C(324)-C(325)  1.429(7) 
C(324)-H(324)  0.9500 
C(325)-H(325)  0.9500 
N(301)-Pd(31)  2.061(3) 
N(302)-Pd(31)  2.061(2) 
N(302)-H(32C)  0.894(18) 
Cl(31)-Pd(31)  2.3155(8) 
Cl(32)-Pd(31)  2.3217(8) 
C(401)-O(401)  1.390(18) 
C(401)-C(402)  1.499(9) 
C(401)-H(40A)  0.9900 
C(401)-H(40B)  0.9900 
C(402)-H(40C)  0.9800 
C(402)-H(40D)  0.9800 
C(402)-H(40E)  0.9800 
C(403)-O(401)  1.315(17) 
C(403)-C(404)  1.54(2) 
C(403)-H(40F)  0.9900 
C(403)-H(40G)  0.9900 
C(404)-H(40H)  0.9800 
C(404)-H(40I)  0.9800 





















































































































































































































































































































































































































































































































Table 68. Anisotropic displacement parameters (Å2x 103) for 213aha. The anisotropic displacement factor exponent takes the form: -2 2[ 
h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 25(2)  18(2) 33(2)  2(1) 7(1)  10(1) 
C(2) 26(2)  27(2) 29(2)  -3(1) 3(1)  10(1) 
C(3) 20(2)  18(1) 26(2)  -1(1) 0(1)  4(1) 
C(4) 17(2)  23(2) 20(2)  5(1) 1(1)  6(1) 
C(5) 24(2)  23(2) 30(2)  12(1) 1(1)  9(1) 
C(6) 32(2)  30(2) 23(2)  13(1) 3(1)  17(2) 
C(7) 49(2)  36(2) 22(2)  9(1) 0(2)  22(2) 
C(8) 82(4)  53(3) 24(2)  12(2) 11(2)  47(3) 
C(9) 66(3)  76(3) 39(2)  31(2) 26(2)  50(3) 
C(10) 43(2)  58(3) 41(2)  24(2) 17(2)  25(2) 
C(11) 34(2)  35(2) 32(2)  14(2) 8(2)  16(2) 
C(12) 22(2)  24(2) 23(2)  10(1) 5(1)  12(1) 
C(13) 16(2)  21(1) 25(2)  6(1) 2(1)  10(1) 
C(14) 20(2)  24(2) 30(2)  4(1) 6(1)  9(1) 
C(15) 30(2)  29(2) 29(2)  3(1) 9(2)  13(2) 
C(16) 36(2)  33(2) 30(2)  13(1) 16(2)  21(2) 
C(17) 24(2)  29(2) 40(2)  14(2) 14(2)  13(1) 
C(18) 21(2)  24(2) 30(2)  7(1) 3(1)  9(1) 
C(19) 61(3)  63(3) 56(3)  26(2) 41(2)  34(2) 
C(20) 26(2)  17(1) 32(2)  3(1) 8(1)  10(1) 
C(21) 26(2)  23(2) 39(2)  9(1) 8(2)  11(1) 
C(22) 26(2)  30(2) 42(2)  7(2) 6(2)  14(2) 
C(23) 26(2)  26(2) 45(2)  5(2) 14(2)  10(1) 
C(24) 36(2)  24(2) 37(2)  8(1) 16(2)  13(2) 
C(25) 28(2)  23(2) 32(2)  7(1) 7(2)  13(1) 
N(1) 18(1)  18(1) 26(1)  3(1) 2(1)  7(1) 
N(2) 19(1)  22(1) 17(1)  4(1) 2(1)  8(1) 
O(1) 48(2)  51(2) 38(2)  11(1) 26(1)  23(1) 
Cl(1) 20(1)  25(1) 31(1)  3(1) -4(1)  7(1) 
Cl(2) 20(1)  19(1) 23(1)  6(1) 6(1)  5(1) 
Pd(1) 16(1)  17(1) 18(1)  3(1) 2(1)  6(1) 
C(101) 50(2)  37(2) 14(2)  1(1) 7(2)  15(2) 
C(102) 43(2)  44(2) 21(2)  13(2) 7(2)  17(2) 
C(103) 37(2)  42(2) 19(2)  8(1) -4(2)  15(2) 
C(104) 31(2)  41(2) 28(2)  11(2) -1(2)  15(2) 
C(105) 51(3)  30(2) 27(2)  2(2) 2(2)  6(2) 
C(106) 41(2)  39(2) 30(2)  7(2) 1(2)  -1(2) 
C(107) 38(3)  104(4) 31(2)  23(2) 4(2)  12(3) 
C(108) 45(3)  191(7) 30(2)  24(3) 7(2)  21(4) 
C(109) 36(3)  188(7) 41(3)  18(4) 6(2)  24(4) 
C(110) 33(3)  103(4) 43(3)  17(3) -3(2)  1(3) 
C(111) 47(3)  54(3) 28(2)  8(2) -2(2)  -4(2) 
C(112) 55(3)  65(3) 34(2)  26(2) 23(2)  41(2) 
C(113) 45(2)  55(2) 31(2)  22(2) 20(2)  32(2) 
C(114) 31(2)  61(3) 36(2)  23(2) 16(2)  26(2) 
C(115) 34(2)  46(2) 34(2)  19(2) 18(2)  22(2) 
C(116) 29(2)  44(2) 22(2)  8(1) 10(1)  18(2) 
C(117) 27(2)  44(2) 38(2)  10(2) 13(2)  14(2) 
C(118) 43(2)  43(2) 42(2)  14(2) 21(2)  20(2) 
C(119) 35(2)  41(2) 46(2)  16(2) 19(2)  20(2) 
C(120) 69(3)  60(3) 19(2)  10(2) 17(2)  42(2) 
C(121) 139(5)  92(4) 40(3)  7(3) 25(3)  85(4) 
C(122) 195(7)  172(6) 58(4)  19(4) 41(5)  159(6) 
C(123) 134(6)  236(8) 49(4)  48(4) 41(4)  151(6) 
C(124) 67(3)  178(6) 38(3)  41(3) 31(2)  74(4) 
C(125) 50(3)  85(3) 29(2)  22(2) 18(2)  33(2) 
N(101) 40(2)  31(2) 18(1)  5(1) 1(1)  13(1) 
N(102) 33(2)  34(2) 20(1)  11(1) 6(1)  17(1) 
O(101) 27(1)  40(1) 43(2)  14(1) 16(1)  17(1) 
Cl(11) 49(1)  40(1) 21(1)  12(1) 7(1)  26(1) 
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Cl(12) 36(1)  32(1) 16(1)  5(1) 6(1)  14(1) 
Pd(11) 30(1)  28(1) 15(1)  7(1) 3(1)  13(1) 
C(201) 19(2)  34(2) 19(2)  10(1) 9(1)  11(1) 
C(202) 22(2)  31(2) 29(2)  13(1) 13(1)  11(1) 
C(203) 19(2)  24(2) 23(2)  10(1) 7(1)  8(1) 
C(204) 16(2)  24(2) 24(2)  10(1) 5(1)  9(1) 
C(205) 20(2)  33(2) 15(1)  4(1) 1(1)  9(1) 
C(206) 16(2)  31(2) 21(2)  2(1) 1(1)  5(1) 
C(207) 20(2)  37(2) 27(2)  6(1) 4(1)  5(1) 
C(208) 26(2)  52(2) 31(2)  6(2) 12(2)  2(2) 
C(209) 23(2)  51(2) 47(2)  -6(2) 13(2)  8(2) 
C(210) 23(2)  43(2) 46(2)  1(2) 2(2)  14(2) 
C(211) 19(2)  40(2) 29(2)  6(2) 2(1)  9(1) 
C(212) 22(2)  25(2) 19(2)  -1(1) 3(1)  8(1) 
C(213) 24(2)  24(2) 17(1)  3(1) 6(1)  11(1) 
C(214) 30(2)  30(2) 25(2)  12(1) 10(1)  17(1) 
C(215) 32(2)  23(2) 31(2)  12(1) 13(2)  11(1) 
C(216) 26(2)  29(2) 22(2)  8(1) 11(1)  11(1) 
C(217) 32(2)  30(2) 28(2)  15(1) 15(2)  18(1) 
C(218) 31(2)  22(2) 24(2)  9(1) 12(1)  12(1) 
C(219) 33(2)  34(2) 48(2)  15(2) 23(2)  9(2) 
C(220) 21(2)  32(2) 27(2)  13(1) 12(1)  11(1) 
C(221) 30(2)  47(2) 29(2)  16(2) 12(2)  18(2) 
C(222) 29(2)  64(3) 47(2)  38(2) 18(2)  26(2) 
C(223) 44(2)  41(2) 75(3)  36(2) 36(2)  28(2) 
C(224) 46(3)  25(2) 73(3)  12(2) 31(2)  14(2) 
C(225) 28(2)  31(2) 44(2)  6(2) 14(2)  7(2) 
N(201) 17(1)  27(1) 16(1)  7(1) 6(1)  8(1) 
N(202) 17(1)  22(1) 19(1)  5(1) 4(1)  7(1) 
O(201) 27(1)  38(1) 36(1)  19(1) 17(1)  15(1) 
Cl(21) 28(1)  24(1) 25(1)  5(1) 8(1)  11(1) 
Cl(22) 34(1)  34(1) 16(1)  7(1) 5(1)  20(1) 
Pd(21) 16(1)  21(1) 15(1)  5(1) 4(1)  7(1) 
C(301) 35(2)  23(2) 24(2)  14(1) 8(1)  11(1) 
C(302) 32(2)  23(2) 29(2)  8(1) 8(2)  12(1) 
C(303) 29(2)  24(2) 26(2)  6(1) 7(1)  14(1) 
C(304) 30(2)  30(2) 25(2)  5(1) 8(1)  17(1) 
C(305) 25(2)  32(2) 22(2)  8(1) -2(1)  6(1) 
C(306) 20(2)  30(2) 27(2)  5(1) 1(1)  7(1) 
C(307) 23(2)  29(2) 30(2)  6(1) 7(1)  8(1) 
C(308) 29(2)  34(2) 35(2)  12(2) 10(2)  5(2) 
C(309) 24(2)  53(2) 35(2)  8(2) 11(2)  2(2) 
C(310) 28(2)  55(3) 52(3)  2(2) 15(2)  14(2) 
C(311) 28(2)  41(2) 48(2)  12(2) 10(2)  16(2) 
C(312) 39(2)  23(2) 23(2)  7(1) 14(2)  13(1) 
C(313) 31(2)  26(2) 21(2)  8(1) 10(1)  14(1) 
C(314) 28(2)  23(2) 24(2)  6(1) 6(1)  11(1) 
C(315) 29(2)  29(2) 26(2)  12(1) 12(1)  15(1) 
C(316) 35(2)  30(2) 21(2)  7(1) 10(1)  17(2) 
C(317) 37(2)  25(2) 27(2)  5(1) 12(2)  7(2) 
C(318) 33(2)  31(2) 24(2)  7(1) 11(2)  11(2) 
C(319) 51(3)  62(3) 30(2)  5(2) 23(2)  19(2) 
C(320) 57(3)  22(2) 33(2)  15(1) 24(2)  15(2) 
C(321) 51(3)  32(2) 57(2)  26(2) 32(2)  25(2) 
C(322) 82(4)  51(3) 88(4)  44(3) 63(3)  44(3) 
C(323) 121(5)  53(3) 101(5)  46(3) 82(5)  54(4) 
C(324) 152(6)  32(2) 40(2)  17(2) 52(3)  36(3) 
C(325) 85(3)  27(2) 35(2)  16(2) 27(2)  17(2) 
N(301) 24(1)  23(1) 21(1)  7(1) 5(1)  8(1) 
N(302) 22(1)  20(1) 16(1)  3(1) 6(1)  8(1) 
O(301) 52(2)  37(1) 28(1)  0(1) 20(1)  13(1) 
Cl(31) 44(1)  21(1) 19(1)  4(1) 12(1)  10(1) 
Cl(32) 25(1)  20(1) 22(1)  6(1) 7(1)  10(1) 





Table 69. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 213aha. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 9477 2592 9244 31 
H(2A) 10336 1763 10176 35 
H(2B) 10791 2660 10212 35 
H(3) 11431 2569 9331 28 
H(4A) 11941 1568 9076 26 
H(4B) 12344 1775 9859 26 
H(5A) 9911 2523 8331 32 
H(5B) 9000 1729 7959 32 
H(7) 9576 785 7455 44 
H(8) 10809 595 6952 58 
H(9) 12537 1513 7141 61 
H(10) 13013 2649 7808 52 
H(11) 11769 2857 8296 40 
H(12A) 11100 -207 9501 27 
H(12B) 12273 453 9796 27 
H(14) 10290 -631 8282 30 
H(15) 10710 -884 7342 35 
H(17) 13797 656 8171 35 
H(18) 13364 894 9114 31 
H(19A) 13817 486 7112 77 
H(19B) 13590 -280 6663 77 
H(19C) 14052 -182 7442 77 
H(21) 7544 2185 8630 35 
H(22) 5722 1559 8563 40 
H(23) 5326 716 9254 38 
H(24) 6765 478 9994 37 
H(25) 8593 1088 10044 33 
H(2C) 10920(20) 849(18) 9889(9) 24 
H(101) 6419 2337 7105 42 
H(10A) 6221 1164 7313 43 
H(10B) 5559 773 6545 43 
H(103) 7834 1806 7103 42 
H(10C) 8349 1264 6341 42 
H(10D) 7616 572 6575 42 
H(10E) 7874 3018 6793 49 
H(10F) 7131 3054 6084 49 
H(107) 7644 2770 5122 74 
H(108) 9021 2711 4708 114 
H(109) 10655 2628 5391 113 
H(110) 10937 2673 6506 83 
H(111) 9578 2765 6920 62 
H(11A) 7991 985 5196 52 
H(11B) 6925 277 4794 52 
H(114) 6771 -832 5544 46 
H(115) 7697 -1657 5818 40 
H(117) 10522 -116 5771 43 
H(118) 9600 702 5512 47 
H(11C) 8974 -2141 6363 55 
H(11D) 9721 -2445 6041 55 
H(11E) 8581 -2405 5588 55 
H(121) 5489 3147 6741 96 
H(122) 3781 3301 6343 141 
H(123) 2181 2281 5830 137 
H(124) 2256 1103 5676 99 
H(125) 3951 938 6036 60 
H(12C) 6280(20) 284(13) 5653(18) 33 
H(201) 3925 2269 3736 27 
H(20A) 2613 1231 2528 31 
H(20B) 3070 1045 3254 31 
H(203) 4893 1458 3263 26 
H(20C) 5301 1478 2285 26 
H(20D) 4253 734 2173 26 
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H(20E) 5710 2776 3866 29 
H(20F) 5694 3407 3431 29 
H(207) 6657 3508 2593 36 
H(208) 8053 3286 2263 47 
H(209) 8794 2419 2679 51 
H(210) 8181 1794 3455 47 
H(211) 6832 2038 3814 37 
H(21A) 3527 1473 724 28 
H(21B) 3646 736 965 28 
H(214) 5201 2511 761 31 
H(215) 7022 2891 754 33 
H(217) 7292 1016 1375 32 
H(218) 5462 626 1342 29 
H(21C) 8465 2788 432 55 
H(21D) 9665 2897 920 55 
H(21E) 8894 3267 1153 55 
H(221) 1762 2000 2234 39 
H(222) 495 2622 2099 50 
H(223) 820 3624 2885 53 
H(224) 2387 4015 3801 54 
H(225) 3621 3383 3953 42 
H(22C) 3122(16) 1305(14) 1654(16) 23 
H(301) 3095 4665 2264 32 
H(30A) 2072 3669 1424 34 
H(30B) 1242 4080 1061 34 
H(303) 3606 4524 1273 31 
H(30C) 3408 4969 325 32 
H(30D) 2368 4206 117 32 
H(30E) 4544 5636 2174 35 
H(30F) 4005 6260 2195 35 
H(307) 4003 7064 1353 33 
H(308) 4815 7586 603 41 
H(309) 5931 7066 221 48 
H(310) 6277 6054 625 54 
H(311) 5473 5535 1385 46 
H(31A) 2962 5976 -78 32 
H(31B) 1682 5835 -427 32 
H(314) 3681 5932 -935 30 
H(315) 3638 5385 -1947 31 
H(317) 820 3712 -2063 36 
H(318) 822 4285 -1078 34 
H(31C) 2797 4968 -3078 69 
H(31D) 2642 4177 -3454 69 
H(31E) 3605 4543 -2767 69 
H(321) 283 4506 1588 48 
H(322) -803 4641 2214 70 
H(323) -19 5169 3293 88 
H(324) 1888 5568 3793 83 
H(325) 3037 5379 3184 57 
H(32C) 1233(17) 4810(15) -1(14) 23 
H(40A) 4070 5793 5341 150 
H(40B) 3388 4997 4866 150 
H(40C) 4830 5254 6175 184 
H(40D) 4998 4905 5536 184 
H(40E) 4022 4438 5788 184 
H(40F) 1652 5128 4886 134 
H(40G) 2446 5933 5280 134 
H(40H) 576 4987 5527 243 
H(40I) 874 5842 5462 243 

















































































































































































































































































































Symmetry transformations used to generate equivalent atoms:  
  
Table 71. Hydrogen bonds for 213aha [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(2)-H(2C)...Cl(2)#1 0.900(17) 2.483(19) 3.345(3) 161(3) 
 N(102)-H(12C)...Cl(12)#2 0.901(18) 2.377(19) 3.273(3) 173(3) 
 N(202)-H(22C)...Cl(2)#2 0.901(18) 2.47(2) 3.318(3) 156(3) 
 N(302)-H(32C)...Cl(32)#3 0.894(18) 2.364(19) 3.244(3) 168(3) 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,-y,-z+2    #2 -x+1,-y,-z+1    #3 -x,-y+1,-z  
 
4.3.3 X-ray Crystallographic Information for C,N,N Pd(II)-amino-azetidine complex 213gaa 
 
 
Table 72. Crystal data and structure refinement for 213gaa. 
Identification code  213gaa 
Empirical formula  C24H25Br N2Pd, 0.62(C4H8O2), 0.38(C4H10O) 
Formula weight  610.56 
Temperature  120(2) K 
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Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 2/c 
Unit cell dimensions a = 30.2910(5) Å = 90°. 
 b = 9.6252(2) Å = 90.9440(10)°. 
 c = 17.6711(4) Å  = 90°. 
Volume 5151.43(18) Å3 
Z 8 
Density (calculated) 1.574 Mg/m3 
Absorption coefficient 2.298 mm-1 
F(000) 2478 
Crystal size 0.20 x 0.12 x 0.10 mm3 
Theta range for data collection 2.92 to 27.48°. 
Index ranges -39<=h<=39, -12<=k<=12, -22<=l<=22 
Reflections collected 27495 
Independent reflections 5888 [R(int) = 0.0353] 
Completeness to theta = 27.48° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8028 and 0.6565 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5888 / 149 / 351 
Goodness-of-fit on F2 1.119 
Final R indices [I>2sigma(I)] R1 = 0.0287, wR2 = 0.0612 
R indices (all data) R1 = 0.0344, wR2 = 0.0643 
Largest diff. peak and hole 0.489 and -0.686 e.Å-3 
 
Notes: The structure includes a molecule of solvent disordered such that O(101), O(102), C(101)-C(104) is an ethyl acetate molecule while O(11’), 
C(11’)-C(14’) is an ether molecule, with a refined percentage occupancy ratio of 62:38 respectively. 
Hydrogen atoms were fixed as riding models.
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Table 73. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 213gaa.  U(eq) is defined as one third of the 
trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 969(1) 5647(3) 3473(1) 17(1) 
C(2) 529(1) 4847(3) 3350(1) 20(1) 
C(3) 768(1) 4021(3) 2721(1) 18(1) 
C(4) 586(1) 3760(3) 1935(1) 18(1) 
C(5) 447(1) 2457(3) 1683(2) 22(1) 
C(6) 321(1) 2270(3) 927(2) 24(1) 
C(7) 341(1) 3385(3) 426(2) 22(1) 
C(8) 478(1) 4692(3) 678(1) 19(1) 
C(9) 597(1) 4902(2) 1434(1) 16(1) 
C(10) 1003(1) 7208(3) 3604(1) 18(1) 
C(11) 1095(1) 9273(2) 2777(1) 18(1) 
C(12) 1157(1) 10302(3) 3419(1) 19(1) 
C(13) 813(1) 10623(3) 3903(2) 24(1) 
C(14) 872(1) 11601(3) 4474(2) 28(1) 
C(15) 1271(1) 12285(3) 4557(2) 29(1) 
C(16) 1614(1) 11984(3) 4080(2) 30(1) 
C(17) 1558(1) 10992(3) 3513(2) 24(1) 
C(18) 1555(1) 4853(3) 2518(2) 20(1) 
C(19) 1828(1) 6089(3) 2287(1) 19(1) 
C(20) 1782(1) 6599(3) 1554(2) 22(1) 
C(21) 2027(1) 7735(3) 1321(2) 28(1) 
C(22) 2322(1) 8365(3) 1822(2) 32(1) 
C(23) 2371(1) 7873(3) 2551(2) 32(1) 
C(24) 2123(1) 6736(3) 2787(2) 24(1) 
N(1) 1092(1) 5217(2) 2683(1) 16(1) 
N(2) 829(1) 8027(2) 2949(1) 16(1) 
Br(1) 263(1) 8207(1) 1312(1) 19(1) 
Pd(1) 742(1) 6602(1) 2011(1) 13(1) 
C(101) 3464(10) 7430(20) 4425(15) 27(3) 
C(102) 3500(30) 6250(80) 3850(40) 39(3) 
C(103) 2895(4) 9002(18) 4793(9) 27(2) 
C(104) 2454(5) 9590(20) 4602(11) 41(2) 
O(101) 3044(7) 8130(19) 4251(12) 23(2) 
O(102) 3120(1) 9330(5) 5350(3) 49(2) 
C(11') 3451(17) 7190(40) 4380(30) 34(5) 
C(12') 3490(40) 6210(130) 3810(70) 39(3) 
C(13') 3008(7) 9000(30) 4895(15) 35(4) 
C(14') 2566(8) 9680(30) 4759(16) 53(6) 




Table 74. Bond lengths [Å] and angles [°] for 213gaa. 
_____________________________________________________ 
C(1)-N(1)  1.509(3) 
C(1)-C(10)  1.523(3) 
C(1)-C(2)  1.550(3) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.555(3) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.506(3) 
C(3)-N(1)  1.515(3) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.395(3) 
C(4)-C(9)  1.411(3) 
C(5)-C(6)  1.395(4) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.394(4) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.395(4) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.393(3) 
C(8)-H(8)  0.9500 
C(9)-Pd(1)  1.974(2) 
C(10)-N(2)  1.490(3) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-N(2)  1.479(3) 
C(11)-C(12)  1.515(3) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-C(17)  1.393(4) 
C(12)-C(13)  1.394(4) 
C(13)-C(14)  1.388(4) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.383(4) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.379(4) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.392(4) 
C(16)-H(16)  0.9500 
C(17)-H(17)  0.9500 
C(18)-N(1)  1.479(3) 
C(18)-C(19)  1.509(3) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(19)-C(20)  1.390(4) 
C(19)-C(24)  1.393(4) 
C(20)-C(21)  1.387(4) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.386(4) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.379(4) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.395(4) 
C(23)-H(23)  0.9500 
C(24)-H(24)  0.9500 
N(1)-Pd(1)  2.0661(19) 
N(2)-Pd(1)  2.164(2) 
N(2)-H(2)  0.9300 
Br(1)-Pd(1)  2.4405(3) 
C(101)-O(101)  1.47(3) 
C(101)-C(102)  1.54(6) 
C(101)-H(11C)  0.9900 
C(101)-H(11D)  0.9900 
C(102)-H(12A)  0.9800 
C(102)-H(12B)  0.9800 
C(102)-H(12C)  0.9800 
C(103)-O(102)  1.229(13) 
C(103)-O(101)  1.36(3) 
C(103)-C(104)  1.483(12) 
C(104)-H(14A)  0.9800 
C(104)-H(14B)  0.9800 
C(104)-H(14C)  0.9800 
C(11')-C(12')  1.39(10) 
C(11')-O(11')  1.42(5) 
C(11')-H(11E)  0.9900 
C(11')-H(11F)  0.9900 
C(12')-H(12E)  0.9800 
C(12')-H(12F)  0.9800 
C(12')-H(12G)  0.9800 
C(13')-O(11')  1.44(5) 
C(13')-C(14')  1.51(2) 
C(13')-H(13A)  0.9900 
C(13')-H(13B)  0.9900 
C(14')-H(14D)  0.9800 
C(14')-H(14E)  0.9800 

























































































































































Table 75. Anisotropic displacement parameters (Å2x 103) for 213gaa. The anisotropic displacement factor exponent takes the form: -2 2[ 
h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 17(1)  19(1) 15(1)  3(1) -1(1)  0(1) 
C(2) 19(1)  22(1) 19(1)  4(1) 2(1)  -1(1) 
C(3) 15(1)  16(1) 22(1)  4(1) -1(1)  -1(1) 
C(4) 11(1)  17(1) 25(1)  -2(1) 1(1)  2(1) 
C(5) 18(1)  18(1) 29(1)  -1(1) -1(1)  1(1) 
C(6) 17(1)  22(1) 35(2)  -9(1) -1(1)  2(1) 
C(7) 16(1)  28(1) 22(1)  -9(1) -2(1)  4(1) 
C(8) 16(1)  22(1) 20(1)  -3(1) 0(1)  3(1) 
C(9) 12(1)  16(1) 19(1)  -2(1) 0(1)  2(1) 
C(10) 17(1)  21(1) 16(1)  -1(1) -2(1)  0(1) 
C(11) 20(1)  16(1) 18(1)  -2(1) 1(1)  -1(1) 
C(12) 22(1)  17(1) 19(1)  1(1) 0(1)  -1(1) 
C(13) 23(1)  24(1) 25(1)  -5(1) 3(1)  -3(1) 
C(14) 34(2)  26(1) 24(1)  -6(1) 6(1)  3(1) 
C(15) 39(2)  25(1) 24(1)  -8(1) -8(1)  0(1) 
C(16) 26(1)  29(2) 33(2)  -3(1) -7(1)  -7(1) 
C(17) 22(1)  24(1) 25(1)  -2(1) 1(1)  0(1) 
C(18) 14(1)  21(1) 24(1)  2(1) 0(1)  3(1) 
C(19) 13(1)  18(1) 24(1)  -2(1) 2(1)  4(1) 
C(20) 17(1)  25(1) 22(1)  -1(1) 2(1)  0(1) 
C(21) 25(1)  28(2) 32(2)  6(1) 4(1)  1(1) 
C(22) 21(1)  26(2) 51(2)  2(1) 6(1)  -5(1) 
C(23) 18(1)  31(2) 47(2)  -9(1) -4(1)  -2(1) 
C(24) 16(1)  28(1) 28(1)  -2(1) -2(1)  4(1) 
N(1) 13(1)  17(1) 17(1)  1(1) 0(1)  1(1) 
N(2) 16(1)  16(1) 16(1)  -2(1) 0(1)  0(1) 
Br(1) 20(1)  19(1) 18(1)  1(1) -2(1)  3(1) 
Pd(1) 13(1)  13(1) 14(1)  0(1) 0(1)  1(1) 
C(101) 21(4)  31(7) 28(4)  -8(5) -3(3)  -5(5) 
C(102) 38(5)  33(4) 46(7)  -3(4) 8(4)  -6(3) 
C(103) 29(5)  32(3) 18(4)  2(3) 0(3)  -6(4) 
C(104) 32(5)  43(5) 49(6)  4(4) 8(4)  10(4) 
O(101) 22(2)  24(5) 22(6)  5(4) -1(3)  -2(3) 
O(102) 55(3)  56(3) 35(3)  -13(2) -9(2)  6(2) 
C(11') 25(7)  33(12) 44(11)  4(6) 1(8)  -5(8) 
C(12') 38(5)  33(4) 46(7)  -3(4) 8(4)  -6(3) 
C(13') 41(11)  40(6) 25(8)  -8(5) -5(7)  -2(7) 
C(14') 51(13)  43(8) 66(15)  16(9) 35(9)  11(9) 






Table 76. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 213gaa. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 1159 5145 3851 20 
H(2A) 282 5431 3163 24 
H(2B) 441 4275 3788 24 
H(3) 913 3169 2932 21 
H(5) 437 1698 2026 26 
H(6) 222 1386 755 29 
H(7) 262 3254 -92 27 
H(8) 489 5445 331 23 
H(10A) 836 7456 4061 22 
H(10B) 1316 7458 3698 22 
H(11A) 953 9764 2345 21 
H(11B) 1390 8964 2613 21 
H(13) 536 10170 3842 29 
H(14) 637 11800 4807 33 
H(15) 1309 12963 4944 35 
H(16) 1888 12454 4139 36 
H(17) 1796 10785 3188 28 
H(18A) 1557 4155 2107 24 
H(18B) 1692 4424 2974 24 
H(20) 1582 6166 1209 26 
H(21) 1993 8080 820 34 
H(22) 2491 9139 1662 39 
H(23) 2573 8308 2893 38 
H(24) 2155 6401 3291 29 
H(2) 549 8337 3078 19 
H(11C) 3465 7060 4947 32 
H(11D) 3714 8091 4378 32 
H(12A) 3234 5681 3853 58 
H(12B) 3759 5668 3978 58 
H(12C) 3540 6640 3340 58 
H(14A) 2318 9941 5062 62 
H(14B) 2267 8858 4379 62 
H(14C) 2486 10345 4237 62 
H(11E) 3694 7869 4346 41 
H(11F) 3482 6711 4879 41 
H(12E) 3248 5534 3840 58 
H(12F) 3773 5726 3859 58 
H(12G) 3473 6680 3315 58 
H(13A) 3250 9675 4828 42 
H(13B) 3028 8619 5415 42 
H(14D) 2513 9787 4214 79 
H(14E) 2566 10601 5000 79 


































































































Symmetry transformations used to generate equivalent atoms:  
  








Table 78. Crystal data and structure refinement for (trans)-215d. 
Identification code  (trans)-215d 
Empirical formula  C24H23N5, 0.5(CHCl3) 
Formula weight  441.16 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 5.8473(6) Å = 90°. 
 b = 36.267(4) Å = 92.220(4)°. 
 c = 20.608(2) Å  = 90°. 
Volume 4366.9(8) Å3 
Z 8 
Density (calculated) 1.342 Mg/m3 





Crystal size 0.17 x 0.04 x 0.01 mm3 
Theta range for data collection 2.98 to 25.03°. 
Index ranges -6<=h<=6, -40<=k<=43, -24<=l<=24 
Reflections collected 21376 
Independent reflections 7487 [R(int) = 0.1189] 
Completeness to theta = 25.03° 97.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9974 and 0.9574 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7487 / 0 / 559 
Goodness-of-fit on F2 1.185 
Final R indices [I>2sigma(I)] R1 = 0.1380, wR2 = 0.2068 
R indices (all data) R1 = 0.2538, wR2 = 0.2569 
Largest diff. peak and hole 0.363 and -0.386 e.Å-3 
 
Notes: There are two crystallographically-independent molecules in the structure, with half a molecule of chloroform per molecule. 
The hydrogen atoms were fixed as riding models. 
 
Table 79. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for (trans)-215d.  U(eq) is defined as one third of 
the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 5936(14) 1118(2) 5741(4) 30(2) 
C(2) 7043(14) 730(2) 5668(4) 33(2) 
C(3) 9251(14) 804(2) 5321(4) 32(2) 
C(4) 8822(15) 1177(2) 4994(4) 34(2) 
C(5) 6612(15) 1729(2) 5289(5) 41(2) 
C(6) 8440(15) 2005(2) 5109(4) 35(2) 
C(7) 10068(17) 2111(3) 5579(5) 47(3) 
C(8) 11797(18) 2358(3) 5428(6) 54(3) 
C(9) 11939(18) 2492(3) 4797(5) 49(3) 
C(10) 10314(19) 2377(3) 4333(5) 52(3) 
C(11) 8568(17) 2134(3) 4481(5) 47(3) 
C(12) 8591(16) 349(2) 4386(4) 35(2) 
C(13) 10135(14) 172(2) 4010(4) 28(2) 
C(14) 9757(14) -47(2) 3407(4) 31(2) 
C(15) 7724(15) -242(2) 3303(4) 37(2) 
C(16) 7347(16) -453(2) 2750(5) 41(2) 
C(17) 9037(16) -470(2) 2285(4) 36(2) 
C(18) 11031(16) -281(3) 2389(4) 38(2) 
C(19) 11399(14) -69(2) 2945(4) 35(2) 
C(20) 5393(14) 1218(2) 6430(4) 30(2) 
C(21) 7028(15) 1184(2) 6935(4) 35(2) 
C(22) 6472(14) 1281(2) 7565(4) 36(2) 
C(23) 4279(16) 1409(2) 7655(5) 39(2) 
C(24) 3252(14) 1353(2) 6592(4) 32(2) 
N(1) 7647(11) 1377(2) 5502(3) 31(2) 
N(2) 9897(11) 522(2) 4841(3) 29(2) 
N(3) 12160(11) 457(2) 4769(4) 35(2) 
N(4) 12311(12) 247(2) 4259(4) 36(2) 
N(5) 2651(12) 1449(2) 7191(4) 38(2) 
C(101) 9192(15) 867(2) 1492(4) 33(2) 
C(102) 8134(14) 658(2) 900(4) 37(2) 




C(104) 6092(14) 543(2) 1874(4) 33(2) 
C(105) 8128(16) 968(3) 2628(4) 42(2) 
C(106) 6285(14) 1156(2) 2997(4) 31(2) 
C(107) 5990(16) 1538(3) 2950(4) 42(2) 
C(108) 4184(17) 1709(3) 3246(4) 46(3) 
C(109) 2666(16) 1506(3) 3593(4) 43(3) 
C(110) 2939(15) 1129(3) 3657(5) 44(3) 
C(111) 4704(16) 958(3) 3348(4) 38(2) 
C(112) 6367(14) -153(2) 828(4) 33(2) 
C(113) 4809(13) -431(2) 720(4) 30(2) 
C(114) 5181(14) -824(2) 609(4) 32(2) 
C(115) 7237(15) -952(3) 361(4) 39(2) 
C(116) 7585(16) -1326(3) 252(5) 43(2) 
C(117) 5881(16) -1576(3) 373(4) 43(2) 
C(118) 3861(16) -1457(3) 614(5) 45(3) 
C(119) 3501(15) -1083(3) 725(4) 38(2) 
C(120) 10058(14) 1251(3) 1358(4) 35(2) 
C(121) 12204(15) 1373(3) 1544(5) 43(3) 
C(122) 12835(16) 1733(3) 1422(5) 44(3) 
C(123) 11278(18) 1958(3) 1103(5) 51(3) 
C(124) 8598(15) 1507(2) 1047(5) 40(2) 
N(101) 7354(12) 888(2) 1958(3) 35(2) 
N(102) 5107(11) 154(2) 920(3) 30(2) 
N(103) 2854(11) 72(2) 865(3) 35(2) 
N(104) 2638(12) -281(2) 739(3) 38(2) 
N(105) 9147(14) 1853(2) 910(4) 50(2) 
C(201) 4925(15) 2829(3) 2558(5) 44(3) 
Cl(21) 5574(5) 2861(1) 3403(1) 70(1) 
Cl(22) 2034(4) 2723(1) 2420(2) 61(1) 
Cl(23) 6659(4) 2494(1) 2206(1) 55(1) 
________________________________________________________________________________ 
 
Table 80. Bond lengths [Å] and angles [°] for (trans)-215d. 
_____________________________________________________ 
C(1)-N(1)  1.470(10) 
C(1)-C(20)  1.510(11) 
C(1)-C(2)  1.560(11) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.525(11) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-N(2)  1.480(10) 
C(3)-C(4)  1.529(11) 
C(3)-H(3)  1.0000 
C(4)-N(1)  1.465(10) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(1)  1.472(10) 
C(5)-C(6)  1.520(12) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(11)  1.383(12) 
C(6)-C(7)  1.385(12) 
C(7)-C(8)  1.395(13) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.392(13) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.387(14) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.390(13) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-N(2)  1.342(10) 
C(12)-C(13)  1.371(11) 
C(12)-H(12)  0.9500 
C(13)-N(4)  1.380(10) 
C(13)-C(14)  1.486(12) 
C(14)-C(19)  1.379(11) 
C(14)-C(15)  1.391(11) 
C(15)-C(16)  1.386(12) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.404(12) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.363(12) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.392(12) 
C(18)-H(18)  0.9500 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.392(11) 
C(20)-C(24)  1.397(11) 
C(21)-C(22)  1.396(11) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.383(12) 
C(22)-H(22)  0.9500 
C(23)-N(5)  1.332(11) 
C(23)-H(23)  0.9500 
C(24)-N(5)  1.343(10) 
C(24)-H(24)  0.9500 
N(2)-N(3)  1.359(9) 
N(3)-N(4)  1.303(9) 
C(101)-N(101)  1.471(10) 
C(101)-C(120)  1.508(12) 
C(101)-C(102)  1.546(11) 
C(101)-H(101)  1.0000 
C(102)-C(103)  1.558(11) 
C(102)-H(10A)  0.9900 
C(102)-H(10B)  0.9900 




C(103)-C(104)  1.523(11) 
C(103)-H(103)  1.0000 
C(104)-N(101)  1.459(10) 
C(104)-H(10C)  0.9900 
C(104)-H(10D)  0.9900 
C(105)-N(101)  1.466(10) 
C(105)-C(106)  1.506(11) 
C(105)-H(10E)  0.9900 
C(105)-H(10F)  0.9900 
C(106)-C(107)  1.397(12) 
C(106)-C(111)  1.396(11) 
C(107)-C(108)  1.387(12) 
C(107)-H(107)  0.9500 
C(108)-C(109)  1.375(13) 
C(108)-H(108)  0.9500 
C(109)-C(110)  1.384(13) 
C(109)-H(109)  0.9500 
C(110)-C(111)  1.380(12) 
C(110)-H(110)  0.9500 
C(111)-H(111)  0.9500 
C(112)-N(102)  1.351(10) 
C(112)-C(113)  1.373(11) 
C(112)-H(112)  0.9500 
C(113)-N(104)  1.383(10) 
C(113)-C(114)  1.460(12) 
C(114)-C(119)  1.387(12) 
C(114)-C(115)  1.403(11) 
C(115)-C(116)  1.392(12) 
C(115)-H(115)  0.9500 
C(116)-C(117)  1.378(12) 
C(116)-H(116)  0.9500 
C(117)-C(118)  1.370(13) 
C(117)-H(117)  0.9500 
C(118)-C(119)  1.392(12) 
C(118)-H(118)  0.9500 
C(119)-H(119)  0.9500 
C(120)-C(121)  1.372(12) 
C(120)-C(124)  1.402(12) 
C(121)-C(122)  1.382(12) 
C(121)-H(121)  0.9500 
C(122)-C(123)  1.371(13) 
C(122)-H(122)  0.9500 
C(123)-N(105)  1.348(12) 
C(123)-H(123)  0.9500 
C(124)-N(105)  1.328(11) 
C(124)-H(124)  0.9500 
N(102)-N(103)  1.351(9) 
N(103)-N(104)  1.315(9) 
C(201)-Cl(22)  1.746(9) 
C(201)-Cl(23)  1.758(10) 
C(201)-Cl(21)  1.772(10) 

















































































































































































































Table 81. Anisotropic displacement parameters (Å2x 103) for (trans)-215d. The anisotropic displacement factor exponent takes the form: -2 2[ 
h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 30(5)  31(5) 31(5)  -2(4) 7(4)  -2(4) 
C(2) 39(5)  25(5) 35(5)  -8(4) 0(4)  1(4) 
C(3) 29(5)  34(6) 34(5)  3(4) 3(4)  -1(4) 
C(4) 36(5)  29(5) 36(5)  1(4) 13(4)  -2(4) 
C(5) 40(5)  29(6) 54(6)  6(5) 4(5)  2(4) 
C(6) 36(5)  26(5) 42(6)  6(4) 1(5)  13(4) 
C(7) 61(7)  36(6) 44(6)  13(5) -2(6)  4(5) 
C(8) 65(7)  25(6) 71(8)  -6(5) 8(6)  2(5) 
C(9) 62(7)  31(6) 56(7)  7(6) 19(6)  -6(5) 
C(10) 78(8)  36(6) 44(7)  4(5) 25(6)  11(6) 
C(11) 59(7)  41(6) 40(6)  7(5) 2(5)  -3(5) 
C(12) 43(6)  28(5) 33(5)  4(4) -6(5)  -8(4) 
C(13) 35(5)  27(5) 24(5)  3(4) 11(4)  -2(4) 
C(14) 23(5)  31(5) 39(6)  15(4) 3(4)  7(4) 
C(15) 42(6)  33(6) 38(6)  2(5) 17(5)  5(5) 
C(16) 37(5)  28(6) 57(7)  5(5) -7(5)  3(4) 
C(17) 49(6)  27(5) 30(5)  -3(4) -9(5)  14(5) 
C(18) 42(6)  41(6) 31(5)  4(5) 6(5)  11(5) 
C(19) 23(5)  36(6) 46(6)  0(5) 4(4)  -5(4) 
C(20) 29(5)  20(5) 39(6)  3(4) 8(4)  -2(4) 
C(21) 34(5)  37(6) 35(6)  2(5) 2(5)  9(4) 
C(22) 31(5)  41(6) 36(6)  -1(5) 0(4)  -3(4) 
C(23) 47(6)  24(5) 48(6)  -2(5) 7(5)  5(4) 
C(24) 36(5)  23(5) 38(6)  1(4) 2(4)  -1(4) 
N(1) 34(4)  24(4) 36(4)  5(3) 9(3)  -8(3) 
N(2) 29(4)  23(4) 35(4)  4(3) 1(3)  -2(3) 
N(3) 22(4)  31(4) 52(5)  1(4) 9(4)  6(3) 
N(4) 36(5)  25(4) 47(5)  -7(4) 8(4)  -1(3) 
N(5) 37(4)  45(5) 31(5)  -10(4) 5(4)  2(4) 
C(101) 35(5)  34(6) 30(5)  -2(4) 0(4)  2(4) 
C(102) 36(5)  33(6) 41(6)  2(5) -2(5)  6(4) 
C(103) 26(5)  25(5) 42(6)  -10(4) 3(4)  0(4) 
C(104) 27(5)  37(6) 36(6)  -1(4) 0(4)  -1(4) 
C(105) 43(6)  45(6) 39(6)  -11(5) 3(5)  4(5) 
C(106) 27(5)  37(6) 28(5)  -2(4) 4(4)  -3(4) 
C(107) 50(6)  36(6) 41(6)  -3(5) 7(5)  -2(5) 
C(108) 64(7)  34(6) 41(6)  -10(5) 2(5)  -1(5) 
C(109) 45(6)  48(7) 38(6)  -11(5) 18(5)  6(5) 
C(110) 36(6)  45(7) 49(6)  -7(5) 7(5)  0(5) 
C(111) 59(6)  30(5) 24(5)  3(4) -9(5)  -3(5) 
C(112) 22(5)  47(6) 30(5)  3(5) 3(4)  -1(4) 
C(113) 15(4)  35(6) 39(6)  -5(4) 4(4)  -6(4) 
C(114) 33(5)  41(6) 22(5)  -8(4) -1(4)  -3(4) 
C(115) 35(5)  45(6) 37(6)  -1(5) 11(5)  -8(5) 
C(116) 35(5)  35(6) 60(7)  -9(5) 1(5)  -8(5) 
C(117) 54(6)  34(6) 42(6)  -4(5) 4(5)  -4(5) 
C(118) 43(6)  44(7) 50(6)  7(5) 5(5)  -17(5) 
C(119) 28(5)  48(7) 38(6)  5(5) 0(4)  0(5) 
C(120) 29(5)  44(6) 34(5)  -2(5) 7(4)  12(5) 
C(121) 31(5)  39(6) 59(7)  -8(5) 7(5)  5(5) 
C(122) 38(6)  37(6) 58(7)  -13(5) 1(5)  2(5) 
C(123) 57(7)  27(6) 69(8)  -1(5) 10(6)  -15(5) 
C(124) 25(5)  30(6) 66(7)  -10(5) -2(5)  2(4) 
N(101) 32(4)  43(5) 29(4)  -5(4) 4(4)  -7(4) 
N(102) 20(4)  44(5) 26(4)  -5(4) 1(3)  -1(3) 
N(103) 28(4)  38(5) 39(5)  -10(4) 6(4)  -1(4) 
N(104) 30(4)  44(5) 39(5)  -9(4) 5(4)  -2(4) 
N(105) 43(5)  34(5) 73(6)  3(5) 2(5)  -4(4) 
C(201) 40(6)  33(6) 60(7)  -5(5) -2(5)  -16(5) 




Cl(22) 32(1)  51(2) 100(2)  -4(2) 6(1)  -3(1) 
Cl(23) 38(1)  45(2) 82(2)  -6(2) 6(1)  -2(1) 
______________________________________________________________________________ 
 
Table 82. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for (trans)-215d. 
_______________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 4510 1133 5459 36 
H(2A) 7371 616 6099 40 
H(2B) 6022 564 5408 40 
H(3) 10532 831 5653 39 
H(4A) 10274 1300 4888 40 
H(4B) 7841 1153 4594 40 
H(5A) 5707 1831 5643 49 
H(5B) 5561 1685 4909 49 
H(7) 10006 2016 6007 56 
H(8) 12879 2436 5756 65 
H(9) 13121 2658 4688 59 
H(10) 10396 2466 3901 62 
H(11) 7477 2058 4154 56 
H(12) 6970 349 4336 42 
H(15) 6578 -229 3617 45 
H(16) 5954 -586 2685 49 
H(17) 8793 -613 1902 43 
H(18) 12183 -294 2077 46 
H(19) 12796 63 3009 42 
H(21) 8516 1095 6852 43 
H(22) 7558 1260 7918 43 
H(23) 3903 1474 8085 47 
H(24) 2126 1378 6250 38 
H(101) 10478 717 1687 40 
H(10A) 9111 448 780 44 
H(10B) 7925 824 520 44 
H(103) 4572 701 992 37 
H(10C) 4599 553 2084 40 
H(10D) 6984 331 2050 40 
H(10E) 9497 1129 2625 51 
H(10F) 8568 735 2851 51 
H(107) 7034 1681 2713 51 
H(108) 3995 1969 3209 55 
H(109) 1424 1626 3789 52 
H(110) 1925 989 3909 52 
H(111) 4847 697 3375 45 
H(112) 7989 -172 836 39 
H(115) 8408 -781 267 47 
H(116) 9000 -1409 93 52 
H(117) 6106 -1831 290 52 
H(118) 2699 -1630 707 54 
H(119) 2078 -1004 884 45 
H(121) 13260 1210 1757 51 
H(122) 14306 1822 1557 53 
H(123) 11733 2203 1011 61 
H(124) 7095 1428 925 49 















































































































































4.3.2 General Remarks 
 
The datasets were measured on a Bruker CCD diffractometer at the window of a Bruker FR591 rotating 
anode. The data collections were driven by COLLECT
166
 and processed by DENZO.
167 
Absorption 
corrections were applied using SADABS.
168
 The structure was solved using ShelXS-97
169
 and refined by a 




 All non-hydrogen atoms were refined with 
anisotropic displacement parameters. All hydrogen atoms were added at calculated positions and refined by 
use of a riding model with isotropic displacement parameters based on the equivalent isotropic displacement 
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